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Abstract 
This thesis is about the politics and the possibilities of aetiology. 
Firstly, the possibilities. Does an infectious disease have one, single pathogenic cause or many, 
interacting causes? In the medical microbiologic"al sciences, there is no definitive answer, one way or 
another, to this question: there, the conditions of aetiological possibility exist in a curious tension. Ever 
since the birth of the 'germ theory of disease' and the concomitant birth of the singular aetiological 
object, these conditions have allowed for the co-existence of a very different, and far less well 
understood kind of object: the multifactoria/ object. That SARS was caused by one, singular viral agent, a 
coronavirus (CoV), is now entrenched as microbiological fact. And yet, the curious thing about SARS is 
that the history of the 2003 outbreak is littered with moments at which the possibility of the 
multifactorial object presented itself to, and was actively considered by, medical microbiologists. So how 
did we get here - to SARS-CoV, an infectious disease that could be understood and storied in this, the 
most singular of ways? And what happened along the way to deny the multifactorial aetiological object 
any kind of existence at all? In an attempt to grapple with these questions, the thesis seeks to recover 
the possibili!J of the multifactorial object through a deep, ethnomethodological reading of the moments 
at which it flared up precise/y as a possibili!J for medical microbiologists investigating the outbreak. What 
emerges from that recovery operation is a sense that the multifactorial object was never actually ruled 
out or disproved in any way, but rather, was vanished. Put another way, the suggestion is that various 
medical microbiological practices and interventions, whilst establishing singularity, were serving, at the 
same time, to create an illusion of multifactorality's non-existence; an illusion behind which the issue of 
multifactorality, its possibility, could be discarded without ever having to be resolved, one wqy or the other. 
In the closing sections of this thesis a move is made towards suggesting that SARS-Co V, the singular 
disease, was the product of a choice-, a choice that was made to explore one aetiological possibility at the 
expense of another. And that is where the politics comes in. For if politics, the realm of the political, 
can be taken to arise in situations where various possibilities exist but not all possibilities can be chosen, 
then it follows that what this thesis provides is an opportunity to foreground the politics bound up 
with the practical doing of aetiology. As a result, and based on the experience of attempting to recover 
the vanished multifactorial object from the 2003 SARS outbreak, the thesis concludes with an attempt 
to inhabit the present in such a way as to make it possible to think, in a little more detail, about where 
aetiology, as understood by medical microbiologists, might be heading in the future: might recent shifts 
in practical, everyday, seemingly innocuous microbiological technique, have begun to make it easier to 
coax the multifactorial object out into a spa<;e of visibility? Might those shifts actually herald the 
crossing of an epistemological threshold in the medical sciences? And might the conditions of 
aetiological possibility be changing, and changing in ways that would drastically alter what it meant to 
speak of a 'disease', an 'infection' and a 'pathogen'? 
Key Words: Severe acute respiratory syndrome (SARS), aetiology, conditions of possibilify, singular and 
multifactorial objects, medical microbiology, ethnomethodology, the scientific court of appeal, reasonable doubt. 
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1 
SARS-Co V as a 'normal' disease? 
Medical microbiology and the conditions of aetiological 
possibility 
HIV-AIDS, SARS-CoV, Pp-related illness, EBV-HPS.l In medical microbiology 
hyphens matter - and they matter because they point to a very distinctive shaping of 
microbial matter. Consider the label SARS-Co V, for example. On one side of the 
hyphen, a syndrome: severe acute respiratory syndrome (SARS). On the other side, a 
pathogen: a human coronavirus (CoV). But when we read of 'SARS-CoV', when the 
two entities have been sutured together in this way, we no longer flnd ourselves in the 
presence of a syndrome and a pathogen. For the total effect is now far more than the 
sum of its parts. SARS-Co V indexes a disease. An infectious disease. During the early 
weeks of the 2003 SARS outbreak, the fIrst appearance of this hyphen heralded the 
crossing of an epistemological threshold for the medical microbiological sciences. 
From that moment forth, practices of identifying, culturing, observing, probing, 
dissecting, neutralising, isolating, limiting, controlling, containing and diagnosing 
'SARS' would start to change, and change quite drastically. 
But how did 'severe acute respiratory syndrome' become 'severe acute respiratory 
syndrome caused by a hitherto unknown coronavirul? How did a syndrome, a vague, non-
speciflc set of bodily signs and symptoms become a disease, a precise, unitary object of 
medical knowledge? In this thesis my aim will be to develop an understanding of the 
conditions of possibility that structured the practical doing of aetiology by medical 
micro biologists during the SARS outbreak. 2 Whilst pursuing this aim, however, I will 
also be hoping to do something with a little more critical intent. Put simply, I will be 
looking for a politics; a politics that was bound up with the practical doing of aetiology 
as a medical microbiological activity. In this introductory chapter my task will be to try 
and unpack these aims, explaining in a little more detail why they should prove to be 
capable of generating an interesting study of aetiology, a biomedical terrain that has, 
to date, received little sociological attention.3 The first section of the chapter provides 
some tentative and provisional defmitions of important terms, before moving to detail 
the specific research problem to be addressed. To achieve the latter task, it seeks to 
story the way in which we got here - to SARS-Co V, an infectious disease that could be 
presented in this particular way, as something of a curiosiry, or perhaps more accurately, 
as something of a puz:de. The second, much shorter section, presents the tesearch 
questions that will be deployed in order to grapple with, if not entirely to answer, this 
puzzle. 
I. THE CONDITIONS OF AETIOLOGICAL POSSIBILITY 
As a concept aetiology can perhaps be defined as the study of disease causation. But 
during March and April 2003, as an infectious syndrome of unknown cause and high 
'attack rate', 'reproductive rate' and 'mortality rate' began to spread around the world, 
aetiology was something that had to be done, and done quickly, in and as practice, by 
medical microbiologists. 4 Considered as such, 'aetio~ogy' could never be captured 
under such a coherent conceptual label. In the case of SARS it was a 'one-off, unique 
to the disease-event in question, and involving a whole complex of epistemic activities 
- sampling, culturing, isolating, purifying, id~ntifying, analysing (at a molecular level), 
retrospective diagnostic testing, polymerase chain reaction (PCR) kit primer 
development, blotting, observing, public presentation, proving, animal testing, writing, 
arguing and so on - that eventually came to be associated with the generation of a new 
aetiological object. the SARS coronavirus (SARS-Co V). 5 For medical practitioners 
working with patients on the 'front-line' of the outbreak, it was a vitally important 
object. Consider, for instance, the issue of diagnosis. Prior to the generation of SARS-
Co V clinicians had only bodily signs and symptoms to go on during attempts to 
diagnose 'SARS,.6 And, as many of them were later to recount, this made any kind of 
diagnostic specificiry virtually unachievable: 
It is virtually impossible to conf1m1 SARS at the primary care setting ... a diagnosis 
based on clinical criteria alone is almost impossible. (Rain er 2004, 82) 
Clinical symptoms are rather non-specific and may be due to influenza or other causes 
of atypical pneumonia, such as Mycoplasma, Chlamydia and Legionella ... There are no 
specific radiographic features that can reliably distinguish bacterial from non-bacterial 
causes of pneumonia. The radiographic appearances of SARS, indeed, share common 
features with other causes of pneumonia. (Hui 2004, 56-57)7 
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The radiographic appearance of peripheral air-space OpaCities in SARS is 
indistinguishable from other causes of atypical pneumonia such as Mycoplasma, 
Chlamydia, and Legionella and overlap with other types of viral pneumonia in adults. 
(Wong et al. 2004,405) 
This lack of specificity stemmed from the fact that SARS, as a pneumonia-like illness 
was, medically speaking, unremarkable. 8 As Dr. Trinh Huan, Director of Preventative 
Medicine at the Vietnamese Ministry of Health, was to note at a World Health 
Organisation (WHO) convened press conference on 26th March: 
As a doctor in the field, or a nurse, or a primary health care worker, you can't just look 
at the patient and say 'this is SARS'. SARS looks like lots of other things. (WHO 2003t) 
But with the WHO's 16th April announcement that 'the disease called SARS is being 
caused by a coronavirus' (WHO 2003m), things started to change. For if SARS looked 
like a lot of other things, SARS-Co V did not. The hyphen marked a definite 
intervention within the medical field of perception. Gradually, as laboratory diagnostic 
tests were developed it became possible for clinicians to visualise a patient not as. a 
surface, but rather, as a depth. No longer the (often futile) attempts to piece together a 
SARS diagnosis from various non-specific clinical and radiographic signs and 
symptoms. With the aid of the laboratory those signs and symptoms could now be 
understood as mere aspects of the disease; aspects that surfaced; manifestations of a 
deeper, underlying aetiological object that lurked within that patient's bodily tissues. 
With the discovery of the object SARS-CoV at the level of the laboratory, certainty 
began to displace doubt: the diagnostic ability to say 'this is SARS' was born:9 
1. 'This is SARS' = SARS-Co V detection by laboratory methods. 
2. 'This is non-SARS' = non SARS-Co V detection by laboratory methods = possibility 
of 1v1ycoplasma, Chlamydia or Legionella infection. 
But what now of the 'conditions of possibility'; the conditions I am suggesting 
'structured the doing of aetiology during the SARS outbreak'? What is this phrase 
intended to suggest? I have to be careful here, for I want this term to act not as a 
concept, but rather as an ethnomethodological policy, as something that, once introduced, 
will start to dissolve, silendy and without much· fanfare, into the very structuring of 
the arguments, discussions, analyses and interrogations that follow. 10 So, a brief 
definition; one that draws on a section of John Law's After Method: mess in social science 
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research (2004). Therein, under the heading 'A note on Foucault: limits to the 
conditions of possibility', it is suggested that: 
Apparatuses of scientific ... production produce something akin to what Michel 
Foucault described as the conditions of possibility. If we go with the economic 
metaphor then they set necessary limits - more or less permeable, but nevertheless 
limits - to those conditions. (ibid., 35 my emphasis) 
For now I want to let this stand as a usefully abstract definition of the 'conditions of 
possibility'. Working alongside it, I want to suggest that I am after two things here in 
this thesis. The first is an understanding of the necessary limits that structured the doing 
of aetiology during the 2003 SARS outbreak; an understanding ~f the kinds of objects 
that apparatuses of microbiological production made possible and, by implication, the 
kinds of objects that they made impossible. 
And the second thing? 
The second thing is the politics of it all; the choices that shaped those necessary limits 
during 2003, and, perhaps most interestingly, the choices that might come to shape 
those limits in the future. 
Dr. Stohr's singular normality: the necessary limits of medical microbiology? 
But how to try and locate those necessary limits? 
Amongst the various chapters collected together in the edited volume Learningfmm 
JARS: Preparingfor the next disease outbreak (Mahmoud et aL 2004) there is one entitled 
'The World Health Organisation response to SARS and preparations for the future' 
(MacKenzie et aL 2004). It is as useful a starting point as any here. l1 Authored bya 
research group from the WHO's Global Outbreak Alert and Response Network 
(GOARN), it tells of the 'unprecedented multifaceted, multilateral, and 
multidisciplinary response' that was mounted during the early months of 2003 as 
SARS 'moved into the spotlight of intense global concern' (ibid., 44). SARS, it 
suggests, was 'initially recognised as a global threat in mid-March 2003, and was 
successfully contained in less than 4 months largely because of an unprecedented level 
of international collaboration and cooperation'. And, as the chapter goes on to 
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suggest, much of that collaboration and cooperation was 'facilitated' and 'coordinated' 
by the WHO (ibid., 42): 
The management of the global SARS response involved intense daily coordination in 
the areas of aetiology and laboratory diagnosis, surveillance and epidemiology, clinical 
issues, animal sources, and field operations. (ibid.) 
WHO Regional Offices, 'working through a worldwide network of Country Offices 
and inter country networks', were the 'main channels for support to affected 
countries': 
While the six WHO Regional Offices were fully engaged in the global coordination of 
the SARS response, the WHO Western Pacific Regional Office - covering the area 
where the vast majority of cases were occurring - bore the brunt of the response, 
deploying a total of 116 additional experts as short-term consultants during the 
outbreak. At WHO headquarters, 75 people worked on the SARS outbreak response, 
with additional surge capacity provided by partners in the GOARN. (ibid., 45) 
Indeed it seems that GOARN, the network for which the article's authors worked 
during the outbreak, played a particularly important part in organising the 'aetiology 
and laboratory' response: 
Through GOARN, WHO coordinated development of a number of networks that 
proved pivotal in developing tools and standards for containment of the epidemic. The 
networks met regularly by teleconference, usually on a daily basis, to share information 
and data in real time. (ibid., 46) 
The article then goes on to detail the main functions of the clinical and epidemiological 
networks that GOARN helped to set up and establish. But here, it is the third 
network, the laboratory network, which will prove to be of most interest: 
The laboratory network was established to assist with identifying the aetiologic agent of 
SARS and to develop specific and robust laboratory diagnostic tests for the agent 
responsible. The network comprised members of the international influenza laboratory 
network in those countries in which cases of SARS had been reported. Thus a total of 
11 expert laboratories in nine countries were included in the network. (ibid., 45) 
By 25th March, severe acute respiratory syndrome, or SARS as it came to be known, 
had developed into an emerging epidemic of global significance. It was on that same 
day that the co-ordinator of the WHO's outbreak-response team, Dr. Klaus Stohr, 
gave a press conference detailing the latest laboratory findings on SARS. Reading 
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from a prepared statement he reminded the journalists gathered at the WHO's 
headquarters in Geneva how: 
Eight days ago, WHO established a network of 11 laboratories in 9 countries. We 
invited these laboratories to participate in this collaborative effort to help identify the 
causative agent of [SARS] ... Now, 8 days later, these 11 laboratories in these 9 
countries have found already two very strong contenders, two viruses which are 
consistently isolated from many patients from very many different countries. (WHO 
2003d, para. 4) 
The two VltUses to which St6hr referred were, respectively, a human 
metapneumovirus (henceforth hMPV) from the family Paramyxovirus and the order 
Nidovirales, and a coronavirus of the family Coronaviridae and the order 
Mononegavirales. 
But for St6hr, and indeed for the members of the laboratory network whom he 
sought to represent during that press conference, these were not deemed to be 
aetiologically significant findings. The fact that more than one virus had been 
identified was something that, in their opinion, had to be worked through. It was, in 
other words, litde more than interference. Noise. Stohr's metaphoric reference to 'two 
very strong contenders' in the extract above already seems to be hinting at the 
laboratory network's belief in some kind of final singularity-to-come. But there is no 
need for any deep rhetorical analysis here. For as St6hr went on to confess during that 
same conference, 'we are all a bit puzzled by these results' (ibid. para. 16). And the 
'puzzlement' of this collective 'we' stemmed from the fact that: 
It is not normal that one disease is caused by two viruses' (ibid. para. 5 my emphasis). 
As a result of what was, by implication, an 'abnormal' situation; a situation in which 
two viruses were consistendy being isolated from patient samples, 'research was 
ongoing' and 'laboratories would have to strengthen their research activities' (ibid.).12 
The first indications that SARS was a 'normal' rather than an 'abnormal' disease were 
not long in coming. Indeed, with remarkable rapidity the hMPV findings were 
forgotten, and a consensus began to build around the aetiological significance of Co V 
and Co V alone. The denouement to this tale of aetiological discovery came soon 
afterwards, at the afore-mentioned 16th April press conference. Many of the scientists 
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from the network's eleven research institutes joined Stehr on the panel for this 
particular conference. In his opening statement, Stehr made clear that 'all the data 
have been put on the table, have been reviewed, and the colleagues have come to a 
consensus agreement' (WHO 2003m, para. 3). The consensus agreement, as he went 
on to note, meant that 'we can now, with all confidence, say that the causative agent 
of SARS is the coronavirus first detected in Hong Kong on 21 st March 2003' (ibid. 
para. 8). 'The conclusion today,' as Dr. Albert Osterhaus, a member of the 
Netherlands group added later on during a question and answer session was that 'the 
coronavirus alone was capable of causing the typical symptoms [of SARS], (ibid. para. 
27 my emphasis). 
'It is not normal that one disease should have two causes ... ' 
What to make of such a statement? 
Certainly what I want to suggest we see here in Stehr's normality is the silent, 
structuring influence of 'the germ theory of disease'. Consider, for instance, what 
Sarah Nettleton has written in relation to this theory and its relationship to 'medicine 
and the biomedical model' (2006, 2-3): 
Modem Western medicine rests upon what has become known as the biomedical 
model. This model is based on five assumptions. First, that the mind and the body can 
be treated separately ... second, that the body can be repaired like a machine; thus 
medicine adopts a mechanical metaphor, presuming that doctors can act like engineers 
to mend that which is dysfunctioning ... third, and consequently, the merits of 
technological interventions are sometimes overplayed, which results in medicine 
adopting a technological imperative. Fourth, biomedicine is reductionist, in that 
explanations of disease focus on biological changes to the relative neglect of social and 
psychological factors. Finally, such reductionism was accentuated by the development 
of the germ theory of disease in the nineteenth century which assumed that every 
disease was caused by a specific identifiable agent - namely a 'disease entity' (such as a 
parasite. virus or bacterium). This is referred to as the doctrine of specific aetiology. 
(ibid., 2 my emphasis) 
Re-considered in this light, St6hr's words might perhaps suggest that very little has 
changed aetiologically since the nineteenth century. Indeed Stehr's normality, his 
'principle of one disease has one cause', is frequently described 'as the cornerstone of 
contemporary biomedicine' (Epstein 1996, 57). 'In this paradigm', as Brandt (1985) 
describes it, 'individuals become infected with a parasite that causes dysfunction of 
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some sort; disease is defined as a deviation from a biological norm. Social conditions, 
environmental phenomena, and other variables are generally discounted as causes of 
disease. The physician dispenses "magic bullets" that restore the patient to health' 
(ibid., 4 my emphasis). 
A theory as normality? Familiarity, it would seem, has bred, if not contempt, than at the 
very least, a degree of apathy in the medical microbiological sciences. In the century 
that has elapsed since Robert Koch, Louis Pasteur and others waged their 
monomorphic battles against the pleomorphism that held sway in so much of the 
European medical establishment, the doctrine of specific aetiology seems to have 
become so well established, so medically constructive, that it has become, literally, un-
remarkable.13 That one disease had one pathogenic cause was simply a matter of cold, 
hard, uncontroversial biomedical fact for Dr. Stohr. Indeed, given the isomorphism 
on display during the SARS outbreak between a pre-established theoretical normality -
one disease has one cause - and a subsequently discovered empirical normality - one 
disease (SARS) has one cause (a coronavirus) - it might initially appear as if we had 
stumbled upon the present conditions of possibility within contemporary medical 
microbiology; as if the doctrine had somehow placed limits, 'necessary limits' as it 
were, upon the kind of aetiological objects that medi~al microbiologists could 
generate. 
Essence and Process 
But if these are the conditions of possibility; if this episode has now gone cold, then 
surely, there would be very little to dispute from a sociological point of view. As 
Bruno Latour (1987) has counselled, for instance: 
When talking about a cold part of technoscience [or even biomedical science] we should 
shift out method like the scientists themselves who, from hard-core relativists have 
turned into dyed-in-the-wool realists. Nature is now taken as the cause of accurate 
descriptions of herself. We cannot be more relativist than scientists about these parts 
and keep on denying evidence where no one else does. Why? Because the cost of 
dispute is too high for an average citizen. even if he or she is a historian or sociologist 
of science .... Nature talks straight, facts are facts. Full stop. There is nothing to add and 
nothing to subtract. (ibid., 100 my emphasis) 
Yet at this juncture, and bearing in mind Dr. Stohr's specific choice of words, it is 
perhaps worth recalling the well-rehearsed sociological point that the normal and, by 
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implication, the abnormal, are always indexical entities.14 So what happens if, enthused 
by this point, one seeks to ignore Latour's counsel? What happens if Dr. St6hr's 
formulation is explored in just a little more detail; if it is treated with a little less 
respect and a little' more of the symmetrist's scepticism? 15 Put simply, St6hr's 
seemingly solid, seemingly unquestionable normality starts to appear a little shakier, 
and a little more questionable than his rhetoric would perhaps care to recognise. 
Indeed, the greater the dose of scepticism administered, the less like an 'avet;age 
citizen', standing alone and bereft of any medical microbiological allies, one starts to 
feel. Why? Because the 'abnormality' Dr. St6hr so casually sought to dismiss - the idea 
that one disease might actually have more than one cause - is in fact a 'normality' when 
considered from a slightly different microbiological perspective. 
The 'germ theory of disease', it would seem, is not quite so monolithic a theory as it 
sometimes appears when glossed in contemporary medical textbooks. Consider, for 
example, Penn and Dworkin's article 'Robert Koch and Two Visions of Microbiology' 
(1976). Therein, they suggest that: 
Emerging alongside the Kochian tradition in 19th century microbiology, was another 
competing, distinctive, and less conspicuous tradition associated with the name of 
Sergei Winogradsky. (ibid., 276) 
Did both 'traditions' accept that bacterial forms were fixed and immutable? Yes. Did 
both traditions accept that germs were pathogenic forms? Yes. And yet, nevertheless, 
what Penn and Dworkin suggest we see here in these 'competing' traditions is 'the rise 
of two distinctive modes of microbiological thought' (ibid.): on the one hand, a 
Kochian tradition - which they refer to as the 'essentialist mode' - and, on the other 
hand, a Winogradskian tradition - which they refer to as the 'processual mode' (ibid.):16 
By 'essentialist' we mean, roughly, the view that conceived of microbial cells as 
independent entities possessing an intrinsic anatomic and physiological scenario, 
knowledge of which would be adequate for an understanding of their behaviour. The 
'processual' view, in contrast, emphasised process and sequential' interaction as a 
persistent feature of microbial phenomena. In this view, furthermore, single cells are 
always located in cell populations, and their physical and chemical properties derive, 
accordingly, from various interactive processes within the population. (ibid., 279-280) 
Robert Koch and the 'essentialist' medical microbiological school that he founded, 
'advanced two separate but related criteria' establishing the reality of singular 
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aetiological objects. 17 The first of those criteria was the existence of 'fixed and 
immutable bacterial species' (ibid., 280). But in addition to the notion of 
morphological identity came the suggestion that 'a causal bond held between 
differentiable pathogens and specific diseases' (ibid.). Coupled together in this way, 
they were criteria that enabled Koch to envisage medical microbiology as a discipline 
of singu/ariry; a discipline that would seek to isolate distinct species of bacteria, and 
thus, in doing so, isolate distinct, and very singular, aetiological objects. 
Winodgradsky's 'processual' oudook, on the other hand, led him to a very different 
conception of bacterial life. Whereas Koch based his account upon the morphological 
form of individually existing pathogens, Winogradsky based his study upon interaction 
between various different rypes of pathogen. It is true, of course, that like Koch he believed 
that the orderly investigation of bacteria required the idea of stable species. But 
whereas . from Koch's standpoint microbial 'form' amounted to 'a generalised 
description of specific and invariant varieties of microbes', it was, for Winogradsky, a 
convenient designation for 'intricately different constellations of microbes 
competitively adapting to varying environmental conditions' (ibid., 281). And thus, 
whilst Koch could come to suggest that a universal, standardised, 'one size fits all' 
gelatin culture would suffice as a tool with which to isolate and to grow those 
invariant, singular microbes in vivo, Winogradsky could not. For if 'microbial functions 
in nature are governed by competition for energy resources', then: 
The method for investigation of actual processes mediated by microbes in nature 
should be based on the study of microbial communities as a whole, in nature, rather 
than on the study of species isolated from nature. (Winogradsky 1952a, 789 cited in 
Zavarzin 2006, 506) 
Koch's pure gelatin culture method, in other words, was un-natural to Winogradsky: 
We cannot register all [pure-culture] isolated species as natural ones, identical to their 
wild prototypes, because it is probable that they are mere ecological species whose 
properties depend on nutrient conditions. In short. they may be artifacts. (Winogradsky 
1952b, 128 cited in ibid., 505 my emphasis) 
For Winogradsky, 'wild' bacteria had to be viewed not as static entities, but in 
developmental terms; as interactive in contrast to the essentialist mode of Koch. Seen 
from such a perspective, medical microbiology was a discipline of mu/tip/iciry; a 
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discipline centrally concerned with the kind of objects that Koch would have 
understood to be ill-disciplined. Perhaps the deep philosophical difference separating 
these two microbiologists can best be captured in the difference between a Kochian 
'grouping' and a Winogradskian 'biotype'. Writing of his identification of 'distinct 
bacteric forms' during a study of various traumatic infective diseases, for instance, 
Koch could note how: 
The differences between these bacteria are as great as could be expected between 
particles which border on the invisible. With regard to these differences, I refer not 
only to the size and form of bacteria, but also to the conditions of their growth, which 
can best be recognised by observing their situation and grouping. I therefore study not 
only the individual alone, but the whole group of bacteria, and would, for example, 
consider a micrococcus which in one species of animal occurred only in masses (i.e., in 
a zooglea form), as different from another which in the same variety of animal, under 
the same conditions of life, was only met with as isolated individuals. (Koch [1880]1961, 
97) 
As this extract unfolds, it becomes clear that Koch's conception of a 'grouping' of 
bacteria was precisely that of his isolated, individual bacterium clustered together with 
others of the same species. A clonal grouping. In Winogradsky's work, however, a 
'biotype' came to appear as something akin to a Deleuzian assemblage, or, better still, 
a Whiteheadian event. 18 'Nature', for Winogradsky, was not made up of singular 
things. On the contrary, singular pathogens were always located in cell populations, 
with their physical and chemical properties deriving, accordingly, from various 
interactive processes within the population. Within a biotype, process and sequential 
change were persistent features of microbial phenomena. Under natural conditions, in 
situ as it were, microorganisms lived in communities; communities in which 
cooperation and competition were characteristic and interactions between pathogenic 
organisms were extremely complex. Competition was the key 'natural' phenomenon 
for Winogradsky. The chemical activities of a pathogenic organism depended upon its 
complex and varied relationships with other organisms. As he noted in one of his 
major philosophical expositions, because 'the great majority of microbes are found in 
nature and carry out their normal activities not in pure cultures, but in mixed 
populations', microbiologists seeking an understanding of microbial life in 'nature' 
would need 'to see the microbe in question, engaged in the life contest with other 
microbes. (Winogradsky 1952a, 344 cited in Zavarzin 2006,508) 
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For Koch, the differentiating characteristics of solitary organisms and the physically 
and physiologically independent pathogen; for Winogradsky the associative 
dependencies of a mixed population and their communal interrelations. Aetiologically, 
the differences between these two 'visions of microbiology' were profound. Under the 
essentialist assumptions of Koch, aetiological objects were to be envisaged as singular, 
pure and distinct, whilst under the processual assumptions of Winogradsky, they were 
to appear as multiple, impure and interactive. The singular ... and the multiple. 
The singular and the multiple: a tale of co-existence 
But might not the fact that Stahr was able to trope the co-presence of coronavirus 
and human metapneumovirus in patient samples as 'abnormal' simply suggest that 
Winogradsky's processual understanding of aetiology had long since been placed 
outside the limits of the present conditions of possibility in medical microbiology? 
Certainly, it is true that some microbiologists do dismiss the possibility of the 
multifactorial object as a symptom of a lack of knowledge; of a failure to narrow 
things down properly and to get at which one of the multiple pathogens in question 
during a particular investigation is aetiologically culpable. As Kuller (1987) has written, 
for example: 
The concept of multifactorial aetiology of many diseases may be a measure of our 
ignorance of causality rather than a biological principle. (ibid., 364) 
There, the multifactorial object is an epistemological obstacle; pre-scientific; 
something in need of destruction. So perhaps Stahr's identification of co-factors really 
was, theoretically speaking, meaningless? If so, then there would be little for a 
sociologist like myself to dispute. Once again I would be alone, an 'average citizen', 
bereft of any living medical microbiological allies and lurking around in science's 
backyard as little more than a sociological laughing stock.19 
And yet, thankfully, things are °not quite so simple. For just as with the 'homogenous' 
and the 'heterogeneous' in Bataille's psychological description of 'society' ([1979] 1997), 
the singular and the multiple are actually locked together. Inextricably entwined, they 
co-exist. Ever since the birth of the 'germ theory of disease' and the concomitant birth 
of the singular aetiological object, the multifactorial object has always been present as a 
possibi/i(y within the discipline of medical microbiology. To get at the peculiarity of this 
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co-existence, it is worthwhile re-considering the passage cited above from Netdeton's 
The Sociology of Health and Illness (2006): 
The germ theory of disease in the nineteenth century assumed that every disease was 
caused by a specific identifiable agent - namely a 'disease entity' (such as a parasite, 
virus of bacterium). This is referred to as the doctrine of specific aetiology. (ibid., 2-3 
my emphasis) 
'The doctrine of specific aetiology': the phrase so often used to describe the 
conditions of possibility currendy structuring the discipline of medical microbiology. 
As with any medical or scientific phrase, however, the closer you get to it, the murkier 
things become: stability vanishes; divergences, inconsistencies and contradictions 
abound.20 Indeed, the irony here is that Rene Dubos, the French microbiologist who 
first coined the phrase in his Mirage of Health: Utopias, Progress, and Biological Change 
([1959] 1996), intended it in a pejorative rather than a celebratory sense. For as with his 
predecessor, Sergei Winogradsky, and as with his contemporaries, microbiologists like 
Thomas Rivers and Frederick Shope, he held to a multifactorial understanding of 
aetiological objects.21 
Ostensibly written as an introduction to the idea of medicine as a social science, 
Dubos used Mirage of Health to develop what can best be described as a general 
philosophy of life. In one chapter therein, 'Environment and Disease', he paused to 
ask the following question: is the doctrine of specific aetiology still a useful aid for 
studies of disease causation in humans (ibid., 95-128)? Initially, it is true, he appears to 
be suggesting that, yes, it is. 'Unquestionably' he writes, 'the doctrine of specific 
aetiology had been the most constructive force in medical research for almost a 
century' (ibid., 102). It had achieved 'spectacular successes and gained almost 
universal acceptance in medicine' (ibid., 118). Indeed, the 'theoretical and practical 
achievements to which it has led [now] constitute the bulk of modern medicine'. 
'Louis Pasteur, Robert Koch, and their followers' had 'shown by laboratory 
experiments that disease could be produced at will by the mere artifice of introducing 
a single specific factor - a virulent microorganism - into a healthy animal' (ibid., 
101).22 It is also true that such comments might not have seemed at all out of place in 
1959. For western medical practitioners like Dubos, the 1950s and 1960s were a time 
of great optimism. The doctrine's 'spectacular successes', its previous 'practical and 
theoretical achievements', had created a climate in which it was by no means 
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impossible to dream of a time, perhaps a time not too far distant, when all but the 
most insignificant of infectious diseases would have been conquered. Dr. Salk's mass 
experimental polio vaccinations, stretching from 1955 to 1967, not only made the 
might of modem biomedicine witnessable to all during this period - reducing cases in 
America, year by year, from 76,000 to 1,000 - but also served to strengthen, to make 
plausible, those medical dreams. Indeed by 1967 the U.S. Surgeon General, William H. 
Stewart, would be so convinced of imminent success in the fight against infectious 
diseases, that he would tell a White House gathering of state and territorial health 
officers that it was time to 'close the book' on infectious disease research. All national 
attention was now to be re-directed towards understanding what he termed 'the new 
dimensions' of health: chronic disease. 23 
But Dubos was no optimist. The closure envisaged by Stewart was for him little more 
than a mirage. A singular mirage. Whether knowingly or not, Dubos suggested, those 
who believed such a closure to be at all possible were in thrall to an Aristotelian 
philosophy of life. There, 'the affairs of man [sic.] and the external environment' were 
held to be separable, with any interplay between the two controllable, in the final 
instance, by 'man' (ibid., 77). For Dubos, this was hubris. The interplay was not so 
much pure and controllable as processual and unpredictable. As with Winogradsky, 
Dubos saw in life only impurity; a co-implication of human, bacterial and viral 
existence; a mutual immersion in the conditions of each other's evolution. 24 If 
Stewart's book had existed, then for Dubos the hand seeking to close it would forever 
have been teeming with pathogenic life. This was why his initial eulogy to the doctrine 
of specific aetiology was merely the prelude to a scathing attack. The doctrine, he 
suggested, had become more of a hindrance than a help in the quest to understand 
infectious diseases. 'Few are the cases in which it has provided a complete account of 
the causation of disease'. 'Despite frantic efforts' he pointed out, 'the causes of many 
diseases remain undiscovered'. And whilst 'it is generally assumed that these failures 
are due to technical difficulties', in reality, 'the search for the cause may be a hopeless 
pursuit because most disease states are the indirect outcome of a constellation of circumstances 
rather than the direct result of single determinant factor! ([1959] 1996, 102 my emphasis). The 
influence of Winogradsky' processual vision of aetiological objects is also palpable as, 
during a later work, Man, Medicine and Environment (1968), he goes on to note how 
these problems stemmed from the doctrine's 'artificiality': 'specificity' was 'much less 
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readily demonstrated in natural clinical situations that in experimental laboratory 
models' (ibid., 106). To capture natural aetiology 'a new formulation of aetiological 
theory' was needed (ibid., 108). And for him, only a multifactorial understanding of 
causation would be able to 'bring scientific understanding a litde nearer to the 
complexities of the real world'. 'Multifactorial aetiology', he suggested, was 'the rule 
rather than the exception' (ibid., 109).25 
The co-existence of the multifactorial and the singular could be foregrounded in any 
number of sites, be they texts, reviews, conference papers, or archives. But as one 
final example, I want to focus upon a site a litde closer to the present: a chapter 
entided 'Diseases of unknown aetiology: the role of infectious agents' (Fredricks 2004) 
and included within the edited textbook Infectious Diseases (Cohen and Powderly 2006). 
Therein, under the sub-heading 'elusive associations and hidden pathogens', it is 
noted that 'there are several reasons why microbe-disease associations may be missed'. 
And one of those reasons is presented as follows: 
Diseases may result from pathogenic microbial communities. Failure to identify all co-
pathogens in the community will lead to spurious conclusions about disease causation. 
We are familiar with the paradigm in which each disease is caused by a single microbe. 
What if disease required the interaction of several microbes? In this setting, 
identification of a single pathogen may not reliably predict disease. (ibid., 95) 
Perhaps even more importandy, a number of examples of multifactorial diseases are 
then listed in order to illustrate the point: 
The synergtstlc interaction between hepatitis D virus and hepatitis B virus is an 
example of this interaction. Hepatitis D virus is a defective virus that requires hepatitis 
B surface antigen for infectivity. Patients who have chronic stable hepatitis B infection 
can develop fulminant hepatitis after co-infection with hepatitis D. Bacterial 
communities may also cause disease. Periodontitis is a disease that has been linked to 
particular assemblages of pathogenic bacteria at the tooth surface. Some 
gastrointestinal disease may be caused by aberrant microbial communities, including 
ulcerative colitis and Crohn's 'disease. (ibid.) 
The 2003 SARS outbreak and the possibility of the multifactorial object 
But even if the conditions of possibility were in this tension; even if they had allowed 
for the co-existence of two ways of doing aetiology within their 'necessary limits', it 
does not necessarily follow that there was any evidence to indicate the possibility of a 
multifactorial object during the SARS outbreak. Of course, there were Dr. Stohr's 
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comments at the 25th March press conference in relation to the co-presence of human 
metapneumovirus and coronavirus in patient samples. But might they not simply have 
been anomalous results? 
I would suggest not. For the curious thing about the SARS outbreak is that despite 
the fact that it eventually came to stand as SARS-Co V, a purely singular disease 
outbreak, its history is littered with moments at which the possibility of the 
multifactorial object presented itself. Consider, fIrstly, the sheer number of other co-
factorial discoveries that were made as 'probable SARS' case samples were subjected 
to laboratory testing.26 In the cohorts from which samples were taken and then used . 
in order to perform continuous cell-line culturing, for instance, the percentage fIgure 
that kept cropping up for co-infected cases was never lower than 2 - 3%, but actually 
went as high as 23% in one cohort from Hong Kong (Lee et aL 2004), 44% in a 
cohort from Canada (poutanen et aL 2003), and 100% in another cohort from 
Guangdong Province, China (Hong et aL 2003). In research articles that dealt with 
outbreaks in Hong Kong, Canada, Singapore, and Vietnam during the fIrst few weeks 
of the outbreak, one of the most frequently identifIed co-factorial agents was the 
hMPV mentioned by Dr. St6hr. Human metapneumovirus, those reports concluded, 
had been 'co-circulating' with Co V during early 2003. Statistically speaking, if the 
cohorts from each of those studies are collected together, then a total of 290 
retrospectivelY tested cases can be generated. And, of that number, a total of 86 were 
found to have been co-infected with Co V and hMPV. In percentage terms, 29% of 
the 290 retrospectively tested cases.lfthat sample can be accepted as representative of 
the total number of 2,307 conflrmed cases of SARS-Co V infection from those 
countries (see WHO 2004c: Hong Kong: 1,755; Singapore, 238; Canada: 251; Viet 
Nam: 63) - then it follows that around 669 cases (29%) were actually co-infected. 
But then perhaps this last paragraph smacks of the 'average citizen' scraping around in 
the discarded refuse of science's backyard, retrieving the scraps of something - i.e the 
possibility of the multifactorial - that the 'microbiological citizen' had not even 
noticed. Perhaps it seems as if I am making too much of these co-factorial fIgures. 
And yet, to cite another piece of Latourian (2005, 12) advice, I did little more in that 
paragraph than 'follow the actors themselves'. Consider, for instance, what Dr. Frank 
Plummer, the head of one of the WHO's 11 laboratory network institutes, had to say 
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about the aetiological question during an interview with a journalist a few days before 
the Co V announcement was made: 
'The coronavirus is definitely around in the environment, it's defInitely circulating', he 
said 'but the relationship with SARS, based on our data, appears to be fairly weak. It 
could be that it causes SARS and we are sampling the wrong sites. Or we are getting 
poor specimens. But we don't believe it's because of our testing. It could be you need 
more than one thing to get SARS. Or it could be an epidemic of coronavirus 
superimposed on an epidemic of something else, and we're trying to work through that. 
(plummer cited in Walgate, 2003) 
Consider also the conclusions from a research paper, 'Identification of SARS in 
Canada' (poutanen et aL 2003) that Plummer and his research team published 
subsequently in the New England Journal of Medicine: 
SARS is a condition associated with substantial morbidity and mortality. It appears to 
be of viral origin, with patterns suggesting droplet or contact transmission. The role of 
human metapneumovirus, a novel coronavirus, or both requires further investigation. 
(ibid., 1995) 
And, as one final example, consider 'Chlamydia-like and coronavirus-like agents found 
in dead cases of atypical pneumonia by electron microscopy' (Hong et at. 2003), an 
article written by a research team from the Chinese Centre for Disease Control, 
Beijing. Therein, the following aetiological conclusions are drawn: 
To explore the causative agents of the atypical pneumonia (also SARS) that occurred 
recendy in some regions of [China] ... Organ samples of 7 dead cases of SARS were 
collected from Guangdong, Shanxi, Sichuan Provinces and Beijing for electron 
microscopic examination. 293 cell lines were inoculated with the materials derived from 
the lungs in order to isolate the causative agent(s). The agents in the organs and cell 
cultures were revealed by immunoassay ... Both Chlamydia-like and coronavirus-like 
particles were found by electron microscope ... Since the novel Chlamydia-like agent 
was found co-existing with a coronavirus-like agent in the dead cases of SARS, it 
appears most likely that both agents play some role in the disease. At the present time, 
however, it is not possible to determine whether these agents interact synergistically, or 
whether one follows another. This requires further study. (ibid., 632) 
So, two possible visions. And two possible objects. Yet only one possibility became-
real. Consider, for instance, the WHO's final case-listings for the outbreak that 
appeared in December, 2003. Total cases: 8,096; number of deaths: 774. And the 
cause of infection in each case? CoV and CoV alone.27 A little over eight months after 
the WHO's aetiological announcement and everything had stabilised and solidified in 
the shape of the singular. 
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11. THE POLITICS OF DOING AETIOLOGY 
On the one hand 'one disease has one cause' and the singular aetiological object; on the 
other hand 'one disease has many, interacting causes' and the multifactorial aetiological 
object. Both objects are possible, both are plausible, both can, and indeed both do, co-
exist within the 'necessary limits' of contemporary medical microbiology. As this is so, 
the problem to be addressed in this thesis can perhaps best be presented in the form 
of the following question: given that two entirely different ways of doing aetiological 
objects co-existed during the outbreak, and, given that both initially seemed to be equally 
possible, how did we end up in a world in which only one of those possibilities 
became-real whilst the other was denied any kind of existence at all? 
My strategy for addressing this problem in the four case-study chapters that follow 
will be to try and recover the possibility of multifactorality from the brief moments at 
which it flashed up preciselY as a possibiliry for medical microbiologists during the 
outbreak. Once recovered, it will be possible to try and understand the ways and the 
means via which those moments, and thus the possibility of the multifactorial object 
which they possessed, were forced into the realm of the impossible. But then, at this 
juncture, a sceptic, a Latourian dissenter as it were, might very well demand some 
answers to the following kinds of questions: if the aim is to recover a possibility that 
never came to be granted any existence, then what really is the point of holding to 
such an aim? What, exactly, is the purpose of such a recovery operation? Why seek to 
recover the possibility of the multifactorial object? And why now, in a world in which 
SARS-Co V is settled, singular and so so dull? My answer to each of these questions 
would hinge on the word 'politics', and a particular understanding of that word. If 
politics, the realm of the political, can be taken to emerge in situations where various 
choices exist yet not all of those choices can be chosen, then what I am after here in 
this recovery operation is a politics; a politics of aetiology as it is done, in and as 
practice, by medical microbiologists.28 
A politics of the present and, perhaps most interestingly, a politics of the future of aetiology. 
Firstly, a politics of the present. if both forms of doing aetiology were available, and if 
both forms of aetiological object were possible, then how did we get here - to SARS-
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CoY, an infectious disease that could be storied and understood in the singular rather 
than in any other way? How did one possibility get transformed into reality, whilst 
another was transformed into non-reality? And again, if both were available and both 
were possible, then how was this possible co-existence managed and negotiated 
during the outbreak? Was the loss of the possibility of multifactorality the end-result 
of active forms of medical microbiological management and negotiation? And if so, 
then what form did those processes of management and negotiation actually take? 
But then, a politics of the future too: what might the ways in which this tension came to 
be resolved during the 2003 SARS outbreak tell us more generally about the discipline 
of medical microbiology? Put another way, is it possible, based on such an 
understanding of that particular outbreak, to inhabit the present in such a way that 
one can think, in a little more detail, about where aetiology, as understood by medical 
microbiologists, might be heading in the future? Is it possible, in other words, to 
grapple with the question of whether or not multifactorial aetiology will always and 
forever more be lost to the world of medical microbiology? And what might it be 
possible to suggest about the shape of aetiological objects of the future: will they 
perhaps be singular objects ... or multiple objects? 
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Notes 
1 HIV-AIDS stands, of course, for human immunodeficienry virus associated acquired 
immunodeficienry {)'ndrome. SARS-Co V stands for severe acute respiratory ryndrome associated 
coronavirus. Pp-related illness can be explained as follows: Pfiesteria piscicida (Pp) is an 
'estuarine dinoflagellate which has been associated with fish kill events in estuaries 
along the. eastern seaboard of the US'. Recently it has been linked aetiologically to a 
syndrome that the US Centre for Disease Control has previously referred to as 
'estuary-associated syndrome (PEAS)' which involves 'Pp-related human illness' 
(Hathcock et aL 1999, 381). Finally, EBV-HPS stands for Epstein-Barr virus associated 
hemophagorytic syndrome. According to Isome et aL (2005) hemophagocytic syndrome 
(HPS) 'is a rare syndrome characterized by common clinicopathological features such 
as fever, pancytopenia, hepatosplenomegaly, liver dysfunction, coagulopathy, and 
pathological findings of hemophagocytosis in bone marrow and other tissues'. It has 
been associated 'with a variety of infectious agents, as well as genetic, neoplastic, and 
autoimmune diseases'. Among the infectious agents, 'Epstein-Barr virus (EBV) is 
especially linked with HPS'. 'EBV-HPS has high mortality, with death usually resulting 
from hemorrhage, infection, or multiple organ failure, and sometimes occurs in 
patients with immunosuppressive conditions during the treatment of autoimmune 
diseases' (ibid., 226). 
2 Deriving from ceti%gia, the Latin for 'giving a cause', 'aetiology' is the 
preferred spelling in the United Kingdom and continental Europe. In the United 
States and Canada, however, 'etiology' without the 'a' is preferred. Throughout this 
thesis I have 'followed the Europeans' in referring to 'aetiology'. But in instances 
where extracts from American publications have been cited, I have left their 
references to "etiology" unaltered. 
3 'Little' sociological attention, but certainly not 'none at all'. Perhaps the 
earliest sociological study of aetiology, though very rarely recognised as such, is 
Fleck's Genesis and Development of as cientiftc Fact ([1935] 1979). For as Fleck re-traces an 
historical path leading from a vague popular idea of 'syphilitic blood' to the 
introduction of the Wasserman reaction and the definition of the clinical 
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distinctiveness of syphilis, he is also, and at the same time, tracing a path from one 
form of aetiological object to another. In relation to AIDS and to the emergence, 
discovery, identification and ensuing controversy over the aetiological agent HIV, see 
Fujimura and Chou (1993) and Epstein (1996, 45-178). And, more recently, in a 
special issue of Social Studies of Science entitled 'Race, Genomics, and Biomedicine' there 
are some papers that touch on the question of aetiology in the medical sciences (in 
particular, see Fujimura et aL (2008); and Fausto-Sterling (2008)). More specifically in 
relation to the 2003 SARS outbreak, there has been a great deal of interest in, for 
instance: the naming strategies and conceptual metaphors deployed during the 
outbreak in order to 'anchor' SARS as a social phenomenon (see for example, Baehr 
(2006), Chiang and Duann (2007), Wallis and Nerlich (2005), Washer (2004), Zhang 
(2006)); the significance of the disease's global 'mobility' and the ways in which it 
demonstrated the vulnerability of core urban systems to threats previously regarded as 
problems of the periphery (see for example Ali and Keil (2006), Bowen and Laroe 
(2006), Davis (2005, chapter 6), Keil and Ali (2007), Little (2006), Urry (2007)) and the 
various forms of SARS-related stigma that developed during the outbreak (Baehr 
(2005), Eichelberger (2007), Lee et aL (2005), Mak et aL (2006), Smith (2006), Zhan, 
2005)). And yet, despite such differing research interests, what connects those studies 
together is their complete lack of interest in the 'aetiological question'. In each, the 
fact that 'SARS is caused by a novel coronavirus' is taken as an analYtical startingpoint. 
As a result, everything of sociological interest happens after the aetiological question 
has already been settled, and SARS has already become SARS-Co V. In this thesis, 
however, the statement that 'SARS is caused by a novel coronavirus' acts as 
something like an analYtical end-point, with everything of sociological interest taking 
place before that statement became possible, and precisely so as to make that statement 
possible. In ethnomethodological terms, where previous studies of the SARS outbreak 
have taken the fact that 'SARS is caused by a novel coronavirus' as a resource" I have 
treated it, instead, as a topic. 
4 For the most useful and most understandable introduction to the 
epidemiological concepts of 'attack rate', 'reproductive rate' and 'mortality rate', see 
Giesecke (1994; the later edition (2001) is glossier, and definitely contains more 
pictures, but is a little more simplistic). Also, for more advanced understandings, see 
Dwyer and Groves (2001), Goodman et aL (1990), and Gordis (2004). And for an 
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understanding of how those concepts played themselves out during the SARS 
outbreak, see Donnelly et aL (2003), Donnelly et aL (2004), and Evans (2004). 
5 On the relatively recent resurgence of interest in 'objects' such as SARS-CoV 
ill the hitherto 'object-less' social sciences, see Engestrom and Blackler (2005), 
Garfinkel et aL (1981), Latour (2000), Law (2002), Pels et aL (2002), and Suchman 
(2005). 
6 On the early weeks of the outbreak, see Anonymous (2003a), Evans (2004), 
Fidler (2004), Fleck (2003), McClean et aL (2004), Parry (2003a; 2003b; 2003c); Wai 
and Qing-Wei (2004); and, for the WHO's initial statements in relation to what was, at 
the time, a syndrome of unknown cause, see WER (2003a - 2003j); and WHO 
(2003a-z; 2003za-zy) 
7 Because of the frequency with which bacteria with italicised proper names 
like Mycoplasma pneumoniae and Chlamydia pneumoniae appear in this thesis, the following 
presentational rule will apply throughout: where there is a need to emphasise a 
particularly important word, phrase, or passage in an extract such as this one - i.e. an 
extract separated out from the main body of the text, and in which nearly all 
references to bacteria are to be found - underlining, and not italicisation, will be 
deployed, so as to avoid any confusion. 
S On the p~oblem of the un-remarkable pneumonia-like illness, and the 
difficulties of diagnosing 'a pneumonia' as 'a pneumonia caused by a specific pathogen', see 
Cunha (1991; 1997; 1998; 2000; 2003; 2005; 2006a; 2006b; 2008). More specifically in 
relation to SARS, on the problem of the non-specific appearance of SARS as a 
radiographic phenomenon see Antonio et aL (2003; 2004), Ho et aL (2003), Wong et aL 
(2003a; 2003b); and on the ad hoc practices through which clinicians and 
radiographers sought to overcome that problem, see Chan et aL (2004a; 2004b), Chen 
et aL (2004a; 2004b), Hui et aL (2004), Leung et aL (2004), Ooi (2003), Ooi et aL (2003), 
Rainer et aL (2003), Rainer (2004). 
9 In this sense, my understanding of the 'aetiological object' is similar to Mol's 
understanding of a 'virtual object' in her studies of how various different 
'atheroscleroses', enacted in various different sites within a hospital, can sometimes 
come to be sutured together and understood as one, single disease entity, 
atherosclerosis: 'if the various "atheroscleroses" performed, map onto each other, 
they may be taken to be aspects of a single entity. This single entity is then projected 
as a virtual object behind the "aspects" that "surface". This virtual object resides 
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inside the body. The techniques "approach" it' (Mol 1998, 150; and also see Mol 
2002a, 163). 
10 As will hopefully become clear, this thesis seeks to operate upon a broadly 
conceived ethnomethodological terrain. And here, the distinction drawn between 
'concepts' and 'policies' is informed by Lynch's (1993) reading of ethnomethodology's 
'central text' (ibid., 12), Garfinkel's Studies in Ethnomethodology (1967): 'Garfmkel's 
prolegomenon was written as a practical document rather than a statement of 
theoretical doctrines. Its explicit aim was to announce a programme of studies and to 
present some of the research in hand. Garfinkel deliberately eschewed methodological 
principles and instead outlined a few "maxims" and "polices" for 
ethnomethodological investigations. He presented these policies as throwaway items 
rather than names for generic concepts, and did not use them to define an abstract 
system of organizational principles and analytical elements for explaining the 
constitution of society' (ibid., 13). 
11 Though for a more detailed discussion of the infrastructure of global disease 
surveillance and response that the WHO has developed, largely from scratch, sllce 
the mid-1990s, see Doherr and Audige (2001), Heymann (2001; 2002; 2004; 2006), 
Heymann and Rodier (1998). 
12 The theme of the 'normal' and the 'abnormal' in medical microbiology is 
present during nearly every one of the WHO's SARS press conferences. For instance, 
just two days later, on 27th March, St6hr was asked by a journalist whether 'the cause 
of SARS might still be the combination of the coronavirus and the human 
metapneumovirus' (WHO 2003e, para. 28). He responded thus: 'we believe that the 
coronavirus is the major causative agent. Now that the data that is forthcoming from 
very many different laboratories which investigated samples from Viet N am, from 
Hong Kong, from Singapore, from Germany, and from Canada, all these laboratories 
are consistendy finding coronavirus in those patients' (ibid., para. 29). Perhaps a litde 
confused by St6hr's reference to the 'major' causative agent, the journalist followed 
up his/her initial question, by seeking a litde more clarification: 'so the paramyxovirus 
[i.e. the human metapneumovirus] was not the cause of the disease?' (ibid., para. 30). 
And it was at that stage that St6hr. sought to make use of his normal/abnormal 
distinction: 'there are normally few diseases which are caused by two pathogens. The 
majority of diseases are caused by only one pathogen. Now we are seeing here 
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consistent isolation of one pathogen in very many SARS patients. That gives us 
confidence that coronavirus is linked to SARS' (ibid., para. 31 my emphasis). 
13 Monomorphism versus pleomorphism: an important 19th medical 
controversy. The doctrine of monomorphism suggested that bacteria could be divided 
into distinct and constant species that bred true, preserving their characteristic forms 
and action. The doctrine of pleomorphism, on the other hand, suggested that bacteria 
constandy underwent such profound morphological and physiological 
transformations, such profound changes of form and action, that any such division 
into constant and distinct species was impossible. Both doctrines had their defenders 
during the late 19th century. A controversy flared. And, during that controversy, the 
very future of the medical sciences was at stake. For a pleomorphic biologist like Carl 
Nageli, for instance, the pathogenic character of a bacterium was not its inherent 
property, but rather, a function of its environment. In other words, the contagious 
nature of disease was not necessarily implied from its bacterial cause. If bacteria were 
highly pleomorphic - if, for example, a coccus could change into a Vibrio or an 
innocuous micro-organism into a virulent parasite - then as Amsterdamska (1987) has 
noted in relation to Nageli's work, 'all morphological and physiological descriptions of 
bacteria associated with specific diseases would be of limited practical value for the 
prevention of these diseases and the containment of epidemics' (ibid., 664). By 
doubting 'the efficacy of a selective control of micro-organisms, Nageli's extreme 
pleomorphism ... denied the medical relevance of the knowledge that a particular 
bacterial form is regularly associated with a particular disease' (ibid.). Only with the 
triumph of the Kochian belief in fixed and stable bacterial forms did the 'biomedicine' 
that we now take so much for granted become possible. 
14 At least, 'well-rehearsed' for those who have studied Dorothy Smith's article 
'K is mentally ill: the anatomy of a factual account' (1978). Therein, the central 
concern is with the ways in which Angela (apparentlY K's friend) seeks to describe K's 
actions as peculiar, even bizarre. One of the most important points to emerge from 
Smith's subsequent analysis was that the 'fact' of normality was indexical; in other 
words, that it was not enough for Angela simply to describe an action of K's that could 
be consensuallY recognised as peculiar or bizarre. Why? Because peculiarity and 
bizarreness had to be constructed in discourse. On this 'well-rehearsed point', also see 
Potter (1996) and Wooffitt (1992). 
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15 On the notion of sociological 'symmetry' and my own .particular 
understanding of what sociological 'symmetry' entails, see chapter 2, below. 
16 On Winogradsky, see Charlton et aL (1997), Penn and Dworkin (1976), 
Schlegel (1996), Thornton (1953), Waksman (1946; 1952; 1953a; 1953b; 1959; 1968), 
Zavarzin (1987, 2006); and also, of course, see Winogradsky (1952a; 1952b). 
17 On the 'Kochian school of medical microbiology' see Barlow and Barlow 
(1971), Bulloch ([1938]1979, chapter IX), Carter (1985a; 1985b; 1987; 1997), Ligon 
(2002) and Mortimer (1999). 
18 For a recent engagement with Whitehead's philosophy of the event from an 
STS inflected perspective, see Haraway (2008), Latour (1999), and Stengers (2008), 
and, specifically in relation to 'social theory', see Halewood (2005) and Halewood and 
Michae1 (2008). And see note 25, below. 
19 Here I am playing around with Bloor's ([1977]1991) cautionary note that 
any 'sociologists' attempting to symmetrically analyse beliefs qfter scientific closure had 
been reached 'would be putting themselves where their critics would, no doubt, like to 
see them -lurking amongst the discarded refuse in science's backyard' (ibid., 30). The 
reference to a 'sociological laughing stock' is drawn from Simon (2002): 'to pursue a 
symmetrical post-closure study of N-rays or cold fusion would be the equivalent of 
proclaiming that fairies are real. It would make sociology into a laughing stock' (ibid., 
14). 
20 Here I am paraphrasing Gieryn and Figert (1990, 68). 
21 On Thomas Rivers' belief in the existence of multifactorial aetiological 
objects, see Rivers (1937): 'for the progress of knowledge of infectious 
diseases ... blind adherence to Koch's postulates may act as a hindrance instead of an 
aid. For instance, the idea that an infectious malady can be caused only by the action 
of a single agent is incorrect, and, if [Richard] Shope had adhered to old ideas, he 
would never have discovered that swine influenza as it occurs in nature is caused by 
the combined or synergistic action of two agents, one a virus not cultivable on lifeless 
media, the other an ordinary hemophilic bacterium. Furthermore, it has been 
demonstrated that at least one natural disease of plants is induced by the combined 
action of two viruses, each of which has been obtained free from the other and when 
so obtained each produces a characteristic malady different from that caused by the 
synergistic action of the two agents' (ibid., 4-5). And, for the work of the virologist 
cited by Rivers, Richard Shope, see in particular, Shope's 'Swine Influenza: flltration 
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experiments and aetiology' (1931): 'When the filterable virus was mixed with pure 
cultures of H. influenifle suis and administered to swine a disease identical clinically and 
pathologically with swine influenza was induced. The data presented indicate that the 
filterable virus of swine influenza and H. influenzae suis act in concert to produce swine 
influenza and that neither alone is capable of inducing the disease' (ibid., 384). 
22 On the doctrine of specific aetiology and its importance for modern western 
medicine, see Nettleton (2006, 2-4), and Gordon (1988). For more detailed histories 
of its emergence during the late nineteenth century, Carter (2003, 129-147). A number 
of biographies of Robert Koch also discuss the ways in which the bacteriological 
techniques he helped to develop and to standardise - most notably the culture 
technique and the streak-plating method - made the singularity posited by this 
doctrine discoverable, 'out-there', for other bacteriologists (see for instance Barlow 
and Barlow (1971, 241-269); and Brock (1988)). 
23 It should also be noted at this point that William H. Stewart was not alone 
in this way of thinking. Burnet (1962, 47), for instance, wrote of how 'one can think 
of the middle of the twentieth century as the end of one of the most important social 
revolutions in history, the virtual elimination of the infectious disease as a significant 
factor in social life'. Sigerst ([1933]1971, 371) too, was moved to note how 'most of 
the infectious diseases ... have now yielded up their secrets ... Many illnesses ... have 
been completely exterminated; others have been brought largely under control'. The 
story of William H. Stewart's address to the state and territorial health officers comes 
from Garrett (1994, 33; and also see Hemming (1957)). Also useful here are the 
accounts of this period of 'biomedical optimism' to be found in Cohen (2000), 
Cunningham (2005) and Gualde (2003). For a recent sociological engagement that 
discusses both this period of optimism and the 'turning' that followed, see Van Loon 
(2002, 123-146). 
24 Interestingly, Dubos' philosophical arguments against his fellow medical 
practitioners involved the same kind of arguments that A.N. Whitehead developed in 
his critique of those western philosophers whom he felt had been led astray by the 
'evil' of Aristotelian notions of 'primary substance' (Whitehead [1929] 1978, 30). 
Whitehead's main point of attack was directed towards the philosophical and scientific 
assumptions that structured contemporary conceptions of matter, objects and subjects. 
And if Whitehead came to characterise his own project as 'the philosophy of 
organism ... a recurrence to pre-Kantian modes of thought' (ibid., xi) then it is perhaps 
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possible to characterise Dubos' project in the same way. For in both, purity and 
simplicity were displaced by the processual and the complex. Indeed, Dubos' stance in 
relation to medical and scientific work prefigures, by at least 20 years, the kind of 'pre-
Kantian' (or, put another way, the 'non-modern') sociological and philosophical work 
undertaken in recent years by figures such as Haraway (1997) Latour (1993; 1999), 
Stengers (2008) and Whatmore (2002). 
25 Also see Dubos (1950, 1960, 1974). 
26 On the initial distinction drawn by the WHO's SARS case-definition, 
between 'suspect SARS' - high fever, recent history of travel to areas reporting cases of 
SARS, and cough and difficulty breathing - and 'probable SARS' - a suspect case with 
chest x-ray findings of pneumonia - see WHO (2003b; 2003zs; 2004a; 2004b), and 
Goh et aL (2005). 
27 See WHO (2004c) 
28 This particularly Arendt-ian understanding of 'the political' is drawn from 
Annemarie Mol's work (in particular 1999; 2002a). There, one fmds 'a specific 
interpretation of politics, one that is posed in terms of deliberation or choice' (1999, 
86). But for Mol, the political is only one half of that which is really of interest in her 
work: 'ontological politics'. So what, then, of the term 'ontological politics'? In standard 
philosophical parlance, ontology defines what belongs to the real; that which is stable 
and secreted. Politics, on the other hand (and certainly in Mol's work) defines what 
belongs to the future; that which is open and fiercely contested. Is the term not, then, 
an oxymoron? Not for Mol. For if, as she argues, reality is done and enacted rather 
than observed; if it is manipulated 'by means of various tools in the course of a 
diversity of practices, then there is no necessary reason why reality should not be 
thought of as containing multiple realities (ibid., 77). Take clinical 'anaemia' for 
example: 'the reality of anaemia takes various forms. These are not perspectives seen 
by different people, .. neither are they alternative, bygone constructions of which only 
one has emerged from the past ... they are different versions, different performances, 
different realties, that co-exist in the present' (ibid., 79). So, reality, yes. But for Mol, 
when we talk of reality we are also and at the same time talking of realities, of choices 
between possible realities, and thus, of politics: 'the word ontological politics suggests 
a link between the real, the conditions of possibility we live with, and the political' 
(ibid., 86). Is this thesis an investigation into the ways in which that 'link' performs 
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itself within the medical microbiological practice of aetiology? I would like to think 
that it is. 
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2 
Entering the Scientific Court of Appeal 
In the previous chapter a number of research questions were put forward. On the one 
hand, there were questions relating to the present conditions of possibility within 
medical microbiology, and, on the other hand, there were questions relating to the 
ways in which those conditions might come to be shaped in the future. But as I also 
sought to make clear in that chapter, the initial challenge would be to try and recover 
the possibility of multifactorality from the outbreak. For only with the recovery of 
that possibility would such questions become ask-able. And so, in this brief chapter, 
the methods deployed in order to meet that initial challenge during the four case-
study chapters of this thesis are outlined. In the fIrst section of the chapter, 'the brute 
effort of reading', I deal with the question of where the possibility of the multifactorial 
object was sought for within the vast and ever expanding terrain of SARS-Co V 
research. The question of how it was made to become recoverable, or rather, extractable, 
from amidst that vast terrain, is dealt with in the fInal section of the chapter, 'entering 
the scientifIc court of appeal'. 
I. THE BRUTE EFFORT OF READING 
Methodologically, a focus on practice - not just what scientists think or write but also 
what they do and the materials they work with - is now well established in the history 
and sociology of science. Since at least the late 1970s, post-positivist and post-
Kuhnian scholars in the empirical human sciences, and especially those in history and 
science-studies, have been making various sorties and excursions onto a terrain once 
considered the sole preserve of epistemologists: the technical content of science. 1 In 
particular, there have been a number of attempts to investigate the technical content 
of laboratory work via the use of ethnographic, and, in some cases, 
ethnomethodological methods. 2 And, as the practical and day-to-day. work of 
laboratories has been opened up in this way to sociological analysis, so too has the 
maten"al basis of that research: 'experimental systems' 3 research 'platforms' 4 and 
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research 'infrastructures,;5 in short, all of those closed-off sections of the material 
world that scientists have to employ in order to carry out their day-to-day work. 
In this thesis my interest will also be in the practices and interventions of scientists; in 
this case, the practices and interventions through which aetiology was done by 
medical microbiologists investigating the SARS outbreak. To recover the possibility of 
a multifactorial object that never quite came into being, the material basis of that 
microbiological work will have to be foregrounded and studied with an almost 
obsessive attention to detail.6 And yet, unlike those afore-mentioned post-positivist 
studies of practice, I have sought to pursue my interest in the practical doing of 
aetiology via textual rather than ethnographic or ethnomethodological methods. 
Although I consulted many archives, engaged many practicing microbiologists in 
conversation, and visited a microbiological laboratory on a number of occasions 
whilst conducting my research, the route I ended up following through the field of 
medical microbiology derived, for the most part, from the published record; that is, 
from literally hundreds of decidedly little known publications with tides such as 
'Retrospective serological investigation of SARS coronavirus antibodies in recruits 
from mainland China'; from contemporary, up-to-date laboratory manuals, textbooks 
and journals; from laboratory manuals and textbooks dating back to the 1950s and 
1960s; from conference proceedings; from World Health Organisation documents, 
recommendations, reports, updates, press conferences, and so on and so forth. 
In a sense, the suggestion that textual rather than ethnographic or 
ethnomethodological methods are to be deployed might seem to be a statement of the 
obvious. There is, after all, nothing left for the 'anthropologist' with an interest in the 
doing of SARS-CoV to investigate: the World Health Organisation declared the 
SARS-Co V outbreak over a number of years ago, and, since then, it has not re-entered 
the social body. Yet in another sense it is a suggestion requiring of a little more 
explanation. For it seems to me that a generally held assumption in the history and 
sociology of science is that whenever direct access to the day-to-day doing of 
laboratory work is lost, then so too is any possibility of recovering laboratory practices 
and interventions in all their corporeal glory, as they hesitate and as they stutter. On 
this assumption, of course, my own research task, that of recovering the possibility of 
multifactorality from textual reports of practices and interventions, would be rendered 
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virtually un-achievable. But then, does this assumption necessarily hold in the case of 
the 2003 SARS outbreak? Does it have to follow, necessarily, that when direct practice 
is lost to history, the name of the research game suddenly has to change? 
The implied and the (non)implied reader 
I want to suggest that it does not; that just because one is left with textual data, and 
textual data alone, it does not at all follow that any possibility of recovering the 
intricacies, hesitations and stutterings of practice is suddenly lost. Consider, for 
example, Michael Lynch's Scientific Practice and Ordinary Action (1993). At one point. 
therein, Lynch develops an ethnomethodologically inflected critique of the use of 
reports, archives, transcripts, codified data, and other such documents by social 
scientists as representations of practice. It is a critique based around the idea that a 
'gap' exists between the work of composing a text and the retrospectively analysable 
properties of the resultant document. As one traverses this gap, moving from the 
former work of composing to the resultant document, the suggestion is that any 
active, direct sense of the former work is necessanly lost. To make this suggestion a 
little clearer, Lynch recounts a simple exercise carried out by one of Harold 
Garfinkel's students, Stacy Burns: 
Bums produced a videotape that framed a typist's hands at an electronic typewriter 
keyboard. The tape documents the typist's hands working at the keyboard while her 
voice gives a running commentary of "what she is doing" as she composes the text. 
The typed document is shown unfolding on a sheet of paper positioned in the carriage 
while the typist strikes a sequence of keys, crosses out and restarts a passage, and 
pauses between letters while considering aloud what to do next. The video tape thus 
frames a distinctive "pair" of intelligible documents: (1) a "real-time" video sequence of 
typing, complete with hesitations and commentary, and (2) a typed page that can be 
read, copied, and analysed independently of the real-time sequence. On the videotape, 
the typed page can be seen as the product of a course of work, but when the page is 
read as a disengaged text, its coherent semiotic features implicate a different order of 
"authorship". The completed sentences stand as documents of a coherent set of 
"ideas", "intentions", "grammatical competencies", and so forth, which no longer 
display the local history of production documented by the video tape. The written text's 
analytic features do not document the singular "hesitations". "interruptions". and 
"second thoughts" made evident by the tape. (ibid., 289-290 my emphasis) 
From an ethnomethodological perspective, as Lynch goes on to note, 'the two 
documents stand in a relation of "asymmetric alternation": one document (the 
videotaped sequence) enables the recovery of the other (the text on the page), but not 
vice versa; the written text's analysable field no longer retains a trace of the surplus details of 
typing' (ibid., my emphasis). And, for Lynch, this example: 
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Clearly demonstrates the kind of reduction that is accomplished whenever social 
scientists use reports, archives, transcripts, codified data, and other such documents as 
representations of a practice. (ibid., my emphasis) 
A lack of 'hesitation'; 'no trace of a surplus'; a form of 'reduction': at the very heart of 
Lynch's ethnomethodological enterprise is the denial of any kind of formal equivalence 
between literary representations and life-world activities. The suggestion seems to be 
that without an investigation of direct practical activity, one is able to say very litde 
about that activity. If this is so, then it follows that my ability to recover anything but 
the possibility of SARS-Co V, the singular object that came into existence and was 
subsequendy made textually presentable, would be lacking. As with the typist's 
document, bereft of any hint of a 'running commentary', so too the various 
microbiological documents relating to SARS-CoV. Bereft of all 'hesitations', 
'interruptions', 'surpluses' and 'second thoughts', they would therefore lack any hint 
of a multifactorial object; an object that could have been, but never managed to get 
much further than the confines of a few laboratories dotted around the world. 
Coming at this problem from a literary and stylistic point of view, however, it seems 
to me that Lynch is unnecessarily pessimistic about the use of literary inscriptions in 
the study of practical scientific work. His critique, which can be said to be built 
around a very particular understanding of a text's 'implied reader', presents the social 
scientific reader as something of a 'textual dope'; as someone who only ever seems 
capable of following, very direcdy, in the footsteps of a text's author.7 And what that 
author, as an author, manages to lose, is subsequendy lost forever to the reader. 
Lynch's social scientific reader never seems able to see beyond the 'reductions', or the 
'losses' perpetrated. But as Michael Toolan had made clear in his Narrative (2001), this 
particular understanding of a text's 'implied reader' would be frowned upon by most 
contemporary literary theorists and stylisticians: 
We assume that the author had a particular kind of reader in mind. But then again 
perhaps they did not, or perhaps - as reader - I don't care even if they did, and refuse 
to comply with that oblique effort to include or exclude me. As Waiter Ong pointed 
out [in Orality and Literary 1975], the writer's audience is always a fiction, a convenient 
provisional target. Real readers. real audiences. can apprehend stories in quite 
unpredicted ways. seeing a different point to them. (ibid., p. 68 my emphasis) 
Of course, whilst it is true that microbiological documents relating to SARS-Co V did, 
when considered as isolated entities, present formal, purified and simplistic accounts 
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of how SARS-CoV was always already 'out-there' in 'nature' waiting to be discovered, 
this was not an insurmountable problem. For it was possible to apprehend those 
documents 'in quite unpredictable ways', 'seeing a different point to them', and 
drawing out the possibility of a multifactorial object that was, however implicidy, 
implicated within the stories that they told. And in two ways. Firsdy, by focusing in 
upon the seemingly innocuous and mundane technical details included within those 
documents. And then, secondly, by tracing a path outwards from those details and 
into the (inter)textual mass of medical microbiological, and SARS-Co V research 
literature. Indeed, that mass of literature, the literary idea of the intertextual, is 
something else that Lynch's critique of textual methods fails to take into account. For 
such is the sheer scale of contemporary scientific publishing that there is always a way to 
become a (non)implied reader; or, put another way, there is always a way to take a 
mere 'detail', extracted from its 'host' text, somewhere else: here, a different opinion 
regarding its importance; there, a multifactorial microbiologist who tropes that detail 
in an entirely different way; here, an out of date microbiology textbook that reveals 
something about that detail which is now passed over in silence by contemporary 
textbooks; there, the work of a different research group that has begun to 
problematise that detail. And so on and so forth. If Lynch's implied reader can be said 
to be a litde too good-mannered, then today, there are plenty of ways that one can 
find to abuse the isolated scientific document. 
An ethnomethodology of the text 
Defensive theoretical arguments to one side, however, there is also a purely pragmatic 
argument to be made for the use of textual methods in the recovery of medical 
microbiological practice. For certainly in the case of this particular thesis, the brute 
effort of reading literally thousands of documents with tides like 'Retrospective 
serological investigation of SARS coronavirus antibodies in recruits from mainland 
China' came to seem the onlY adequate wqy to enter into the doing of SARS-Co V; the 
only adequate way, in other words, to get at the texture and the density of a whole 
. field of activity. And this was so because of course the sheer scale of SARS research, 
the involvement of medical micro biologists working out of hundreds of laboratories 
across the world, meant that any direct, ethnographic or ethnomethodological 
methods would have limited one's ability to roam freely across the 'research front'. 
Unhindered, almost anarchic movement, was precisely what was required in order to 
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recover a possibility that had slipped into so many temporally and geographically 
diverse spaces: here, a nasopharyngeal sample collected in a Hong Kong hospital; 
there, a continuous cell line in Adanta, U.S., from which a 'master-seed' had been 
taken; here, a cynomolgus macaque in a Rotterdam Laboratory, infected with the 
coronavirus and waiting to die; there, a genetically modified N protein developed 
from a strain of the SARS-Co V virus and put to work in a diagnostic enzyme-linked 
immunosorbent assay in a Chinese research laboratory. Indeed, rather than describing 
this strategy, somewhat dismissively, as the 'brute effort of reading', it should, perhaps, 
be marked as a bona fide approach to sociological research seeking to· grapple with 
the contemporary medical sciences; an approach that takes scientific literature as a 
primary injo17Jlant or source. And although it was suggested earlier that this thesis would 
refuse all ethnomethodological methods, perhaps it would be better to suggest that it 
will not involve any of the by now well established ethnomethodological methods for 
studying material practice. For what I would suggest is that the reading method 
deployed in the following four chapters, the 'brute effort of reading', is better 
described as a form of textual ethnomethodology.8 
A summary of the chapters 
In short, the focus here in this thesis will be on the places where people recorded 
what they did and how they did it. The whole mass of the medical microbiological 
literature detailing the SARS outbreak is taken as 'the work' to be analysed. The 
narratives I present in the following chapters attempt to pick a thread through this 
mass of literature, doing highly specific empirical work on the general possibility of 
multifactorality. Each of those chapters proceeds along a similar line, focusing in 
upon a particular medical microbiological technology, and .the particular assemblage 
of medical microbiological practices and interventions involved in its use. In each case 
the assemblage in question is one that proved to be particularly important in 
establishing that SARS was caused by SARS-Co V and SARS-Co V alone. And in each 
case what I will be attempting to foreground are those sudden, flickering moments of 
danger at which the possibility of the multifactorial object flared up, before, somehow, 
being doused. 
Thrust into the research spotlight in chapter 3, for instance, is the 'continuous cell-
culture line', the diagnostic technology upon which medical microbiologists were 
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entirelY dependent during their attempts to isolate the singular human coronavirus from 
patient samples. The following chapter, chapter 4, focuses in upon the technology of 
'Koch's Postulates, as modified by Rivers for viral diseases'. This was the aetiological 
'proof' deployed by microbiologists at the Erasmus Medical Centre in Rotterdam in 
order to establish that the coronavirus, and the coronavirus alone, was 'capable of 
causing the typical symptoms of SARS' (Fouchier et a/. 2003, 240). Perhaps the most 
fiercely technical of all the technologies dealt with during this thesis is then introduced 
in chapter 5: the enzyme-linked immunosorbent assay (ELISA). ELISA was the first 
diagnostic technology to be deployed in the post-outbreak-period. And, as such, it was 
made to work back, retrospectively, through allSARS patient samples collected during 
the outbreak sorting 'positive SARS-CoV cases' from 'non SARS-CoV cases'. The 
final chapter, chapter 6, changes tack a litde, and looks to foreground rhetorical rather 
than medical technologies. Placed centre stage therein is a popular science article 
entided 'China's Missed Chance' (Enserink 2003). The first such account to appear in 
the 'post-outbreak' period, it tells of the work of one particular team of multifactorial 
micro biologists from China that, during the outbreak, sought to explore the 
aetiological question. Of interest about that telling are two things: firsdy, the ways in 
which it seeks to explain why that research team got it wrong, and wf?y SARS was 
always destined to become the very singular, and very uncomplicated, SARS-CoV; and 
secondly, the ways in which it came to inform many subsequent accounts of that 
research team's work. 
11. THE SCIENTIFIC COURT OF APPEAL 
But what of the actual act of reading itself? Now that the idea of an 
ethnomethodological approach to the research literature has been set out, the 
question of precisely how to read that literature still needs a litde more attention. For 
as was hinted at earlier, this is by no means an easy question to answer. Things quickly 
became 'cold' in relation to SARS-Co V: contingency was forgotten, controversy 
smoothed over, and uncertainty bracketed. Already by late June, 2003, for instance, 
around the time that the last chains' of human transmission had been broken, SARS 
had long since become SARS-Co V, whilst the possibility of SARS as a multifactorial 
disease had long since been forgotten about. 9 So how to read in such a situation? How 
to read for the possibility of multifactoriality in a world where that possibility was very 
rarely, if ever, written about direcdy? 
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The difficulty of reading for the multifactorial 
At this point it is useful to try and clarify the precise nature of the problem by looking 
at the way in which it played itself out during my attempts to study the continuous 
cell-culture line in chapter 3. Therein, the key research article was 'A novel 
coronavirus associated with Severe Acute Respiratory Syndrome' (Ksaizek et aL 2003). 
The article's aim, stated clearly in the introductory text, was 'to identify the etiologic 
agent of this outbreak' (ibid., 1953). And, at the end of the study, the conclusion was 
that 'a novel coronavirus was associated with this outbreak' (ibid., 1961). So how was· 
the article's initial aim of discovery achieved? 'The identification of this novel 
coronavirus relied on classic tissue culture isolation to amplify the pathogen' (ibid., 
1960 my emphasis). Cell lines were 'inoculated with oropharyngeal specimens' from 
one of the study's nineteen patient samples, and 'cytopathic effect in the Vero E6 cell 
was first noted on the fifth post-inoculation day' (ibid. 1956). Examination of 
'cytopathic-effect-positive Vero E6 cells by thin-section electron microscopy revealed 
characteristic coronavirus particles within the cisternae of the rough endoplasmic 
reticulum and in vesicles' (ibid., 1956-1957). The image which the thin-section 
electron microscope revealed was also presented very direcdy to the article's 
readership, as a micrograph of the infected cell-culture: 
'Figure 1: Vero E6 cells inoculated with oropharyngeal 
specimens from patients with SARS. The early typical 
cytopathic effect seen with coronavirus isolates from 
patients with SARS is shown (x40)'. (Ksiazek et at. 2003, 
1958) 
What we see here in these indentations are several colonies of coronavirus, each made 
up of clones; viruses from the same viral class, order and family. 'One disease has one 
cause'. 'SARS is caused by SARS-CoV'. And so on and so forth. 
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Faced with such an impressive display of singularity, the fact is that even with a close 
ethnomethodological reading of this article; even with a reading that could get so close 
to it, so close to the discipline of medical microbiology, that it would become possible 
to go native and forget one's identity as a sociologist, there would still be litde if any 
chance of recovering the possibility of multifactorality. For in. the end, in the final 
instance, things would still come to seem utterly unquestionable. Granted, one would 
have learnt a great deal more about how the unquestionable was made into the 
unquestionable, but as with the example of the typist in Lynch's ethnomethodological 
critique, the way in which the unquestionable 'hesitated', was 'interrupted' and had to 
deal with 'second thoughts' would have been lost. In fact, the danger of becoming too 
much of a native, too much of a believer in singularity and thus, too much of a sceptic 
about multifactorality, would be ever present. Not that this kind of a deep 
ethnomethodological reading had to be discarded. It was still necessary. Vital, even. 
But it had to be modified; granted a sharper edge. It had to become a tool not for 
knowing but for cutting. to The consensus regarding SARS-Co V as a singular disease had 
become so strong that it would have been impossible for any kind of even-handed 
analysis to have recovered anything but the ever present reality of singularity. The 
recovery of the possibility of multifactorality, in other words, depended upon a sceptical 
reading strategy; one that could, literally, go looking for that possibility. 
Entering the scientific court of appeal 
This was where the SSK idea of 'symmetry', the idea that 'the same types of cause 
would explain, say, true and false beliefs' (Bloor 1976[1991], 5) came to my aid. Of 
particular interest were a set of studies in which symmetry was interpreted not as a 
'methodological injunction for even-handed analysis', but rather, 'as the desired 
rhetorical outcome' of the study (Ashmore 1993, 70). This slight difference is a crucial 
one. Starting out from Bloor's initial suggestion that we should treat true and false 
science in the same way, these were studies that moved to note how !),mmetry did not 
necessarily have to entail neutrality. Orthodoxy, they seemed to be suggesting, could 
sometimes look after itself whilst we attended to history'S scientific 10sers.11 Consider, 
for instance, Ashmore's (1993) study of the N-Ray affair. Therein, the discourse of 
Rene Blondlol's chief critic and debunker, R. N. Wood is analysed in such a way that 
Wood's credibility·precisefy as a critic and debunker is called into question: 'if one takes 
Wood's account(s)· as literal reporting(s) of events, 'their discrepancies and 
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inconsistencies are such that it becomes difficult to maintain ... assent to his version(s) 
of events' (ibid., 89). In this way, a historical closure is unsettled. But perhaps most 
important here are Ashmore's comments in relation to how that 'unsettling' had to be 
effected: 
When the consensus is as strong as it is in the case ofN-rays, even-handed analysis will 
be unable to achieve the re-evaluation desired by symmetrists. Thus, in my paper, I am 
not even-handed: my strategy is to attack the credibility of the major historically 
accredited agent of the social destruction of N-rays in a rhetorically self-conscious 
effort to alter the grounds of consensus. (ibid., 70) 
And again, as one final example here, consider Pinch's (1979) paper on the problem 
of demarcating genuine 'science' from 'pseudo-science'. Therein, he sought to show 
how it would be possible to turn the demarcation arguments used against 'pseudo-
sciences' such as parapsychology, against the fraud hypothesis itself: 
What I will attempt to show is that the fraud hypothesis can be rejected as unscientific 
for the same sorts of reasons that have been used to reject parapsychology ... I hope to 
work in the same polemical spirit as those who have mounted the case against 
parapsychology (with, of course, the appropriate gloss of open-mindedness). It may be 
helpful to read the arguments as though a revolution in physics has taken place, and 
paranormal phenomena are now generally accepted, so that our problem is to expose 
the 'mistakes' made by those scientists who interpreted the first results of this 
revolution in terms of fraud. (ibid., 334-335) 
The confidence to remain sceptical in the face of an established consensus; the ability 
to cut into a situation that seems, at first sight, to be stable and unquestionable; and 
the courage to tread where others might fear to tread in the hope of eventually finding 
something that, at the outset, seems completely invisible: these were precisely the kind 
of traits that I tried to adopt whilst reading for the possibility of the multifactorial 
object in the SARS-Co V literature. 
But I also sought to adopt something else from those symmetry studies. Or, rather 
more accurately, I sought to develop something else from them. For as I studied them I 
began to notice that they were all laden with criminal-judicial metaphors: Latour, 
writing in Science in Action (1987), for instance, sets up his own fictional tribunal, and 
makes a number of references to the relativist as a defence lawyer in trials of 
rationality: 'instead of rushing to find bizarre explanations for still more bizarre beliefs, 
we are simply going to ask who are the accusers, what are the proofs, who are their 
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~itnesses, how is the jury chosen, what sort of evidence is legitimate, and so on, 
setting up the complete frame of the tribunal in which the accusation of irrationality 
takes place' (ibid., 185); and again, Ashmore, in his study of the N-Ray affair, also 
notes how he is 'looking for justice!' (1993, 70); similarly, Pinch writes of a fictional 
STS hero, 'whose first campaign would be "Justice for the cold-fusion two'" (1992, 
509) and, elsewhere, in relation to the widely discredited molecular biologist Franz 
Moewus, he asks 'why cannot an attempt be made now to seek some justice for 
Moewus?' (1993, 372). Incipient within these texts but never quite fully articulated, it 
seemed to me, was the idea of ... a scientific court of appeal. And that is the idea that I 
have sought to develop from those studies, and put to use here in this thesis. 
A scientific court of appeal? 
Well, why not? It would, of course, be an entirely fictitious affair. But, nevertheless, it 
would have a number of methodological strengths in relation to the task at hand. For in 
the adversarial Anglo-American criminal-judicial system, cross-examination is 
essentially hostile. It involves a contest between two sides as to which can produce the 
more convincing story about whether and how some incident happened. In an appeal 
court, in particular, reasonable doubt regarding an original conviction or judgement 
can be created if the defendant's legal team can muddy the waters with a plausible 
alternative to the original judgement. And, ultimately, the standard for deciding which 
side's story is the more convincing is, of course, the verdict of the jury.12 What better 
place to conduct this particular recovery operation? So yes, a scientific court of appeal, 
in session, here, in this thesis. And with myself cast in the role of defence lmryer for the 
defendant multifactorality; with the four case-study chapters all set to act in the role of 
court heatings; and with you, dear readers, occupying the role of the jury, 
multifactorality's re-trial is almost ready to commence.13 
But not quite ready. Because first, the scene has to be set in a little more detail. The 
original judgement handed down during 2003 stated that the SARS outbreak was 
caused by Co V and Co V alone. By implication the judgement also made clear that the 
possibility of SARS having been, even if only in part, a multifactorial disease, was 
unfounded. As the defence lawyer for the possibility of multifactorality, these are the 
judgements that I will seek to contest before the scientific court of appeal. Re-called 
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to the court in order to defend their original testimonies are the main witnesses for 
the prosecution: the cell-culture, Koch's postulates, ELISA, and the popular science 
article, 'China's Missed Chance'. And of course once transformed in this way from a 
simple postgraduate student, writing a thesis, into a dashing defence lawyer, 
orchestrating an appeal case and strutting his stuff in a court of law, it follows that my 
'cross-examination' of each of those witnesses can stray, just a litde, from the path of 
even-handedness. Indeed, as will become clear, my strategy during each of those 
cross-examinations will be to probe the witness from a multifactorial perspective, 
seeking out the points at which the seemingly solid, seemingly unquestionable 
judgement that they helped to pass was, perhaps, on slighdy weaker ground. And, if 
the waters of the case can be muddied enough, then it might just be possible to 
generate a modicum of reasonable doubt. 
The first hearing: a summary 
Once again, it is useful to see how this strategy plays itself out in relation to the 
continuous cell-line chapter. Starting with that one, crucial research article, 'A novel 
coronavirus associated with Severe Acute Respiratory Syndrome' (Ksiazek et aL 2003), ' 
each technical point, each technical term, each moment when something done during 
the laboratory investigations was' reported upon - inoculation, the generation of 
nasopharyngeal specimens, the identity and the characteristics of the Vero E6 and 
NCI-H292 continuous cell lines, the concept of the 'cytopathic effect', the concept of 
the 'master seed', and so on - becomes an opportunity for the cross-examination to 
go into overdrive. The brute effort of reading begins with those moments and those 
details, moving out from the independent text into a network of textual relations in 
order to try and understand what role each might have played in the generation of 
singularity and, by implication, the suppression of multifactorality. In this way, some 
of those moments are eventually forced to confess to their participation in practices and 
interventions within which the possibility of multifactorality had actively been 
managed and negotiated; practices and intervention, for instance, that were described 
elsewhere in the literature as 'processes of purification', 'the removal of 
contamination' and 'interference'. From a multifactorial perspective what this allows 
for is the generation of reasonable doubt. if those moments were moments at which the 
original judgement - that SARS was caused by SARS-Co V and SARS-Co V alone -
had relied upon the active negotiation and management of multifactorality, then might 
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the possibility of the multifactorial object simply have been forced out rather than ruled 
out? And, if so, then might not multifactorality, at the very least, deserve to have its 
right to a possible existence during the SARS outbreak handed back to it? 
This same reading strategy, this same, self-conscious pursuit of multifactorality, is 
undertaken in the other three case-study chapters also. Ultimately, of course, the aim 
is not simply to generate reasonable doubt, but to foreground the politics bound up 
with the doing of aetiology. Such doubt is, in a sense, only the means to the end of 
asking the kind of research questions that were set out in the opening chapter. And 
indeed, at a point later on in this thesis, in chapter 7, I will have to cast aside the garbs 
of the defence lawyer and become, once more, a humble sociologist. But, nevertheless, 
until that point is reached, it is the hostile atmosphere of the appeal court that will 
provide the setting for the recovery of that all-important possibility of the 
multifactorial object ... 
A crowd of the most vadegated people had congregated in a medium sized, two wind owed court-room, 
which,just below the roof, was sUfTOunded by a gallery, also quite packed. Just inside the railing that 
divided the spectators from the court, the witnesses sat on cowhide-bottomed chairs. Their backs were 
to the gallery. To the left of the court-room entrance sat the jury, straight and alert. The defence lazryer 
and the defendant perched at tables in the centre of the court. A brown notebook, a few dog-eared 
scraps of paper and some yellow tablets Iqy on the lazryer's table; the defendant's table was bare save 
for a copy of Kafka's The Tdal (1925[1986]). In the far corner of the room, slumped in a swivel-
chair and propping her feet up on the bench was the presiding Judge. Around her scumed greyfaced 
little court clerks; creatures of their environment, they appeared as if untouched by wind or sun . .. 
' ... the continuous cell-line culture!' 
In answer to the clerk's booming voice, a little bantam cock of a non-human actant rose and strutted 
to the witness stand, its Vero E6 cells reddening at the sound of its name ... the defence lazryer too 
rose to his feet. Opening his coat and hooking his thumbs into his vest, he walked across to the two 
long windows, and looked out. His glasses had slipped a little, and as he turned and strolled back 
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towards the witness stand he pushed them up on his nose. The jury, unsettled, and thinking 
themselves under close scrutitry paid attention; so did the witnesses, thinking likewise ... the 
questioning began ... 
411Pagc 
Notes 
1 W~, exacdy, did the Mertonian, functionalist sociology of science of the 
post-war period place scientific content off-limits? There, as Merton himself noted, 
the aim was to seek 'not the methods of science, but the mores with which they are 
hedged about' and to disown any 'adventure in polymathy' that would lead one 
towards the former rather than the latter (Merton 1996, 267). So why was this? An 
interesting answer to this question is to be found in Zammito (2004): 'Merton and his 
school adopted an approach to science that conformed perfecdy to what philosophers 
of science in the logical positivist/empiricist tradition had articulated to define their 
own pursuits. This positivist collusion revolved around Reichenbach's discrimination 
of the context of discovery from the context of justification, now reformulated as the 
discrimination of scientific practices from scientific outcomes. Merton and his 
colleagues were prepared to study only practices, consigned already by the 
philosophers of science to the murky actualities of psychology and happenstance, 
while outcomes were reserved for the pure logics of the philosophers of science and 
for the natural scientists themselves' (ibid., 129). For an account of the ways in which 
writers like Fleck, Kuhn, Polanyi, Lakatos and Feyerbend helped sociologists to break 
free from the constricting framework of Merton's functionalist sociology of science, 
and inspired them to start suggesting that 'all the beliefs and practices of any culture 
[i.e, even science] are, in principle, open to sociological explanation' (Barnes 1972,374 
my emphasis), see Lynch and Woolgar (1990, 2-4) and Zammito (2004, 128-136). And, 
for the papers in which the first hints of a move towards a post-positivist sociology of 
science, a sociology in which scientific content would most definitely be placed on-
limits, see Barnes (1969; 1972), Dolby (1971), and King (1971). 
2 The earliest 'laboratory studies' are, of course, Collins (1985), Knorr-Cetina 
(1981), Latour and Woolgar ([1979]1986), Law and Williams (1982) and Lynch (1985). 
But, more recendy, researchers have extended the approach, problems, and style of 
early laboratory studies to other areas. And, of interest there in relation to the 
development of this thesis are Merz and Knorr-Cetina's (1997) study of CERN, the 
European Laboratory for Particle Physics, Henke's (2000) study of agricultural field 
trials, and Breslau and Yonay's (1999) study of economic modelling. 
3 This is Rheinberger's (2000) term for those closed-off sections of the 
material world that scientists employ as 'machines for making the future'. 
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4 The notion of a 'biomedical platform' is taken from Keating and 
Cambrosio's Biomedical Platforms: realigning the normal and the pathological in late-twentieth-
century medicine (2003). There, it was used to foreground less the space of the laboratory 
per se, and rather more the spaces that existed in-between various laboratories. For 
unlike laboratory research, research at the level of the platform 'concerns less the 
production of local and unprecedented "epistemic things" than the constitution and 
circulation of protocols, instruments, and substances between laboratories and the 
establishment of conventions that allow them to be used in the generation of 
biomedical facts' (ibid., 3). Keating and Cambrosio's method during their study of a 
specific biomedical platform, immunophenotyping, was thus to 'detail the 
interlaboratory constitution of conventional substances - in their case cell-surface 
markers - and the equipment, procedures, and clinical and scientific categories 
required for the conduct of interchangeable activities on a global level' (ibid.). Thus, 
biomedical platforms came to be defined as 'specific combinations of techniques, 
instruments, reagents, skills, constituent entities (morphologies, cell-surface markers, 
genes), spaces of representations, diagnostic, prognostic, and therapeutic indications, 
and related aetiological accounts' (ibid., 4). In a sense, my own investigation into the 
practical doing of aetiology during the 2003 SARS outbreak operates at just such an 
inter-space level. 
5 On the notion of the 'infrastructure' as I am using it here, see Bowker and 
Starr's analysis of classificatory technologies in Sorting Things Out (2000). Therein, the 
trick they manage is to study the infrastructure that orders information, objects, and 
people into categories rather than the individual instances of those facts, objects or 
persons. 
6 In this thesis I have preferred to introduce existing sociological studies as 
and when they become relevant during the presentation of particular empirical 
findings. But here, at this particular juncture, I do want to flag up some of the studies 
that were of great help at a more general, methodological level. Taken together, as a 
whole, these were studies that operated in a space between what might, following 
Lock, Young and Cambrosio (2000, 3), be termed the anthropology of medicine, and 
what might, following Law (2004, 12-13) be termed science and technology studies. 
With their close, almost obsessive attention to the technicalities of the biomedical 
sciences, they pushed me to think about the possibility of a deep, 'epistopic' reading 
of the object SARS-CoV (on this, see footnote 8, below). Perhaps of most importance 
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here was the 'praxiographic' work of Mol in relation to the enactment of the unitary 
object of medical knowledge (see for example 1998, 2000, 2002a, 2002b; Mol and 
Berg, 1994, 1998; Mol and Elsman, 1996; Mol and Law, 2004; Mol and Mesman 1996). 
But also of great interest was the work of Berg in relation to medical standards and 
protocols (1992; 1998; Berg and Akrich 2004; Berg and Harterink 2004; and Berg and 
Timmermans 2000); Singleton's (1998) work on the role of the laboratory in cervical 
screening; Hirschauer's (1991) article on the practical doing of surgical work; 
Moreira's (2000; 2004; 2006) work in relation to angiography and neurosurgical 
practice; Landecker's (2007) 'anthropology' of the cell-tissue culture; Casper and 
Clarke's (1998) study of the pap smear; Cambrosio and Keating's research into the 
practice of immunology (Cambrosio and Keating 1995, 1988), and again, elsewhere, 
into the inter-laboratory spaces that have come to regulate the practice of flow 
cytometry (I<eating and Cambrosio 1997; 1999); and, finally, Rasmussen's (1993) work 
on the epistemic role and responsibilifY of the electron microscope for the study of 
mesosomes. 
7 On the concept of the 'implied reader' see Wales (2001). 
8 Another way to make this claim is to engage directly with the 
ethnomethodological literature. In Scientific Practice and Ordinary Action (1993), for 
instance, Lynch's overarching aim is to develop a 'program of investigation' (ibid., 
299); that is, a way in which to 'investigate the sciences' and to 'respecifj (ibid., xi my 
emphasis) the topics that 'so often come up in discussions of science, topics like 
"observation", "representation", "measurement", "proof' and "discovery'" (ibid.). 
Instead of proceeding on the assumption that, say, "observation" possesses an 
epistemological or cognitive unity, any 'Lynch-ian' investigation would begin with a 
re-specification; that is, an examination of how an activity came to identify itself 
precisely as an "observation". The trick, in other words, is to conduct an investigation 
'without assuming from the outset that the local achievement of such activities can be 
described under a rule or definition' (ibid., 281-282). 'Such an investigation', as Lynch 
makes clear, 'would seek to demonstrate how a vernacular use of the term observation 
is uniquely adequate to some practice' (ibid., 283). "Observation", then, would no 
longer be considered as a 'concept', but rather, as an 'epistopic', a complex of various 
epistemic activities uniquely adequate to a particular situation (ibid., 299-308). Now, 
what I have been seeking to make clear in the main body of the text is that here, in 
this thesis, and in order to recover the possibility of the multifactorial object from the 
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2003 SARS outbreak, I have sought to follow Lynch's 'programme of investigation' 
by re-specifying aetiology; that is, by treating it as an epistopic. Lynch would no doubt go 
with me on this. But what I have also been seeking to make clear is that I have sought 
to do so by treating 'aetiology' as a textuallY recoverable epistopic. And it is at that point 
that my own 'programme of (ethnomethodological) investigation' departs from 
Lynch's original 'programme'. (In relation to the possibility of an ethnomethodology 
of the sciences more generally, see Button (1991), Garfmkel et aL (1981), and Lynch 
(1985; 1991; 1992; 2002)). 
9 According to the WHO's own guidelines, SARS could only be declared 
'halted', or 'interrupted' (WHO 2004b, 12), when all known chains of person-to-
person transmission had been broken. And the criteria for determining whether those 
chains had been broken were as follows: 'twenty-eight days' had to have passed 
'between the last reported case of SARS globally having been placed in isolation or 
died and the source(s) and route(s) of transmission having all been identified and 
contained' (ibid., 28). Technically, what this meant was that the official date on which 
the SARS outbreak actually ended was 5th July, 2003 (see WH02004a). As an aside, I 
cannot avoid some mention here of the fact that the WHO's insistence on a 'waiting 
period' of 28 days for infectious diseases like SARS-Co V provided the inspiration for 
the title of Danny Boyle's excellent post-apocalyptic-virus-infected-zombie-horror film, 
28 days later (2002). 
10 Here I am paraphrasing from Foucault's discussion of genealogical, or 
'effective', histories: 'knowledge is not made for understanding; it is made for cutting' 
(1986,88). 
11 Though on the problems of negotiating 'neutrality' and 'symmetry', see 
Ashmore (1996). 
12 For more details on the adversarial system of the Anglo-American court, see 
Drew (1992); and for Goodwin's comments, specifically in relation to the Rodney 
King trial(s), see Goodwin (1994). 
13 Incidentally, for the transcripts of Rene-Prosper Blondlot's day in court, see 
Ashmore (1993); for Franz Moewus, see Sapp (1990); and for Bemard Kettlewell see 
Rudge (2005); and for the curious case of the Piltdown Man 'forgery', see Ashmore 
(1995). 
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'The problem of contamination was overcome ... ,1 
Culturing the coronavirus 
In a global alert issued on 12th March, 2003, the WHO reported a series of 'outbreaks 
of a severe form of pneumonia in Viet Nam, Hong Kong Special Administrative 
Region, China and Guangdong Province in China'. Much of the alert was given over 
to the listing of case numbers, clinical symptoms, and epidemiological information for 
each separate outbreak. But as was also made clear, 'no link 'ha[d] so far been made 
between the outbreaks' (WHO 2003a, para.' 7). Three days later things had changed. 
The WHO issued another global alert in which the outbreaks were treated not as local 
phenomenon but as local instances of a trans-Iocal phenomenon: SARS. With this one 
performative statement the WHO were seeking to render disparate instances into 
expressions of some essence whose structure they all (supposedly) shared. 2 At a 
textual level at least, a singular disease outbreak had been born. What is so striking 
about this 15th March global alert, however, is not so much its performative-work, but 
rather the fact that references to the issue of causality, and the need to provide that 
label with a causal agent, abound. The following extracts are all taken from that short, 
700 word alert: 
During the past week, WHO has received reports of more than 150 new suspected 
cases of SARS, an atypical pneumonia for which a cause has not yet been determined. 
(WHO 2003b, para. 1 my emphasis) 
"This syndrome, SARS, is now a worldwide health threat," said Dr. Gro Harlem 
Brundtland, Director General of the WHO. "The world needs to work together to find 
its cause, cure the sick, and stop its spread". (ibid. para. 3 my emphasis) 
As more information has become available,' WHO-recommensJed SARS case 
definitions have been revised as follows ... Probable Case [of SARS]: A person with an 
unexplained respiratory illness resulting in death, with an autopsy examination 
demonstrating the pathology of Respiratory Distress Syndrome without an identifiable 
~. (ibid. para. 6 my emphasis) 
Until more is known about the cause of these outbreaks, WHO recommends that 
patients with SARS be isolated with barrier nursing techniques and treated as clinically 
indicated. (ibid. para. 7 my emphasis) 
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As the co-ordinator of the WHO's outbreak response team Dr. Klaus Stohr was to 
note some weeks later, the WHO's initial response to SARS was built around the 
principle that 'the unidentified causal agent could lead to an exceptionally dangerous 
outbreak'. In the view of 'WHO epidemiologists and virologists, as long as the causal 
agent remained unknown, and no specific interventions against the agent were 
available,' not only would the chances of SARS 'establish[ing] endemicity' increase, 
but 'specialists in infectious disease control would be forced to resort to the control 
tools of isolation and quarantine'. 3 That was why, as Stohr continued, the 
'identification of the causal agent' had been given 'paramount importance in the 
overall containment strategy' (Stohr 2003, 1730). Indeed, just two days after the initial 
SARS alert on the 15th March, the WHO 'set up a network of scientists from 11 
leading laboratories around the world to expedite identification of the causative agent 
of SARS' (see table 1, below). Collaboration took place 'through daily teleconferences 
and use of a secure WHO website to post electron microscopy pictures of candidate 
viruses, protocols for testing phylogenetic trees, PCR primer sequences, and results of 
various diagnostic tests' (ibid., 1731). 
Virological data soon began to accumulate. As was made clear in chapter 1, for 
instance,4 it was during a WHO organised press conference on 25th March that Stohr 
was able to report on how: 
These 11 laboratories in these nine countries have found already two very strong 
contenders, two viruses which are consistently isolated from many patients from very 
many different countries. (WHO 2003d, para. 4) 
The two viruses to which he referred were, respectively, a humanmetapneumovirus 
(hMPV) from the family Paramyxovirus and the order Nidovirales, and a coronavirus 
(Co V) of the family Coronaviridae and the order Mononegavirales. The former had at 
that stage been identified by the network-affiliated laboratories in Canada, Germany, 
Hong Kong SAR (the Government Virus Unit), and the Netherlands, whilst the latter 
had been identified by the German laboratory and similarly affiliated laboratories in 
Hong Kong SAR (University of Hong Kong faculty of medicine) and the United 
States. But for Stohr, and indeed for the members of the network whom he sought to 
represent during that press conference, these were not aetiologically significant 
findings. The fact that more than one virus had been identified was riot, in their 
opinion, evidence that a complex, multi-factorial disease outbreak was in the process 
47 I P age 
of developing. Already, his metaphoric reference to 'two very strong contenders' in 
the extract presented above might have hinted at his belief in some kind of final 
singularity-to-come. But there is no need for any deep rhetorical analysis here. For as 
he went on to confess during that same conference, 'we are all a bit puzzled by these 
results' (ibid. para. 16). And the 'puzzlement' of St6hr's collective "we" stemmed 
from the fact that, as he had explained a few minutes earlier, 'it is not normal that one 
disease is caused by two viruses' (ibid. para. 5). As a result, 'research was ongoing' and· 
'laboratories would have to strengthen their research activities' (ibid.). 
Research Institute Country 
Centres for Disease Control and Prevention, United States of America 
Georgia, Atlanta. 
Erasmus Universiteit, National Influenza Centre, Netherlands 
Rotterdam. 
Government Virus Unit, 9/F Public Health Hong Kong Special Administrative Region (SAR) 
Laboratory Centre. 
Virology Laboratory, Chinese University of Hong Hong Kong SAR 
Kong, Prince of Wales Hospital. 
Institut fur Medizinische Virologie im Klinil.:um der Gennany 
Johann Wolf gang Goethe-Universitiit Frankfurt am 
Main, Frankfurt. 
Institut Pasteur, Unite de Genetique Moleculaire des France 
Virus Respiratories, National Influenza Centre 
(Northern France), Paris. 
National Institute ofInfectious Diseases, Japan 
Department of Viral Diseases and Vaccine Contro~ 
Tokyo. 
National Microbiology Laboratory, Population Canada 
Public Health Branch, Health Canada, Winnipeg. 
Public Health Laboratory Service, Central Public United Kingdom 
Health Laboratory, London. 
University of Hong Kong Faculty of Medicine, Hong Kong SAR 
Queen Mary Hospital. 
Virology Unit, Singapore General Hospital. Singapore 
Table 1: The ongmal members of the WHO SARS laboratory network 
The first indications that SARS was a 'normal' rather than an 'abnormal' disease were 
not long in coming. Indeed, with remarkable rapidity the hMPV ftndings were 
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forgotten, and a consensus began to build around the aetiological significance of Co V 
and Co V alone. The denouement to this tale of aetiological discovery came soon 
afterwards, at another WHO-led press conference on 161h April. Many of the scientists 
from .those eleven networked research institutes joined Stohr on the panel for this 
particular conference. In his opening statement to the journalists who had gathered at 
the WHO's headquarters in Geneva, Stohr made clear that 'all the data have been put 
on the table, have been reviewed, and the colleagues have come to a consensus 
agreement' (WHO 2003m, para. 3). The consensus agreement, as he went on to note, 
meant that 'we can now, with all confidence, say that the causative agent of SARS is 
the coronavirus first detected in Hong Kong on 21 sI March 2003' (ibid. para. 8). 'The 
conclusion today,' as Dr. Albert Osterhaus, a member of the Netherlands group 
added, was that 'the coronavirus alone was capable of causing the typical symptoms [of 
SARS], (ibid. para. 27 my emphasis). 
I. IN DEFENCE OF A POSSIBILITY 
As this story has been designed to suggest, the aetiological investigation into the 2003 
SARS outbreak started and ended in a world of singularity. One disease normally has 
one cause, and in this instance one disease - SARS - was found to have one cause - a 
coronavirus. With remarkable speed, Dr. Stohr's normality, the cornerstone of 
modem medical microbiology, was vindicated by laboratory diagnostic techniques. 5 
Aetiologically, then, things were remarkably stabl~, unproblematic and natural during 
the telling of this story. Indeed litde would appear to have changed since Robert Koch 
and a team of German bacteriologists went looking for the one, single causal agent 
behind a cholera outbreak in Egypt during 1884, and returned home a year later to a 
hero's welcome having found that one, single causal agent: the cholera bacillus, or, as it 
is now known, the Vibrio Cholerae.6 In this chapter, however, I want to try and defend 
the possibiliry of multifactorality; the possibiliry that this one disease, SARS, could, in fact, 
have had multiple pathogenic causes. Given the stable and seemingly unproblematic 
nature of SARS-Co V this is a difficult task for a simple defence lawyer. But note: all I 
seek to defend here is the possibiliry, not the actual existence, of multifactorality. In this 
court of appeal it is enough, sometimes, simply to be able to give back to a defendant 
the rights to their own possibility; rights that they previously had taken away from 
them with no attention to due process. 
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But the question that needs to be asked now of course is whether multifactorality ever 
had this kind of a possibility in the fIrst place. Much of this chapter is necessarily 
given over to answering that question. In section ll, below, an attempt is made to 
narrow the focus a litde with an examination of a research article in which one of the 
first research groups to actually identify the coronavirus detailed their 'discovery-
work'. The article in question is 'A novel coronavirus associated with severe acute 
respiratory syndrome' (henceforth NCA), and the group in question, working out of 
the Centres for Disease Control and Prevention Adanta, USA, was led by the 
virologist Dr. Thomas Ksiazek. 7 An initial reading of the article makes clear that 
despite a multitude of different diagnostic techniques having been at play during the 
group's discovery-work, all were in fact dependent on just one single technique: the 
cell-culture. It had to do its diagnostic work before they could be made to do theirs. A 
much closer ethnomethodological reading of that group's cell-culturing work is then 
presented in sections Ill, IV and V. Delving into the technical details of the paper it is 
suggested that the cell-culture was actually coercing singularity into existence: from the 
initial gathering of patient samples to the final observation of the cultured cell-line, a 
number of technical virological practices were deployed in order to enact a singular 
pathogen, isolated and alone, whilst also, and at the same time, suppressing any hint of a 
multifactorial object. To strengthen the defence case, those multifactorial "hints" are 
recovered from the moments in which they were discarded, and the ways in which 
they could have been taken to have been pointing towards the possible co-existence of 
two equally plausible, and equal!J possible, aetiological objects, brought to the fore. In 
the chapter's closing comments (section VI), an accusation is made against the cell-
culture. Rather than acting as an innocent party to a stable, unproblematic and natural 
world of singular aetiological objects, I move to suggest that the cell-culture had, in 
fact, actively and knowingly sought to silence, suppress and exclude, any other kind of 
object again and again, anew, afresh, each time it was set to work during the outbreak. 
11. ISOLATING THE CORONAVIRUS 
Three of the eleven research teams in the laboratory network were quick to publish 
research papers detailing their work of discovery. On April 8th, a team led by Malik 
Peiris at the University of Hong Kong Faculty of Medicine, Queen Mary Hospital in 
Hong Kong, published the results of their studies in The Lancet (peiris et aL 2003). 
Then, on April 10th, two teams, one led by Thomas Ksiazek at the Centre for Disease 
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Control and Prevention, in Adanta, USA, and the other team led by Christian Drosten 
from the Bemard Nocht Institute for Tropical Medicine in Hamburg, Germany, 
published the results of their own respective studies in the New England Journal of 
Medicine (K.siazek et al 2003; and Drosten et al 2003; and see table 1 above).8 Allowing 
for a few minor variations in modalising technique the conclusions to all three papers 
are identical: 
A coronavirus was isolated from patients with SARS that might be the primary agent 
associated with this disease. (peiris et a/. 2003, 1319) 
A novel coronavirus was isolated from patients ... and the evidence indicates that this 
virus has an etiologic role in SARS. (Ksiazek et a/. 2003, 1953) 
A novel coronavirus ... was isolated. The novel coronavirus might have a role in causing 
SARS. (Drosten eta/. 2003, 1967) 
'Isolation' of the coronavirus seems to have represented a key moment for each of the 
research groups. In linguistic terms, the verb 'to isolate' indicates an intention process: 
the Actor, the scientific research team, deliberatelY connecting with its Goal, the 
coronavirus. Left out of this formulation, however, placed in a textual ellipsis as it 
were, is the identity of the Inanimate Actor through which the connection between 
Actor and Goal had been established.9 Given that the 'ideal reader' in each instance 
was a professionally trained microbiologist, omissions such as these are to be expected. 
Nevertheless, they make it a litde more difficult for the (non-ideal) lqy reader to 
establish the exact identity of the diagnostic technique, or techniques that performed 
the isolation.1O The three papers in question are packed full of references to a whole 
range of different diagnostic techniques, all of which were used at some stage during 
the investigation: cell cultures, electron microscopes, enzyme-linked immunosorbent 
assays (ELISAs), reverse transcriptase and real-time polymerase chain reactions 
systems (RT-PCRs), indirect fluorescent antibody tests, immunohistochemical assays, 
and so on and so forth. 
But which had performed the crucial work of 'isolation'? 
Interestingly, it is Malik Peiris, the leader of the Queen Mary University, Hong Kong 
research team, who provides the most useful hint to a lay-reader at this stage. In a 
retrospective paper, looking back at the aetiological investigation many months after 
the outbreak had ended, he wrote that: 
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It was interesting how the techniques that played the key roles in identification of the 
aetiological agent of SARS in all three laboratories [that is, his own, Drosten's and 
Ksiazek's] were the traditional methods of cell culture. (peiris and Guan 2004, 39 my 
emphasis) 
The 'interest' in this for Peiris was undoubtedly caused by the counter-intuitive nature 
of what he was suggesting. For although virus isolation on cell-culture had once 
represented the "gold standard" of diagnostic virology, the method to which all others 
were compared and adjusted, 11 the recent development of molecular diagnostic 
methods such as the polymerase chain reactionl2 - which is capable of searching for 
specific viral RNA genome segments in clinical specimens - had been taken by some 
to have heralded the dawn of a new era in virological research.13 In 2000, for instance, 
and three years before the SARS outbreak, a laboratory manual was published in 
which it was noted, quite matter of facdy, that cell-culture techniques were 'gradually 
being replaced by immunologic and molecular procedures' (Storch 2000a, 2).14 But at 
this juncture, if we turn to examine NCA in a litde more detail, it is possible to 
understand that Peiris' retrospective comments, however counter-intuitive they might 
have been, were not exaggerating. For despite their apparent displacement at the 
hands of molecular methods, the following reference to cell-cultures can be found 
therein: 
The identification of this novel coronavirus relied on classic tissue-culture isolation to 
amplify the pathogen and then on electron-microscopical studies to identify the type of 
virus, a member of the family Coronaviridae, and molecular studies to conftrm the 
identity of the virus, characterise its unique nature, and help link it to the disease. 
(Ksiazek et aL, 1961 my emphasis) 
With Peiris' comments in mind, this reference starts to appear noteworthy. It is not 
mere coincidence that the cell-culture method appears first in order of textual 
importance here. In order to explain why, the two underlined words in the passage 
above require some comment. Firsdy, 'amplify'. By its very nature, the technique of the 
. cell-culture 'is an amplification method that increases the amount of the putative 
pathogen, facilitating detection and characterisation'. This, its ability to create more of 
the object of interest to researchers, is what 'sets it apart' from other diagnostic 
methods (Storch 2007, 568). It is also that which made it a crucial technology in the 
context of the SARS outbreak - virologists like Ksiazek were having to work with 
minute samples taken from very ill, highly infectious, and sometimes even dying, 
52 I P age 
patients.15 Indeed this latter point goes some of the way towards explaining the double 
meaning of the second italicised word, 'reliee!. On the one hand, whilst 'amplifying' the 
material in samples, the cell-culture acted to discover that material: it made a stock of 
so~ething, and that something turned out to be a colony of coronaviruses. Ksiazek 
and his team relied on the cell-culture to discover the coronavirus. But, on the other hand, 
and in order to 'identify the type of virus' under electron microscope, and to 'confirm 
the identity of the virus' with molecular studies, that same basic stock of coronavirus 
material had to be turned, ethnomethodologically speaking, from topic into resource. 
Ksiazek and his team relied on the cell-culture to confinn the discovery of the coronavirus. 
The findings presented in NCA, in other words, were built out of the technology of 
the cell-culture. Everything that Ksiazek and his team of research scientists did 
stemmed from the cultivation of a coronavirus on various continuous cell-culture 
lines. Indeed this claim can be evidenced in a little more detail if NCA's 'methods' 
section is explored. Firstly, there were the electron microscopy studies, in which: 
Tissue-culture samples showing cytopathic effect were prepared for electron-
microscopical examination. (Ksiazek et al. 2003, 1954 my emphasis) 
Secondly, there were the serological tests. A 'master seed' of coronavirus (of which 
more will be written in section (IV), below) was prepared: 
From the culture supematant and cells by freeze-thawing the culture flask, clarifying 
the thawed contents by centrifugation at 1000xg, and dispensing the supematant into 
aliquots stored in gas phase over liquid nitrogen. (ibid., 1955 my emphasis) 
This 'seed' was then used to generate 'antigen' for further diagnostic tests, and was: 
Sub cultured into 850cm2 roller bottles of Vero E6 cells for the preparation of formalin-
fixed positive control cells for immunohistochemical analysis, mixed with normal E6 
cells, and gamma-irradiated for preparation of spot slides for indirect fluorescence 
antibody tests or extracted with detergent and gamma-irradiated for use as an enzyme-
immunosorbent assay (ELISA) antigen for antibody tests. (ibid.) 
Thirdly, there were the immunohistochemical studies, in which: 
The pathological and immunohistochemical studies began with the staining of the 
formalin-ftxed, parafftn embedded Vera E6 cells infected with the novel coronavirus. 
(ibid., myemphasis) 
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And, finally, there were the molecular PCR tests in which: 
RNA extracts were derived from 100~ of each specimen (or culture supernatant) with 
the automated NucliSens extraction system. (ibid., 1956my emphasis) 
It might initially appear from this extract as if not all RNA extracts necessarily derived 
from previously cultured materials ('of each specimen (or culture ... )'). But what this 
slighdy ambiguous formulation lacks, however, is a sense of its own temporal defeITal. 
For what has to be understood here is that it was the primary cell-culture material that 
allowed, eventually, for this either/or choice to become a possibility for Ksiazek and 
his colleagues. This has to be so. PCR tests are 'probe specific'; that is, they need a 
primer, containing genomic information on a known virus within a distinct order and 
family, in order to detect nucleotides specific to that virus within a case sample.16 And 
as N CA makes clear: 
Oligonucleotide primers used for amplification and sequencing of the SARS-related 
coronavirus were designed from alignments of open reading frame 1 b of the 
coronavirus polymerase gene sequences obtained from Genbank. including human 
coronaviruses 229E and OC43 (accession numbers X69721 and AF124989 
respectively). (ibid., 1955 my emphasis) 
To obtain these specific sequences from Genbank,17 Ksiazek and his colleagues must 
already have suspected that they were dealing with a coronavirus. And the only way in 
which they could have suspected that was if the patient samples had already been 
cultured and examined through an electron microscope. This reference to 'Genbank', 
in other words, is evidence that the peR tests were carried out after the cell-cultures 
had done their preparatory work. Only from that point forth could the selection of 
gene sequences 229E and OC43, with the accession numbers X69721 and AF124989 
respectively, have been anything other than pure guesswork. And only from that point 
forth too, could it have been irrelevant whether primary 'specimen' or secondary 
'culture supernatant' was to be used in a PCR test. 
The cell-culture, then, that seemingly mundane, innocuous diagnostic technology, 
turns out, on my reading at least, to have been crucial in the enactment of the SARS 
coronavirus. Borrowing a metaphor from Derrida's work, it can perhaps be said to 
have acted as something akin to a 'transcendental signified' for all subsequent 
diagnostic tests. 
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Ill. NCA AND THE CELL-CULTURE 
Having argued for the centrality of these technologies, I now want to try and develop 
a deeper, epistopic reading of the cell-culture work detailed in 'A novel coronavirus 
associated with severe acute respiratory syndrome' (NCA). As already stated, my aim 
here is simple: to search for the possibility of multifactorality. And that is why, over 
the course of the next few sub-sections, a great deal of attention will be paid to the 
ways in which: (a) an inoculum was developed for inoculation onto cell-cultures; and 
(b) the ways in which those cell-cultures subsequently worked to 'amplify' that 
inoculum. 
Moving upstream 
In the laboratory manual Jawetil Me/nick & Ade/berg's Medical Microbiology (Brooks et al. 
2004) there is a section entitled 'Purification and Identification of Viruses' (ibid., 380-
381). Therein, it is noted that the 'starting material' for studies of viruses 'is usually 
large volumes of tissue culture medium, body fluids, or infected cells' (ibid., 380). But 
as that section goes on to make clear, those starting materials have to go through a 
process of 'purification' (ibid., 380) prior to their actual inoculation onto a cell-
culture: 18 
Pure virus must be available in order for meaningful studies on the properties and 
molecular biology of the agent to be carried out. (ibid. 381 my emphasis) 
The question of why purity is deemed such an imperative can, for the moment, be left 
to one side. Here, it is enough to relate this procedural information back to the work 
of discovery reported in NCA. For what Ksiazek and his research team made clear 
during that article's introductory section is that they 'received clinical specimens from 
[SARS] patients in several countries' before then testing them in the hope of 
'identify[ing] a range of potential pathogens' and, perhaps even 'the etiologic agent of 
the outbreak' (Ksiazek et al. 2003, 1953 my emphasis). Given this information, it can 
safely be assumed that one of their flrst research tasks would have involved some kind 
of 'puriflcation' of those 'received clinical samples'. 
So what might that puriflcation have entailed? 
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This is by no means an easy question to answer. Consider the following extracts. Both 
appear in the 'Methods' section of NCA (ibid., 1954-1956), the first under the sub-
heading 'Molecular Analyses', the second under the sub-heading 'Isolation of Virus': 
RNA extracts were prepared from 100 ~ of each specimen (or culture supernatant) 
with the automated NucliSens extraction system (bioMerieux). Oligonucleotide primers 
used for amplification and sequencing of the SARS-related coronavirus were designed 
from alignments of open reading frame Ib of the coronavirus polymerase gene 
sequences obtained from GenBank, including human coronaviruses 229E and OC43 
(accession numbers X69721 and AF124989, respectively), canine coronavirus 
(AF124986), feline infectious peritonitis virus (AF124987) ... Primer pair IN-2(+) 5' 
GGGT TGGG ACTA TCCT AAGT GTGA3' and IN-4 (-) 5' TAAC ACAC AACI 
CCAT CATCA3' was previously designed to conserved regions of open reading frame 
1 b to achieve reactivity with the genus coronavirus. These primers were used to 
amplify DNA from SARS isolates, and the amplicons sequences obtained were used to 
design SARS-specific primers Cor-p-F2 (+) 5' CTAA CATG CTTA GGAT AATG 
G3' Cor-p-F3(+) 5' CTAA CATG CTTA GGAT AATG G3' and Cor-p-Rl (-) 5' 
CAGG TAAG CGTA AAAC TCA-TC3' ... All specimens were tested for human 
glyceraldehyde 3-phosphate dehydrogenase to confum RNA integrity and 
control. .. One primer for each set was 5'-end-Iabelled with fluorescent dye 6-
carboxyfluorescein (6-FAM) to facilitate GeneScan analysis. One step amplification 
reactions were performed with the Access RT-PCR System (promega) as previous 
described. Positive and negative RT-PCR controls, containing standardized viral RNA 
extracts, and nuclease-free water were included in each run. (ibid., 1955-1956) 
To identify viruses associated with SARS, we inoculated a variety of clinical specimens 
(blood, serum, material from oropharyngeal swabs or washings, material' from 
nasopharyngeal swabs, and tissues of major organs collected at autopsy) onto a number 
of continuous cell lines, including Vero E6, NCI-H292, MDCK, LLC-MK2, and B95-8 
cells. All cultures were observed daily for cytopathic effect. Maintenance medium was 
replenished at day 7, and cultures were terminated 14 days after inoculation. (ibid., 
1954) 
The first extract provides detailed information about the vatlous PCR tests 
undertaken on ribonucleic acids extracted from SARS samples. There are two things 
that are of interest about it here. Firstly, its content. It is a severelY technical extract, 
probably beyond the comprehension of all but those with a background in virological 
research. Secondly, its length. As the ellipses perhaps indicate, the extract presented 
above represents only a quarter of the total information included within the sub-
section 'molecular analyses'. The second extract, however, is far less technical and 
occupies far less textual space than the first. Indeed it represents the only attention 
given by NCA to the practice of working-up a cell culture. These differences are 
significant. That the specific conditions of production for the molecular test are 
displayed, and displayed at such great length and in such painstaking detail, indicates 
something of their 'new-ness' within the virological sciences. K.siazek and his research 
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team have to lead their readers through nearly every step that they took at a molecular 
level. Human hands and human ingenuity are readily identifiable. But those hands 
suddenly disappear when attention switches to the cell-cultures. Over their many years 
of use within the medical microbiological sciences, they have become entrenched 
methods. And that is why, in comparison to NCA's molecular methods, they seem to 
have been taken for granted. Ksiazek and his research team do not feel the need to 
lead their readers through so many steps here: a few basic references are given, but 
that is all. Perhaps the only glimpse of human hands and human ingenuity comes with 
the use of the transitive verb 'to inoculate'. And yet, even there, nothing is written 
about the specificities of the process. An entire context of discovery slips away into 
the shadows created by this verb.19 
This 'slippage' is both a problem and an analytic insight. An analytic insight because 
of course when it gets as difficult as this to re-cover the how of something, the chances 
of anyone asking wf?y are gready diminished.20 A problem too, however, because NCA 
is treating this section's object of interest, the purification process pursued by Ksiazek 
and his research team in order to make NCA possible, as so mundane and 
uninteresting as to warrant litde comment. To solve this problem and to keep the 
object of interest in sight, it is necessary to take a step backwards, developing the 
defence case from a position upstream in the scientific-knowledge-production-process 
before the publication ofNCA became a possibility.21 
The collection, transportation and preparation. of clinical samples 
As good an upstream starting point as any is the most recent edition of the 
"virologists bible", Fields Virology (Knipe and Howley (eds.) 2007). Included within 
chapter 17, 'Diagnostic Virology' (Storch 2007, 565-594), is a small sub-section 
entided 'specimens for viral diagnosis' (ibid., 566). Therein, it is noted that 'the 
likelihood of making a specific viral diagnosis depends largely on the quality of the 
specimen that is received in the laboratory'. Important variables are listed as ~the type 
of specimen, the quality and amount of specimen material obtained, and the time and 
conditions of transport to the laboratory' (ibid.). NCA itself does in fact provide a 
litde information on the first variable, the type of specimens received by Ksiazek's 
research team: 
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To identify viruses associated with SARS, we inoculated a variety of clinical specimens 
(blood, serum, material from oropharyngeal swabs or washings, material from 
nasopharyngeal swabs, and tissues of major organs collected at autopsy) onto a number 
of continuous cell lines. (I<::siazek et al, 1954 my emphasis) 
And, despite the fact that it omits any reference to the quality of the specunens 
(variable 2), or the ways in which they were prepared for transport to, and inoculation 
within, the laboratory (variable 3), such information is not hard to come by. For as has 
already been mentioned, Ksiazek's research team were working as part of the WHO's 
SARS laboratory network. As a result, they were using samples prepared and 
transported along lines set out in the WHO's own SARS laboratory recommendations. 
Table 2, below, for instance, is taken from the WHO's own sampling 
recommendations, and can be found in the WHO's 'Sampling for severe acute 
respiratory syndrome (SARS) diagnostic tests' document (WHO 2003zu, henceforth 
'Sampling): 
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1 
I 
Type of specimen I Method I Medium/ container/ shipment 
Na~QjlhaI):n~al Q[ Swab: us~ Qnl}: stl::ril~ Dal:ron or St~ril~ vials with viral trllnsp0!1 m~dia 
orophaI):ngeal ra}:Qn swab with plastil: shaft 
Ship on ic~ (+1;0Q 
Tracheal 
I 
Aspirate Centrifuge half aU pellet fixed in formalin. 
Un.rpunfluid in sterile tiaL Ship on ice; or fzxed 
cells at RT, unfi.wd cells frozen. 
Bronchalveolar lavage 
I 
Pleural fluid 
I 
Pleural tap 
Urine Clean catch, sterile container CentnJuge, n-suspend sediment in 2-3 ml sterile 
transport medium, tissue cultun medium, or 
phosphate-buffend sali",. 
Stool 
I 
1 0-50 ml in a stool cup or urine 
container. Ship on ice 
-
Conjunctiva Swab: use only sterile Dacron or Sterile vials with viral transport media 
rayon swab with plastic shaft 
Ship on ice 
Serum 
I 
>= 200 m I preferred. Ship on ice or 
frozen 
Whole blood 
I I 
EDTA 
Ship on ice 
Blood 
.1 1 
Standard blood culture bottle 
Tissue (biopsy, autopsy) 
I 
Lung, upper airway Sterile container with liral transport medium or 
saline. Fresh frozen: _70°C 
I 
Major organs Formalin fixed or paraffm embedded. 
Ship at RT (Room Temperature] 
.... TABLE 2 - WHO Summary of SamplIng POSSibilItIes (my emphasIs) 
Given that NCA refers to its use of nasopharyngeal specimens, and given too that 
Sampling suggests such specimens as 'the specimens of choice for the detection of 
respiratory viruses' (ibid.), I want to devote some attention to the WHO's 
recommended methods for collecting nasopharyngeal samples: 
Have the patient sit with head tilted slightly backward. Instill 1 - 1.5 ml of 
nonbacteriostatic saline into one nostril. Flush a plastic catheter or tubing with 2-3 ml 
of saline. Insert the tubing into the nostril parallel to the palate. Aspirate. 
nasopharyngeal secretions. Repeat this procedure for the other nostril. (ibid., my 
emphasis) 
Already at the very ftrst stage of specimen collection it would seem that a process of 
'puriftcation' has begun. 'Nonbacteriostatic saline', 'saline': removal of unwanted 
bacteria seems to have been of paramount importance here. Indeed as one laboratory 
manual concludes 'a preliminary puriftcation [at the level of the clinic] will remove 
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most non-viral matter' (Butel 2007, 380). But what now of variable 3, preparation of 
those samples for transport? The medium for storage advocated by the WHO was: 
Sterile vials with viral transport media [henceforth VTMJ. (WHO 2003zu) 
Why? Because, as one review article puts it, clinical samples collected from the nose 
will be 'contaminated with microbial flora' (Leland and Ginocchio 2007, 50 my 
emphasis). The metaphor of contamination perhaps already suggests what is going to 
happen to the flora. But another laboratory manual makes its fate even clearer: 
'normal endogenous flora must be suppressed ... contaminating organisms must be 
removed during sampling' (Elliot et al. 2007, 127). This also explains why the WHO 
recommended that they be collected with a Dacron or polyester swab and 
subsequendy placed in a sterile vial with a VTM, given that VTMs will 'contain 
antibiotic! along with 'a buffered salt solution, and a proteinaceous substance (such as 
albumin, gelatin, or serum), and a pH indicator' (Leland and Ginocchio 2007, 50 my 
emphasis).22 
These antibiotics and 'nonbacteriostatic saline' solutions, then, marked the start of a 
de-contamination process that would have continued when the specimens arrived at 
Ksiazek's laboratory. ~ut even at this stage, there is only one passage from NCA in 
which any kind of hint is given as to what the laboratory processes of purification 
might have entailed: 
Given the serious nature of SARS and the suggestion of person-to-person transmission, 
it was decided to handle all clinical specimens in a biosafety level 3 environment. All 
division into aliquots, pipetting, and culture attempts were performed in laminar-flow 
safety cabinets in a biosafety level 3 laboratory. (Ksiazek et a/. 2003, 1954) 
It seems to have been deemed more important to alert readers as to where 'handling' 
and 'culture attempts' had taken place, rather than how they had taken place. And so, 
once again, it is necessary to look beyond NCA in order to understand the activities 
suggested by these phrases. Turning to JawetiJ Me/nick & Ade/berg's Medical Microbiolo!!Jl 
(Brooks et al. (eds.) 2007) the following information is presented under the heading 
'Virus culture: preparation of inocula':23 
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Bacteria-free fluid materials such as cerebrospinal fluid, whole blood, plasma, or white 
blood cell buffy coat layer may be inoculated into cell cultures directly or after dilution 
with buffered phosphate solution (PH 7.6). (Carroll2007, 725) 
However, it is also noted that materials containing: 
Bacteria (throat washings, stools, urine, infected tissue, or insects) must be inactivated 
or removed before inoculation. (ibid., my emphasis) 
The nasopharyngeal swabs received by Ksiazek's research team were obviously 
materials of the latter type. They would have been 'contaminated'. Processes of 
'inactivation' or 'removal' thus had to be completed in the laboratory rather than the 
clinic. But how would this have been achieved? Although 'specimen processmg 
guidelines differ from laboratory to laboratory' it is nevertheless true that 'most 
laboratories clarify certain sample types (e.g., respiratory samples) as follows prior to 
inoculation into cell cultures' (Leland and Ginocchio 2007,50):24 
The transport medium tube is vortexed, the swab is discarded, the liquid medium is 
centrifuged ... material may [then] be liquefied in antibiotic - containing medium and 
filtered through a 0.45-llm ftlter. The end product is a supematant fluid that can be 
used to inoculate cell cultures. (ibid., my emphasis) 
In virological terms, 'to vortex something is to release the contents of the swab into a 
fluid solution. But it is the use of a differential centrifuge that is perhaps of most interest 
here.25 In a differential centrifuge: 
A suspension is centrifuged at low speed (not >2000 rpm) for 10 minutes to sediment 
insoluble cellular debris ... It is a convenient method for removing many bacteria from 
heavily contaminated preparations of small viruses. Bacteria are sedimented at low 
speeds that do not sediment the virus, and high-speed centrifugation «2000 rpm) then 
sediments the virus. The virus-containing sediment is then re-suspended in a small 
volume. (Carroll 2007, 727-728) 
In this way not only bacteria, but also fungi, cells, blood mucus, fibres, etc., are pelleted into 
the bottom of the spun tube, while the viruses in the 'suspension', which will not be 
spun down by the g-force generated by most general laboratory centrifuges, can be 
collected. A fascinating form of distribution. Much effort in constructionist science 
studies over the years has been devoted to grappling with the question of how 
controversies close. The end result has usually been a suggestion that things could have 
been otherwise; that alternative constructions of reality might have been possible in the 
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past, but that they vanished before they ever could fully blossom. In the case of this 
differential centrifuge, however, it is possible to suggest that there is actually a 
possible co-existence of two different realities - the singular object and the multiple 
aetiological object. The only caveat that has to be added here (and it is an important 
caveat) is that the technology itself manages to distribute the two realities into 
different but co-present 'sites'. At this stage, it seems as if two different yet equally 
possible worlds are separated by less than a few inches of murky liquid. This tension 
between distance and proximity will be seen again and again in the readings that 
follow.26 
It is also worth pointing out here that the 'liquid medium' referred to above would 
have been treated with 'bactericidal agents', either antibiotics or even ether if it had been 
considered non-harmful to the virus in question. 27 These agents would have been 
added to the supematant in concentrations of 10-15%. In addition, it is possible that 
'extensively contaminated material' from the nasopharyngeal aspirates would have 
been 'liquefied in antibiotic-containing medium and ftltered through a filter (Smith 
2000, 13). The extract presented above suggests the use of a 0.45-f.lm (micro-metre) 
size ftlter, but in fact the size of the ftlter would have been up to Ksiazek and his 
colleagues (the standard sizes are 0.45-f.lm 0.65-f.lm and 0.90-f.lm). Irrespective of the 
final' choice, however, the function of the ftlter is clear: to separate smaller viral 
particles from the larger bacterial 'debril (Forman and Valsamakis 2003, 1228 my 
emphasis): bacterial life forms, measuring between 1 and 5 micrometres in diameter, 
would not have found their way through the ftlter. Again, a form of distribution: the 
difference between the singular object and the multiple aetiological object might, 
ultimately, have been determined here by a pore less than a micrometre in diameter. 
Before moving on, however, it is important to make clear that I have not based my 
analysis around the nasopharyngeal samples because they were in some way uniquely 
touched by this purification process. If we look, briefly, at the preparation of 'tissue 
samples' (see table 2, above) we see a similar process of purification being advocated. 
The method of collection suggested in the WHO document was simply 'lung/upper 
airway'. In other words, there was no special method of collection of tissue samples: 
physicians could use their own pro to cols there. The samples were to be transported to 
Ksiazek's laboratory without any preparation except that of the viral transport 
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medium. But turning to some other laboratory manuals it becomes clear that, upon 
arrival at Ksiazek's laboratory, these tissue samples would have been worked over in 
the following ways: 
Washed in media or sterile water, minced into small pieces with scissors, and ground to 
make a homogeneous paste. Diluent is added in amount sufficient to make a 
concentration of 10-20% (weight/volume). (Carro1l2007, 727) 
Then, these steps would have been followed by: 
The concentration of the virus particles by precipitation with ammonium sulphate, 
ethanol or polyethylene glycol ,or by ultra ftltration. (Butel 2007, 380) 
And finally, the resulting suspension would either have been passed through a 
'millipore type membrane mter of cellulose acetate or similar inert material to separate 
smaller viral particles from the larger debris', or, alternatively, it would have been 
'centrifuged at low speed (not >2000 rpm) for 10 minutes' (ibid). 
Purifications 
These practices all had to be performed before Ksiazek and his research team could 
write in NCA of how they: 
Inoculated a variety of clinical specimens (blood, serum, material from oropharyngeal 
swabs or washings, material from nasopharyngeal swabs, and tissues of major organs 
collected at autopsy) onto a number of continuous cell lines. (Ksiazek et aL, 1954) 
But what to make of this purification process from the perspective of multifactorality? 
If the process through which those samples had passed had been designed to purify 
samples of all laboratory contaminants; that is, entities that had contaminated samples 
rifter their collection from the body, then there would be little that a multi-factorialist 
would find troubling about it. But laboratory contaminants were not the only 
contaminants being purified. Entities from the same bodies, and the same sites within 
those bodies, as any potentially viral entities were also being treated as 'contaminants' 
and 'impurities'. And, as a result, it is difficult to see how a'!)' but viral particles could 
have survived in the clinical samples received by Ksiazek's laboratories in Atlanta. 
Of course from Dr. St6hr's perspective, it is easy to see why bodily 'contaminants' 
were treated precisely as 'contaminants' - if one disease normally has one cause, then 
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inevitably, with a disease like SARS, in which none of the cases were responding to 
antibiotic treatment, only viral particles were likely to be of interest. But from a 
multifactorial perspective this starts to seem very much like a self-vindicating style of 
practice. To explain why, it is useful to recall the multifactorial belief that: 
The great majority of microbes are found in nature and carry out their normal activities 
not in pure cultures, but in mixed populations. (Winogradsky, cited in Waksman 1949, 
333) 
The 'most essential ecological factor' here was 'competition, since it is precisely this 
factor that determines the distribution of the processes implemented by microbes in 
nature, and automatically directs the succession of these processes' (Winogradsky 
1952, 783). As a consequence, 'the complexity of .most ecological systems rendered it 
difficult to single out anyone particular component of the system as playing a role of 
unique importance in the causation of disease' (Dubos [1959]1996, 108-109). Indeed, 
the very possibility of the multifactorial object is perhaps reflected in the amount of 
rhetorical work that laboratory manuals have to perform in order to draw some kind 
of dividing line between 'purity' and 'impurity': 
Specimen from sites with a normal flora (e.g. upper respiratory tract, faeces, genital 
specimens) - cultured on selective media designed to suppress normal endogenous 
flora but allow likely pathogens to grow. 
Sputum and urine specimens are sometimes described as 'clean contaminated', because 
normally both should be sterile, although they may become contaminated during 
sampling: sputum by upper respiratory tract flora or urine by perineal flora. Some 
'contaminating organisms' may also cause contamination (e.g. pneumococci from the 
pharynx may contaminate sputum). Quantitative culture is performed to help 
distinguish contamination Qow numbers of bacteria/several different bacterial species) 
from infection (high numbers of single bacterial species). (Elliot et aL 2007, 127 my 
emphasis) 
'Normal flora', 'clean contaminated', 'contamination versus infection': from a 
multifactorial perspective these distinctions simply make no sense. 
And yet what the making of such distinctions serves to achieve in the case of a disease 
like SARS is the removal of all that might have been of interest from a multifactorial 
perspective: the bacterial life-forms that co-existed with, and perhaps even interacted 
with, viral life-forms. Even the slightest possibility that the samples in question might 
have been taken from patients suffering from a multifactorial disease was suppressed. 
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Might those 'contaminants' and 'impurities' have played their parts in the aetiology of 
SARS? I cannot answer this question one way or the other. But rather more 
importandy, neither can Ksiazek or his research team. 
These practices of bacterial purification are explicit and obvious. But then, might there 
not also be implicit processes of purification at work here on any viral matter included 
within those samples? Consider the information provided in Table 2 regarding the 
'method' for obtaining nasopharyngeal samples. There, reference is made to the need 
to keep the sample cool (2 to SC or on wet ice) until a time when cell culture 
inoculation can begin. Why this need for cool temperatures? Because: 
In contrast to molecular or serologic detection techniques, which can often identify 
virus in the absence of intact virus ... viral isolation techniques require intact, infectious 
virus. (Specter et al. 2002, 243) 
And to preserve the viral titer and viral infectivity of culture specimens: 
The specimen should be transported to the laboratory as quickly as possible after 
specimen collection to ensure its integrity. When immediate transport is not possible, 
the specimen should be kept refrigerated or on wet ice. In general, it is never a good 
idea to hold specimens at room temperature, and if a delay or more than 24h in 
transport of specimens is anticipated, specimens should be rapidly frozen to -70C or 
lower and transported to the laboratory on dry ice. (ibid p. 244) 
This represents a generally accepted method for preserving the viral titer and viral 
infectivity of clinical samples during storage.28 The "gold standard", as it were. But it 
is not difficult to start picking some holes in this gold standard. Elsewhere in the 
literature, for instance, it is readily admitted that 'a number of clinically important 
viruses are labile and will not survive prolonged transport' (Starch 2007, 567).29 Their 
instability has to do primarily with the issue of temperature. Whilst some may be 
preserved through freezing or cooling, others may not: 
Some viruses can be completely destroyed by freezing. (Collier and Oxford 2000, 244) 
The recovery of some viruses may be greatly affected by freezing (e.g., cytomegalovirus, 
varicella-zoster virus, and respiratory syncytial virus). (Specter et al. 2002,244) 
The recovery of some viruses is seriously compromised by any freezing ... recovery of 
cytomegalovirus by culture is very unlikely if the time of transport is 24 hours or 
greater, regardless of whether the sample is at room temperature or 4C. (Starch 2007, 
567) 
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These kinds of issues would have been direcdy relevant in the case of Ksiazek's 
laboratory work in Adanta, Georgia, United States. His initial 'clinical samples', 
coming as they did from 'patients with SARS in Singapore, Bangkok, and Hong Kong' 
(K.siazek et al 2003, 1955), would have spent some time in storage, and almost 
certainly at low temperatures. Pursuing the logic of the textbook accounts above, it is 
possible to get at what is at stake here by focusing on the example of respiratory 
syncytial virus (RSV). Given that RSV is known to cause the kind of symptoms that 
the majority of SARS patients were presenting with, might it not have been there, in 
those samples, before being 'purified' out during the stage of storing and transporting 
these samples? This is entirely possible. But from a multifactorial perspective it is also 
possible to go a litde further than this, bringing these textbook accounts back into 
contact with the kind of microbiological knowledge that they seem to ignore. 
Note, for instance, how the accounts cited above focus entirely on known viruses. And 
yet, once you accept, as these manuals and textbooks seem to have accepted, that 
viruses are unstable and unstable in a variety of different ways, then why draw the line 
at the known? For all that they are admitting here is that known viruses are labile, and 
that, with some changes in temperature, known viruses can either be protected or, in 
some cases, destroyed. The possibility that hitherto unknown viruses, just like CoY, 
might also be labile, and labile in different ways to known viruses, is simply not 
considered (here, for example, the role of an agent such as 'ether' could be questioned 
- if it is known to be harmful to viruses such as enteroviruses and vaccinia, and thus 
not used when such viruses are suspected (ButeI2007, 727), then there is no reason to 
suppose that it might not have been harmful to currendy unknown viruses). Yet, 
nevertheless, it is a definite possibility. After all, the SARS coronavirus itself was 
unknown prior to its isolation by Ksiazek and his colleagues. Indeed, since the 1980s 
at leastten new viruses have been discovered (see table 3, below). 
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As the microbiologist Jeffrey Kahn (2007, 478) has noted, 'the aetiology of the 
majority of respiratory tract infections is thought to be viral, yet in only 40% of cases 
can a viral agent by identified'. To him, 'this suggests that previously unidentified 
viruses may· be circulating' (ibid). And as one other virology textbook makes quite 
clear, 'conventional microbial detection technologies may miss unconventional 
microbes' (Fredricks 2004, 95). Therein too, current knowledge of viral life is made 
sense of through a very revealing agricultural metaphor: 'the low-hanging fruit has 
been picked and the remaining fruit will require more work and some technical 
innovation to grasp a more elusive harvest' (ibid., 95).30 
IV. CELL CULTURES AND THE 'PHENOMENA' OF VISION 
'To identify viruses associated with SARS,' Ksiazek and his research team noted, 'we 
inoculated a variety of clinical specimens ... onto a number of continuous cell lines, 
including Veto E6, NCI-H292, MDCK, LLC-MK2, and B95-8 cells (NCA, 1954). 
And, a few paragraphs later, the following photograph of an inoculum growing on 
one of the Vero E6 cell-lines is presented: 
'Figure 1: Vero E6 cells inoculated with oropharyngeal specimens from 
patients with SARS. The early typical cytopathic effect seen with coronavirus 
isolates from patients with SARS is shown (x40)'. (Ksiazek et a1. 2003, 1958) 
Isolated and alone, all of these similar looking indentations denote the growth of 
coronaviruses; a colony of coronaviruses, all of the same viral phylum, class, order and 
family. But how did we get here - to a singular pathogen understood and presented in 
these ways? 
Viruses, unlike bacteria, 'require cellular machinery for replication' (Storch 2007, 568). 
As a consequence, lifeless media such as agar cultures, which are used to cultivate 
68 I P age 
bacteria, are of no use to virologists. 'Living systems must be used in laboratories in 
order to stimulate viral replication' (ibid.).31 This explains why, ever since the 
pioneering virological work of those like Beijerink, Loeffler and Frosch at the turn of 
the 19th century, the "methodological holy grail" for virologists has been, in effect, a 
bo4J outside of the bo4J; a body in which viral replication could become directly 
observable.32 Prior to the development of cell-culture systems viruses could only be 
propagated in intact animals or plants.33 Only as late as the 1940s and early 1950s did 
a set of experiments carried out under the direction of the virologist John Enders 
demonstrate how cell-cultures could be used 'as a means of producing large quantities 
of virus particles, as a mode of diagnosis in which a patient sample could be tested to 
see whether it infected a cell culture, or as a system for studying the effect of virus 
infection on cells' (Landecker 2007, 17).34 The ultimate value of cell-cultures to 
virologists, then, lay in their relocation of the event of infection from the expeninental animal to 
the cell. Direct observation of what happened to infected cell cultures over time thus 
displaced the need to see and measure infection with the indicator that had been used 
up until then - an animal sickened by infection of the virus. As Enders himself was to 
note some years later, he had 'come to regard cultures of human cells as a fairly 
satisfactory substitute in certain operations for the living host which, in the case of 
this species, is often difficult to obtain in sufficient numbers' (Enders, n.d.). A body 
outside of the body, then: it had finally been developed, granting the virologist a 
'god's eye' over the viral world.35 
Or had it? 
Here is Enders again, looking back on the development of the cell-culture system: 
Study of these agents [i.e. viruses] from both the biologic and practical points of view 
would have been greatly limited had phenomena not been discovered which clearly and 
accurately indicate the occurrence of viral multiplication within the tissue culture 
system itself. Thus it is probable that if it had remained necessary to inoculate 
experimental animals in order to demonstrate virus in the culture, the method would 
have been largely utilised as a convenient means for the preparation of virus 
suspensions. (Enders et a/. 1964,453 my emphasis) 
Note that: phenomena. This is the kind of remark, the kind of admission, that one has 
to go back to now out of date virological texts in order to find. Enders' message is 
clear: without those phenomena no virological 'god's eye'. The photograph included 
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within NCA, then, must be of a cell-culture that had, inscribed within its very 
workings, a series of phenomena that enabled the coronavirus to become-visible. 
So what were those phenomena?36 
The photograph's caption is in fact hinting at one such phenomenon when it suggests 
that we are observing 'the typical early cytopathic effect seen with coronavirus 
isolates' (K.siazek et al 2003, 1958 my emphasis). Indeed in the text more generally, it 
is noted that: 
Cytopathic effect in Vero E6 cells was first noted on the fifth post-inoculation day. 
The cytopathic effect was focal, with cell rounding and a refractive appearance in the 
affected cells that was soon followed by cell detachment The cytopathic effect quickly 
spread to involve the entire cell monolayer within 24 to 48 hours. (ibid., 1956 my 
emphasis) 
This is indeed the first of Enders' phenomena: the rytopathic effect. Defined in textbooks 
terms, CPE is: 
The term used for morphological changes noted as a result of viral replication in the 
cell culture. The CPE of cells may be described as clumping, destruction, granulation, 
rounding or vacuolation, giant cell or syncytial formation, or refractile cells. (Specter 
and Bendinelli 2005, 1539-1540)37 
This, then, is what the photograph shows: a cytopathic effect. And it is made possible 
because continuous cell-lines like the Vero E6 are populated by clone cells. Each of 
its cells derives from an originary cell that was cultured and coaxed to divide, 
eventually establishing clonal populations of cells. 38 Again, it is a now out-dated 
textbook that makes the significance of this cloning operation clear: 
As might be expected, a cell culture consists of a heterogeneous collection of cells 
which do not react in a uniform manner to a given virus. Better results are therefore 
obtained when the cell culture is a clone in which all the cells are derived from a single 
cell. (Smith 1962, 56 my emphasis) 
The body outside of the body, it seems, is a standardised body.39 In a Vero E6 cell line a 
virus of a specific species and family will be amplified. And, as it is amplified, it will 
infect each clone cell in exactlY the same wqy. A standardised infection will result. If, say, 
another virus of a very different species and family is amplified in another Vero E6 
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cell line then it will display a different pattern of infectivity. Known viruses have thus 
come to have known CPEs. These 'signature marks' are the creation of the cell-
culture and the cell-culture alone. And that is why Ksiazek and his research team 
could write of how: 
Examination of cytopathic-effect-positive Veto E6 cells by thin-section electron 
microscopy revealed characteristic coronavirus particles. (Ksiazek et al. 2003, 1957-1958 
my emphasis) 
This, however, is not quite the full story. For this 'characteristic' CPE to have become 
apparent, another one of Enders' phenomena had to have been at play in Ksiazek's 
laboratory: trypsin. Trypsin is used in the development of cell-cultures such as the Vero 
E6 line in order to obtain suspensions of single cells that can then be grown as 
monolayers on glass or plastic surfaces.40 What results are uniform continuous cell 
lines, consisting of a single sheet or monolayer of cells, ensuring that any CPE will 
occur on a surface. And to ensure that this is a visible surface, monolayers of 
trypsinized cells are also cultivated 'upon glass, thus making it possible to recognise 
viral infections of cells by the detection of the 'cytopathic effect" (Collard 1976, 167). 
Here, in this way, the body outside of the body is not simply being standardised, but 
exposed to a field of virological perception. The final phenomenon on display in NCA's 
cell-line photograph is the 'plaque technique'. Developed during the 1950s, this 
technique allowed for the spread of virus through a cell-line medium to be prevented 
by overlaying the cell monolayer with nutrient agar immediately after inoculation of 
the virus into cells.41 Under these conditions only direct spread of the virus became 
possible, resulting in the development of plaques that would quickly become visible to 
the naked eye. From that point forth not even a low powered microscope had to b~ 
used - the ~aked virological eye could now gaze upon a singular species of virus 
unaided. So the body outside of the body is not just a standardised and exposed terrain, 
but a regulated one also. 
Making singularity: a few final puzzles 
Given that this is so, these standardising 'phenomena' can perhaps initially be 
understood to be generating something that Daston and Galison (2007, 18-21) have 
elsewhere referred to as a 'working object': a visual representation of an 'unrefmed 
natural object' that 'train[s] the eye to pick out certain kinds of objects as 
71 I P age 
exemplary ... and to regard them in a certain way'. But then, as the defence lawyer for 
the possibiliry of multifactorality, it would not quite be enough to make such a 
suggestion and leave things there. For the more important question has to do with 
that which the photograph is training the virological eye not to pick out and not to see 
as exemplary. Consider, for instance, the following extract. It is taken from a book 
written by two virologists and entided An Introduction to the History of Virology: 'with the 
standardisation of the CPE', they suggest, 'the principle of one infective particle - one lesion 
hadfinal!J been achieved' (Waters on and Wilkinson 1978, 76 my emphasis). There it is. 
The principle. Dr. Stahr's 'normality'. That, it seems, is what Enders' phenomena had 
been seeking all along. Indeed, if one disease is known to 'normally' have one cause 
then a great deal of the epistemological responsibility for maintaining such an 
understanding as 'factual' lies with the standardisation, exposure and regulation of the 
cytopathic effect. The visual 'phenomena' enabling the achievement of this principle 
share something with the purification practices I foregrounded in the previous section, 
namely, that they would appear to form part of a self-vindicating style of aetiological 
practice. 
In a sense, this is an obvious point to make. But there are two further, slighdy less 
obvious points that I want to make; points that involve minute details: the questioning 
of a few factoids, and the setting up of one or two litde puzzles that, ultimately, will 
go un-solved by me, but also, and perhaps most crucially, by Ksiazek and his research 
team as well. What I am hoping is that will be able to weaken, just a litde more, the 
obvious-ness and the natural-ness of NCA's one, singular and isolated coronavirus. 
The first of these puzzles has to do with something that is known in virological circles. 
as the 'interference assay'. Although not alluded to in NCA it has to receive some 
mention here _ indeed the very fact that it is not alluded to in NCA is, as I will try to 
make clear below, the reason is has to be mentioned. Firsdy though, a quote: 
The replication of certain viruses in cell culture generally does not produce any CPE. 
(Specter et aL 2009,245 my emphasis) 
Given that the whole enterprise of 'virus isolation and identification' in cell-cultures is 
built around the identification of a CPE this fact (and it is stated as a fact) might seem, 
to an outsider, to be a slighdy alarming one.42 But for virologists, it is not. For as the 
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textbook from which the extract above was taken continues, 'the replication of these 
agents [which do not produce CPE] can be detected by alternative techniques' (ibid.). 
One such technique is the 'interference assay'. It is based on the observation that a 
cell culture infected by an 'interfering virus' can be rendered resistant to infection by 
other viruses to which it was originally sensitive. As far as I have been able to make 
out, this is the one concession that is made, in cell-culturing, to the possibility of 
multifactorial interaction and synergy. Interestingly, in order to make the usefulness of 
this assay clear to their readers, all of the textbooks and laboratory manuals I have 
been able to find cite this one following exampleY 
Some viruses, notably rubella, may grow without producing CPE and are detected by 
taking advantage of the phenomenon of interference. When an interfering virus grows 
in cell culture, it renders the cell culture resistant to other viruses to which it is 
ordinarily susceptible. 
For example, when rubella virus grows in primary monkey kidney cells, those cells 
become resistant to infection with echovirus type 11 virus. To test for interference in 
the laboratory, a culture in which rubella virus is being sought is "challenged" with a 
laboratory strain of echovirus type 11. If the echovirus fails to grow (but grows when 
inoculated into a companion cell culture that was not inoculated with the clinical 
sample) the culture is said to be positive for an interfering virus. (Storch 2000a, 5-6 my 
emphasis) 
I write that this use of one standard example is 'interesting' because it localises the 
phenomenon of interference, that one concession to multifactorality, troping it as 
something that is virologically useful. But of course, once the phenomenon of 
interference has been admitted in this way, is it really possible to localise the infection 
it might create within the discipline? Might its existence not, at the very least, hint at 
the possibility that it is a more general problem in cell-culturing? And, if so, would it 
not also hint at the fact that interference might, sometimes, be less useful than those 
textbook accounts seem to be suggesting? In the one example that they cite the first 
virus grows, rather handily, without generating a CPE. In such a case, a virologist 
would know that a sample from an ill patient had been inoculated and yet nothing had 
grown on the culture. An unusual situation; and one that would, subsequendy, open 
up the possibility of interference as a useful diagnostic aid. But what if things 
sometimes happened the other way round? Imagine the following scenario: an 
inoculum is cultured and a virus grows, demonstrating a CPE. But as it grows it also 
renders the cell-line resistant to another virus, of a different order, family and species 
that was also present in the original inoculum. The virologist, recogrusmg the 
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cytopathic effect of the amplified virus, and recognising that one pathogen had been 
found, would have no reason to "challenge" the culture. It is interesting to consider 
this scenario in light of Ksiazek's search for a hitherto unknown coronavirus. For in 
that particular instance, viruses did grow on particular cell-cultures. There was, in 
other words, no reason for those cell-cultures to be challenged. Is any of this 
significant? Again, if I cannot answer these questions, one way or the other, then 
neither can Ksiazek or his research team. 
The final puzzle here has to do with NCA's rather Nietzschean sounding reference to 
a 'master-seed' during the 'virus isolation' sub-section of the 'results' section: 
Cytopathic effect in Veto E6 cells was ftrst noted on the ftfth post-inoculation day. 
The cytopathic effect was foca~ with cell rounding and a refractive appearance in the 
affected cells that was soon followed by cell detachment. The cytopathic effect quickly 
spread to involve the entire cell monolayer within 24 to 48 hours. Subculture of 
material after preparation of a master seed resulted in the rapid appearance of 
cytopathic effect. (I<.siazek et al. 2003, 1956 my emphasis) 
In virology, a master-seed comprises the final, purest form of a virus. In theory it is an 
inoculum free of all contaminants: the purest of the pure, in other words, from which 
all other investigations could either begin ('here is a stock of coronavirus to test'), or 
be informed by ('the virus to be sought is of the family coronavirus'). But a master-
seed is normally only used in· vaccine development to ensure that a subsequendy 
developed vaccine is safe for use (i.e. that it is free of any unwanted pathogenic life-
forms). Indeed, none of the other papers that appeared alongside NCA in the special 
'SARS edition' of the April 10th New England Journal ojMedicine make any reference to a 
master seed. So why NCA's need for a master seed? In order to prepare a stock of 
culture for other, subsequent diagnostic tests like ELISA and PCR? Perhaps this is so. 
And yet, the article's two separate references to two separate CPEs in the extract 
above are still a litde curious. Following the logic of the text, it would appear that a 
CPE that 'spread to involve the entire cell monolayer within 24 to 48 hours' was 
observed initially. But then a 'master-seed' was prepared from the cell-culture on 
which the CPE had been observed. And that master-seed then generated a 'rapid' CPE 
on a new cell-culture. The suggestion here is surely that the second CPE developed 
more quickly than the first. But if this is so, then why the difference in response time? 
Was there something in the initial inoculum, an impurity perhaps, impeding the CoV's 
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ability to infect the cell-cultures? Could it be that the initial inoculum was 
'contaminated' with other viral particles? 
V. 'A NUMBER OF CONTINUOUS CELL LINES' 
Consider the following extract: 
To identify viruses associated with SARS, we inoculated a variety of clinical specimens 
(blood, serum, material from oropharyngeal swabs or washings, material from 
nasopharyngeal swabs, and tissues of major organs collected at autopsy) onto a number 
of continuous cell lines, including Vero E6, NCI-H292, MDCK, LLC-MK2, and B95-8 
cells. (K.siazek et al, 1954 my emphasis) 
Why did NCA refer to 'a number of these continuous cell lines'? Why was there this 
need for Ksiazek and his research team to use more than one cell-culture? Put simply, 
because there is no one, 'all-purpose' cell-culture currendy in existence: 
Each cell culture line displays a differential susceptibility to each group or member of 
the virus families. (Specter et aL 2002, 244) 
Thus, 'for a given sample type, this necessitates the use of multiple cell lines that are 
selective on the basis of the families of viruses capable of infecting a given [cell-
culture] system' (ibid.). Listed below are a few of the continuous cell culture types 
used to detect medically important viruses: 
Cell Line Sensitive Viruses 
Rabbit Kidney Herpes simplex virus, adenovirus, 
Human embryonic kidney enteroviruses 
Fibroblasts (e.g. MRC-S, Wi38) CMV, VZV, HSV, rhinovirus, enteroviruses 
(some) adenovirus, RSV 
Hep-2 Respiratory syncytial virus, adenovirus, herpes 
simplex viruses, parainfluenza viruses (some), 
enteroviruses (some) 
AS49 Herpes simplex virus, adenovirus, 
enteroviruses 
MDCK Influenzaviruses 
LLC-MK2 Parainfluenza viruses, human 
metapneumovirus 
Rhabdosarcoma (RD) Echoviruses 
Buffalo green monkey Coxsackievirus 
Table 5: 'Cell culture types used to detect medically Important vuuses' (Storch 2007,569) 
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As this table makes clear, quite a high degree of specificity is involved in the method 
of cell-line culturing. Very few viruses will grow on any but a very narrow range of 
cell-culture lines. So how to know which cell-cultures to deploy when faced with a 
disease outbreak like SARS? 
Determining which cells to use for a given specimen is based on the viruses likely to be 
present in that specimen. Thus, communication between clinicians and the laboratory 
is essential to maximise yield. (ibid., 568) 
At the time that NCA was being prepared, SARS was known, at a clinical level, to 
manifest as an upper respiratory tract infection in humans. That explains why NCA 
makes reference to cell-lines such as MDCK and LLC-MK2 rather than, say, the 
A549 line listed in table 5, above. 
But as table 5 also makes clear, viruses that are similar in the sense of causing similar 
kinds of upper respiratory tract infection (e.g. RSV, hMPV, influenzaviruses) are very 
rarely susceptible to the same kinds of cultures. And what that generates is the 
potential for the same kind of 'distribution' that was alluded to earlier during the 
discussion of the centrifuge and the filter: the cell-culture as a laboratory diagnostic 
method has the potential to keep apart objects that, in the human bo4J, might well 
interact. Indeed, NCA provides an interesting example of distribution-in-action. In 
the 'results' section, under the sub-heading 'virus isolation' it is noted how: 
Two cell lines, Vero E6 cells and NCI-H292 cells, inoculated with oropharyngeal 
specimens from Patient 16 Ca 46-year old male physician with an epidemiologic link to 
a hospital with multiple patients with SARS) initially showed cytopathic effect. .. A 
rhinovirus was isolated from the inoculated NCI-H292 cells. Further study suggested 
that this virus was not associated with patients with SARS, so it will not be discussed 
here. Cytopathic effect in the Vero E6 cells was first noted on the fifth post-
inoculation day. The cytopathic effect was focal, with cell rounding and a refractive 
appearance in the affected cells ... examination of cytopathic-effect-positive Vero E6 
cells by thin-section electron microscopy revealed characteristic coronavirus particles 
within the cisternae of the rough endoplasmic reticulum and in vesicles. (I<::siazek et al. 
2003, 1957-1958 my emphasis) 
From that one patient, patient 16, two separate and distinct viruses were isolated and 
amplified. One of them, the rhinovirus, was known at the time to be the cause of the 
common cold, whilst the other, the coronavirus, was also, at the time, known to be 
the cause of the common cold (the specific nature of this particular strain had not yet 
been determined). Neither could have been considered an anomaly, the result of, say, 
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some kind of laboratory contamination: both were known to cause upper respiratory 
tract infection in humans. They were also known to inhabit the same kinds of sites 
inside bodies like that of (patient 16'. Did they interact? Synergistically? And if so, 
how? Had they formed some kind of a viral assemblage? Or was one virus perhaps 
acting in the role of multifactorial 'satellite' to the other? 44 
But these are precisely the questions that the cell-culture technique foreclosed upon. 
Consider the extract above one last time. There were two cell-lines in operation: Vero 
E6 and NCI-H292. The former amplified the coronavirus, the latter the rhinovirus. 
And, separated out in this way, Ksiazek and his colleagues could subsequendy come 
to conclude that 'further study suggested that this [rhino]virus was not associated with 
patients with SARS, so it will not be discussed here'. Yet at this point it might be . 
useful to refer back, once· again, to Sergei Winogradsky's original multifactorial 
critique of pure cell-culture systems at the turn of the 19th century: 
... on the whole, however, we cannot register all isolated species [i.e. cultured species] 
as natural ones, identical to their wild prototypes, without any critical evaluation, 
because it is probable that they are mere ecological species whose properties depend on 
nutrient conditions. In short, they may be artifacts resulting from the conditions of in 
vitro cultivation of pure cultures. (Winogradsky 1952, cited in Zavarzin 2006, 505 my 
emphasis) 
What I want to take from this critique is the idea that although they were 'amplified' 
on separate cell-lines, this cannot exclude the possibility that interactions between 
them took place inside the body of 'patient 16'. The fact that these two viruses appear 
isolated and alone is an artifact of the cell-culture system. They were distributed out 
into different sites. Vero E6, for instance, are cell lines 'established from the kidney of 
a normal adult African Green monkey' that are susceptible to the following known 
VltUses: 
Polio, coronviruses, rubella, arbbviruses and reoviruses. (Specter et al. 2009, 154 my 
emphasis) 
The NCI-H292 cell line, on the other hand, is 'derived from a cervical node metastasis 
of a pulmonary mucoepidermoid carcinoma from a 32 year old Negro female,' and 'is 
sensitive' to the following known viruses: 
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Vaccinia virus, herpes simplex virus, adenoviruses, BK polyomavirus, reoviruses, 
measles virus, respiratory syncytial virus, some strains of influenza virus type A, most 
enteroviruses, and rhinoviruses, in addition to the parainfluenza and mumps viruses. 
(ibid., my emphasis) 
So the two cell lines did not, indeed could not, harbour both viruses together at the 
same time. The technology of the cell-culture cancelled any possibility that interaction 
between these two pathogens, in the development of patient 16's illness, could be 
made observable to the virological eye. As a result, the comment in the extract from 
NCA presented above, that 'further study suggested that this virus was not associated 
with patients with SARS, so it will not be discussed here' is a curious one. It is not 
made clear what the further study entailed, but whatever it did entail, it was study that 
took place in a world in which isolated pathogens had already been established. 
One final question here is this: did this particular form of distribution involve patient 
16's samples, and patient 16's samples alone? Perhaps not. For as NCA makes clear, 
after the initial batch of samples had been received, 'further samples were submitted 
for SARS testing': 
A variety of respiratory pathogens were also identified by RT-PCR whose samples were 
submitted for further testing, including 5 with human metapneumovirus and 12 with 
rhinoviruses. None of the patients who were positive for human metapneumovirus had 
pneumonia. (Ksiazek et al 2003,1961 my emphasis) 
What is perhaps most interesting about this extract is that which is left un-said. It is 
not made at all clear, for instance, whether samples from those same patients also 
yielded coronavirus when inoculated onto appropriate cell-cultures. If they had, then 
there would have been the same kind of possible multifactorality as in patient 16. But 
only now on a much larger scale. Despite NCA's lack of detail, however, the article 
does seem to suggest the presence of coronavirus, as well as rhinovirus, in those 
samples. First of all, for those further samples to have been submitted for SARS 
testing they would already have been classified, at the clinical level, as 'suspect' or 
'probable' SARS cases. At the very least, then, they would have been from patients 
displaying pneumonia-like symptoms. But then, secondly, consider the point made in 
the extract above about 'none of the patients who were positive for hMPV ha[ving] 
pneumonia'. On the face of it, this is a comment designed to discount hMPV as the 
possible aetiologic agent ofSARS: no pneumonia, no SARS. Nothing, however, is said 
about whether or not patients who were positive for rhinovirus had pneumonia. Why 
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not? Because they did? Most probably. But then, if they did, then what had caused 
their pneumonia? The coronavirus? Again, given what we now know about the 
outbreak, this seems likely. If this is so, then it also seems likely that Ksiazek and his 
colleagues would have identified coronavirus particles from those patients in 
appropriate cell-culture lines. And if this conclusion can be accepted, then it would 
mean that patient 16 was no longer the sole example of a possible co-infection. In 
total, it would mean that were in fact 13 patients in Ksiazek's sample who were 
showing signs of possible dual infection. Would this just have been co-incidence? For 
those who held on to a multifactorial understanding of aetiology, the question would 
at least have merited some discussion. For those who simply held on to the glass 
plate of a cell-culture line, however, it was not. 
IV. CONCLUSIONS 
In this court session I sought to build a case for the defence of multifactorality's 
possibility during the SARS outbreak. To achieve that I examined, often in great detail, 
one of a series of research articles that proved crucial in passing down the original 
judgement of non-existence on multifactorality. And now, having done so, I want to 
try and sum up the case for the defence. 
First of all, it seems to me that the seemingly 'perfect fit' within NCA between theory 
- one disease has one cause - and methods-of-discovery - the cell-culture - was not at 
all natural or serendipitous. On the contrary, it seems rather more like the product of 
a particular style of aetiological practice. This term, style of practice, is one that I borrow 
from the transcripts of a previous court case, Ian Hacking vs. stability in the laboratory 
sciences (1992). I shall hold off on developing the term at any great length, however, 
until my closing summations (see chapter 7). Here, at this early stage of proceedings, it 
is enough simply to note that styles of practice are self-authenticating entities; entities 
in which we find that types of theory and types of apparatus have slowly, over time, 
become mutually adjusted to each other. NCA, I want to suggest, was the product of 
just such a self-authenticating style of practice: Dr. Stohr's theory of normality seems 
to have been inscribed within the very practices of cell-line diagnosis that eventually 
came to find one pathogen. This would of course be a terrible case for the defence of 
multifactorality were it not for the further suggestion that whilst creating its singular 
aetiological object, the cell-culture also, and at the same time, seems to have been 
suppressing any hint of a multifactorial object. These were practices, in other words, 
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that were either directlY or indirectlY removing the presence of everything that might 
have been of interest from a multifactorial perspective. 
Is there any hope that these suggestions might have real-world effects? No. Of course 
not. Things are setded now. As Latour might counsel, 'nature talks straight' now, and 
'facts are facts' (1987, 1000). But as I mentioned earlier, it is sometimes enough just to 
be able to give back to a defendant the right to its own possibility. 
So is there any hope on that particular score? 
Well, possibly. 
For although there has been neither revelation nor critique during this hearing, there 
has been detail. And detail is precisely what is required when seeking to muddy the 
waters in an appeal court case such as this one. Indeed, given the kinds of detail that I 
sought to foreground in this hearing, there might, perhaps, be just a litde more 
reasonable doubt now than there was before I rose to speak. Perhaps, for instance, 
the trustworthiness of this technology, along with its status as a reliable witness, can 
now be called into question just a litde bit. Was it playing the role of a naive and 
atheor~tical intermediary? I, myself, would suggest not. Indeed what I want to. close 
this particular court session with is the suggestion that the 'theoretical assumption' of 
aetiological singularity was actually 'built into the apparatus itself' (Galison 1987,251). 
Multifactorality was not ruled out, but forced out. And of course, if that suggestion can 
be accepted, or, at the very least, taken to be plausible, then multifactorality's possibiliry 
is perhaps a litde closer to being handed back to it. 
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Notes 
1 The direct quote here is taken from a passage in Barlow and Barlow's 
biography of Robert Koch - imaginatively titled Robert Koch (1971) - in which the 
development of virology as a microbiological discipline is the focus of attention. As the 
authors suggest, 'it was not long after Koch had laid down the precise methods by 
which bacteriologists should work in their pursuit of bacteria, that researchers in the 
field became aware that some infective agents were still eluding them' (ibid., 302). But 
how to 'track down something which could not be seen, although it was known to be 
there' (ibid., 307)? The 'main problem' was 'to discover a means of cultivating the 
virus in order to study it'. This, however, proved to be 'one of the hardest technical 
problems to resolve'. Why? Because 'viruses could not live and multiply like bacteria 
on gelatine broths' (ibid.). Known culture methods were, in other words, of no use in 
the pursuit of viral cultivation. Eventually, what became 'absolutely clear' through the 
in vitro plasma and tissue experiments of Alexis Carrel in the 1920s, and those of Hugh 
Maitland with finely chopped hen's kidney in the 1920s and 1930s (on this also see 
Carrell 1923, 1926; and Maitland and Maitland, 1928) was that 'tissue culture was 
essential to further progress, the more so because while bacteriologists had no great 
difficulty in finding suitable animal hosts in which to cultivate bacteria, virologists 
were finding it extremely difficult to find hosts in which to breed viruses' (ibid., my 
emphasis). The problem with tissue culture, however, was one of 'contamination'. 
And, as Barlow and Barlow went on to note, 'it was not until the advent of powerful 
antibiotics that the problem of contamination was overcome and the growth of 
bacteria in the tissues could be prevented. Nowadays penicillin, streptomycin and 
other drugs are added to the culture media for this purpose' (ibid., 308 my emphasis). 
2 I have been able to find out very little in relation to the process through 
which SARS came to be named precisely as SARS. Though a little hyperbolic, the 
most fascinating account can be found in Helen Branswell's (2008) report for the 
Toronto Star, 'SARS memories linger five years later'. Having read her account I was 
struck, in particular, by the comments of the WHO's press officer, Dick Thompson: 
'on March 12 the WHO sent out an unprecedented health alert warning of a new 
'atypical pneumonia.' By the 14th, a Friday, Canada and Singapore were also reporting 
cases, Dr. David Heymann, then WHO's executive director of communicable diseases, 
recalls. 'We were very afraid that it was a disease pandemic developing,' says Heymann, 
who is now an assistant director-general for health security and the environment. The 
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next day Heymann, [Dick] Thompson and Denis Aitkin, a senior official in the office 
of then director general Gro Harlem Brunddand, huddled to name the new disease. 
'How many times do you get the chance to name a disease?' Thompson recalls, his 
voice still tinged with wonder'. 
3 It is perhaps easier to understand why 'endemicity' was to be avoided at all 
costs. But 'quarantine'? Quarantine was undesirable not from a public health perspective, 
but rather, from a political perspective: the overarching objective of the international 
health regulations (regulations that were, at the time, legaljy binding on all of the WHO's 
191 member-states) was to 'provide maximum security against the international spread 
of disease with a minimum interference with world traffir! (WHO 1983, art. 2-13 my 
emphasis). 
4 See chapter 1, pp. 4 - 7, above. The story of the WHO SARS laboratory 
network and its aetiological discovery is re-told here, in a litde bit more detail, because 
it serves to foreground the sheer epistemic power of the diagnostic cell-line. 
S As Dr. David Heymann, Executive Director for the WHO Communicable 
Diseases Programme was to note on the 16th April, the day, the coronavirus was 
confirmed as the aetiological agent, 'the pace of SARS research has been astounding' 
(WHO 20031, para., 2). And again, on the 16t\ and whilst opening the WHO 
convened press conference in which the confirmation was given, Dr. Stohr was keen 
to point out that 'it has been done in record time' (WHO 2003m, para., 2). On this 
story of 'rapid-scientific-discovery', also see Feng and Gao (2007), Fidler (2004), and 
Hawkey et at. (2003). 
6 The story of 'the race to discover the pathogen responsible for causing 
Cholera' can be found in a number of sources. Perhaps the most comprehensive 
accounts are in Barlow and Barlow's Robert Koch (1971, 81-104), and Lechevalier and 
Solotorovsky's Three Centuries of Microbiology (1965). Similar, though slighdy less 
scientifical!J detailed accounts appear in Brock (1988), Knight (1963), and Wailer (2002). 
Ogawa (2000) and Lowy (1992) also shed some interesting light on the cholera 
research of Koch and Haffkine, and the resistance to the results of that research in 
European medical circles. 
7 NCA was an incredib!J well-cited text. In terms of citations, most 
contemporary microbiological research articles struggle to reach triple figures. But, as 
of June 2009, I had been able to find some 2,165 scientific research papers or texts 
that cite 'A novel coronavirus associated with severe acute respiratory syndrome' 
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(Ksiazek et aL 2003). To give some idea of just how unusual it is for a research paper 
to receive so many citations, it is worthwhile comparing this figure to the kind 
received by similar 'discovery' papers in cases of by now well known and well 
established infectious diseases. Firsdy, there are the discovery papers published during 
the early years of the AIDS epidemic. On May 4th, 1984 a research team led by the 
virologist Robert Gallo had four papers published simultaneously in Science. Of the 
two that dealt specifically with issues of discovery and aetiology, Popovic et aL (1984) 
had, as of June 2009, received 2,322 citations, whilst Gallo et aL (1984) had received 
2,165 citations. Secondly, there is the research paper published in 1982 by Stanley 
Prusiner, and entided 'Novel proteinaceous infectious particles cause scrapie' 
(prusiner 1982). There, for the first time, the discovery of the infectious 'prion' 
thought to be responsible for causing transmissible spongiform encephalopathies (and, 
later, bovine spongiform encephlopathy, and Creutzfeld-Jakob disease) was reported: 
'because the novel properties of the scrapie agent distinguish it from viruses, plasmids, 
and viroids, a new term 'prion' is proposed to denote a small proteinaceous infectious 
particle which is resistant to inactivation by most procedures that modify nucleic 
acids' (ibid., 136). Again, as of July 2009, the paper had received 2,120 citations. 
8 It should be noted, however, that there were a number of other SARS-
related articles included within that particular edition of the New England Journal of 
Medicine, most notably, for instance: 'A cluster of cases of severe acute respiratory 
syndrome in Hong Kong' (fsang et at. 2003); 'A major outbreak of severe acute 
respiratory syndrome in Hong Kong' (Lee et al. 2003); and 'Identification of severe 
acute respiratory syndrome in Canada' (poutanen et aL 2003). I have chosen to focus 
on the papers by Peiris et aL (2003), Ksiazek et aL (2003) and Drosten et aL (2003) in 
the main body of the text, however, because, as I see it, theirs were the papers in 
which most attention was paid to laboratory, rather than clinical and epidemiological 
findings. 
9 My approach here in this paragraph constitutes a very basic form of 
transitivity analysis. For stylisticians, transitivity forms the very heart of representation. 
As Sara Mills (1995) has argued, 'the study of transitivity is concerned with how 
actions are represented; what kind of actions appear in a text, who [or what] does 
them and to whom [or what] they are done'. The crucial point about transitivity is that 
it has rhetorical effects: 'in producing texts there are a range of choices to be made, 
and every text which has been produced could have been produced differendy' (ibid., 
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143-144). The distinction between Actor, Process and Goal is drawn from Simpson's 
work (2004, 22-23; also Simpson 1993, 88). 
10 The 'ideal reader', the 'perfect reader' (Leavis 1952), the 'mock reader' 
(Booth 1961), the implied reader (Iser 1974): whatever; it makes no difference. What I 
intend the concept to suggest here, in this particular instance, is actually quite simple: that 
the author, or authors of a text may well write for a particular readership, which may 
then be -inscribed in the text in the form of presuppositions or assumed shared 
knowledge. The implied reader, understood in this simplified manner, basically 
involves 'that which the textual rhetoric itself implicates or involves' (Wales 2001, 
204). As a non-implied reader analysing a microbiological text in New England Journal of 
Medicine, moments such as this, moments of incomprehension, are inevitable. But not 
insurmountable. For as discussed in chapter 2, the way to deal with them is to move 
beyond the text in question, and out into an inter-textual space. In a sense, it is from 
this point forth in the main body of the text that 'the brute effort of reading' begins. 
11 Descriptions of cell-culturing as a 'gold standard' for diagnostic 
microbiology used to be common within the relevant medical microbiological 
literatures. As far as I have been able to ascertain, the first research paper to deploy 
this phrase was Hsuing's 'Diagnostic virology: from animals to automaton' (1984, 
727-733). Since then, Hsuing's paper has become something of an 'obligatory point of 
passage' for many subsequent researchers, an easy citation for those wishing to add an 
extra degree of credibility to their cell-culturing work (this, at least, is the slighdy 
Machiavellian, slighdy predictable reading that a Latourian might develop (see Latour 
1987, 1988)). The section in which the 'gold standard' reference is made proceeds as 
follows: 'in the early years [of diagnostic microbiology] experimental animals were 
used for isolation and diagnosis ... these techniques were cumbersome, tedious and 
time consuming ... with the discovery [in the 1950s] that poliovirus can be isolated in 
cultured cells which were not derived from neural tissue a new era in diagnostic 
virology began. The use of cell culture has replaced the use of live animals and 
provided the measure which diagnostic virologists have used, and are still dependent 
upon, as the 'gold standard' for virus diagnosis' (Hsuing 1984, 727-729 my emphasis). 
12 For an interesting 'anthropological' analysis of the development of the 
polymerase chain reaction during the 1980s by the Cetus Corporation, an American 
biotechnology firm, see Rabinow (1996 and 2000); for an sociological analysis of the 
development of the PCR kit as an 'immutable mobile', see Jordan and Lynch (1998) 
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and Lynch (2002). For more detailed, and highly technical discussions of how a PCR 
kit can be deployed as a diagnostic tool during the practice of medical microbiology, 
see Gillespie and Bamford (2007), Levinson (2008), Storch (2000a; 2007), and Ward et 
al (2009, 306-314); and, specifically in relation to the SARS outbreak, see Chan et al 
(2004), Lau et aL (2003), Mahoney and Richardson (2005), Poon et al (2003a; 2003b; 
2004a; 2004b; 2004c). 
13 Of the 'some' ID question, perhaps the most enthusiastic, and earliest, 
champion of the PCR as a quicker, more sensitive diagnostic technology than cell-
culturing was Richman (1993). But also see Buller's (2000, 310 my emphasis) 
discussion of the diagnosis of emerging infectious diseases: 'molecular biology 
techniques are revolutionising the practice of infectious disease medicine' (ibid., 310); 
and Storch's (2000a) further discussion of 'molecular diagnosis': 'diagnostic 
techniques based on the detection of specific viral nucleic acids are currently 
transforming the field of diagnostic virology' (ibid., 12 my emphasis). 
14 Also of interest in this light is the review article 'Role of Cell Culture for 
Virus Detection in the Age of Technology' (Leland and Ginocchio 2007). Therein, 
one finds the following question being asked: 'is virus isolation in cell cultures still a 
useful approach in viral diagnostics?' (ibid., 50); and also see the passage in 
'Laboratory diagnosis of viral diseases' (Ward et al 2009, 313), where it is noted that 
'virus isolation on living cells is now used for diagnosis much less than formerly, with 
the advent of more rapid tests'. 
15 For the clinical details of a cohort of critically ill 'suspected SARS' patients 
see Fowler et aL (2003); and for the pathogenesis of SARS, see Franks et al. (2003). 
16 For discussions of the practices and interventions involved in the 
development of a PCR primer, see Gillespie and Bamford (2007, 15-16), Levinson 
(2008, chapter 34), Murray, Rosenthal, Pfaller (2009, 165-168); and, more specifically 
in relation to SARS patient diagnosis, see Louie et aL (2004). 
17 GenBank's homepage and its related retrieval and analysis servIces, are 
operated by the National Centre for Biotechnology Information (NCBI) Homepage 
(available at http://www.ncbi.n1m.nih.gov). But if that is where it is, then what is it? 
According to an article published recendy by a research team from the NCBI (Bens on 
et aL 2003), GenBank 'is a comprehensive database that contains publicly available 
nucleotide sequences for more than 260,000 named organisms, obtained primarily 
through submissions from individual laboratories and batch submissions from large-
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scale sequencing projects' (ibid., 25). Most submissions 'are made using the web-based 
BankIt or standalone Sequin programs and accession numbers are assigned by 
GenBank staff upon receipt' (ibid.). This, in other words, is where medical microbiologists 
store their viral findings. 'Daily data exchange with the European Molecular Biology 
Laboratory Nucleotide Sequence Database in Europe and the DNA Data Bank of 
Japan ensures worldwide coverage' (ibid.). But it is also where they go when 
developing diagnostic tests, retrieving nucleotide sequence information in order to 
generate specific PCR primers. 'GenBank is accessible through NCBI's retrieval 
system, Entrez, which integrates data from the major DNA and protein sequence 
databases along with taxonomy, genome, mapping, protein structure and domain 
information, and the biomedical journal literature via PubMed. BLAST provides 
sequence similarity searches of GenBank and other sequence databases. Complete 
bimonthly releases and daily updates of the GenBank database are available by FTP' 
(ibid.). On the homepage web site as of July 2009, for instance, is a link to 'the newest 
2009 H1Nl influenza A sequences': 'The Centres for Disease Control and Prevention 
(V.S.) and other health officials are actively tracking the recent emergence of human 
cases of swine influenza A (H1Nl) virus infection. Influenza A virus sequences from 
patients affected by this strain are being submitted to GenBank and can be accessed 
through the NCBI Flu Resource'. 
18 On this so-called 'purification process', also see Minor's 'Concentration and 
purification of viruses' (1999), and Storch (2000b; 2000c). 
19 The distinction between a context of discovery and a context of justification 
was central to logical positivist philosophy, and to the belief stemming from this 
philosophy that philosophy had a priori authority vis-a-vis the empirical sciences. The 
sciences, or empirical inquiry more generally, set about discovering how the world 
might be, but whatever the results of those inquiries, they had to be submitted to the 
sovereign judgement of philosophy to be warranted as valid or justified knowledge 
(on these points, see Zahar (1983, 243-261) and Siegel (1980, 297-321). Although this 
distinction has been discarded in nearly all post-Kuhnian studies of science, the idea 
of a "context of discovery" is still quite a nice metaphorical way of capturing something 
of the hard epistemic work involved in medical microbiological knowledge production. 
20 On similar process of 'black boxing', see Latour (1987); and on 'deleting and 
splitting', see Latour and Woolgar ([1979]1986). 
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21 The metaphor of 'upstream' is borrowed from a passage in Gieryn's Cultural 
Boundaries of Sdence (1999). Although we end up looking in different directions, I do, 
nevertheless, like the image he conjures of scientific knowledge production as a river. 
'lingering debates over relativism versus realism, over the fraction of a scientific 
theory caused by natural versus social forces, over the existence of chairs at 30,000 
feet have become stale, even a litde mouldy. Possibly the time is ripe for sociologists 
to look at science from a different vantage point - not upstream at facts in their 
making, but downstream at their consumption' (ibid., ix). 
22 On this also see Slack (2007, 666-668), and Forbes, Sahm and Weissfeld 
(2002) 
23 Again, these issues of preparation are addressed in greater detail in various 
clinical laboratory manuals. Of particular interest here are Cann and Irving (1999), 
Storch (2000b; 2000c), Smith (2000), Wiedbrauk and Johnston (1993). 
24 Information that differs only very slighdy in relation to these processes of 
selecting, collecting, transporting and purifying clinical samples for viral culture can be 
found in several other reference texts and laboratory manuals. Those which I found to 
be of particular use as 'triangulation resources' whilst seeking to confirm the accuracy 
of Leland and Ginnochio's (2007, 50) statement regarding 'most laboratories', were: 
Burleson et al. (1992), Forman and Valsamakis (2003), and Smith (2000). 
25 According to Waters on and Wilkinson's History of Virology (1978), the 
centrifuge has an interesting history, and one that can be traced right back to the first 
emergence of bacteriology as a medical discipline during the late 19th century. From 
the early twentieth century onwards, centrifugation was 'frequendy used in 
conjunction with filtration in studies on the aetiology of diseases thought to be viral' 
(ibid., 19). Although any detailed discussion of the centrifuge would stray too far from 
the defence case, it is worthwhile noting that here too is a technology that would seem 
to have the theory of singularity inscribed within its very workings. In 1898, for 
example, the bacteriologist Sanarelli, who had been unable to separate the large 
poxvirus of rabbit myxomatosis from accompanying tissue elements by filtration, 
'used centrifugation to obtain an optically completely pure and totally sterile serum, 
which nevertheless retained full infectivity' (ibid., 18-19 my emphasis). And again, 
with the development of the differential centrifuge by MacCallum and Oppenheimer in 
their 1922 vaccinia virus studies, the 'completely pure and totally sterile' became ever 
more of a realistic possibility for virologists (see MacCallum and Oppenheimer 1922). 
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The two researchers had effectively pioneered the use of the differential'centrifuge as 
a separation device, working-up fluids of different specific gravities in which to suspend 
the viral serum, before using the centrifuge to 'concentrate' the virus by stepwise 're-
suspension' and 'purification' of the solutions (ibid., 410). 
26 This reference to 'constructivist science studies' is informed by a reading of 
Mol (in particular 1999; 2002a, 33-44). The reference to 'distribution' is again 
informed by a reading of Mol, and, rather more specifically, her work in relation to 
the distribution of possible realities in surgical treatment (see 2002a, 108-114). 
27 Enteroviruses and vaccinia viruses, for example, are known to be harmed by 
ether. Thus, in cases where infection with either family of virus is expected, ether is not 
used in the preparation of samples. But of course, to talk of what is known and expected, 
is also to raise some rather interesting questions about where the line is drawn in 
medical microbiology between the known and the unknown and the expected and the 
unexpected. So read on ... 
28 See the references in note 23, above. 
29 As Storch (2007, 568) also makes clear, 'inadequate or improper specimen 
collection and transport accounts for the largest source of error in the accuracy of 
viral test results'. 
30 For more detailed discussion of the problem of the unknown in virological 
research, and, more specifically, the ways in which new molecular diagnostic 
techniques are beginning to reveal hitherto unknown pathogenic forms, see Blaser 
(1994), Gillim-Ross and Subbarao (2006), Kroes, Lepp, Relman (1999), Sloots et al. 
(2008) and Suau, Bonnet, Sutren et al. (1999). 
31 Though for a discussion of Peter Olitsky's claim to have cultured viruses in 
cell-free media, see Creager (2002, 38-42). 
32 For a general introduction to the production of cell-culture lines, see Blake 
and Stacey (1999). There are also a number of useful historical accounts that touch on 
the laboratory work of Beijerink, in relation to tobacco mosaic disease, and Loeffler 
and Frosch, in relation to the foot-and-mouth virus (in particular, see Bulloch 
([1938]1979), Hughes (1977), Waters on and Wilkinson (1978); and also see Collier's 
(2005) 'history of 'propagation in tissue culture'). More specifically in relation to the 
many historical attempts that were made to develop a boc!J outside of the boc!J, the most 
useful overview that I have been able to find is a review article from 1959, entitled 
'Tissue culture in relation to viruses' (Westwood 1959). 
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33 At least, a sense of this being a question of 'only', as in 'animals not being quite 
good enough' emerges when one considers the relatively few historical texts in which the 
relative advantages and disadvantages of 'bodies' and 'bodies outside of bodies' as 
culturing devices were actually discussed. For Westwood (1959), for instance, 'the 
recognisable 'cytopathogenic' changes in cell cultures of poliovirus have thus done 
away with the necessity for using large numbers of monkeys for tests and even as a 
source of virus ... when Enders, Weller and Robbins (1949) demonstrated that 
poliovirus would multiply in non-neural tissues in culture, they provided at one stroke 
not only the main driving force behind much of the tremendous volume of tissue-
culture research of the last decade, but also a simple, cheap laboratory host for 
poliomyelitis research. Where. previously. a monkey would provide a single 
observation. tissue cultures derived from it will now provide several thousand' (ibid., 
181 my emphasis; and also see Smith 1962, 55-57). 
34 The 'sets of experiments' referred to here were carried out during attempts 
made by Enders' and his research team to study, and thus to cultivate, the 
poliomyelitis virus. As Landecker (2007, 122) has noted: 'previous scientists trying to 
cultivate polio in vitro had decided that the virus was 'stricdy neurotropic' - it would 
grow only in neurological tissues'. It was thus a starding breakthrough not just for the 
field of polio research, but for the entire field of vir%gica/ research more genera/IY, when the 
Enders lab easily multiplied polio in human embryonic skin and muscle tissues. That, 
at least, is how those 'sets of experiments' have come to be viewed by virologists and 
medical microbiologists who have since written histories of the development of 
diagnostic virology (see for instance, Collier (2000; 2005); Whitaker (1972, 73)). Some 
of Enders' most important articles in relation to the question of virological cell-
culturing are Enders (1959), Enders et al. (1949); Enders and Peebles (1954), Feller, 
Enders and Weller (1940), Weller and Enders (1948); and also see the work of his 
research collaborator, Weller, in relation to the application of cell-tissue culturing 
(Weller, 1953). For a more general account of John Enders' work, see the obituary 
'John Franklin Enders: February 10, 1897 - September 8, 1985' that was written by 
Weller and Robbins (1991). 
35 On the 'god's eye trick' see Haraway (1991). 
36 One 'phenomenon' that I will not dwell upon in the main body of the text -
having written about it so extensively in previous sections - is that of 'anti-bacterial' 
agents. Nevertheless, it is interesting here, in a footnote, to note the rhetoric of 
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'contamination' that is used in the medical microbiological literature in order to 
explain the diagnostic need for such agents: 'it was not until the advent of powerful 
antibiotics that the problem of contamination was overcome and the growth of 
bacteria in the tissues could be prevented' (Barlow and Barlow 1971, 308 my 
emphasis); 'primary cell cultures are prepared directly from tissue, usually from an 
animal or an embryo. Preparation involves mincing the tissue, digesting with 
proteolytic enzymes to disperse the component cells further, and seeding the cells into 
an appropriate glass or plastic container with nutritive media that contain 
antimicrobial agents to inhibit bacterial and fungal overgrowth' (Storch 2000a, 3 my 
emphasis); 'the discovery and development of antibiotics have proved of inestimable 
value to tissue-culture methods, since by their addition to the medium bacterial 
contamination is eliminated without effect on the virus'. (Smith 2000, 55 my 
emphasis). 
37 More detailed discussions of specific CPEs can be found in Ward et aL 
(2009, 313-314). On the morphological properties that have allowed for the 
classification of cell-lines into two main types (epithelial and fibroblasts) and, also, on the 
ways in which those properties affect the shape and the texture of any subsequent 
CPE, see Paul (1970, 371-372); and, finally, for an extremely detailed discussion of the 
rypes of cytopathic effect produced by various viruses see Paul (1970, 371-373) and 
Whitaker (1972, 74-75). There are, it seems, five types of CPE. The point of noting 
them here is to give some sense of the 'professional (virological) vision' (see Goodwin 
1994) bound up with the doing of diagnostic virology. Firstly, there is total destruction; 
secondly, and as a less severe type of cell-damage, there is sub-total cellular degeneration; 
thirdly, focal degeneration, involving the development of intranuclear inclusion bodies 
commencing in a focus and progressing centrifugally in plaques; fourthly, morphological 
changes without a1!Y cessation of cellular metaboh'sm, which consists in the swelling of cells 
which form clumps and become granular and degenerate; and, finally,foamy degeneration, 
in which many large intracytoplasmic vacuoles are produced, causing a lace-like effect 
(paul 1970, 371-373; Whitaker 1972,74-75). 
38 As late as the 1940s, and prior to the work carried out by Enders and his 
research team, efforts to grow clonal populations of cells from a single source cell 
(and thus to make possible a pure cell-culture that could mimic the pure-gelatin 
cultures used by bacteriologists) had met with continual failure. Such was the 
frustration that some scientists were left questioning whether cells of higher animals 
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could actually proliferate in vitro. Consider, for instance, the comments of Albert 
Fisher in Biolol!Y ojTissue Cells (1946): 'although the cells possess considerable mobility, 
they nevertheless remain part of a tissue; the migration away from the mother 
fragment is not too great to prevent them from maintaining their mutual cytoplasmic 
connections. This circumstance must undoubtedly be considered an expression for 
strong positive affinities between cells, making possible a cooperation without which 
they would soon perish' (ibid., 331). 
39 But note: on the ever present problem of cross-contamination between 
different cell-lines, see Landecker (2007, 140-179); and Nelson-Rees (2001). 
40 On the historical importance of trypsin as the substance that, ultimately, 
made virological diagnosis routine-isable, see Collier (2005, 5) and, in particular, Collard 
(1976, 167 my emphasis): 'trypsinised cells in monolayers upon glass made it possible 
to recognise viral infection of cells by the detection of CPE. As CPE can easily be 
observed with a low power microscope (xl00) this has made diagnostic examination 
of specimens from patients a routine procedure'. And for the original article in which 
the use of trypsin as a diagnostic aid was reported, see Younger (1954). 
41 On this, see Dulbecco (1966). Over the years that followed Dulbecco's 
work, further refinements to this technique were made in order to sharpen up the 
focus of the visual 'phenomenon' in question, for example, by using a 'monolayer of 
chick-embryo cells and by adding tris (hydroxymethyl) aminomethane to the agar 
overlay in order to obtain well-defIned plaques with vaccinia, ectromelia and herpes 
simplex viruses' (see Smith 1962, 57 my emphasis). 
42 As Landecker (2007, 3) has noted, 'it takes an anthropologist in the 
laboratory to note the strangeness of what has become quickly routinised or banal to 
its practitioners'. 
43 Almost identical accounts, word for word, are to be found in Levinson 
(2008, 233), Specter et al. (2002,246), Specter and Bendinelli (2005, 1541) and Storch 
(2007,569). 
44 On the notion of the 'multifactorial satellite' see the comments that were 
made in the introductory chapter, above, and also, the 'mini case-study' of hepatitis D 
in the concluding chapter, below. 
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4 
'The coronavirus alone is capable of 
causing the typical symptoms ... ' 
K.och's Postulates and the fmal judgement on multi-factorality 
During the last week of April, 2009, the United States Government notified the WHO 
of a series of outbreaks of 'pneumonia-like illness' (WHO 2009a, para. 1) in the states 
of Texas and California. At the same time, the Government of Mexico also reported a 
series of similar outbreaks in the capital, Mexico City, and the border towns of San 
Luis Potosi, and Mexicali (ibid., paras. 1-2). Epidemiologically, the spatial and 
temporal proximity of these outbreaks proved difficult to ignore. Or at least, it did for 
the members of the WHO's Global Outbreak and Response Network (GOARN), 
their subsequent response developing around an assumption that these ostensibly 
local and isolated outbreaks were in actual fact manifestations of a trans-Iocal 
phenomenon: a unitary infectious disease outbreak. Pursuing the strategy of 
dissemination that had been trialled so successfully during the 2003 SARS outbreak 
they began issuing daily updates regarding (what they were now performing as) this 
singular and ongoing infectious disease event. The second of those updates contained 
the following information: 
As of 26 April 2009, the United States Government has reported 20 laboratory 
confirmed human cases of swine influenza A/H1N1 (8 in New York, 7 in California, 2 
in Texas, 2 in Kansas and 1 in Ohio). All 20 cases have had mild Influenza-Like Illness 
with only one requiring brief hospitalization. No deaths have been reported. 
Also as of 26 April, the Government of Mexico has reported 18 laboratory conflttDed 
cases of swine influenza A/H1N1. Investigation is continuing to clarify the spread and 
severity of the disease in Mexico. Suspect clinical cases have been reported in 19 of the 
country's 32 states. (WHO 2009b, paras. 1-2 my emphasis) 
The time-lag between the first and this, the second update, was just two days. But as 
this extract makes clear, in that short space of time an aetiological agent had been 
identified. An epistemological threshold had been crossed for those investigating the 
outbreaks: 'pneumonia-like illness' could now be understood as 'swine influenza 
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caused by influenza A/H1N1'. The speed of diagnosis in this particular instance 
stands in stark contrast to the delays, false-leads and hesitations that marked the 
aetiological investigation into the 2003 SARS outbreak. There, it was not until update 
31, some five weeks after the initial update, that similarly detailed laboratory 
information regarding an aetiological agent could be released into the public domain 
(see for example, WHO 2003zr). 
The explanation for this comparative delay lies in the fact that whereas the influenza 
A/H1N1 virus was already well known to microbiologists working in those American 
and Mexican laboratories during 2009, the virus CoY was, as of early 2003, unknown 
to the medical world generally. And this, the difference between the 'known' and the 
'unknown', is an important one in the practice of diagnostic microbiology. The 
laboratory detection of known viruses is aided by a whole host of 'probe specific' 
technologies that 'involve reagents designed to detect specific viruses' (Richman 1993, 
91). In the event of a disease outbreak they can immediately be put to use in order to 
'search' patient samples. In the case of the 'pneumonia-like illness', for instance, it 
would have been probe specific technologies like the PCR and the ELISA that made 
the rapid identification of A/H1N1 possible. But of course those methods are of little 
use when the virus in question is a hitherto unknown one. That explains why Ksiazek 
and his colleagues, in seeking to identify the novel SARS coronavirus, 'relied' not on 
newer, probe-specific molecular methods, but rather, on 'classic' cell-culturing 
technologies (I<.siazek et al. 2003, 1961; see Chapter 3): unlike 'probe specific' 
methods, cell-culture technologies are 'open-minded' and 'do not require advance 
knowledge of the kind of virus sought' in order to begin a diagnostic search (Richman 
1993,91). But as the previous chapter perhaps made clear, a price had to be paid for 
that 'reliance': rather than simply waiting for the virus to come to them, as with a 
probe specific technology, they had to make the virus come to them. And that was a 
price paid in the currency of delays, false-starts and hesitations. 
Despite these differences, however, the point I want to make is that in neither the 
2009 swine influenza outbreak nor the 2003 SARS outbreak was it a case of making 
an either/or choice - either probe specific or open minded technologies. On the 
contrary, both types of method would have been deployed from the very outset in both 
cases in order to expedite information on any possible aetiological agents. 1 This 
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both/and logic explains why, along with references to cell-culturing, passages like the 
following can be found in research papers written by research teams that had 
participated in the WHO SARS laboratory network: 
Respiratory and blood specimens from the patients in Frankfurt were tested by 
polymerase chain reaction (PCR) with specific primers for MYfoplasma pneumoniae, 
Chlamydia pneumoniae, human cytomegalovirus, adenoviruses, respiratory syncytial virus, 
parainfluenzavirus types 1, 2, 3, and 4, Hendra virus, Nipah virus, human 
metapneumovirus, influenzaviruses A and B, rhinovirus, and human coronavirus 
strains OC43 and 229E, as well as with universal primers for herpesviruses, 
arenaviruses, bunyaviruses, enteroviruses, alphaviruses, flaviviruses, ftloviruses, and 
paramyxoviruses. Respiratory specimens were also tested by antigen enzyme linked 
immunosorbent assay (EUSA) [i.e. a probe specific technology] for M. pneumoniae, 
influenzaviruses A and B, and respiratory syncytial virus. Antigen EUSA for Legionella 
species was performed with urine. Paired serum samples were tested serologically for 
C. pneumoniae (IgA and IgG), C. trachomatis (IgA and IgG) , C. psittaci (IgG) , M. 
pneumoniae, Coxiella burnetii, influenzaviruses A and B (IgG and IgA), dengue virus (IgG 
and IgM), measles virus (IgG and IgM), hantaviruses, adenoviruses, parainfluenzavirus 
types 1, 2, and 3, and respiratory syncytial virus. (Drosten et aL 2003, 1969 my 
emphasis) 
During the SARS outbreak this mix of 'probe-specific' and 'open-minded' methods 
resulted in the identification of a whole host of other pathogens besides the novel 
coronavirus. As mentioned in the previous chapter, for instance, Ksiazek and his 
colleagues amplified a rhinovirus, as well as a coronavirus, from the sample of one 
SARS patient sample. Indeed, each of the early SARS research papers published 
alongside NCA in the May 15th edition of the New England Journal of Medicine reported 
similar non-coronavirus findings. In 'A major outbreak of SARS in Hong Kong' (Lee 
et aL 2003), for instance, it was reported that of five positive 'sputum cultures' from a 
cohort of 138 patients, 'three were positive for Haemophilus influenifl, one for 
Streptococcus pneumoniae, and one for Klebsiella pneumonid. Of the 'nasopharyngeal 
aspirates' cultures that had also been prepared, 'one was positive for influenzavirus A, 
" 
one was positive for influenzavii:us B, and two were positive for respiratory syncytial 
virus' (ibid. 1989-1990). And, as one final example, in the article 'Identification of a 
Novel Coronavirus in patients with SARS' (Drosten et aL 2003), it was noted that 
samples taken from the 'index case' in their study had yielded not only the 'novel 
coronavirus', but also the bacterium (Chlamydia pneumoniae' (ibid., 1969). 
It is instances such as the latter, instances of 'co-infection' in which a SARS patient 
was found to have been infected with the SARS coronavirus and another pathogen as 
well, that I want t6 concentrate on here. The most consistendy identified 'other', as it 
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were, was a virus mentioned briefly in the previous chapter: human metapneumovinis 
(hMPV).2 Because of its quantitative significance I want to spend a little bit of time 
making clear the process through which its aetiological significance came to be 
understood by virologists investigating the outbreak. At the time of the outbreak a 
number of reports regarding outbreaks in Hong Kong, Canada, Singapore, and 
Vietnam began to appear. Therein, the identification of hMPV among patients with 
suspected or confirmed SARS-CoV infection was reported. 3 HMPV, the reports 
concluded, had been 'co-circulating' with Co V in those countries during early 2003.4 
For a number of reasons (reasons that I shall explain at length in the following 
footnote), it is difficult, if not impossible, to calculate the actual number of co-
infections that developed.s Nevertheless the following rather rough calculation can be 
made. From a series of aetiological studies published by research teams in those afore-
mentioned countries, 290 retrospectivelY tested cases can be accumulated. 6 Of that 
number, a total of 86 were found, either by cell-culture or serologic testing, to have 
been co-infected with Co V and hMPV. In percentage terms, this figure represents 
29% of the 290 retrospectively tested cases. If that sample can be accepted as 
representative of the total number of 2,307 confirmed cases of SARS-Co V infection 
in those countries (with the total made up as follows (see WHO 2004c): Hong Kong: 
1,755; Singapore, 238; Canada: 251; Viet Nam: 63), then it follows that around 669 
cases (19%) were actually co-infected.7 
Perhaps, then, a space had emerged within which the possibiliry of a multifactorial 
disease, separate and distinct from SARS-Co V, could have become apparent; a space 
in which such a possibility could have been explored in a litde more detail. Perhaps, as 
with a disease like hepatitis D, for instance, it was possible that two separate viruses 
were acting together as an aetiological assemblage.s And yet such an exploration never 
came to pass. As was mentioned in the previous chapter, the WHO organised press 
conference on 16th April marked a watershed moment for multifactorality. The WHO, 
represented by Dr. Klaus St6hr, used the conference to announce that 'we can now, 
with all confidence, say that the causative agent of SARS is the coronavirus 
[henceforth Co V] first detected in Hong Kong on 21 sI March 2003' (WHO 2003m, 
para. 8). But that was not all that they made clear. Later on during the conference, a 
Dr. Albert Osterhaus from the Erasmus Universiteit, Rotterdam (an institute that 
formed part of the WHO SARS laboratory network), made clear that his research 
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team had carried out a series of aetiological experiments based around something 
called 'Koch's Postulates'. Although the possibility of a 'double aetiology' (ibid., para. 
26) had been examined - specifically a double aetiology involving Co V and hMPV -
he went on to note that the experiments had allowed them to conclude 'that the 
coronavirus alone is capable of causing the typical symptoms of SARS' (ibid. para. 28). 
And that was it. 'Koch's postulates' had been brought to bear on the issue, and, as a 
result, the possibility of multifactorality had been discounted. What is more, things 
quickly moved on. A research 'bandwagon' formed,9 with virtually all subsequent 
research coming to focus on one or other of the following tasks: deciphering the Co V 
genome, 10 developing Co V diagnostic test, 11 and developing a Co V vaccine. 12 
CoV ... CoV ... CoV. As a result, hMPV's role in the outbreak was almost entirely 
forgotten. At best, it could be found lurking around in some later studies in the role of 
a secondary infection; a parasite as it were, and even then, only in 'some cases'. In this 
chapter, however, an attempt will be'made to free up the possibility of multifactorality 
once more. In order to achieve this, the 'Koch's Postulates experiments' carried out 
by Osterhaus and his research team will be treated as if they represented a judgement, a 
judgement handed down by a scientific court held at the Erasmus Universiteit during 
early 2003 and stating that singularity had been proven, multifactorality dts-proven. As 
the defence lawyer for the possibility of multifactorality my strategy will be to try and 
pick as many holes in the original case for the prosecution as I can with the hope of 
making the court's judgement appear Gust a lit de) un-safe.13 
In section I, the most crucial of Koch's Postulates in denying the possibility of 
multifactorality is identified and then subjected to an external critique: that postulate, I 
suggest, can be called into question if the work of other virologists is brought to bear 
upon it. In section H, however, I switch strategy, subjecting that same postulate to an 
internal critique: even if the postulate can be accepted as an aetiologically definitive one, 
I go on to suggest that its fulfilment during the Rotterdam experiments failed to meet 
the standards demanded by the postulate itself. In a concluding section, section IH, I 
seek to make clear the double bind that these twin arguments have (hopefully) placed 
'Koch's Postulate experiments' within: if you do not accept the theoretical validity of the 
postulate in question then that postulate is unable to foreclose upon the chance and the 
possibility of multifactorality; if you do accept the theoretical validity of the postulate, however, 
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then the practices through which it was fulfilled in this particular instance were still 
unable to foreclose upon the chance and the possibility of multifactorality. 
I. COMPARABILITY - AN EXTERNAL CRITIQUE 
In his opening statement to the 16th April press conference, Dr. Klaus Stahr noted 
that he had been 'talking during the past four and a half weeks a lot about the 
contribution of the 11 - now 13 - laboratories in the hunt for the SARS aetiological 
agent' (WHO 2003m, para. 3). Today, he continued, he was 'very pleased to be able to 
introduce some of the colleagues in person' (ibid.). Each of the subsequent 
introductions was followed with a few words about that particular colleague's role in 
the laboratory network. Of Dr. Albert Osterhaus, from 'the Erasmus Universiteit, 
National Influenza Centre, the Netherlands' Stahr had this to say: 
Dr. Osterhaus is the one. He and his colleagues, who have been adding the fmal piece 
of the puzzle of research that took place during the past five weeks. His team has 
conducted the trials in monkeys with the coronavirus. He is the one who reported this 
morning that the Koch's postulates have been fulfilled. We can now with all 
conftdence say that the causative agent of SARS is the coronavirus. (ibid. para. 8) 
Later·on, during a question and answer session, Dr. Osterhaus got a chance to explain 
exactly how he and his colleagues had managed to p~ove the aetiological role of the 
coronaVltUs when a journalist from 'Kyoto News in Japan' asked the following 
question: 
Previously there was some speculation that paramyxovirus and/or Chlamydia could 
have been playing a role in causing SARS. Now today that you have identified the 
causative agent as coronavirus, can we now safely say that it is caused solely by 
coronavirus and that paramyxovirus and Chlamydia does not play any role in this? (ibid. 
para. 24) 
Dr. Osterhaus' response to this question began with a formulation of precisely why 
he and his research team had proceeded in the way that they had: 
Regarding the cause of the disease, I think that if you look, what happens is that ftrst of 
all this paramyxovirus - this human metapneumovirus - was found. But we were quite 
astonished that this virus as such should be the cause of this new disease; now that 
would not make sense. Then we were very happy to learn that originally in Malik Peiris' 
work in Hong Kong, he identifted the virus that we have all followed up [the 
coronavirus]. So we ended up with two different viruses: the coronavirus and the 
hMPV. This led us to postulate that it would not be impossible that we would perhaps 
have a double etiology. or one virus coming ftrst and the other one coming later and 
then aggravating the situation. This is what we discussed with the network in our 
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telephone conversations. Then we decided to do experiments in monkeys. (ibid. para. 
26 my emphasis) 
According to Dr. Osterhaus' own fonnulation it would appear that at this early stage, 
the possibility of some kind of multifactorial disease - a 'double aetiology' - was 
indeed a real possibility. Singulati(y, involving one virus and one virus alone, and 
multifactorali(y, involving 'synergy' and 'interaction' within a viral 'assemblage', were 
being considered alongside the idea of a quasi-singulati(y, in which one virus would 
have acted first, before another, acting parasitically, would have come along and 
exacerbated the infection. The suggestion 'then we decided to do experiments in 
monkeys' points to the fact that the experiments were deliberately designed to 
ascertain which of these aetiological possibilities was, to paraphrase Dr. Stehr, 'the 
one'. As Dr. Osterhaus then went on to note: 
This experiment was set up in such a way that we infected monkeys either with the 
coronavirus that was cultured or with the human metapneumovirus. A third group we 
infected ftrst with coronavirus and then with metapneumovirus. (ibid. my emphasis) 
Represented diagrammatically, the experiment was set up as follows: 
Macaques set #1: Co V infected 
Macaques set #2: hMPV infected 
Macaques set #3: Co V and hMPV infected 
Osterhaus then presented the results of the experiments: 
The interesting thing we found, and that goes back to the Koch's postulates that were 
formulated more than 100 years ago, that the animals infected with the coronavirus 
alone developed full-blown disease. They developed SARS, they developed clinical 
symptoms, and they also developed the pathological lesions that are identical to what 
we have seen in people who have died from SARS. The animals with the human 
metapneumovirus, the ftrst virus that was found, developed only a very mild rhinitis, 
they had very mild symptoms, and defmitely not the typical SARS pattern. The third 
group of animals, ftrst infected with the coronavirus and then super-infected with the 
metapneumovirus, did not develop more serious disease. (ibid.) 
Again, represented diagrammatically, with an 'X' representing macaque disease 
comparable to human SARS disease and an '0' representing macaque disease non-
comparable to human SARS disease, the results were as follows: 
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Macaques set #1: Co V infected - X 
Macaques set #2: hMPV infected - 0 
Macaques set #3: Co V and hMPV infected - X 
But how, exacdy, was this an answer to the Japanese journalist's question? Put another 
way, why were these results so significant for Osterhaus? An answer to these 
questions can be found in the previous reference to something called 'Koch's 
Postulates'; a reference which Osterhaus then went on to explain: 
The Koch's postulates are firstly that the agent should be present in basically all the 
individuals that are suffering from the disease. That holds true predominantly for the 
coronavirus and not for the metapneumovirus because it is less than 50% of the people 
infected or having SARS that were infected with metapneumovirus. The second 
postulate is that you should be able to cultivate the virus. That holds true for the two 
viruses. The third postulate is that you should be able to reproduce the disease in the 
host or a related host. That is what we have done for the coronavirus. and coronavirus 
only. The last postulate then is that you should re-isolate the virus back from the 
animals that you have infected with that virus. Those four things have been fulfilled for 
coronavirus and only three of those for the metapneumovirus. (ibid., para. 27 my 
emphasis) 
'Koch's Postulates', it would seem, gave Osterhaus and his colleagues a list of 
'performance indicators' with which to assess each pathogen. The pathogen scoring 
the largest numbers of 'ticks' was the aetiological agent. Co V had scored four ticks, 
hMPV only three. Ergo, Co V was the singular aetiological agent and hMPV was not. 
But note: the crucial differentiating factor, the tick which hMPV could not receive, 
had to do with disease comparability. And that was why, as Osterhaus went on to 
note, the conclusion that he and his research team had come to was that: 
The coronavirus alone is capable of causing the typical symptoms. (ibid. para. 28) 
But where had the possibility of a 'double aetiology' gone during all of this? Put 
simply, the comparability postulate had destroyed it as a possibility. For the fact that 
'four things had been fulfilled for Co V and only three for hMPV' did not just mean 
that Co V was the agent responsible for causing SARS in patients who had been 
infected solely with CoY. Look again at the diagrammatic representation: 
Macaques set #1: Co V infected - X 
Macaques set #2: hMPV infected - 0 
Macaques set #3: Co V and hMPV infected - X 
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In sets 1 and 3, the signs and symptoms were identical. In set 1 'the animals infected 
with the coronavirus alone developed full-blown disease. They developed SARS, they 
developed clinical symptoms, and they also developed the pathological lesions that are 
identical to what we have seen in people who have died from SARS' (ibid., para. 26). 
And in set 3, 'the third group of animals, first infected with the coronavirus and then 
super-infected with the metapneumovirus, did not develop more serious disease' (ibid. my. 
emphasis). The only thing that could have altered the outcome in set 3 as compared to 
set 1, the only independent variable as it were, was the hMPV inoculum. But it did not 
alter the outcome. And, in this way, the additional inoculation of hMPV in set 3 was 
made to become visibly insignificant. Because of the way in which these experiments 
had been set up, hMPV could, quite literally, be seen to be adding nothing to the Co V 
infection. At most, then, hMPV might have been parasitic uponCoV in some of the 
cases that had been reported. Quasi-singularity was possible, Osterhaus conceded, but 
he and his research team had found no evidence of it in their tests: 
We cannot formally exclude that other agents, such as the human metapneumovirus, 
and the Chlamydia that has been found in China, or a number of other viruses, coming 
after you have this primary infection with the coronavirus, would eventually aggravate 
the situation, but the data especially from Hong Kong, suggest that where we have 
coronavirus alone, also in humans, those data together with the monkey data I think 
quite strongly show that the coronavirus is the primary cause of this. (ibid., para. 28) 
Having made these laboratory findings public during the 16th April conference, 
Osterhaus then joined a research team from the University who were preparing a 
series of journal articles in order to present them at greater length. The first 
publication to result was 'Koch's Postulates fulfilled for SARS virus' (henceforth KPF) 
in the 15th May edition of the prestigious Nature journal (Fouchier et aL 2003).14 In that 
article, very little had changed from the original press-conference presentation, except 
that the possibility of a 'double aetiology' was no longer even deemed worthy of 
mention: 
CoV ... fulftls all of Koch's postulates as the primary aetiological agent of SARS. This 
does not exclude the possibility that other pathogens, including human 
metapneumovirus may have exacerbated the disease in some SARS patients. However, 
lesions in macaques infected experimentally with hMPV isolated from a non-SARS 
individual were limited to mild suppurative rhinitis and minimal erosion in conducting 
airways, and disease was not exacerbated in two Co V infected macaques subsequently 
inoculated with hMPV. (Fouchier et aL 2003, para. 6 my emphasis) 
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The comparability postulate was, once again, crucial to these conclusions. Of the six 
paragraphs comprising the main text of KPF, fully two of them seek to make clear the 
comparability between the human disease of SARS, and the disease manifested by 
cynomolgus macaques when inoculated with Co V. Firstly, clinical information about 
these cynomolgus macaques is presented: 
Both SCV[SARS coronavirus]-inoculated macaques became lethargic from 3 d.p.i 
onwards and developed a temporary skin rash, and one suffered respiratory distress 
from 4 d.p.i. onwards. (ibid., para. 4) 
Secondly, pathological information: 
At gross necropsy, one macaque had severe multifocal pulmonary consolidation, and 
SCV infection was detected in lung tissue by RT-PCR and virus isolation. (ibid., para. 
5) 
Then histological information: 
Both macaques had interstitial pneumonia of differing severity. The one with gross 
lesions had diffuse alveolar damage, marked by necrosis of alveolar and bronchiolar 
epithelium and flooding of alveolar lumina with proteinaceous fluid, admixed with 
fibrin, erythrocytes, alveolar macrophages and neutrophils. Occasional multinucleated 
cells (syncytial) were present in the lumen of bronchioles and alveoli. (ibid.) 
And finally, laboratory results: 
The macaques excreted virus from the nose and throat at 2-6 d.p.i., as shown by 
polymerase chain reaction with reverse transcription (RT-PCR) and by virus isolation. 
(ibid., para. 4) 
The point of presenting all of this information ill such detail was to emphasise 
comparability: 
These lesions are indistingyishable from those in biopsied lung tissue and in autopsy 
material from SARS patients, including the presence of syncytial in alveolar 
lumina ... the isolated virus was identical to that inoculated. (ibid. para. 5 my emphasis) 
In comparison, very little textual space is given over to the presentation of the hMPV 
inoculation studies. Of hMPV all we learn is that: 
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Lesions in macaques infected experimentally with hMPV isolated from a non-SARS 
individual were limited to mild suppurative rhinitis and minimal erosion in conducting 
airways. (ibid. para. 6) 
Because of CoV's comparability and hMPV's lack of comparability, then, the third set 
of monkeys appear to have been creating a double visibiliry; that is, making CoV's role 
as the primary cause of the infection visible whilst also, and at the same time making 
hMPV's non-aetiological role visible. 
Koch's Postulates: a black box? 
Yet despite the press conference and the research paper sharing similar 
understandings of comparability as the crucial differentiating factor, they were not 
quite identical. For if the two presentations are compared, two slighdy different 
understandings of 'Koch's Postulates' become apparent. Here, ftrsdy, is how KPF 
presents 'Koch's postulates': 
According to Koch's Postulates as modified by Rivers for viral diseases, SL"{ criteria are 
required to establish a virus as the cause of a disease. [footnote 1] The first three 
criteria - isolation of virus from diseased hosts, cultivation in host cells, and proof of 
f1lterability - have been met for SCV by several groups. [footnotes 2 - 5] Moreover, of 
96 individuals complying with the World Health Organization'S defmition of SARS 
[footnote 6] in Hong Kong, 86 (90%) yielded laboratory evidence of SCV infection. 
We have tested for the three remaining criteria: production of comparable disease in 
the original host species or a related one, re-isolation of the virus, and detection of a 
specific immune response to the virus. (Fouchier et aL 2003, paras. 2-3 my emphasis) 
So, on the one hand, there are 'Koch's Postulates' as formulated at the 16th April press 
conference: 
l.The agent should be present in basically all the individuals 
2.You should be able to cultivate the virus 
3.Y ou should be able to reproduce the disease in the host or a related host 
4.Y ou should re-isolate the virus back from the animals that you have infected. 
And, on the other hand, there are 'Koch's Postulates as modified by Rivers for viral 
disease! as formulated in the 15th May publication, KPF: 
l.Isolation of virus from diseased hosts 
2.Cultivation in host cells 
3. [Proof of filterability] 
4.Production of comparable disease in the original host species or a related one 
s.Re-isolation of the virus 
6. [Detection of a specific immune response to the virus] 
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In the second formulation, Fouchier and his co-authors were no longer referring 
simply to 'Koch's Postulates', but rather, to 'Koch's Postulates as modified by Rivers 
for viral diseases'. The second formulation also contains six postulates rather than the 
four originally alluded to during the 16th April press conference. And whilst the 
'animal comparability postulate', the postulate of interest here, remains in both 
formulations, overall, the content of the Postulates seems to have changed. Two 
entirely new postulates have been added, one in the position of postulate 3 - proof of 
filterability - and one in the position of postulate 6 - detection of a specific immune 
response to the virus . 
. This is a curious change. Between 21st March and 23rd April a total of 12 WHO press 
conferences were held during which a number of WHO representatives, medical 
officers, and members of the laboratory network made reference to something, or 
some-things, called 'Koch's Postulates,.15 Throughout, they were treated as akin to 
one of Latour's (1987) cold, hard, solid and unquestionable black boxes. During the 
first ever SARS press conference at the Palais des Nations on the 21 st March, for 
instance, the following exchange took place between an un-named journalist and 
David Heymann, the WHO's Executive Director for Communicable Diseases: 
Q. I am not a medical expert, but once you have virus detected and identified and 
determined, what do we do next? Where do we go from here? 
A. Let me try and explain. Once the cause is identified, then a diagnostic test can be 
made. A test which may detect infection in blood or other body secretions. Once this 
had been done we must use what we call Koch's postulates to tell us if we have an 
organisms. and to be clear whether or not that organism is causing the disease. (\'\'HO 
2003c, para. 8) 
Heymann's use of the 'must' as an auxiliary verb suggests some kind of imperative 
requirement to use the postulates. As such, it pre-figures the kind of treatment they 
were to receive at later conferences. One particular exchange between a journalist and 
members of the panel on 11 th April is worth examining in a little more detail. A 
journalist in the audience asked for some clarification, and Dr. Mark Salter, a medical 
officer with the WHO's Communicable Disease Surveillance and Response (CSR) , 
was the panel member who responded: 
Question: ... because two days ago, I think, the CDC [Centre for Disease Control, 
Atlanta, US] came out saying that they'd actually now verified the, identified the virus. 
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And from what you're saying today, I think, is that we're still in the same position as: 
we think it is but it's still not a 100%. 
Answer: Identifying a virus is only one step down the road to actually establishing 
whether that is the organism which is causing an infection. And yes, a number of 
laboratories, as well as laboratories in the United States, have identified a virus which 
apparendy, from the tests that have been [done] to date, is identical. It then requires a 
number of steps to establish whether that virus is actually causing the infection. And 
that is where the use of animal models is very effective, in that animals can be given 
this virus; if they then develop the symptoms, we can say "well, it's causing it". And if 
then we can take virus from those individual animals and pass it on to other animals 
and they too have the symptoms, we can then start saying, ''well this does appear to be 
the causative agent". And this follows what we would call Koch's Postulates. (WHO 
2003;, para. 55-56) 
Moments later, Dr. Heymann, sitting to Dr. Salter's right on the panel intervened in 
the discussion: 16 
Just so you're clear, the virus was first found in Hong Kong, ftrst identified in Hong 
Kong, and now it's been identifted by all the other laboratories. But, you know, the 
Koch's Postulates have to be fulfilled, as Klaus [Stohr] said the other day and as Mark 
[Salter] has said today. (ibid., para. 59) 
Again, the presupposition 'the' in 'the Koch's Postulates' perhaps suggests a very 
hard, very stable black box. An aetiological black box. A final arbiter of aetiology that 
simply 'is', requiring of no further explanation. Yet for 'things' that were being spoken 
about so unproblematically, they appear to have displayed a worrying degree of 
fluidity, changing both their form and their content between the press conference on 
16th April and the publication of KPF on 15th May. These are details, no doubt. But it 
does not at all follow that they are 'minor' details, or even 'mere' details. 17 And 
certainly not in this particular case. If something that appeared to be so solid in April 
can be presented in such an altered state a month later, then my hunch is that we are 
nearing a point at which those who made the original judgement were on weak 
ground. Indeed, given that my aim is to pick some holes in the original judgement of 
'non-existence' passed down upon multifactorality by those wielding 'Koch's 
Postulates' it seems only fair to ask whether or not these details can offer up a 
plausible reason for their existence. 
Thomas Rivers and the importance of immunology 
As was made clear in the previous section, aside from the actual content of the 
postulates, in KPF 'Koch's Postulates' are re-labelled as 'Koch's Postulates as 
modified by Rivers'. To recall, the article presents the following information: 
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According to Koch's Postulates as modified by Rivers for viral diseases, six criteria are 
required to establish a virus as the cause of a disease. [footnote 1] The first three 
criteria - isolation of virus from diseased hosts, cultivation in host cells, and proof of 
fllterability - have been met for SCV by several groups. [footnotes 2 - S] Moreover, of 
96 individuals complying with the World Health Organization of SARS [footnote 6] in 
Hong Kong, 86 (90%) yielded laboratory evidence of SCV infection. (Fouchier et al. 
2003, paras 2-3 my emphasis) 
'[Footnote 1]', which appears immediately after the reference to the six postulates of 
'Koch's postulates ... ' presents the reader with the following reference: 
tRivers, T. M. (1937) 'Viruses and Koch's Postulates,' Journal of Bacteriology 33, 1-12. 
The reference is, quite obviously, to Thomas Rivers' work. Not to Koch's work. Nor 
to the work of whoever ftrst articulated 'Koch's Postulates,.18 And nor is it to any 
previous work carried out by Osterhaus and his colleagues. The information in this 
footnote, and the fact that it is appended to a sentence which begins 'according to 
Koch's Postulates as modifted by Rivers for viral diseases ... ' suggests that the 
aetiological modiftcations on display in KPF derive entirelY and exclusivelY from the work 
of Thomas Rivers. If Rivers' paper is studied, in other words, it should be possible to 
ftnd an explanation, the explanation, for the variation shown by the two versions of 
Koch's Postulates. 
In his 1937 paper, 'Viruses and Koch's Postulates,' Rivers' aim appears to have been 
that of establishing a viable and practical understanding of aetiology for use within the 
emerging fteld of virological research. Robert Koch's work on the aetiology of bacterial 
diseases formed his starting point in this endeavour. 'At the time when they were 
formulated', he noted, 'Koch's postulates were essential for the progress of knowledge 
of infectious diseases' (ibid., 4). His criteria for establishing aetiology had 'had a 
profound influence on workers investigating infectious maladies and for many years 
an infectious agent was not accepted as the cause of a disease unless the postulates 
had been satisfted' (ibid. 3). Rivers then presents the following extract from Koch's 
work, a speech to the Tenth International Congress of Medicine in Berlin, 1890: 
If it can be proved: first that the parasite occurs in every case of the disease in question, 
and under circumstances which can account for the pathological changes and clinical 
course of the disease: secondly. that it occurs in no other disease as a fortuitous and 
non-pathogenic parasite; and thirdly. that it, after being fully isolated from the body 
and repeatedly grown in pure culture, can induce the disease anew; then the occurrence 
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of the parasite in the disease can no longer be accidental, but in this case on other 
relation between it and the disease except that the parasite is the cause of the disease 
can be considered. (Robert Koch, cited in ibid., my emphasis) 
As he went on to suggest, 'the above conditions laid down for the proof of the 
etiological relation of a microorganism to a disease constitute what are now known as 
Koch's postulates' (ibid.). It would seem, then, that for Rivers, 'Koch's Postulates' 
only consisted of three postulates, rather than the four presented by Osterhaus at the 
16th April press conference. No matter. There is enough similarity between the two 
accounts to ignore this particular detail. More important here is what Rivers goes on to 
suggest: 
It is unfortunate that so many workers have blindly followed the rules [set out in 
Koch's postulates] ... this blind adherence to Koch's postulates may act as a hindrance 
instead of an aid. (ibid., 4) 
'Progress,' he concluded, had 'left behind old rules' (ibid.).19 And if it is 'obvious that 
Koch's Postulates have not been satisfied in viral diseases', it is 'equally evident that 
proof of the etiological significance of viruses has been obtained without their 
satisfaction' (ibid., 6). Yet for Rivers this was not to be taken to imply that 'anything 
goes' aetiologically. On the contrary it was clear to him that: 
Certain conditions [still] have to be met before the specific relation of a virus to a 
disease is established. (ibid.) 
Those 'certain conditions', presented in 'Viruses and Koch's Postulates' for the first 
ever time, were the centrepiece of the article: 
The conditions are: (a) A specific virus must be found associated with a disease with a 
degree of regularity. (b) The virus must be shown to occur in the sick individual not as 
an incidental or accidental finding but as the cause of the disease under investigation. 
(ibid.) 
It would appear that Rivers created just two conditions, and not the six that KPF 
seems to be suggesting with its reference to 'Koch's Postulates as modified by 
Rivers'.2()The differences between the 'host' and the 'parasitic' text can be represented 
as follows: 
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'Koch's Postulates as modified by Rivers for viral diseases' (Koch's Postulates 
Fulfilled, 2003) 
l.Isolation of virus from diseased hosts 
2.Cultivation in host cells 
3. [proof of ftlterability] 
4.Production of comparable disease in the original host species or a related one 
S.Re-isolation of the virus 
6. [Detection of a specific immune response to the virus] 
Thomas Rivers' 'conditions for identifying viral diseases' (Viruses and Koch's 
Postulates, 1937) 
A. A specific virus must be found associated with a disease with a degree of regularity 
B. The virus must be shown to occur in the sick individual not as an incidental or 
accidental finding but as the cause of the disease under investigation 
Condition A seems to map pretty nicely onto KPF's postulate 1. But condition B is 
not at all specific. Indeed it is so un-specific that it might perhaps be concluded that it 
allows for precisely the kind of 'artistic license' shown by KPF. Perhaps, then, 
Osterhaus and his research team simply found it easier to divide condition B into five 
other postulates? And yet, even if this were true, there would still be a question mark 
hanging over their style of referencing: KPF's 'Koch's Postulates' quite clearly were 
not 'Koch's Postulates as modified by Rivers' but rather, 'Koch's Postulates as 
modified by Rivers and, subsequendy, by Fouchier and colleagues'. If Fouchier and 
his colleagues were simply making up their own tests, then this should have been stated 
quite explicidy. Indeed, if that is all proof of viral aetiology requires, the making of 
one's own aetiological tests, then I can rest my case right here and now: would it not 
be just as possible and just as plausible to make up other tests that did not exclude the 
possibility of multifactorality so definitively? 
A more significant argument against such an interpretation, however, comes when 
Rivers subsequent discussion of the 'conditions', and how they differed from 'Koch's 
postulates', is brought into the foreground. First of all, he noted that with his 
conditions as an aetiological guide, culturing of the virus in question was no longer 
necessary (ibid. p. 6). Secondly, he noted that it was no longer necessary to find the 
virus in every sample studied. Thirdly, the existence of virus carriers could now be 
recognised (ibid.) But finally, and most importandy here, he noted that in creating 
such a non-specific condition (B) he had quite deliberately taken away the absolute 
need to induce a disease comparable to any human disease in an animal host. This 
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postulate, as he sought to make clear, had proved an unreliable guide to aetiological 
significance. There were a number of technical reasons why this was so: 'animals are 
subject to viral diseases of their own which may be encountered with sufficient 
frequency to cause mistakes' (ibid., 7); and, in addition, 'they may become accidentally 
contaminated with an alien virus being studied in the laboratory to which they are 
susceptible' (ibid., 8). But perhaps more interestingly here are the theoretical reasons. 
'Not infrequendy', he· suggested, 'the pathological picture observed in the 
experimental hosts is quite different from that seen in human beings dead of [a particular 
disease]' (ibid., my emphasis). Again, later on in the text, he notes that 'at times the 
same virus does not induce similar changes in different hostl (ibid., 7 my emphasis). And, as 
one final example, there is a direct reference to the problem of unwanted 
(multifactorial) interference: 
At one time I thought I had transmitted varicella to rabbits, for, when material from 
varicella patients was injected into rabbits and serial testicular passages were made, a 
virus that produced lesions similar to those observed in cases of human varicella was 
regularly obtained. However, later work ... demonstrated conclusively that the virus 
with which I was working, now known as virus Ill, does not cause varicella in human 
beings, but produces a specific disease peculiar to rabbits. My experimental animals 
were already carrying an agent capable of inducing lesions similar to those seen in 
varicella; the virus was activated by the experimental procedures. (ibid. 8) 
Interestingly, it was Rivers' long time collaborator, Lester King, who was to make the 
most sustained critique of comparability that I have been able to find. In a 1952 
paper, entitled 'Dr. Koch's Postulates', he noted how 'many accepted disease agents 
which produce a fairly characteristic clinical picture in man are also pathogenic for 
lower animals. But the disease produced in the lower animals is quite distinct from that found in 
man'. 'Diptheria' he noted, citing one contemporary example, 'attacks the human 
throat'. The membrane of diphtheritic patients, 'if injected into a guinea pig, will 
prove lethal'. 'Nevertheless', he continued, 'the guinea pig does not reproduce the disease, 
diphtheria, as it is found in humanl. 'A disease has been produced, but is it the disease?' 
he asked rhetorically, before concluding, 'actually, this question is of no particular 
importance. It makes very little difference whether a disease transmitted to animals reproduces the 
original disease of humans or no! (ibid., 358-359 my emphasis). 
These, it seems, were the reasons why condition B was presented in such a non-
specific manner by Rivers. Indeed as Rivers went on to argue, it was precisely this 
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non-specificity that was crucial to the future efficacy of his conditions as a whole. For 
here, in this 1937 paper, and in this condition B, the newly emerging science of 
immunology was being enrolled for use within aetiological investigations for the first 
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ever tllne: 
With the development of the science of immunology .... immunological reactions added 
much to the knowledge of the specific relation of microbes to disease, and now it is 
possible to bring excellent evidence than an organism is the cause of a malady without 
the complete satisfaction of the postulates. (ibid., 3) 
In order to meet condition B, for instance, comparability is not even considered: 
Knowledge regarding the regularity with which a virus is associated with a disease may 
be highly important, but information concerning the presence of antibodies against the 
agent and the time of their appearance in the serum of patients is equally important as 
evidence of etiological significance of the virus. (ibid., 10) 
Serological analysis, Rivers was suggesting, a technique unknown to Robert Koch in 
the 19th century, would become more and more important, displacing the role that 
animal isomorphism had once played for the latter figure in establishing disease 
causation. The 'spirit of Koch's rules' still held, he argued, but these new conditions 
freed up space for 'the methods' of doing aetiology to become 'different from the 
ones used by Koch', though 'equally efficient'. Where 'the production with a degree of 
regularity of a transmissible infection in susceptible experimental hosts' held sway in 
aetiological research 'at the present time', 'tissue-culture techniques and serological 
reactions,' Rivers suggested, 'would soon come to be used far more extensively' (ibid., 
11). Disease comparability, in other words, was being displaced by Rivers', conditions. 
Interestingly, perhaps most interestingly here, is the fact that this was not at all a paper 
that simply died having never been read or cited. On the contrary, in the decades that 
followed, Rivers' questioning of the need for comparability and his championing of 
serologic tests were to influence many other virologists and many other aetiological 
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mvestlgatlOns. 
The possibility of multifactorality 
Thomas Rivers and Lester King built their critiques of comparability around examples 
of aetiological investigations in which just one inoculation was made into one set of 
animals. What they were subsequently able to point to was the lack of comparability 
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between the disease caused by the inoculum in humans, and the disease caused by the 
inoculum in a laboratory animal. 
In the case of the experiments reported in KPF, two known viruses were injected into 
two sets of animals with the aim of comparing animal infection to human SARS 
infection in each set. The structure of those experiments actually increased the 
likelihood of the 'Rivers-King' critique becoming relevant. Pursuing the logic of that 
critique, there are, at the very least, three questions that could be asked of those 
experiments: were the macaques accurately mimicking CoY disease in humans? Were 
the macaques accurately mimicking hMPV disease in humans? And were the 
macaques accurately mimicking Co V /hMPV disease in humans? But of course, if the 
logic of that critique was pursued more ruthlessly, it would be possible to conclude 
that the fact that one set of the macaques displayed comparable disease whilst another 
did not is empidcalfy meaningful, yet theoreticalfy meaningless. Either way, it is worth 
asking the following question: how come KPF came to place so much emphasis on 
the comparability postulate? After all, I<PF's Koch's Postulates were supposed to be 
'as modified by Rivers'. And Rivers was the virologist who had not only made the 
original critique of comparability but had then gone on to suggest the use of serologic 
tests as an alternative to comparability. Fouchier and his colleagues must have been 
aware of that suggestion given that they included serologic tests as one of their 
'Koch's Postulates as modified by Rivers'. So perhaps a better way of formulating the 
question would be as follows: how come KPF came to place so much emphasis on 
comparability despite the use of serologic tests? 
My answer to this question centres on the fact that comparability was the one and 
only postulate capable of separating the two pathogens - it left one pathogen as an 
object that could be seen to be aetiologically significant and one that could be seen to 
be aetiologically insignificant. KPF's primary task, remember, was to establish singular 
aetiology in a situation in which two viruses were vying for the role of aetiological 
object. And in order to complete that task, some kind of an iconoclastic gesture had 
to be made. Rivers' serologic postulate might well have been the more contemporary 
and more credible of the two postulates, but the fact is that both viruses had managed 
to pass the serologic test, whilst only one had managed to pass Robert Koch's original 
comparability postulate. If 'Koch's Postulates as modified by Rivers' really had been 
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'as modified f?y Rivers and Rivers alone', then no separation of the two pathogens would 
have been possible. But where the postulates were, effectively, 'Koch's Postulates plus 
Rivers' postulates as spliced together f?y Fouchier et al.', then a separation, an iconoclastic 
gesture, became possible. 
As the defence lawyer for the possibility of multifactorality, the point I want to draw 
from all of this sleuthing around is most certainly not that hMPV rather than Co V 
could have been the causal agent responsible for causing SARS. It seems quite certain 
the Co V did indeed play the major aetiological role in cases infected solely with Co V. 
The point here, however, has to do with instances in which co-infection of hMPV and 
Co V was reported. In the previous paragraph I noted that KPF's primary aim was to 
establish singular aetiology in a situation in which two viruses were vying for that role. 
But it should not be forgotten that the secondary aim of the experiments reported in 
KPF was to explore the possibility of multifactorality. Given what has just been noted 
about the possible unimportance of the comparability results, I would suggest that the 
result of the tests conducted in the third set of monkeys ... 
Macaques set #1: Co V infected - X 
Macaques set #2: hMPV infected - 0 
Macaques set #3: Co V and hMPV infected - X 
... did not have to constitute a reason for discarding the possibility of a multifactorial 
disease in the cases in which co-infection was discovered. Again, relying solely on the 
logic of 'Koch's Postulates as modified by Rivers' then the tests were inconclusive. 
Why? Because all macaques had shown serologic reactions to both hMPV and CoV. 
And that fact, irrespective of any animal comparability, would have been enough to 
keep open the possibility that, in the 5-10% of cases where co-infection had been 
reported, something more complex was occurring. 
Coda: calling an (unlikely) witness for the defence 
The judgement of non-existence passed down on multifactorality by 'Koch's 
Postulates' depended upon the direct comparability of macaque disease to human 
disease. In this section, however, an attempt has been made to challenge the 
seemingly unchallengeable nature of the comparability postulate as presented in KPF. 
And yet, the one thing that perhaps made that attempt seem a litde unconvincing was 
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the fact that KPF had actually reported direcdy observable comparability: Co V 
infected macaques reallY had mimicked SARS infection in humans, hMPV infected 
macaques reallY had not, whilst macaques infected with both Co V and hMPV reallY had 
just mimicked SARS infection in humans. Of course, the whole point of the previous 
section was to suggest that this was all empiricallY meaningful, yet theoreticallY 
meaningless. Nevertheless, the fact that it was visible to both the professional and the 
lay person, might still seem to weaken the case for the defence. 'Granted', it might be 
countered, 'animals might not mimic human disease in most cases, but surely, when 
they do, it must mean something'. To counter such a counter, to strengthen the 
argument that comparability is theoretically meaningless, it is useful to look, briefly, at 
some of the research carried out into possible SARS-CoV vaccines since the 
publication of KPF. 
What does it take to develop a vaccine against a virus like CoY? Most importandy, it 
takes knowledge of: the pathogenesis caused by that virus and the degree to which 
disease is caused by either the cytopathic effect of the virus or by immunopathology;23 
the mechanisms of viral clearance in the infected host;24 the involvement of the 
central nervous system in infection;25 viral shedding pattems;26 and the significance of 
the limited genetic variability seen among SARS-Co V isolates. 27 Only when armed 
with such knowledge is it possible to start developing a vaccine for that one particular 
ViruS. 28 But how to gain such knowledge? Put simply, by observing the disease at 
work, in real time, in a body. And, in the absence of human cases of Co V infection 
(and there have been no such cases since late June, 2003), animals were used as 
substitute bodies, artificially infected with Co V and made to act as laboratory 'models' 
so that virologists could gain such knowledge: 
Attempts to develop vaccines against SARS have been undertaken using a variety of 
strategies and several candidate vaccines have been evaluated in animal 
models ... efficacy of protection [of the vaccine] is evaluated by measuring the level of 
replication of the challenge virus and/or the development of histopathologic evidence 
of disease in animal models. (Subbarao 2005, 210) 
In these vaccine studies, in other words, what was sought were: 
Animal models [that could] mimic the clinical illness that was seen in SARS. (ibid., 206) 
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And what that meant for those seeking to develop SARS-Co V vaccines was that the 
comparability experiments originally conducted by Fouchier and his colleagues ID 
order to fulfil Koch's Postulates now had to be replicated, albeit for different ends. 
But have those attempts to replicate replication been successful? Here are the findings 
from one particularly interesting research article: 'Macaque Model for Severe Acute 
Respiratory Syndrome' (Rowe et al. 2004): 
Cynomolgus macaques (philippine origin and captive bred, 1.5 to 2.0 kg) and rhesus 
macaques (Indian origin and captive bred, 2.9 to 4.9 kg) were administered 107 PFU 
[plaque forming units, i.e. a microbiological measurement of the concentration of 
dosage] of Tor2 SARS CoY by direct instillation into the trachea via an endotracheal 
tube or intravenous infusion via a saphenous vein. 
Clinical sequelae of SARS CoY in our study were minimal and were localized to the 
upper airway. The cyno/IT animals developed a mild cough and slightly decreased 
activity on days 2 and 3 after virus challenge; these findings quickly resolved and the 
animals were asymptomatic until days 8 to 10 when sneezing was noted. 
The observation in our experiments of only mild sequelae of SARS CoY challenge in 
macaques differs from the studies of Fouchier et al. (2003) and Kuiken et aL (2003), 
who suggest a more severe syndrome that resembles SARS. Clinical findings in our 
study were mild and localized to the upper respiratory tract (i.e., mild cough and 
sneezing), while the previous studies described respiratory distress in some animals, 
consistent with diffuse pneumonic processes, although objective confirmation of 
pulmonary compromise was not provided. (ibid., 11401-11403) 
As is noted quite explicidy, there was a failure to replicate the original comparability in 
the same kinds of animals, cynomolgus macaques, and with the same kind of dosage 
of CoY. Nor were these in any way anomalous results. Consider the following 
extracts, all taken from similar articles, with similar end-goals: 
Following inoculation [with SARS-CoV], hamsters were sacrificed at various times and 
organs were collected for viral titration and histopathology. SARS~inoculated and 
mock-infected hamsters were weighed every other day and observed for clinical signs 
of disease; neither weight loss nor clinical signs of disease were observed ... We have 
recently reported efficient replication of SARS CoY in the respiratory tracts of inbred, 
4- to 6-week old BALB/c mice, in the absence of associated pathology or clinical 
disease ... Ferrets are valuable models for the study of influenza viruses because they 
develop a clinical illness that resembles human influenza, with rhinorrhea, fever, and 
sneezing following intranasal infection, and therefore they were investigated as a 
possible model for SARS. Virus replication and Pneumonitis were observed in ferrets 
that were infected intranasally with SARS Co V. The experimentally infected ferrets did 
not develop fever or respiratory signs but were lethargic. The histopathological findings 
in the lungs of ferrets were described as similar to but milder than those seen in 
cynomolgus macaques. (Roberts et aL 2005, 504-509 my emphasis) 
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Adult mice infected with varying doses of SARS-Co V in the respiratory tract showed 
no clinical signs of disease, although the virus replicates in respiratory tissues, peaking 
early after infection, with viral titres in the lungs reaching relatively high levels. The 
infection is accompanied by only mild inflammatory changes of the respiratory tract. 
(Haagmans 2006, 194 my emphasis) 
Wc infected eight cynomolgus macaques with SARS-CoV in three groups [Groups I, Il 
and Ill] ... All animals in groups I and Il displayed mild to moderate symptoms of 
illness beginning between post-infection days 2-4. Observed symptoms included 
decreased activity, decreased feeding, snuffling, and mildly laboured breathing ... We 
observed no overt clinical illness in the group HI animals, which were infected 
intravenously. None of the animals developed a measurable fever. Continuous 
telemetry monitoring in four animals revealed no significant changes in temperature, 
heart rate, blood pressure, or left ventricular pressures. (Lawler et al. 2006, 681 my 
emphasis) 
There are many more examples of failures to replicate the original replication studies 
that could have been presented here,29 But it is perhaps best at this point to let 
Subbarao (2005), whose paper was cited earlier, conclude that: 
None of the currently available30 animal models mimic the clinical illness that was seen 
in SARS. (ibid., 210) 
At this stage, perhaps, the critique made by both Rivers and King starts to seem more 
relevant in this particular instance. If the original comparability results detailed in KPF 
were powerful because they were empirically visible, then perhaps now, with the 
appearance of these replication failures, the possibility that they might also have been 
theoretically meaningless starts to gain the kind of persuasive power that visibility so 
often confers. Rather than try to develop this argument myself, however, it is perhaps 
more interesting to let one of the researchers seeking to develop a SARS-Co V vaccine 
do the job instead. For in the very first article that I cited above, 'Macaque Model for 
Severe Acute Respiratory Syndrome' (Rowe et aL 2004), Thomas Rowe and his 
colleagues draw the following conclusions from their cynomolgus macaque tests: 
How strongly the macaque model supports the conclusion that SARS is caused by the 
novel coronavirus, SARS-Co V, is a matter of debate, Indeed, the extensive 
epidemiologic data that links the virus to the disease are quite compelling. It seems 
prudent, however, to explore other species of animals, as well as adapted strains of 
SARS-CoV, in the development of animal models ofSARS. (ibid., 11404 my emphasis) 
In some ways, this is incredible: the importance of comparability, the one postulate 
that had originally been judged capable of separating Co V from hMPV in the original 
aetiological experiments, was now actually being rejected as an aetiological proofl 
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Instead, Rowe and his colleagues were suggesting that 'epidemiologic data', or in other 
words, the sheer number of those infected with Co V who became ill, actually 
provided the most convincing proof that the 2003 SARS outbreak was caused by 
CoY. That, of course, is flne. But note: if comparability can be rejected in this way, 
then recourse to the numbers infected can no longer be used to discount the 
possibility of multifactorality. By implication then, the one thing that had been used 
previously to discount the possibility of multifactorality was, in this particular extract, 
being rejected, and rejected by a group of virologists who were working to develop a 
SARS-Co V vaccine. 
n. COMPARABILITY: AN INTERNAL CRITIQUE 
Having previously attempted to call the comparability postulate into question from a 
position external to the work conducted by Osterhaus and his colleagues, I now want 
. to change tack a little. In fact, I want to look at things from a position internal to that 
work: even if the comparability postulate's ability to deny the possibility of 
multifactorality can be accepted, does the actual comparability work carried out by 
Osterhaus and his colleagues hold up to scrutiny when judged by the standards 
inscribed within the theory of comparability? To perform such an immanent critique, 
I will consider comparability as an 'epistopic' - something that had to be done, as a 
practical achievement, by Fouchier and his research team at the Erasmus Medical 
Centre in Rotterdam?31 
To recall, the comparability experiment was set up to act as a 'compare and contrast' 
exercise. Initially, two sets of macaque monkeys were inoculated, one set with Co V, 
the other set with hMPV: 
A few drops of the virus preparations were administered on each of the conjunctiva, 
0.5 ml in the nose, and the remainder in the trachea' (Fouchier et aL 2003, 
supplementary information). 
After those inoculations had been performed the research team the!1 had the task of 
'monitoring their clinical signs, virus excretion and antibody response' (ibid.). 
Monitoring took place each day post inoculation for the next 6 days, or, in some 
cases, for the next 16 days (in the supplementary information, the list of information 
provided for each macaque concludes with either of the following rather sobering 
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statements: 'euthanised day 16 after inoculation', or 'euthanised day 6 after 
inoculation' (ibid.)).32 Whichever set of macaques died, or came closest to death, and, 
whilst doing so most closely mimicked the clinical progression of SARS in humans, 
thus enabled the research team to fulfil the 'comparability postulate': 'production of 
comparable disease in the originitl host species or a related one' (ibid., para. 3). As it 
turned out, the macaques inoculated with the coronavirus won that particular contest. 
The aetiological un-importance of hMPV, whether of a singular or multifactorial 
nature, was thus confirmed: the comparability of CoY infection in macaques set #1 
with humans was taken as proof that Co V and Co V alone was the cause of SARS 
infection in humans; and the twin facts that (a) hMPV had caused only mild (i.e. non 
comparable) disease in macaques set #2, and that (b) when inoculated with CoY into 
macaques set #3 had only resulted in the same signs and symptoms as displayed by 
macaques set #1, were taken as proof that the possibility of multifactorality could be 
discounted. In the final set of macaques, in other words, hMPV could literally be seen 
to be doing nothing in terms of disease causation, whilst Co V could literally be seen to 
be doing everything. 
Macaques set #1: Co V infected - X 
Macaques set #2: hMPV infected - 0 
Macaques set #3: Co V and hMPV infected - X 
With this one single move, hMPV's aetiological importance was stripped from it. 
At this particular juncture, however, I want to take a few steps 'upstream' from the 
results of this compare and contrast experiment in order to ask where the inoculums 
used to inoculate the macaques actually came from, and, just as importandy, when they 
were developed. 
The coronavirus - normative and temporal comparability 
KPF itself actually provides no information on either the when or the where of the 
CoY inoculum. This, however, is not an insurmountable problem. For although KPF 
was the ftrst research paper to appear in which the aetiological studies were presented, 
it was certainly not the last. The research team at the Erasmus Medical centre in 
Rotterdam quickly established a dense citation network regarding the tests that had 
established the Co V as SARS-Co V. 33 In a later paper, co-written by Thijs Kuiken 
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(who was listed as the second author in KPF), Ron Fouchier (primary author in KPF), 
Martin Schutten (third author in KPF) and a whole host of others, for instance, the 
initial aetiological experiments were summarised. And therein, in the 'macaque 
investigations' sub-section of the article's 'methods' section, the following information 
appears: 
We made the virus stock used to inoculate cynomolgus macaques from the fourth 
passage of a SARS-Co V isolate, obtained from patient 5688, who died of SARS, and 
inoculated it on to Vero 118 cells cultured in Iscove's Modified Dulbeco's Medium. 
(Kuiken et al. 2003, 263 my emphasis) 
This provides an answer to the question of where the inoculum used in KPF 
originated: patient 5688, who died of SARS. If the WHO's detailed case listings were 
publically available it would be possible to find out more about the identity of patient 
5688. What can be worked out logically, however, is that he or she was an adult: 
according to the WHO's Consensus document on the epidemiology of severe acute respiratory 
syndrome (2004d), there was no mortality reported in children during the SARS 
outbreak. Given that this is so, it is possible to conclude that KPF's CoY 
comparability experiments displayed normative comparabiliry. Patient 5688, having died 
from SARS-Co V infection must have displayed severe and acute respiratory, enteric, 
haematological, and hepatic signs and symptoms. Those signs and symptoms 
subsequendy became the norm against which the signs and symptoms of macaque 
disease were judged. The conclusion that Co V 'fulfilled' the comparability postulate 
thus derived from the' fact that signs and symptoms in macaques were 
'indistinguishable' from those in SARS patients (Fouchier et al. 2003, para. 5). 
Severe and acute signs and 
symptoms in adult 
patient 5688 
~ normatively comparable ~ Severe and acute signs and 
and symptoms in macaques 
The extract above also provides an answer to the question of when the inoculum was 
established. Because the 2003 outbreak was the first known outbreak of SARS ever to 
have occurred, the inoculum had to have been from a patient who had died during 
that same outbreak. And again, given that this is so, it is possible to conclude that 
KPF's CoY comparability experiments displayed temporal comparabiliry as well as 
normative comparability. The strain of CoY that had caused infection and, ultimately, 
117JPagc 
death in patient 5688 was the same strain that was then used to infect the macaques. 
There was, in short, very litde delay between the two infections. 
The disease causing virus ~ temporally comparable ~ The disease causing virus in 
in patient 5688 (2003) macaques (2003) 
So far, so obvious. But the reason I have laboured to make these seemingly obvious 
points will, hopefully, become clear in a moment. 
The human metapneumovirus - normative and temporal comparability? 
So what now of the hMPV inoculum? Initially, a clue as to when it was developed is 
provided by KPF: 
Lesions in macaques infected experimentally with hMPV isolated from a non-SARS 
individual [footnote 7] were limited to mild suppurative rhinitis and minimal erosion in 
conducting airways. (Fouchier et aL 2003, para. 6) 
But for it to be anything more than a clue, the phrase 'non-SARS individual' has ftrst 
of all to be deciphered. Indeed, in what is otherwise a precise piece of scientiftc 
writing this constitutes a curiously ambiguous formulation. What does it mean? An 
initial interpretation might run as follows: KPF had been published in the 15
th 
May 
edition of Nature. Thus, nearly a month had passed since Osterhaus' announcement, 
at the 16th April press conference, that 'Co V and Co V alone is responsible for causing 
SARS' (WHO 2003m, para. 28). I<PF's reference to a 'non-SARS individual' might 
therefore be understood as the product of a process Bruno Latour has elsewhere 
referred to as 'retrofttting' (1999, 168-173). With this one phrase, Fouchier and his 
colleagues might perhaps be seen to be extending the existence of SARS-Co V in time, 
re-interpreting the past in a new light: an individual with pneumonia who was 'at the 
time' considered a possible SARS case, would, in their new history of 'at the time', 
represent an individual infected with hMPV, not CoV, and, as such, also represent a 
'non-SARS case'. 
Initially this seems like a plausible interpretation. But what would it imply about the 
when of hMPV? It would imply that the individual in question was in fact present 
during the 2003 SARS outbreak as a suspect, or perhaps even as a probable, SARS 
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case. And yet that is precisely where such an interpretation fails. For when KPF is 
examined in a little more detail it becomes clear that the 'non-SARS individual' in 
question actually came to the attention of F ouchier and his colleagues a long time 
before 2003. To make this point a little clearer, the '[footnote seven], appended to the 
phrase 'non-SARS individual' in the extract above can be followed. It guides its reader 
to the following reference: 
Van den Hoogen, B.G. et al. Nature Med A newly discovered human pneumovirus 
isolated from young children with respiratory tract disease 7, 719-724 (2001). (Fouchier 
et al. 2003, para. 8) 
Note the date of publication: 2001. KPF's 'non-SARS individual' would appear to 
have been part of an entirely separate disease outbreak. But there is something more 
that can be noted here. Reading through Van den Hoogen's cited article, the following 
passage appears: 
From 28 young children in the Netherlands, we isolated a paramyxovirus that was 
identified as a tentative new member of the Metapneumovims genus based on virological 
data, sequence homology and gene constellation ... Within our diagnostic virology 
setting, we isolated 28 unidentifiable viruses from patients in the Netherlands with RTI 
[respiratory tract infection] over the past 20 years. Of the 26 patients for whom 
personal information was available, eight (31 %) were females, 13 (50%) were between 
the ages of 0 and 12 months, and 12 (46 %) were between the ages of 1 and 5 years. 
(Van den Hoogen et al. 2001,719 my emphasis) 
So although the paper was published in 2001, it does not necessarily follow that the 
'non-SARS individual' referred to by KPF was actually part of a disease outbreak that 
took place in 2001. In fact, as Van den Hoogen and her colleagues makes clear, that 
individual could actually have been infected with hMPV during an outbreak that took 
place as long ago as 1981! Yet neither KPF nor any of the other published reports in 
which the SARS aetiological work was detailed provide any references to the precise 
date of infection for the 'non-SARS individual'. Without such information, the most 
that can be concluded here in terms of the when of I<PF's hMPV is that the 'non-
SARS individual' had to have been infected with hMPV at some point between the 
years 1981 and 2001. And what that means is that KPF's hMPV comparability 
experiments did not display the same temporal comparability as the Co V experiments. At 
best, the hMPV infection had taken place two years before the SARS outbreak, and, at 
worst, twenty-two years before. 
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But what now of the where of this hMPV extract? What, or whom, did this inoculum 
come from? Consider the extract from Van den Hoogen's article one final time: 
From 28 young children in the Netherlands, we isolated a paramyxovirus that was 
identified as a tentative new member of the Metapneumovirus genus based on virological 
data, sequence homology and gene constellation ... Within our diagnostic virology 
setting, we isolated 28 unidentifiable viruses from patients in the Netherlands with RTI 
over the past 20 years. Of the 26 patients for whom personal information was available, 
eight (31%) were females, 13 (50%) were between the ages of 0 and 12 months. and 12 
(46 %) were between the ages of 1 and 5 years. (Van den Hoogen et al. 2001, 719 my 
emphasis) 
Of the 28, all were 'young children', and 96% of them were under the age of 5 years 
old. The 'non-SARS individual', in other words, was far from being the adult that we 
might initially have supposed he or she to be. Given that this is so, it is possible to 
conclude that KPF's hMPV comparability experiments failed to display the same kind 
of nonnative comparability as the Co V compatibility experiments. The non-SARS child, 
having recovered from his or her infection, displayed only mild respiratory, enteric, 
haematological, and hepatic signs and symptoms. But those very mild signs and 
symptoms did not subsequendy become the norm against which the signs and 
symptoms of macaque disease would be judged in KPF. 
To sum up, then, what I have sought to make clear is that whilst the CoY inoculum 
was from an adult JARS patient who died as a result of his or her infection in 2003 the hMPV 
inoculum was from a young child who recovered from his or her infection at some point between 
1981 and 2001. But now of course the question is whether or not these details are 
significant for an attempt to recover the possibility of multifactorality. I want to 
suggest that they are, starting with hMPV's lack of temporal comparability, before 
moving to deal with its lack of normative comparability. 
Antigenic shift and drift - the problem of the human metapneumovirus' 'when' 
In order to get at the problems (potentially) thrown up by this lack of temporal 
comparability, a few basic textbook facts about viral replication need to be brought 
into the discussion. According to the Baltimore Classification system, viruses can be 
classified into the following two groups depending on the nature of their nucleic acid 
components: DNA viruses and RNA viruses. 34 In order to replicate successfully, 
DNA viruses, as with cellular life-forms more generally, depend upon the scrupulous 
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accuracy of DNA polymerase in duplicating genetic information. Like an obsessive 
scholar, DNA polymerase proofreads and corrects every copy of DNA, with the 
resulting error rate remaining as low as one mistake in every billion nucleotides 
copied. RNA viruses, however, are not so careful. Their mutation rates are usually 
many orders of magnitude greater than those of their DNA counterparts.
35 
On 
average, RNA polymerases generate an error in nearly every replication cycle, so that 
when populations of RNA viruses are large, they will harbour a myriad of genetically 
different variants.36 In virology this process of mutation is known as antigenic drift·37 
And the effect of antigenic drift can be to 'render the new strain different enough to at 
least partially avoid the immunity induced by previous strains' (Wilschut et aL 2006, 
16).38 But there is also something else about RNA viruses that mark them out as more 
liable to mutation than DNA viruses. Unlike the latter, where genetic data is contained 
in DNA double helices, RNA viruses consist of single-stranded RNA packages. Thus, 
a co-infection of a host cell by two different viruses can result in a re-assortment of 
their genes.39 Again, in virology, this process is known as antigenic shiJt·40 And the effect 
of antigenic shift is even more radical than that brought about through drift. Shift 
effectively results in the introduction of 'a virus with a new genetic identity into the 
human population' (ibid., 15). Since 'everyone will be immunologically naive to that 
new virus subtype, the infection may spread rapidly and cause high morbidity and 
mortality among the entire population, including young healthy people' (ibid.).41 
But how does all of this relate to hMPV? 
Classified presumptively in the Metapneumovirus genus, Pneumovirus subfamilY, and 
Paramyxovirus familY of the Order Mononegavirales, hMPV is a nonsegmented 
negative-strand RNA virus (more specifically, an enveloped virus with a genome that 
is a single negative strand of RNA of approximately 13 kb).42 First recovered by Van 
den Hoogen and her colleagues in the Netherlands, it has since been isolated in 
several continents and is known to have displayed antigenic drift in the past.43 Previous 
comparisons of sequences available for several hMPV genes or gene fragments have 
shown that the available hMPV isolates can be grouped into two broad genotypes or 
subgroups.44 Here for instance, is Van den Hoogen, writing in 2004, in a paper that 
sought to analyse the genetic diversity of hMPV by phylogenetic analysis: 
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For HMPV, two major genetic lineages have been identified worldwide on the basis of 
analysis of a limited set of sequences .... To develop vaccines, the extent of genetic and 
antigenic variability of the different HMPV trans-membrane glycoproteins must be 
understood. Our results in combination wid1 data published by others [footnotes 26, 27 
and 42 appear here] demonstrate that HMPV clusters in two globally distributed 
serotypes. (Van den Hoogen et al. 2004, 658 my emphasis) 
But as she also went on to note: 
However, the identification of two serotypes does not exclude the possible existence of 
more serotypes or sublineages. (ibid. my emphasis) 
To the best of my knowledge, Fouchier and his research team at the Erasmus Medical 
Centre in Rotterdam never carried out any research into the genetic-make up of the 
hMPV strain that was already, by the time they conducted their macaque tests, known 
to have been circulating with Co V in Hong Kong, Singapore, Canada and Viet N am. 45 
Indeed, the only reference I have been able to find that provides such genetic 
information stems from the work carried out by the National Microbiology 
laboratories in Winnipeg, Canada, into the cause of SARS. In the 15th April edition of 
the Canada Communicable Disease Report (henceforth CCDR) , an article entitled 
'Epidemiology, clinical presentation and laboratory investigation of SARS in Canada, 
March 2003' appeared. And, therein, under the sub-heading 'Laboratory Results', it 
was noted that: 
Testing of initial specimens from SARS cases received at the National Microbiology 
Laboratory was initiated upon receipt ... For virologic examinations, RNA and DNA 
extractions were performed on nasopharyngeal swab, bronchoalveolar lavage and 
sputum specimens as well as serum and whole blood samples using commercial kits 
(Quiagen, Tryzol). Reverse transcriptase-PCR was performed using primers specific for 
the following RNA viruses: influenza A and B, respiratory syncytial virus, parainfluenza 
virus subtypes 1-4, human metapneumovirus, @oviruses (Ebola and Marburg viruses), 
arenaviruses, measles virus, mumps virus, hantaviruses, and Crimean Congo 
hemorrhagic fever virus. PCR was also performed 
All results are negative to date with the exception of testing for human 
metapneumovirus. which could be amplified using a nested PCR approach from six' 
patients. For confirmation, the amplicons were sequenced and found to be unique, 
excluding cross-contamination in the laboratory. (CCDR 2003, para. 4 my emphasis) 
They were found to be 'unique'. Was this an indication that the hMPV strain 
circulating during the early months of 2003 was the product of antigenic drift? 
Probably, yes. But was it also something more, a sign of something more virologically 
worrying: antigenic shift? At the time it would not have been difficult to take such a 
question seriously. After all, it has now generally been accepted that the SARS-Co V 
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outbreak was the end-product of a process of reassortment (i.e antigenic shift) 
between different coronavirus lineages.46 
But what to make of all of this in relation to KPF? 
The first very simple point is this: Fouchier and his colleagues placed a great deal of 
epistemological weight on the issue of comparability during their KPF experiments. 
To recall: 
The Koch's postulates are firsdy that the agent should be present in basically all the 
individuals that are suffering from the disease. That holds true predominandy for the 
coronavirus and not for the metapneumovirus because it is less than 50% of the people 
infected or having SARS that were infected with metapneumovirus. The second 
postulate is that you should be able to cultivate the virus. That holds true for the two 
viruses. The third postulate is that you should be able to reproduce the disease in the 
host or a related host. That is what we have done for the coronavirus. and coronavirus 
only. The last postulate then is that you should re-isolate the virus back from the 
animals that you have infected with that virus. Those four things have been fulfilled for 
coronavirus and only three of those for the metapneumovirus. The coronavirus alone 
is capable of causing the typical symptoms of SARS (WHO 2003m, para. 27 my 
emphasis) 
And as I attempted to make clear in the prevlOus section, the postulate of 
comparability relied on the assumption of the standardised and unproblematic animal 
body producing the same observable clinical symptoms each and every time it was 
infected with the same pathogen. A human had manifested with signs and symptoms x, 
y and z, and the assumption was that macaques infected with the same pathogen would 
also manifest with signs and symptoms x, y and z. But note the italicised phrase 'the 
same' in the two previous sentences. For once the concepts of 'antigenic drift' and 
'antigenic shift' are understood, then that which constitutes 'the same' is, at the very 
least, temporally constrained. A strain of a virus that caused signs and symptoms x y 
and z in a human patient might very well come to cause symptoms u v and w, along 
with x y and z, in ten years time. And that would mean that even if animal 
comparability could be accepted as a useful aetiological postulate, temporality would 
have to be taken into account whilst devising comparability experiments. 
I would suggest that this implies that if comparability is to be accepted as a useful 
aetiological criterion, and if animals are to act as standardised hosts in which one virus 
will cause the same signs and symptoms as in humans, then any inoculum might 
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reasonably be expected to come from humans injected in a very recent disease outbreak. I write 
of what is reasonable here with good reason: after all, Fouchier and his colleagues 
seemed to be well aware of the need for temporal comparability in the case of the Co V 
experiments - there, they seemed very much aware of basic virological facts like 
antigenic drift and shift, with the inoculum coming from a SARS patient who had 
fallen ill as litde as a few days earlier. They knew, in other words, that to test a known 
coronavirus strain from an outbreak prior to 2003 would have been meaningless -
one strain of that virus, which had hitherto been known only to cause the common 
cold in humans, had obviously mutated into a newer and much more virulent strain 
during the early months of 2003. In the case of the hMPV experiments, however, no 
such care or consideration was taken. Temporal comparability was lost. Suddenly the 
issues of drift and shift were no longer deemed to be of any importance. And yet the 
information provided by the Canadian laboratories regarding the 'unique' genetic 
structure of the hMPV that was circulating during early 2003 could, and perhaps 
should, have pointed to the fact that those issues were of absolutelY critical importance. If 
one is prepared, as Fouchier and his colleagues were indeed prepared, to place so 
much epistemological weight on the postulate of animal-human disease comparability 
then it seems remarkably unreasonable to devise a set of experiments in which the 
issue of the temporal comparability of the experimental inoculums could be 
remembered in one set of tests, yet forgotten so completely in the other set. 
As the defence lawyer for the possibility of multifactorality, this is all very interesting. 
If Fouchier and his colleagues had used an hMPV strain from 2003 (a strain, 
remember, which was found to be 'unique'), there was surely a possibility that both 
Co V infected macaques set #1 and hMPV infected macaques set #2 would both have 
displayed the same, similarly severe symptoms. And, if so, the third test, the test set 
up to deal with the question of multifactorial aetiology would have been unable to 
disprove the idea of multifactorial aetiology. 
Under I<PF's original tests, it did: 
Macaques set #1: Co V infected - X 
Macaques set #2: hMPV infected - 0 
Macaques set #3: Co V and hMPV infected - X 
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But under these new conditions it might not have done: 
Macaques set #1: CoY infected - X 
Macaques set #2: hMPV infected - X 
Macaques set #3: Co V and hMPV infected - X 
Of course, all I can write at this juncture is 'might not have done'. But then, by the 
standards that any such comparability test would seem, logically, to demand - i.e. total 
comparability of animals, humans and virus - is it not the case that the possibility of 
my being able to write 'might not have done' should already have been erased by the 
performance of the original tests? That it has not been erased, that the issue is still 
undecidable, stems from the failings of the original experiment when judged against 
the standards that comparability would seem to demand. As a result, it is possible to 
suggest that those tests are unable to definitively reject the possibility of 
multifactorality . 
Children and adults - the problem of the human metapneumovirus' 'where' 
I want to come back now to look at the question of 'where' the hMPV sample came 
from. For despite not being addressed at all by Fouchier and his colleagues in KPF, 
the fact that the 'non-SARS individual' from whom their hMPV sample was taken was 
a 'young child' is potentially quite an important one. It can, if pursued, alter the way in 
which I<PF's comparability studies are understood. 
What was actually meant by comparability in I<PF? As was made clear in previous 
sections, the normative standard was adult, human SARS infection. Patient 5688, 
having died from SARS-Co V infection must have displayed severe and acute 
respiratory, enteric, haematologica~ and hepatic signs and symptoms. Those signs and 
symptoms subsequendy became the norm against which the signs and symptoms of 
macaque disease were to be judged. The conclusion that Co V 'fulfilled' the 
comparability postulate thus derived from the fact that signs and symptoms in 
macaques were 'indistinguishable' from those in adult SARS patients (Fouchier et aL 
2003, para. 5). If this is what I<PF meant by comparability then it is indeed a paper 
that reports on a set of experiments in which CoY, and CoY alone, produced 
comparable disease in both humans and macaques. 
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But what does it report on in the case of the hMPV experiments? 
Given that the Co V sample came from an adult whilst the hMPV sample came from a 
young child, the existence of a normative standard based around adult signs and 
symptoms begs the question of whether or not all SARS patients actually presented 
with the same severe and acute signs and symptoms. Or, put another way, whether or 
not 'SARS patients who were young children' and 'SARS patients who were adults' 
presented with the same severe and acute signs and symptoms. 
It would appear that they did not. In an article entided 'SARS in children', Dr. Chi 
Leung from the Department of Paediatrics and Adolescent Medicine, Princess 
Margaret Hospital Hong Kong, noted how 'the original WHO case definitions for 
surveillance of SARS require[d] that lower respiratory symptoms of cough, shortness 
of breath or difficulty in breathing be present' (2004, 30). The problem in the case of 
children, however, was that even where an 'epidemiologic link to a person [i.e. an 
adult] under investigation for or diagnosed with SARS was available', 'children [did] 
not present with these symptoms' (ibid., 31-32). And as Leung went on to make clear 
in a subsequent article, although 'children were susceptible to infection by SARS-CoV, 
the clinical picture in young children was milder than in adult?, and 'children appeared to be less 
qffected by the disease, with smaller case numbers and less severe illness' (Leung and Chiu 
2004, 275-276 my emphasis). Leung, writing many months after the outbreak had 
ended, projects the agent SARS-CoV into his statements. But at the time of the 
outbreak, that is, at a time before this causal agent had been identified, Leung's 
diagnosis of 'probable SARS' in a young child would have been based solely on 
clinical, epidemiological and haematological findings. So at the time when Fouchier 
and his colleagues were carrying out their aetiological experiments, it would 
undoubtedly have been known, at the level of the clinic, that children with probable 
SARS (caused by an as yet unknown aetiological agent) were not manifesting with the 
same signs and symptoms as adults with probable SARS. What is more, Leung's 
findings with regard to SARS in children were echoed elsewhere. Here, for instance, is 
the abstract from a paper entided 'SARS in Children: the Toronto experience' that 
was prepared by the 'Canadian Hospital for sick children SARS investigation team'; 
An outbreak of severe acute respiratory syndrome (SARS) occurred in Toronto 
between February and April, 2003. The majority of children with suspected SARS were 
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admitted to The Hospital for Sick Children, Toronto ... In young children. SARS 
appears to be a relatively mild non-specific respiratory illness. The SARS coronavirus is 
not reliably detected in NP aspirate specimens using a first generation PCR assay. 
(Bitnun et al. 2003 my emphasis) 
And as Hon et at. (2003b) and Chiu et at. (2003) have both pointed out in papers 
dealing with 'paediatric SARS' at a more general level, the clinical course of SARS 
seems to have been much milder and shorter among patients less than 12 years of age. 
Indeed that is why one group of researchers recommended the term 'mild acute 
respiratory syndrome' for SARS-CoV infection in children (see Wong et at. 2003c, 
261; and Lawler et at. 2006, 678). Compared with adults and teenagers, then, SARS 
seems to have had a less aggressive clinical course in younger children. So, the 'SARS 
patient' from whom KPF's Co V inoculum was drawn was an adult. The 'non-SARS 
individual' from whom I<PF's hMPV inoculum was drawn, on the other hand, was an 
individual from precisely the kind of age range, under 12 years of age, that Hon et at. 
(2003b), Chieu et at. (2003), Bitnun et at. (2003), Leung (2004), and Leung and Chiu 
(2004) were suggesting would have had milder, less severe illness than an adult. 
In the case of KPF's hMPV experiments, in other words, to conclude that hMPV was 
not aetiologically significant because 'lesions in macaques infected experimentally with 
hMPV isolated from a non-SARS individual were limited to mild suppurative rhinitis 
and minimal erosion in conducting airways' (ibid. para. 6), was to work with a 
normative standard drawn from adult SARS infection. But of course, if there had been 
the same kind of normative comparability as displayed in the Co V experiments (i.e., 
for Co V, severe acute adult signs and symptoms found in adults, and then severe acute 
signs and symptoms subsequendy sought for in macaques; whilst for hMPV, mild signs 
and symptoms found in a 'non-SARS' child, and then mild signs and symptoms sought for 
in macaques) then this aetiological conclusion would have been untenable. Why? 
Because the macaques would have been yielding comparable disease, mimicking the 
mild signs and symptoms that children with SARS had presented with. 
In other words, if comparability was to be accepted as a useful aetiological criterion, 
and if the animals were to act as standardised hosts in which one virus would cause 
the same signs and symptoms as in humans, then the normative standard by which 
comparability was to be judged might reasonably have been expected to remain the same 
across all tests. 
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But what does it mean here to write of 'the same'? 
On my reading, 'the same' would mean an adult norm for the Co V tests, and a child's 
norm for the hMPV tests. As a result, the comparability tests would have been 
inconclusive: both would have fulfilled the comparability postulate. For Fouchier and 
his colleagues, however, 'the same' seems to have meant holding the norm as 'adult 
disease' across all tests. In that way, the comparability tests became conclusive. But 
then, for their 'same' to have been reasonable, surely the inoculum used for each and 
every test should have come from two adults who had been infected in a very recent 
disease outbreak? The fact that they did not suggests, to me at any rate, that the 
comparability tests are inconclusive: we simply do not know what would have 
happened had an adult hMPV case been used to develop an inoculum. 
In. CONCLUSIONS 
In this chapter, the Erasmus Unversiteit's 'Koch's Postulates experiments' were 
treated as if a judgement, a judgement handed down by a scientific court held at the 
Erasmus Universiteit during early 2003 that stated that singularity had been proven, 
and multifactorality dzs-proven. As the defence lawyer for the possibility of 
multifactorality I have sought to pick as many holes in the original case for the 
prosecution as I could with the hope of making the court's judgement appear Gust a 
litde) un-safe. 
The effect of this hole-picking has been to place those 'Koch's Postulate experiments' 
in what might, borrowing a metaphor from Gregory Bateson's work, be described as a 
double bind. In section I, the most crucial of Koch's Postulates for denying the 
possibility of multifactorality was identified and subjected to an external critique: the 
postulate, I suggested, could be called into quite serious question if the work of other 
virologists was brought to bear upon it. In section II, however, I switched strategy, 
. subjecting that same postulate to an internal critique: even if the postulate could be 
accepted as an aetiologically definitive one, I suggested, then its fulfilment during the 
Rotterdam experiments failed to meet the standards set by the postulate itself. 
So, a double bind: if you do not accept the theoretical validz!J of the postulate in question then 
that postulate is unable to foreclose upon the chance and the possibility of 
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multifactorality; if you do accept the theoretical validity of the postulate, however, then the 
practices through which it was fulfilled in this particular instance were still unable to 
foreclose upon the chance and the possibility of multifactorality. 
Has this attempt at identifying a double bind succeeded? 
If it has, then the possibility of the multifactorial has at the very least, received some 
form of recompense for its treatment during the 2003 SARS outbreak ... 
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Notes 
1 'Any' because pneumonia-like illness is so non-specific that it can be caused 
by any number of pathogenic agents, whether of viral or bacterial origin. On the 
difficulty of making a definitive diagnosis of pneumonia before laboratory tests can be 
conducted, see Cunha (1991; 1997; 1998; 2000a; 2000b; 2003; 2005; 2006a; 2006b; 
2008). 
2 Indeed, so 'consistendy' was this virus identified by WHO SARS network 
laboratories during the early weeks of the outbreak, that a 'consensus' began to build 
around the idea that hMPV was the one, singular aetiological agent behind the SARS 
outbreak. So confident of this was Dr. Stahr, for instance, that at a press conference 
on 21 sI March, he could note how 'we are now closer to the reality that this 
Paramyxoviridae virus has caused [SARS], (WHO 2003c; and also see WHO press 
releases 2003s; 2003t; 2003w). And again, Dr. Frank Plummer of the Canadian 
laboratory centre, was quoted in the March 29 th edition of The Lancet, suggesting that 
the metapneumovirus was 'the one': 'Scientists believe that the virus [the 
metapneumovirus] has mutated into one that produces much more severe symptoms. 
'1 think it is somewhat reassuring that it is a virus we've seen before', National 
Microbiology Laboratory scientific director, Frank Plummer told reporters. 'But 
important questions remain about why this is so virulent" (see Kondro 2003). As an 
aside, and looking forward to Dr. Hong Tao's treatment at the hands of popular 
science journalists in chapter 6, it is perhaps worth noting just how easily the 
behaviour of this group of rnicrobiologists (and, in particular, the behaviour of Dr. 
Frank Plummer) could quite easily have been, but never was, troped in a similarly critical 
way (is it not the case, for instance, that th~ir initial belief in hMPV was a clear 
violation of Merton's scientific norm of organised scepticism?). 
3 For the initial laboratory results in Canada, see CCDR (2003) and Poutanen 
et al. (2003); for Hong Kong, see Chan et al. (2004) and Lee et al. (2007); for Singapore, 
see the details in Chong et al. (2004) and Leong et al. (2006); and for Viet Nam, see 
WER (2003d), and WHO (2003f). 
4 See Chan et al. (2004), Drosten et al. (2003), Lee et al. (2007), Poutanen et al. 
(2003), Stahr (2003), Tomlinson and Cockram (2003). 
5 During the early weeks of the outbreak, as medical rnicrobiologists working 
within the WHO SARS laboratory network sought to isolate a hitherto unknown 
virus, 'open minded' diagnostic technologies were deployed. As a result, a whole host 
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of different viruses were coaxed out into a space of microbiological visibility. And, 
because the SARS outbreak was of such global significance, the co-factorial diagnostic 
findings generated by that 'open minded' diagnostic work were deemed to be worthy of 
publication. Later on, however, when 'probe specific' diagnostic technologies were 
developed and put into use, things started to -change. Not only did CoV begin to 
appear alone, bereft of its former co-factorial allies, but the diagnostic work became 
mundane. Boring. Unworthy of publication. 'Open minded' discovery, it seems, is the 
preserve of the microbiological 'superstar', the Dr. Ksiazek or the Dr. Peiris; 'probe 
specific' diagnosis, on the other hand, is the work of the lowly technician. 
6 See the information on case cohorts provided in the articles cited in footnote 
3, above. 
7 These are the case figures included in the WHO's final summary of probable 
SARS-CoV cases, published on 21st April, 2004 (see WHO 2004c). 
8 On the case of hepatitis D, see the comments in the introductory chapter, 
above, and also, the mini case-study in the concluding chapter, below. 
9 On the idea of 'bandwagons' in scientific research, see Fujimura (1988). 
10 See Chen et al (2003), Chim et al (2004), Hu et al (2003), Marra (2003), Rota 
(2003), Ruan et al (2003). 
11 Although various molecular (pCR-based) assays have been developed by 
different groups around the world (see for example Chan et al (2004); Jiang et al 
(2004); Wu et al (2004); Zhang et al (2003)), and although some of those assays are 
now available commercially, the failure to develop any kind of rapid laboratory 
diagnostic test has led to diagnostic research remaining a high priority for medical 
microbiologists. Indeed the possibility that SARS-Co V might, at any moment, re-
appear in the social body, has led the WHO to try and stimulate privately funded 
diagnostic research. As they noted in 'Update 71' on June 2nd, 2003, for example, 'to 
expedite the development of better diagnostic tests, laboratories in the WHO 
collaborating network have made critical biological materials and reagents available to 
any laboratory having a sustained interest in the development of diagnostic tests, 
including the commercial sector. Comprehensive bank of clinical specimens, including 
respiratory specimens and samples of blood, urine, and faeces from SARS patients; 
has been established. The bank holds specimens representing all stages of the disease, 
ranging from the onset of symptoms to recovery ... During the development of 
diagnostic tests, such specimens are needed to assess how well a test will perform with 
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real patients specimens, as opposed to under the artificial conditions of a laboratory. 
Specimens from the bank, which was set up by the Hong Kong Department of 
Health and the Hospital Authority, are being supplied by a collaborating laboratory, at 
no charge, to developers of diagnostic tests' (WHO 2003zz, my emphasis). 
12 See Kuiken et al. (2003), McAuliffe et al. (2004), Roberts et al. (2005), 
Subbarao et al. (2004), Zhu (2004). 
13 Here I am paraphrasing Ashmore (1995): 'my strategy is to pick as many 
holes in these results as 1 can find with the object of weakening Gust a litde) the 
unchallengeable character of the Piltdown forgery' (ibid., 592). 
14 It should be noted, however, that at the very bottom of the article the 
following comment appears: 'supplementary information accomparues this 
communication on Nature's website' (Fouchier et al. 2003, 240). The 'supplementary 
information' in question is a set of laboratory results relating to the Co V infected 
macaques. They can be found via a quick search of the Nature website's archives. 
15 See for instance (WHO 2003c; 2003d; 2003f; 2003j). 
16 And here, 'intervened'is the right word. For the journalist in question had 
begun to press Dr. Salter a litde further in relation to the aetiological question: '1 was 
just asking yes or no. I mean, the CDC [Centre for Disease Control, Adanta] said: "we 
have found it". And I was saying in fact what you're saying is that: "we think we've 
found it but we still don't know". That's the situation?' And, at that point, faced with 
the task of re-formulating what he no doubt thought was a pretty good answer, Dr. 
Salter started to struggle a litde: We've found a virus ... [the ellipses are in the original 
transcript, indicating a pause] but we don't know whether ... we have a lot of evidence 
to suggest it is but we're not in a position to say with our hand on heart ... but it seems 
likely that it is' (see WHO 2003e). 
17 Here 1 would simply like to cite an extract from John Law's Aircraft Stories 
(2002) that gave me the confidence to continue pursuing the case for the defence at 
(textual) moments like this: 'when something is said to be a "detail", I hear the 
performance of a fierce form of distribution ... the performance of a hierarchical 
distribution that (sometimes intentionally) demotes whole sets of phenomena to the 
subordinate class of minutiae, that which does not have to be taken seriously' (ibid., 
118). 
18 1 write of 'whoever' first articulated 'Koch's Postulates' with good reason. 
Was Robert Koch actually the first person to formulate them? Or were they initially 
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devised by Koch's former lecturer, Jacob Henle (see Evans'1976, 1978)? And what of 
Edwin Klebs' role in their development (see Carter 1985, 2003)? Or perhaps it was 
actually Koch's colleague, J ohannes Loeffler, writing in an 1884 paper on diphtheria, 
who actually enunciated them in their final 'textbook' form (see Brock 1988, 179-
181)? But then, these authorial uncertainties are merely symptomatic of a deeper, 
underlying curiosity about 'Koch's Postulates', namely, the fact that 'they' have always 
seemed to exist in a curiously fluid, non-definite state. As Carter (1985, 353) has noted, 
the fact that 'different authors state the postulates differently' has led to a situation in 
which 'Koch's Postulates' sometimes seem to consist of just three postulates (see for 
example Fredricks and Relman 1996, 19), and, at other times, as many as five 
postulates (see for example Harden 1992, 253). For an account of a similarly fluid 
technology, the Zimbabwe bush pump, see de Laet and Mol (2000). 
19 For Rivers this was so because of Robert Koch's strict adherence to the 
doctrine of specific aetiology. Once again, the tension between singular aetiology and 
multifactorial aetiology rears its head in Rivers' (1937) critique: 'The idea that an 
infectious malady can be caused only by the action of a single agent is incorrect, and, 
if Shope had adhered to old ideas, he would never have discovered that swine 
influenza as it occurs in nature is caused by the combined or synergistic action of two 
agents, one a virus not cultivable on lifeless media, the other an ordinary haemophilic 
bacteria. Furthermore, it has been demonstrated that at least one natural disease of 
plants is induced by the combined action of two viruses, each of which has been 
obtained free from the other and when so obtained each produces a characteristic 
malady different from that caused by the synergistic action of the two agents' (ibid., 4-
5 my emphasis). 
20 Nor the four postulates that Osterhaus previously referred to during the 
WHO-convened 16th April press conference. 
21 On the discipline of immunology, and its current relationship to diagnostic 
microbiology many years after Rivers' initial enrolment, see Chapter 5, below; and, for 
a historical overview, see Bibel (1988), and Cambrosio and Keating (1995). 
22 See for instance the literature that has developed around the discovery of 
Epstein-Barr virus (EBV) as the cause of infectious mononucleosis. As Evans (1993, 
52 my emphasis) has noted, 'even now, current data are still inadequate to fulftl 
Koch's postulates, since the agent is present in healthy carriers and has not been 
isolated in pure culture, and the disease has not been fully "reproduced anew" 
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experimentally'. And yet despite having been bUilt solely around the detection of EBV 
antibody in patient samples, the aetiological claim that 'EBV causes mononucleosis' 
faced very litde, if any, opposition during its movement from 'claim' to 'medically 
entrenched fact' (and on that movement, also see Evans 1993, and 1976). Also of 
interest here is the aetiological claim that 'H. Pylori is the cause of peptic ulcers'. 
Despite the fact that initial attempts to reproduce the disease in H. Pylon'inoculated 
pigs were unsuccessful (see Marshall et aL 1985), the National Institute of Health in 
America was quick to accept the aetiological connection (on this episode, see Thagard 
1999). And finally, it is also worth noting the many attempts that have been made to 
re-formulate 'Koch's Postulates' ever since Rivers' initial intervention during the 
1930s. What those efforts at re-formulation all seem to share is a desire to replace the 
aetiological requirement of animal comparability with the kind of molecular evidence of 
causality that only recendy developed diagnostic technologies like ELISA and RT-
PCR are capable of generating (see for example Chamberlin et aL 2007, Colwell 1999, 
Fredricks and Relman 1996; Inglis 2007, Salyers and Witt 2005). 
23 See for instance Fowler et aL (2003), and Lee et aL (2003). 
24 See for instance Chan et aL (2004), Ng (2003), and Seto et aL (2003). 
25 As Subbarao (2005, 204) has noted, 'this is an important issue in vaccine 
development', and one that 'has to be evaluated if live attenuated vaccines are to be 
developed.' Although central nervous system involvement was not reported in a'!} 
diagnosed cases of 'probable SARS' during the outbreak, further follow-up studies of 
SARS survivors have sought to clarify whether or not there might have been 
unrecognised involvement. Why? Because of a previously reported association between 
human coronavirus infection and multiple sclerosis, and because another prototype 
coronavirus, mouse hepatitis virus, is neurovirulent (see Arbour et aL 2000). For the 
details of those follow-up studies, see Navas-Martin and Weiss (2003) 
26 Knowledge of viral shedding patterns is vital during the development of any 
vaccine. Why? Because the vaccine is a live attenuated form of Co V. And, as a result, 
the risk of faecal spread following administration of a live attenuated SARS-Co V 
vaccine, although extremelY low due to the attenuated nature of the virus, has to be 
considered. Indeed, it is a risk that, in the case of SARS-Co V at least, has attracted a 
large amount of study in the post-outbreak period: presence of SARS-Co V genome 
has been detected by RT-PCR in the faeces of patients (peiris et aL 2003), including 
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one report of detection as late as 73 days after the onset of illness (Leung et aL 2003). 
Also see Chan et aL (2004) and Yu et aL (2004). 
27 This 'need' explains the proliferation of studies in which various SARS-Co V 
genomes have been sequenced (see for example Chim et aL (2004), Guan et aL (2004), 
Marra et aL (2003), Rota et aL (2003), Ruan et aL (2003)). What each of those studies 
were looking for, in part, were strains of Co V that might elude an immunity that 
would be generated in response to a live-attenuated vaccine designed around a 
different strain of Co V. 
28 For a clear and concise research article detailing the various 'vaccination 
strategies' developed in relation to SARS-CoV, see Zhu (2004). 
29 For example, the following animal models have all been investigated: rhesus, 
cynomolgus and African Green monkey test models (Bukreyev et aL 2004, McAuliffe 
et aL 2004); BALB/c mice (Roberts et aL 2005); cats and ferrets (Martina et aL 2003); 
marmosets (Greenough et aL 2005); and cotton rats (Hogan 2006). 
30 But then again, perhaps it is 'best' to interrupt Subbarao at this point. For as 
the defence lawyer for the possibility of multifactorality I would simply not be doing 
my job properly if, before moving on to deal with other matters, I failed to mention 
something else about these 'replication failures'. It is, potentially, quite an unedifying 
'something', and can be found in Hogan's article, 'Are nonhuman primates good 
models for SARS?' (2006). Rather than develop any kind of meta-commentary, 
however, I will simply present the exhibit to the court, and let the jury draw their own 
conclusions as to its significance here: 'with my colleagues, I conducted a study in 
which both rhesus and cynomolgus macaques were infected with SARS-CoV. I did 
not see any clinical signs of disease or marked lung pathology ... to my knowledge, 
only Osterhaus's laboratory and laboratories from China have reported severe disease 
in SARS-Co V infected macaques. Osterhaus mentions that the variability in results 
may be due to factors such as the strain of virus used, and this is certainly true. 
However, he has not released the virus isolate used in these studies to me or my 
colleagues in spite of requests.' (ibid., 411-412 my emphasis) 
31 I intend the phrase 'immanent critique' in the sense outlined by Pleas ants 
(1999,25): 'immanent critique proceeds by seeking to demonstrate that a proponent's 
position is inadequate because of contradictions and absurdities that are internal to 
that position'. 
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32 The extent to which the modem, 21 st century microbiological or virological 
laboratory relies on the labour-power of animals is perhaps a litde surprising 
(certainly, it surprised me during my investigations into the SARS outbreak). But how 
to react to the way in which value is extracted from those laboratory 'workers'? With 
anger? Horror? Resigned acceptance that this is simply how things have to be in order 
to protect human lives? I do not know. But in trying (and failing) to answer these 
kinds of questions, I have found Haraway's (2008) recent attempts to rethink the 
'instrumental relations' that exist in the menagerie of the modem laboratory around 
the idea of a practical and epistemological 'sharing', to be of interest (ibid., 69-94). For 
further details on other proletariat that are, or have been, cast in the same role as 
Fouchier's cynomolgus macaques, see Radar (2004) on the laboratory mouse, Mitman 
and Gausto-Sterling (1992) on flat worms (planaria), and Clause (1993) on the Wistar 
rat. 
33 A number of SARS-Co V research articles, review articles, and chapters in 
edited volumes, for instance, were either authored, or co-authored by members of the 
original Rotterdam research team in the 'post-outbreak' period. Unsurprisingly, all cite 
the original KPF paper approvingly. See for instance: Kuiken et aL (2003a; 2004); 
Martina et aL (2003); Osterhaus, Fouchier, Kuiken (2004); van den Brand et aL (2008); 
ter Meulen et aL (2004); Peiris and Osterhaus (2005). 
34 The 'Baltimore classification system' was first proposed in 1971 by the 
Nobel Laureate microbiologist David Baltimore. To suggest that it separates out RNA 
from DNA.viruses is correct. But things are not quite as simple as this gloss seems to 
be suggesting. Indeed given that viruses exhibit diversity of morphologies, nucleic acid 
structure, mode of infection, regulation of development, and so on, it would be 
surprising if they were so simple. The Baltimore classification system is based 'on the 
mode of gene replication and expression' (Dimmock and Primrose 1994, 96). As a 
result, 'messenger ribonucleic acid (mRNA) is assigned a central role, since protein 
synthesis takes place by the same mechanism in all cells' (ibid.). All viruses are then 
divided into groups, 'assignment to a group being determined by the pathway of 
mRNA synthesis' (ibid.). In order to maintain unity, all mRNA is designated as 'plus' 
RNA. Strands of viral DNA and RNA which are complementary to the mRNA are 
designated as 'minus' and those that have the same sequence are termed 'plus'. Using 
this terminology, six groups of viruses can be determined: Classes I, lIa, and llb, all of 
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which are made up entirelY of DNA viruses; and, Classes Ill, IV, V and VI, all of which 
are made up entirelY of RNA viruses. 
35 Some populations of DNA viruses are highly variable, however, which hints 
at the possibility that they too have higher mutation rates (on this point see Holmes 
and Rambaut 2004, Sanz et aL 1999, and Truyen et aL 1995). 
36 On error and rates of spontaneous mutation during viral replication cycles, 
see Drake et aL (1998), Malpica et aL (2002); and, as an example of how these 
processes play themselves out 'beyond the text', it is useful to consider the influenza 
virus. As a result of the infidelity of RNA replication, the mutation frequency in the 
influenza virus RNA is approximately one in 100,000 nucleotides. Considering that 
the size of the entire influenza virus genome is about 14,000 nucleotides, this implies 
that many new viral RNA genome copies will contain one or more mutations (see 
Stech et aL 1999). And whilst the majority of those mutations will be 'silent', others 
will result in amino acid substitutions in the translated proteins, thus giving rise to 
new variants with an advantage over the parent virus. 
37 For a more detailed discussion of antigenic drift, see Wilschut et aL (2006, 49-
54), and ~right and Webster (2001). 
38 As Davis (2005, 15) has noted, the progeny of RNA viruses 'are often 
characterised as a "mutant swarm" or "quasi species" because of their extreme 
variability'; and also on this point see Crawford (2000), and Holland (1993). 
39 The strain of influenza virus responsible for causing the worldwide 
pandemic of 1968 in which over a million fatalities were reported, was later found to 
be related to a strain that had previously infected 500,000 cases in Hong Kong during 
1957 (on this see Kilbourne 2006). 
40 For a more detailed discussion of antigenic shift, see Wilschut et aL (2006, 49-
54), and Wright and Webster (2001). 
41 Of particular interest in relation to this point is an article in the European 
Journal of Epidemiolo!!J entided 'Introduction to pandemic influenza through history' 
(Ghendon 1994); also of interest is 'Updating the accounts: global mortality of the 
1918-1920 "Spanish" influenza pandemic' Oohnson and Mueller 2002) in the Bulletin 
of the History of Medicine. 
42 See Biacchesi et aL (2003,2). 
43 The original discovery of hMPV was reported in van den Hoogen et aL 
(2001). On the identification of hMPV as a causative agent in various respiratory tract 
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illnesses around the world since the publication of van den Hoogen's original paper, 
see Bastien et al. (2004), Biacchesi et al. (2003), Falsey et al. (2003), Freymouth et al. 
(2003), and Larcher et al. (2008); and for a review, see Hamelin and Boivin (2004). 
44 As well as van den Hoogen et al. (2001), on the question of genetic 
variability also see Bastien et aL (2003), Biacchesi et aL (2003), and Peret et aL (2002). 
45 On those 'co-factorial' outbreaks, see Chan et aL (2004), and Lee et aL 
(2007); and my comments in the opening section of this chapter. 
46 See for instance, Bush (2004), Rest and Mindell (2003), Stanhope et aL 
(2004), Stavrinides and Guttman (2004); and, more technically, on recombination 
between coronaviruses that involves the spike glycoprotein, see Lai's (1996) review 
article. 
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5 
'There is exquisite specificity in the 
antibody-antigen reaction ... '1 
ELISA and the entrenchment of SARS as SARS-Co V 
Janus was a very old Italian god whom the Romans associated with beginnings. In 
Rome, his double-gated temple in the Forum was always kept open in time of war and 
closed in time of peace. The month of January - a time for people to look backwards 
and forwards - was sacred to Janus. (Gray 1999, 56) 
Looking back now, from the perspective of the present, it is possible to suggest that 
the SARS outbreak had two moments: one in which the aetiological question was not 
yet settled and the contours of the outbreak were still vague, imprecise and not a little 
'fuzzy'; and the other in which the aetiological question was settled and the outbreak 
slowly began to take on a distinctive and well defined shape. In one, the messy 
confusion of a syndrome with any number of potential causes; in the other, the order 
of the singular disease. Over the course of the two previous case-study chapters a great 
deal of attention was paid to the assemblage of epistemic activities that took place 
during the 'moment of uncertainty': cell-culturing, amplifying, inoculating, observation 
of cynomolgus macaques, and so on. And, looking ahead just a little bit, over the 
course of the following chapter, chapter 6, a great deal of attention will be paid to the 
rhetorical tropes through which histories of the outbreak were constructed during the 
'moment of certainty': irony, parentheses, hyperbole, repetition, and so on. In this 
chapter, however, attention will be given over to a kind of space that would have been 
so sacred to Janus; an interstitial space that separated the two moments of the SARS 
outbreak. A space that existed before certainty, and not quite after uncertainty; a space 
in which it was possible for the medical microbiologist to turn either towards the past 
or towards the future without suffering any loss of epistemological credibility: was 
SARS caused by Co V or was it caused by something a little more multifactorial? What 
I want to try and develop, however, is an understanding of the diagnostic technology 
that altered that delicate epistemological balance, and, in so doing, actually nihilated 
the space.2 For having begun its work of diagnosis amidst that interstitial space, it was 
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a technology that ended up dragging microbiological credibility into the future 
moment of certainty, whilst rendering the moment of uncertainty precisely as the past, 
and, as such, the sole preserve of the historian rather than the microbiologist. 
Consider, firstly, the moment of uncertainty; the moment in which the shape of the 
outbreak was still unclear. 'Of paramount importance' within the WHO SARS 
laboratory network during that time was the 'identification of the causative agent 
behind SARS' (Stahr 2003, 1731). And, under an accord signed between individual 
member-states of the WHO and the WHO itself, all available patient samples were 
transported to laboratories within the network. This network, in other words, remains 
the best place to go in search of that moment of uncertainty. Of the eleven research 
teams comprising the network, six subsequently published research articles in which 
their initial aetiological results were detailed. The first of this 'core-set's' publications, 
Peiris' 'Coronavirus as a possible cause of SARS' appeared in The Lancet on 8th April, 
whilst the other five publications appeared simultaneously, just eleven days later, in 
the April 19th edition of the New England Journal of Medicine (Ksiazek et aL 2003; 
Drosten et at. 2003; Lee et at. 2003; Tsang et aL 2003; Poutanen et at. 2003).3 As became 
clear in chapter 3, for example, all of the work detailed in 'Novel coronavirus 
associated with SARS' had been undertaken on just 19 patient samples (Ksiazek et at. 
2003). In 'Coronavirus as a possible cause of SARS', Malik Peiris reported having 
studied '50 patients fitting a modified WHO definition of SARS admitted to three 
acute regional hospitals in Hong Kong between Feb 26 and March 26, 2003' (peiris et 
aL 2003, 1319). And, in 'Identification of a novel coronavirus in patients with SARS', 
Christian Drosten reported aetiological findings deriving from 'a total of 49 samples 
from 18 patients' (Drosten et at. 2003, 1968). Of the five articles, 'A major outbreak of 
SARS in Hong Kong' (Lee et aL 2003) was based on the largest cohort of samples -
'66 male patients and 72 female patients' (ibid., 1986) - whilst the smallest cohorts of 
patient samples were to be found in 'Identification of SARS in Canada' (poutanen et aL 
2003, 1995) and 'A cluster of cases of SARS in Hong Kong' (Tsang et at. 2003, 1977): 
in both articles, only 10 patient samples were available for laboratory work-up. If the 
samples included within these first five studies are added together, a total figure of 
245 patient samples is generated. And, of that total, 97 samples were reported as 
having yielded Co V via laboratory diagnosis. Nine of the 97, however, were also 
reported as having yielded another pathogen in addition to Co V during attempts at 
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laboratory diagnosis. 4 Put another way, 9% of the positive CoY identifications 
reported in those original five articles were identified from samples that had 
harboured more than one pathogen. The idea that some kind of complex 
multifactorial disease was taking place alongside, and perhaps in conjunction with, a 
singular disease was, at the very least, a possibility at this early stage. 
And yet, by 31't December that same year, the moment of certainty had already begun. 
Things had changed. It was on that date that the WHO posted a table entided 
'Summary of probable [i.e. laboratory confirmed] SARS cases with onset of illness 
from 1 November 2002, to 31 July 2003' on its web site (see WHO 2004c). To this day, 
it stands as the final, definitive account of precisely how many cases of SARS were 
reported during the 2003 outbreak. The change is quite starding. Whereas during 
April, 2003, 9 of 97 confirtned cases of SARS-CoV had been from patient samples 
that had also harboured a potential co-factor, by the following December, 8,096 of 
8,096 confirmed cases of SARS were classified as having been caused by CoY, and 
Co V alone. As we traverse our way across the months separating these two dates, it 
seems as though the possibility of multifactorality is, somehow, in some way, deleted. 
But how? 
What had happened in order to allow for the generation, or rather, the re-generation, 
of this disease as a singular disease? 
SARS-Co V or non SARS-Co V 
The answer, put simply, is that 'probe specific' diagnostic technologies happened. At 
some point between the publication of the original research articles in April and the 
posting of the WHO's 'Summary of Probable Cases ... ' in December, 'specific probes 
and specific reagents' capable of searching specificallY for Co V had been developed.5 To 
recall the discussion that took place at the beginning of chapter 4, SARS had been 
promoted to the same 'certainty league' as swine influenza. Faced with huge banks of 
stored specimens that had been collected but never tested during the outbreak, 
microbiologists had gained the ability to search those samples retrospectivelY in the hope 
of making a final, definitive diagnosis of SARS-CoV. And of course with probe 
specific diagnostic technologies, there are only ever two possible diagnoses: in this 
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case, either the sample being found to contain CoV, making it positive for SARS-CoV 
infection, or, alternatively, the sample being found not to contain CoV, making it 
negative for SARS-CoV infection. Nothing happens in the middle.6 Foreclosed upon in 
this way are any and all questions about what else might have been housed within the 
tested sample. But if this process of diagnosis is to be explored in a litde more detail 
during this chapter, then where to begin such an exploration? For certainly, to note 
that probe specific diagnostic technologies had been developed and deployed is not 
quite enough. The WHO's Use of laboratory methods for SARS diagnosis (2003zw), for 
instance, lists three potential diagnostic technologies - a reverse-transcriptase 
polymerase chain reaction (RT-PCR) kit, an enzyme-linked imrnunosorbent assay 
(ELISA) kit and continuous cell-culture lines.7 Did they all play some part in that re-
generation of SARS as exclusively SARS-Co V? If so, then this would suddenly have 
become an un-writable chapter, a thesis in and of itself. But in fact only one of these 
three listed techniques was used retrospectively. Put more accurately, only one could 
have been used: the en:ryme-linked immunosorbent assqy, or, as I will refer to her at times 
during this court-hearing, ELISA.8 As Chan (2004) has noted in a review of available 
SARS diagnostic technologies, for instance: 
Of the three technical approaches to diagnosis of SARS-Co V, ELISA is the only means 
for retrospective diagnosis. (ibid., n.p my emphasis) 
'The only means .. .' because unlike either the RT-PCR or cell-culture techniques, 
serologic tests 'do not require the presence of viable virus' in sample but only viable 
antibodies (Storch 2000, 10). A crucial difference. Whilst the former are extremely 
labile and difficult to keep intact within stored samples (on this, see chapter 3), the 
latter are not.9 
If, in chapter 3, the seemingly mundane, innocuous diagnostic technology of the cell-
culture was identified as crucial to the initial enactment of the SARS coronavirus, then 
here, in chapter 5, the argument is that the ELISA, another seemingly mundane, 
innocuous technology, was crucial to the final, retrospective enactment of the SARS 
coronavirus as the cause of SARS. In a sense, over the course of both chapters, the 
suggestion is that the two stood like Fafner and Fasolt at either end of the outbreak, 
guarding against the possibility of multifactorality. ELISA fulfilled her side of the 
bargain admirably. Here, for example, are the details of an article entided 'Kinetics of 
SARS coronavirus specific antibodies in 271 laboratory confirmed cases of SARS' (He 
et aL 2004): 
Three hundred and four patients fitting the SARS clinical case definition were 
hospitalised at Ditan Hospital, Beijing, China, between 26 March and 31 May 2003. 
(ibid., 792) 
Probable cases, the article goes on to note: 
Were regarded as laboratory confirmed if SARS-Co V specific antibodies were detected 
within 3 weeks of the onset of illness. (ibid.) 
And the results of the retrospective testing that took place? 
SARS-CoV infection was laboratory conftrmed in 271 of 304 (89.1%) of cases, with 33 
individuals testing SARS-CoV negative (10.9%). (ibid.) 
Of the latter group, all were re-tested with other probe-specific techniques and 
subsequently granted 'alternative laboratory diagnoses'. So, only two possible 
diagnoses: either 'positive for CoY', or 'negative for SARS-CoV infection and re-tested'. 
Again, nothing happens in the middle. 10 Silently and without much fanfare, the 
possibility of the multifactorial aetiological object is (being) removed from sight. 
The generation of reasonable doubt 
As with the 'Koch's Postulates' experiments of the previous chapter, the diagnostic 
technology of the indirect ELISA can be understood to have been making two. inter-
connected judgements during its retrospective testing of SARS patient samples. Each 
time it retrospectively recorded a case of SARS-Co V infection it was making a very 
public judgement that the illness of the patient from whom the sample had been taken 
had been caused solely by SARS-Co V. But, at the same time, it was also making a far 
less public, and far more implicit judgement; a judgement that multifactorality was the 
kind of aetiological possibility that no longer had to be given any consideration in 
relation to the SARS outbreak of Z003. 
In this chapter ELISA will take to the witness stand as I attempt to re-examine both 
her original judgement and her original witness statement. Once again, it is the 
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possibilifY that the second judgement foreclosed upon that I want to try and reclaim: 
the possibility of multifactorality. 
But the question now is one of how to do so? 
For such a reclamation is far more difficult now than it was in any of the previous 
chapters. With the main witness for the prosecution standing as a probe specific 
indirect SARS-Co V ELISA kit, it is impossible to directfy reclaim the possibility of 
multifactorality. With the technology of 'Koch's Postulates, as modified by Rivers for 
viral diseases' in chapter 4, for instance, there were still moments during which it was 
possible to sneak behind the first, and very public judgement - that SARS was caused 
by SARS-Co V and SARS-Co V alone - in order to catch a glimpse of the second 
judgement - that SARS was not a multifactorial disease - whilst it was actualfy in the 
process of being generated. The possibility of multifactorality, in other words, was recoverable 
from the moments in which it was actively being considered and then, subsequendy, 
denied. With the technology of the indirect ELISA, however, it is as if the first 
judgement is still standing 'front-stage', but all entrances to the 'backstage' area in 
which the second judgement was being made have been closed off. Even if the 
possibility of multifactorality had still existed at the stage of retrospective ELISA 
testing, there would simply have been no way for me, or indeed for anyone else, to 
recover that possibility any longer. For at the point at which SARS-CoV gained its 
own probe specific diagnostic technologies, things changed at the documentary leveL 
And in a number of ways. Firstfy, the initial diagnostic work in which co-factors were 
found to be co-existing with Co V in 9-10% of patient samples was no longer deemed 
to be worthy of publication in research articles reporting retrospective ELISA test 
results: those co-factors were now simply 'innocent bystanders' not 'potential culprits'. 
Secondfy, very few of the subsequent ELISA diagnostic tests results were deemed 
worthy of publication either. whilst discovery-work is the preserve of medical 
microbiological superstars like Dr. Ksiazek, diagnostic-work, on the other hand, is the 
labour of the lowly technician. And finally, even when those results did appear in the 
public domain, they never yielded a both/ and (both Co V and another pathogen, or 
pathogens), but always an either/or narrative (either CoV or another pathogen). For 
example, consider 'Kinetics of SARS coronavirus specific antibodies in 271 laboratory 
confirmed cases of SARS' once more: 
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A recombinant double-nucleocapsid antigen sandwich enzyme-linked immunosorbent 
assay (ELISA) was used ... SARS-Co V infection was laboratory confIrmed in 271 of 304 
(89.1%) cases, with 33 individuals testing SARS-CoV negative (10.9%; 27 of these had 
alternative laboratory diagnoses). (He et al. 2004, 792) 
A crucial bifurcation point is passed here. The moment of certainty is entrenched as 
the practicalities of making this judgement on the non-existence of multifactorality are 
erased from the public domain. All we get to observe from this point forth is the 
indirect ELISA making one of two diagnoses: either SARS-Co V positive or SARS-Co V 
negative. 
The second judgement, the one I have sought to attack in previous chapters with the 
aim of reclaiming the possibility of multifactorality is, in other words, un-attackable. 
But there is, nevertheless, a way forward here. 
A slighdy less direct, but perhaps no less effective strategy with which to pursue the 
same kind of reclamation. It involves a re-consideration of the first judgement that the 
indirect ELISA made each and every time it was put to work - that SARS was caused 
by Co V and Co V alone. That judgement is still publicly available in the sense that the 
practices through which it was made are fully recoverable from the research literature. 
My aim in this chapter will therefore be to attack that judgement by asking the 
following, very simple question: was ELISA actually diagnosing recent SARS-Co V 
infection in each and every case that she examined? ELISA's subsequent answer will 
of course be that yes, she was diagnosing SARS-Co V in each and every case. And yet, 
what will be sought here is a demonstration that her answer is built out of the 
suppression of what will come to be termed the diagnostic problem of when. Well 
recognised within the medical microbiological literature, this is a problem that could 
quite easily have led to an answer of 'no, she was not .. .'. To perform that 
demonstration, to weaken, just a litde, the hitherto unchallengeable nature of ELISAs 
'yes' answer, I call the medical microbiological literature to the witness stand as 'expert 
witness' for the defence case, and proceed to deconstruct a number of moments at 
which ELISA had to deal with, to manage, and to negotiate that problem. 
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To understand precisely why this demonstration will help to reclaim the possibility of 
multifactorality it is worth recalling that ELISA's first judgement was inextricablY 
entwined with its second judgement: 
(1) SARS is caused by SARS-Co V and SARS-Co V alone, and therefore multifactorali!J is not 
an issue; or, conversely, (2) multifactorality is not an issue because SARS is caused by 
SARS-CoV. 
The two were stuck in a binary relationship. Therefore to attack one is also to attack the 
other. If reasonable doubt can be created regarding ELISA's first judgement that each 
and every case retrospectively examined was a .case of recent SARS-Co V infection, then 
it is also possible to cast some doubt o~ its second judgement that, in each and every 
case, there was no possibility of a multifactorial infection. To sum up, the strategy can 
perhaps be re-phrased in the form of the following (rhetorical) question: if the 
certainty of ELISA's ftrst judgement can be called into question, then on what 
grounds can we trust her second judgement? 
Instructing the jury 
And yet, unlike either the technique of the cell-culture (in chapter 3), or 'Koch's 
Postulates as modifted by Rivers for viral disease' (in chapter 4), ELISA is severelY 
technical. And thus, before examining her witness statement in any great detail, it is 
perhaps wise to provide the court with a brief textbook style introduction to this, the 
method of the enzyme-linked immunosorbent assay.l1 
'It is not always possible', as one textbook puts it 'to isolate a microorganism by 
culture, visualise it microscopically or detect it by antigenic or molecular detection 
techniques,.12 And that is why serologic methods have found such widespread use in 
the medical microbiological sciences: 
An alternative approach is to detennine if the patient has mounted an immune 
response against a specific agent as evidence that he or she has been infected with that 
agent. (Gilligan et aL 2002, 24) 
For a medical microbiologist, 'an immune response' effectively involves just two 
things: antibodies and antigens. Why? Because 'after exposure to an infectious agent': 
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The host's acquired humoral immunity may respond through the production of various 
classes of antibody directed to one or more antigens associated with the agent.' (Mahon 
and Manuselis 1995, 146) 
Specific antigens induce the production of specific antibodies. Structured around this 
knowledge of a host's immune response to infection, ELISA is a common serological 
test. t3 In fact, there are two types of ELISA assay. Firsdy, the direct EUSA which 
employs known antibodies to detect the presence of a particular antigen in a patient's 
sample. And secondly, the indirect ELISA which employs a known antigen, specific to a 
known virus, in order to determine the presence of specific antibodies in a patient's 
sample.14 In each case, however, the diagnostic principle is the same: when the sample 
is brought into contact with the ELISA, an antibody-antigen reaction is being sought. 
If such a reaction is detected, then based on the fact that one half of the highfy specific 
reaction was already known before the test began, it is possible to conclude that the illness of 
the patient from whom the sample was drawn was caused by a certain pathogen. 
In the case of the 2003 SARS-Co V outbreak, indirect ELISAs, but not direct ELISAs 
proliferated. Why? Because SARS-Co V was adjudged to have been a hitherto 
unknown disease; a disease that had only recendy jumped the species barrier in order 
to become a threat to humans. And, as a result, it was assumed that an indirect ELISA 
would have a high level of diagnostic specificity given that very few people would 
manifest as having antibodies to a SARS-Co V antigen had they not recendy been 
infected with SARS-CoV. (However, much of the case against the-indirect ELISA in 
this chapter is built around a questioning of this assumption ... ). The flow-diagram on 
the following page (figure 1) is useful for developing a basic understanding of how an 
indirect ELISA performs a diagnosis. 
In (1), the appropriate viral antigen [Ag], having been obtained from infected cells, 
virions, or genetic engineering techniques, is affIxed (adsorbed) to the walls of a 
microtiter plate· [the black line]. Then, in (2), patient serum is added to the well. If 
antibodies [the long upside-down 'Y' shape] specific to the affixed antigen are present 
in the sample they will form a complex on the wall of the well with the antigen. Other 
non-specific antibodies, however, will not form a complex. After 3-4 minutes, the 
microtiter plate is 'washed' in order to 'remove' all unbound and non-specific 
antibodies from the plate.ls In (3), and then in (4), this invisible complex formation 
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between antigen and antibody is made visible to the eye of the microbiologist. First of 
all, an enzyme conjugated antihuman antibody [E] is added to the solution in the 
microtiter plate.16 These so-called 'reporter' antibodies bind to the antibody-antigen 
complex. An assemblage, then, of three different component parts develops: [Ag], [y], 
[E]. Then, secondly, a substrate [dark coloured shapes in (4)] is added to the solution. 
As a result, a reaction takes place between the 'reporter' antihuman antibody-enzyme 
conjugate and the substrate, with the latter coming to be converted into chromophore, 
precipitate, or light. The conversion changes the colour of the diluted fluid sample 
(see (5)) and the optical density of the sample can subsequendy be measured. Above a 
certain pre-determined cut off point, an increase in the optical density of the solution 
is diagnostically positive for an antigen-antibody complex formation. 
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Figure 1: antibody detection in an indirect ELISA-kit 
(taken from Murray et at. 2005, 187) 
I. ELISA AND THE DIAGNOSTIC PROBLEM OF WHEN 
Consider the following extracts. All are taken from research papers that detail the 
successful development of a probe-specific-indirect-ELISA test for SARS-Co V: 
The N protein was chosen to be produced as a recombinant protein for establishing an 
antigen-capturing ELISA for SARS diagnosis. (Shi et at. 2003, 5781 my emphasis) 
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To explore a sensitive assay which does not involve the manipulation of live SARS-
Co V, we developed an IF A using the Spondoptera fmgiperda insect cell line Sf9 and a 
recombinant baculovirus to express the N195-Sc fusion protein as the antigen for the 
detection of antibodies against SARS-CoV. (He et aL 2005, 322 my emphasis) 
The results revealed by protein micro array analysis were further conftrmed by an N 
protein-based antigen-capturing ELISA. This recombinant full-length N protein-based 
ELISA kit (Sino-American Bioengineering Co.) could detect the total antibodies to the 
N protein of SARS-Co V. (Yu et aL 2005,553 my emphasis) 
To develop an ELISA for the detection of SARS-Co V nucleocapsid protein, two types 
of hyperimmune polyclonal nucleocapsid-specific antibodies were obtained from 
rabbits and guinea pigs after immunisation with purified His6-tagged recombinant 
nucleocapsid protein. (Lau et aL 2004,2885 my emphasis) 
In these extracts we are suddenly faced with a new level of technica/iry. References to 
SARS-Co V as a unitary object of medical knowledge; references that became so 
familiar during the course of chapters 3 and 4, are now interspersed with references to 
its constituent genomic parts. In particular, references to something called the SARS-
CoY N protein abound. From a living entity, amplified on a cell-culture and 
inoculated into a set of cynomolgus macaques, to a set of dis-assembled component 
parts: in the space of a few weeks, the coronavirus would appear to have traced out, in 
miniature, Canguilhem's genealogy of the 20th century life sciences, moving from 
species and bocfy to code and instruction. 17 Everything that happens here in these extracts 
happens at a molecular level.I8 At some point between the isolation of CoY and the 
proving of its aetiological role, and, on the other hand, the appearance of the indirect 
ELISA kits reported in these research papers, a vir%gica/ dissection had to have taken 
place. But how? And why had so much emphasis been placed upon the SARS-Co V N 
protein when it had been completed? 
The dissection of SARS-Co V 
Speaking at a WHO press conference on March 27 th, Dr. Sylvie van der Werf was to 
note how the development of genomic information in relation to SARS-Co V would 
be 'essential for serological diagnostics'. 'It would', she suggested, 'allow for the 
production of specific antigens by molecular techniques that could be made readily 
available to laboratories across the world' (WHO 2003e, para. 49). Such genomic 
information was not long in coming: the complete genomic sequence of the 
nucleotide RNA genomes from two of the first isolates of the SARS-Co V, the SARS-
CoY Tor2 strain from Toronto and the Urbani strain from Vietnam, were mapped 
within weeks of that press conference (and, indeed, within weeks of the publication of 
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'A novel coronavirus associated with severe acute respiratory syndrome' (Ksiazek et aL 
2003), and 'Koch's Postulates Fulfilled for SARS virus' (Fouchier et aL 2003».19 Each 
sequence was subsequently reported in Science, before being made available online at 
sites like Genbank.20 Glossing the details of the genomic mapping for the readership of 
Science, a Dr. Holmes noted that the sequences 'differ[ed] by just eight nucleotides', 
and that they both had: 
All the features characteristic of a coronavirus ... the SARS-CoV genome contains five 
major open reading frames (ORPs) that encode the replicase polyprotein; the spike (S), 
envelope (E), and membrane (M) glycoproteins; and the nucleocapsid protein (N) in 
the same order and of approximately the same sizes as those of other coronaviruses. 
(Holmes and Enjuanes 2003, 1377) 
The complex details of the molecular manipulation that allowed virologists to isolate 
and amplify the N protein from the overall SARS-Co V genome can safely be left to 
one side here?l It is enough simply to note that this genomic information provided 
virologists with the precise genetic details of the coding sequences for specific parts of 
SARS-CoV's major ORFs (for the N protein, for example, this sequence, expressed as 
an amino acid chain, was 5'_CGCGGATCCGATGTCTGATAATGGACC-3'). And, 
with those details ready-to-hand, PCR primers specific to each ORF could be 
developed and then used to 'amplify' the sequence coding, say, the nucleocapsid 
protein from a SARS-Co V patient sample. The end result? An isolated 'master-seed' 
of SARS-Co V N protein that would be capable of acting as 'aptigen' within an 
indirect ELISA kit.22 
But if all of this goes some way towards explaining how the N protein was isolated in 
those cited studies it does not at all explain why; that is, why virologists devoted so 
much attention to the SARS-CoV N protein rather than, say, the SARS-CoV spike (S) 
or envelope (E)? An answer to this question can be found in an article entitled 
'Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus 
pneumonia' ~oo et aL 2004). Like the studies that were cited earlier, it too reports on 
the development of an ELISA kit. But unlike them it was prepared for publication in 
The Lancet rather than a more specialised virological journal - the extracts above, for 
instance, were published in Clinical and Diagnostic Laboratory Immunology (He et aL (2005) 
and Yu et aL (2005», or Journal of Clinical Microbiology (Shi et aL (2003) and Lau et aL 
(2004» _ and, as a result, tries a lot harder to make the N protein's role in the test 
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more explicit for its ideal reader. 'Previous studies ill animal coronaviruses', it 
suggests: 
Have shown that the nucleocapsid protein and spike protein are highly immunogenic, 
are abundandy expressed during infection, and can be used for serodiagnosis of animal 
coronavirus infections. \Woo et al. 2004,844) 
The key phrase here is 'highly immunogenic'. For serologic tests, the N protein had 
previously been found to represent a useful working antigen. Once inside a non-human 
body, in other words, the N protein of already known coronaviruses had been found 
to trigger an adaptive immune response, and, as a result, to induce the development of 
antibodies (hence Woo's reference to it being 'highly immunogenic').23 And because 
the hitherto unknown coronavirus behind the SARS outbreak was, as Holmes had 
made clear during her glossing of the SARS-Co V genomic mapping, known 'to have 
all the characteristic features of a coronavirus' (Holmes and Enjuanes 2003, 1377) the 
same strategy was assumed in Woo's study (and indeed in all those previously cited 
studies) in order to detect Co V infection in human bodies. The assumption was that the 
N protein would once again prove to be a good target antigen; that like a powerful 
magnet, it would pull any CoY antibodies towards it. For a serologic test, then, it 
represented the perfect working object: if a case had been infected by SARS-Co V, 
then that cases' serum would almost certainly contain antibodies to the SARS-Co V N 
protein. 
The N protein and the SARS patient samples 
With these basic points made it is now possible to ask some rather more 'awkward' 
questions about the temporal relationship that held between an ELISA's N protein and 
the samples tested retrospectively by an ELISA. Consider, fIrst of all, the following 
very basic textbook defmition of serology: 
Following an infection, the body makes antibodies against the pathogen. Tests for the 
specific antibodies against that pathogen can then show if there has been that infection. 
(Omi 2006, 295 my emphasis) 
Between the extract's fIrst and second sentences, a subde shift in referential strategy 
takes place.24 'The pathogen' becomes 'lhatpathogen'. 'The pathogen' perhaps suggests 
closeness and immediacy; a sense that 'the pathogen' is in the same body as the 
antibodies. But 'that pathogen' suddenly creates a certain distance; a sense that the 
1511Pagc 
text is no longer focalising 'the pathogen' that was in the same body as the antibodies. 
Rather, it seems to suggest merely a pathogen; a pathogen of the same viral phylum, 
class and order as the original pathogen but not necessarily the original pathogen. At 
the very least, it seems difficult to be sure that 'that pathogen' is the same pathogen as 
'the pathogen'. The possibility of more than one structural interpretation of the text 
exists. But is this a mere detail, a rhetorical slip? I would suggest not. Other textbooks, 
for instance, refer a little more explicidy to the fact that indirect ELISA tests are 
useful principally because they 'do not require the presence of viable virus in samples', 
but rather, come 'pre-preparecf with their own antigen (Storch 2000, 10 my emphasis). 
But then, if this is so, it raises an interesting question, and one that I want to pursue a 
litde bit further: where, exacdy, does the N protein antigen used to set up an indirect 
SARS-Co V ELISA kit come from if not the sample to be tested? According to the 
review article 'Viral Diagnosis of SARS' (Drosten, Chan and Po on 2005), there are 
two ways of generating an N protein antigen for indirect ELISA kits: 
Infected cell culture extracts after appropriate inactivation of infectivity or recombinant 
viral proteins have both been used to detect antibodies in serum. (ibid., 68 my 
emphasis) 
The main difference between these two techniques is slight: whereas one generates 
antigen indirectlY via the intermediary of the cell-culture, the other does so directlY from 
blood samples subjected to peR amplification. 25 Nevertheless, it is enough of a 
difference to warrant an examination of both in an attempt to answer this question of 
ongtn. 
Firstly, then, consider the 'materials and methods' section of the article 'Detection of 
SARS coronavirus Nucleocapsid Protein in SARS patients by Enzyme-Linked 
Immunosorbent Assay' (Lau et al 2004). It contains six sub-sections that attempt to 
present an ideal natural chronology of the time of the events as they occurred during 
the preparation of the ELISA. The first sub-section, 'Viral Strains', tells of the source 
of the antigen, the N protein: 
SARS CoV isolated from a patient with SARS CoV pneumonia in Hong Kong was 
propagated in Vero cells in Dulbecco's modified Eagle's medium (Gibco BRL) with 
10% fetal calf serum. Human coronaviruses 229E (ATCC VR-740) and OC43 
(AATCC VR-759) were propagated in MRC-% cells and BS-C-1 cells, respectively. 
(ibid., 2885) 
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Note that: 'isolated from a patient ... '. The source of the antigen for this infected cell-
culture ELISA was just one, single patient. In the following sub-section, 'expression and 
purification of recombinant SARS-Co V nucleocapsid protein' the details of how the 
\ 
cell-extract was made to yield up a 'master seed' of N protein were reported. Nowhere 
do we find any direct indication as to where the samples to be tested were gathered 
from, although given that the research team was based at the University of Hong 
Kong, it can perhaps be assumed that the samples were gathered from patients 
hospitalised in Hong Kong. But aside from the site(s) of sample collection, the number 
of samples collected is also of interest. In the fifth and penultimate sub-section, 
'clinical specimens', the following information appears: 
Human nasopharyngeal aspirate (n[umber of samples] = 66), urine (n = 94) and fecal 
(n = 65) specimens were obtained from patients. (ibid.) 
A total of 225 samples. There is, then, an a!)mmetrical relationship here between the 
antigen and the antibodies to be tested. 225 patient samples were tested for the 
presence of antibodies to a particular antigen, yet the test antigen had been developed 
from just 1 of those samples. One single source of antigen, in other words, was being 
used to infer the presence of antigen in 224 other patient samples. And this is by no 
means a one-off asymmetry, specific to this particular research paper: On the contrary, 
it is apparent in each and every research paper in which attempts to generate N-
protein antigens from infected cell-culture extracts are reported. As one final example 
consider, for instance, Ksiazek's research article, 'A novel coronavirus associated with 
SARS'. In its methods sub-section, 'serologic analyses', it is made clear that 'an ELISA 
antigen was prepared by detergent extraction of an infected Vero E6 cell and 
subsequent gamma irradiation' (Ksiazek et aL 2003, 1955 my emphasis), before being 
used to test 'serum from patients with SARS in Singapore, Bangkok, and Hong Kong' 
(ibid., 1960 my emphasis). 
But it is an asymmetry that is also apparent in indirect ELISA's developed Via 
recombinant viral protein techniques. In 'Diagnosis of SARS by Detection of SARS 
Coronavirus Nucleocapsid Antibodies in an Antigen-Capturing Enzyme-Linked 
Immunosorbent Assay' (Shi et aL 2003), for example, it is noted that 'the SARS-Co V 
N gene': 
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Was obtained by reverse transcription PCR amplification from blood samples of a 
SARS patient in Beijing. (ibid., 5781 my emphasis) 
Once again, just one sample acting as the source from which the indirect ELISA's 
antigen was to be amplified. And the samples to be tested? Where did they come 
from? 
Serum samples from 200 probable SARS patients from the General Hospital of 
Guangzhou Command of the PLA and the 309 Hospital of the PLA were subjected to 
the N protein antigen-capturing ELISA. (ibid., 5782) 
In fact, the asymmetry on display here is perhaps even more marked than in the case 
of the cell-culture technique. The General Hospital of Guangzhou Command is 
situated in Guangdong's provincial capital, Guangzhou. The 309 Hospital of the PLA, 
on the other hand, is situated in Beijing, some 1,200 miles away. What this means is 
that 200 samples were being tested by an antigen amplified from 1 patient, whilst an 
unspecified number of those samples (those received from the General Hospital of 
Guangzhou Command) had not even been taken in the same hospital, city, or 
province as the antigen. 
In the first instance, then, in the example of the cell-culture extract, the antigen, 
derived from one sample cultured from a patient in Hong Kong, was used to test two-
hundred and twenty-four further samples from patients in Hong Kong. And, in the 
second instance, the antigen came from one serum sample taken from a patient in 
Beijing and was subsequendy used to test two-hundred further samples from other 
parts of the world. 
Now the point in labouring to make this asymmetric relationship apparent has been to 
highlight the fact that these SARS-Co V ELISA kits used an antigen produced 
externally to nearly all the samples in question in order to search for antibodies 
internal to those samples. But note: the articles referred to above were reporting on 
the successful development of indirect ELISA kits. In the hands of later users those 
kits became black boxes, things sUnply to be ordered into the laboratory from 
elsewhere: 
Sera of convalescence phase of SARS patients were collected from Beijing 
Xiaotangshan Hospital, and inactivated by heating at 56'C for 30 min. ELISA kits for 
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!gG or !gM antibodies to SARS-CoV were from Beijing BG!-GBI Biotech Co .. Ltd .. 
(Zhao et aL 2004,37 my emphasis). 
All serum samples were heat inactivated at 56°C for 30 min before analysis. They were 
fIrst screened by using an ELISA kit (Beijing GB! Biotechnology Co. Ltd.) that detects 
antibodies against the SARS-Co V. This whole-virus lysate-based kit was the ELISA kit 
approved by the China State Food and Drug Administration for SARS-Co V antibody 
detection during the 2003 SARS outbreak, and it was the most frequently used assay in 
mainland China. (Yu et aL 2005, 552 my emphasis) 
In their developmental stages, the antigens in these kits would have had at least that 
one connection to the sample from which they were drawn. But as the ELISA became 
a 'product' in this way; as it was transported across the world, its N protein antigen 
.lost all temporal, spatial and geographical connection to the samples it had been 
designed to test. 
Indirect SARS-CoV ELISA's and the diagnostic problem of when 
But is this detail an important detail? Does it matter that such a 'disconnect' between 
antigen and antibody exists in indirect ELISAs? For the defence case, the answer in 
both instances is 'yes'. Consider the diagnostic logic at work in an indirect ELISA kit. 
Either a SARS-Co V diagnosis is made: .~ 
1. Sample antibody /ELISA antigen complex forms -
2. Antigen was present in the sample -
3. A case of SARS-Co V infection. 
Or a SARS-Co V diagnosis is not made: 
A. Sample antibody /ELISA antigen complex does not form -
B. Antigen was not present in the sample -
C. A case of non-SARS-Co V infection 
Everything that happens here depends on the presence or non-presence of antibodies. 
But note: the presence or the non-presence of antibodies is not the end but the means 
to the end of the test. The final end is actually the ability to suggest that a patients' 
sample did, or did not, contain the SARS-Co V N protein antigen at some point previouslY. 
The presence or non-presence of antibodies, in other words, is just an indicator of the 
presence or non-presence of that which really mattered: the antigen, the entity which 
had caused the infection and precipitated the development of antibodies. Critical here, 
however, is the italicised phrase 'at some point previously'. For what, exactly, does the 
presence of antibodies to the SARS-Co V N protein in a patient sample actually 
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signify? Simply that the patient in question had, at some point previously, come into 
contact with the antigen. But because the ELISA uses a proxy antigen in order to 
induce a detectable antibody/antigen complex, and because, therefore, it does not 
require the antigen, the antigen that actually caused the immune response in the first 
place to be present, it can actually determine nothing about when the antigen was 
actually in the sample. If an antibody/antigen complex forms then of course it can be 
accepted that, at some point previously, the SARS-Co V N protein had been present in 
the sample. But precisely when remains unknowable. Was it, or was it not, present in 
that sample during the period of illness when the samples were actually taken? The 
use of an antigen from somewhere other than the sample under test renders an 
indirect ELISA incapable of answering such a question. 
In this way the problem of when rears its head. 
At this juncture, however, it is important to stress that I have not suddenly taken on 
the Heideggerian role of the fIrst philosopher, re-thinking everything from the 
beginning. For this problem of when is well known and well discussed in the medical 
microbiological literature. In Cases in Medical Microbiology and Infectious Disease (Gilligan et 
aL 2002), for instance, one of the 'disadvantages of serology' is described thus: 
Patients may have relatively high antibody levels because of previous infection with the 
test organism and, as a result, may have a false positive result. (ibid., 25 my emphasis) 
Again, in 'Immunoassays for the diagnosis of infectious diseases' (Carpenter 2007), 
the 18th chapter of the slightly more technical Manual of Clinical Microbiology (Murray et 
aL 2007), it is noted that, 'in general': 
A positive titer [i.e. result] means only that an individual has been exposed to a 
particular infectious agent at some point in the past and has detectable 
antibodies ... there have been reports of persistent elevations of antibody for a year or 
more. (Carpenter 2007,259 myemphasis)26 
But then, if what these manuals are suggesting can indeed be accepted then the 
defence case up until this point can be formulated in the following way: if (a) 
antibodies can survive within human bodies for months and even years after an initial 
infection by a particular antigen; and if (b) the ELISA kit is unable to suggest anything 
about precisely when the antigen that had induced SARS-Co V antibodies in SARS 
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patients had been present in those patients: if both of those conditions hold, then can 
it be said with any certainty that each of the ELISA's retrospective diagnoses of 
'SARS-CoV infection' was actually the 'correct' diagnosis? Can it be said, in other 
words, that each and every patient with an antibody reaction to an indirect SARS-Co V 
ELISA's N protein had actually been suffering from SARS-Co V infection at the time 
of the 2003 SARS outbreak? 
At this stage, some initial empirical support for a cautious 'no' answer can be found in 
the form of an article entitled 'SARS-related Virus Predating SARS outbreak, Hong 
Kong'· (Zheng et al. 2004). Written by Dr. Bo Zheng and a team of researchers from 
the University of Hong Kong, it appeared in the February 2004 edition of the journal 
Emerging Infectious Diseases and reported on 'retrospective' serological work carried out 
after the 2003 SARS outbreak had ended. What is so interesting about that 
retrospective work, however, is that it was not carried out on SARS patient samples, 
but rather, on samples that had been taken in 2001, some two years before the SARS outbreak. 
As such, Dr. Zheng's study is almost unique - certainly I have been able to find only 
one other article that proceeds in a similar way, going back to study samples that had 
been taken and stored before this (supposedly) newly emerging disease had erupted 
into the social body.27 The serum samples tested by Zheng's research team had been 
collected 'in May 2001 from 938 healthy Chinese adults in Hong Kong'. As Zheng 
and his colleagues note in the article's introduction, the samples had become of 
interest to them because 'recently SARS-Co V like viruses were isolated in Himalayan 
palm civets and racoon dogs in a retail live animal market' and 'some of the animals 
tested had antibodies to SARS-CoV like virus'. 'Phylogenetic analysis' had 
subsequently shown that 'the SARS-Co V like animal viruses were closely related to 
the viruses found in humans'. What is more: 
Serologic surveillance demonstrated that, in the same market, approximately 40% of 
wild animal traders and 20% of animal slaughterers had antibodies to SARS-Co V or 
SARS-Co V like animal viruses. (ibid., 176 my emphasis) 
In numerical terms this meant that 49 of 123 animal traders tested, and 21 of 105 
animal slaughterers had the antibodies. To Zheng and his research team, 'these 
investigations raised questions about whether the presence of the SARS-Co V like 
virus ... had been prevalent in the human population in southern China28 before the 
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SARS outbreak'. Therefore, their 'retrospective serologic study [had been] conducted 
in order to address these questions' (ibid.). The results were reported as follows: 
Serum samples collected in May 2001 from 938 healthy adults in Hong Kong were 
studied ... seventeen (1.8%) (of the] archived samples from healthy adults showed 
antibodies against the human virus, animal virus, or both (titer range 1: 20 to 1: 1,280) 
and were conftrmed by serum neutralisation assay. An additional six samples [0.6%) 
were antibody positive at a 1: 10 dilution to either animal or human viruses. (ibid. my 
emphasis) 
And the report's conclusion was as follows: 
Our results suggest that a small portion of Hong Kong adults had acquired a SARS-
Co V related virus infection at least 2 years before the 2003 SARS outbreak. (ibid., 177 
my emphasis) 
Important here is the fact that those antibodies had reacted with the antigen from an 
indirect SARS-Co V ELISA kit. Equally important for the moment, however, are the 
numbers involved. If these three separate tests are added together, it is possible to 
suggest that a total of 93 people, from a sample of 1,166 people, had been diagnosed 
as having possessed antibodies to a SARS-Co V related virus long before the 2003 
outbreak had emerged. 
What if ... ? 
Given this data, I want to proceed by considering a 'what if ... ' type scenario; that is, I 
want to construct an imaginary scenario that could have taken place before then 
building the case for the defence around a consideration of that scenario. Is this going 
too far even for the scientific court of appeal? I would suggest not. Indeed, a legal 
precedent has been set here in relation to the 'what if. .. ' strategy by a previous court 
of appeal case, RamI)' vs. local hidden variables (LHVs) in modern physics (Harvey 1981). 
Faced with a post-closure consensus in which a set of LHV experiments had been 
consensually rejected as false, Harvey based his subsequent prosecution of 'social 
context' over and above 'nature' as the main culprit in establishing that consensus 
around a series of speculations regarding 'what might have occurred' if contextual 
conditions had been set a litde differendy. And his rationale for this prosecution? 
Obviously, any discussion of how things might have turned out, had circumstances 
been different, must be speculative. The justification for such speculation is that unless 
we are prepared to consider alternatives to the actual outcome, that outcome can easily 
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be interpreted as inevitable and unproblematic. The whole process of social change 
within science then becomes either inaccessible to sociological analysis, or else 
describable only as the straightforward application of a generalised scientific 
methodology ... Where there is no controversy, as in the LHV case, the sociologist is 
forced into the role of a devil's advocate, however immodest this may appear, if the 
scientists' interpretation is to be rendered problematic. (ibid., 158 emphasis in original) 
It is in this spirit that I invoke a 'what if ... ' scenario. 
To start on the way towards setting it up, I want to take the University of Hong 
Kong's sample of 1,166 serum samples as representative of the population of Hong 
Kong as a whole. Having done so, the focus can immediately shift to the 8% of 
people in that sample with pre-existing Co V antibodies. Given that during early 2003 
there were a total of 1,755 retrospectively diagnosed cases of SARS-CoV in Hong 
Kong (see WHO 2004c) it follows that around 140 cases, that is, 8% of the total, could 
have been ill with pneumonia-like signs and symptoms, but, crucially, with those signs 
and symptoms having been caused by something other than the SARS-Co V? 
Is this a plausible 'what if ... ?' 
I want to suggest that it is. And for a number of reasons. In the tropical region of 
Hong Kong there are usually two peaks of respiratory "virus diseases, a major one in 
February-April and a minor one in July.29 According to the Hong Kong Department 
of Health, in a 'normal' year, during that first major peak, the peak of interest here, 
between 1,500 and 2,000 cases of pneumonia-like illness are reported every month.30 
Furthermore, around half of those 1,500 - 2,000 cases are eventually diagnosed as 
having been of bacterial cause, and, more specifically, as having been caused by either 
Mycoplasma pneumoniae or Legionella, the two most common pathogenic causes of 
pneumonia worldwide.31 So yes, I would suggest that it is at least plausible to speculate 
that the actual cause of disease in those cases, at the time, might well have been 
something other than SARS-Co V. 
But then, so what? 
For an obvious response at this point might well be the suggestion that any such 
aetiological difference would quickly have become apparent at the level of the 
laboratory. And yet this is where SARS' uruqueness, as a global outbreak of 
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pneumonia-like illness caused by a hitherto unknown virus, has to be factored into 
this 'what if ... ' scenario. For during the outbreak, very few such definite laboratory 
diagnoses were made. The case-definition put into operation by the Hong Kong 
health authorities in order to catch cases of SARS had been so broad and non-specific 
that it became 'virtually impossible to confirm SARS at the primary case setting' 
(Rain er 2004, 82). SARS looked like a lot of other things. And, as a result, hospital 
workers in Hong Kong were forced into treating all cases of pneumonia as either 
'suspect' or 'probable' SARS cases. Samples from such cases were indeed taken for 
laboratory testing, but were not immediatelY sent for anafysis. Why? Because the volume of 
samples was simply un:..manageable: 32 as was mentioned in this chapter's opening 
section, only a select sample of case samples were initially sent for initial laboratory 
analysis (to recall, five of the WHO SARS laboratory network's eleven research team's 
had only 245 samples to work with). Only as late as the first week of May, once 
'probe-specific' technologies such as the indirect SARS-Co V ELISAhad. been 
developed, could mass retrospective testing of samples begin. And with that in mind, it 
is useful to come back to the 8% of patients who, in my 'what if. .. ' scenario, had pre-
existing SARS-Co V antibodies, but might actually have been infected with something 
other than SARS-Co V. For when samples from those with pre-existing SARS-Co V 
antibodies were sent for retrospective testing via a probe-specific ELl SA, ELISA 
would have sought neither Mycoplasma pneumoniae, nor Legionella. What she wanted, the 
onfy thing she was able to want, was the exquisite specificity of a SARS-Co V 
antibody!SARS-CoV antigen complex. And she would, of course, have found it, 
detecting the formation of this complex in serum taken from those 140 cases. 
Diagnostically, a case of 'probable SARS' would have been reported to the WHO: the 
patient had displayed pneumonia like symptoms, and the patient's serum had shown 
evidence of SARS-Co V antibodies. 
The point of my presenting this 'what if ... ?' scenario has not at all been to suggest 
that any of this did definitivelY and absolute(y take place. On the contrary, the point has 
simply been to suggest that such a scenario was plausible and possible. Obviously, as 
Harvey (1981) has noted, in a scenario of this kind 'any discussion of what might have 
happened, and what might have been possible, must be speculative'. The justification 
for such speculation in this, the scientific court of appeal, however, is that unless we 
are prepared to consider alternatives to the actual judgement that ELISA made - that 
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SARS-Co V was a singular disease in each and every case diagnosed - then it is an 
outcome that can easily be interpreted as inevitable and unproblematic. And, if that 
outcome starts to seem inevitable and unproblematic, then what hope is there of 
calling into question ELISA's simultaneous judgement that multifactorality was not at 
issue in each and every case diagnosed? The 'what if ... ' scenario, then, has been 
presented in order to free up a space, a clearing as it were, from which I can move to 
question ELl SA's certainty in the face of this 'problem of when'. How successful the 
subsequent questioning proves to be, is something for you, the reader, to determine. 
But before any minds are made up one way or the other, I would ask, firsdy, for this 
'what if ... ' scenario to be accepted as a plausible and a possible one, and secondly, for 
a litde patience whilst I question ELISA from within the clearing it has helped to 
establish. 
Acute and convalescent samples 
If antibodies can survive for years after an initial infection with an antigen, and if an 
indirect ELISA test does not require the presence of the antigen in the samples in 
order to make a diagnosis, then based on the 'what if ... ' scenario above, can it be said 
with any certainty that all patients with antibody reactions to the ELISA's N protein 
antigen were infected with SARS-Co V at the time? 
The problem for those seeking to retrospectively test SARS patient samples, then, was 
one of knowing when a positive SARS-Co V ELISA diagnosis represented recent, 
rather than non-recent, SARS-Co V infection. And initially it appears as if ELISA does 
provide a solution to this problem. According to Fields Virology (Knipe et al. 2007): 
The way to establish primary infection is to determine acute and convalescent sera. 
(Storch 2007,259 my emphasis) 
In practical diagnostic terms, what this suggestion implies is that any retrospective 
ELISA test should, ideally, work with not one, but two, samples from the same patient: 
one taken during the acute phase of the illness (i.e. when the patient in question is very 
ill) and one taken during the convalescent phase (i.e. when the patient in question has 
recovered, or is in the process of recovering, from illness). The point here is that: 
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A significant rise in antibodies detected during the convalescent (recovery) phase 
(usually 2 weeks later) is diagnostic for infection and is referred to as seroconversion. 
(Mahon and Manuselis 1995, 146 my emphasis) 
So if having tested both samples a rise in the titer of antibodies in the second sample 
is identified, it becomes far easier for a microbiologist to suggest that the patient's 
recent illness was caused by the antigen to which the antibodies in the sample had 
reacted. And that explains why the WHO's Use of laboratory methods for JARS diagnosis 
(WHO 2003zw) states that a: 
Four-fold or greater rise in antibody titre between acute and convalescent phase 
sera .. .is very specific for SARS-CoV infection. (ibid., para. 5 my emphasis) 
A patient classified as a 'probable SARS' case during early 2003 could only come to be 
confirmed as a SARS-CoV case if convalescent phase sera showed atleast four times 
greater concentration of antibodies than acute phase sera. 
With the observation of seroconversion in a patient, then, came the ability to narrow 
down the time during which the antigen could plausibly have been in the patient's body. 
Once the ELISA's N protein had detected an antibody titre four times higher in the 
convalescent sera than the acute sera, it could be concluded with some certainty that 
the very recent presence of a SARS-Co V N protein had induced that rapid rise in 
specific antibodies. The effect of such a strategy was, effectively, to strip the alibi of 
'previous infection' from any antibodies within a sample that are found to react with 
the indirect ELISA's N protein.33 Indeed, the strategy of taking 'paired samples' was 
well understood by those seeking to retrospectively investigate the SARS outbreak. 
The literature abounds with references to 'paired sera,.34 In China, for example, where 
the vast majority of probable SARS cases were eventually diagnosed (5,327 of 8,096 
total cases) (see WHO 2003), attempts were made from very early on during the 
outbreak to collect both acute and convalescent sera from patients. 
And yet, consider the following extract. It appears in the WHO's 9th April SARS 
update 25, 'Interim report of WHO team in China, status of the main SARS outbreaks 
in different countries': 
Large banks of stored specimens from suspected and probable SARS cases ... exist at 
the institutions visited [in Guangdong Province] and are stored under suitable 
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conditions; detailed information about the numbers and types of these specimens are 
available ... 
These specimen banks comprise different types of respiratory specimens from which 
the detection of agents can be attempted and serum samples, often as paired acute and 
convalescent sera (i.e. the Hrst sample obtained during the acute phase of the illness 
and the second during recovery) which will allow determination of seroconversions. 
(WHO 2003zl, paras. 8-9 my emphasis) 
The strategy of taking paired sera samples was obviously important. But most 
significant here for the defence case, however, is the modifying adverb that directly 
precedes the reference to paired sera: 'often'. How often was 'often'? Did the 
specimen banks include nearly all paired samples? More than half? Less than half? 
This remains unclear. But at the very least it can be concluded that often implies not in 
every case. And in this sense, the WHO's 'interim report' points, quite nicely, to the 
practical problems that impinge upon ELISA's strategy of taking two separate samples 
from the same patient. Indeed these are problems that on!J start to emerge when 
medical microbiological principles are treated as principles that have to be put into 
practice.35 The first of those problems has to do with the fact that acute samples are 
very rarely taken from all cases during the early weeks of a pneumonia-like disease 
outbreak. Why? Because, as Dr. Trinh Huan put it during a WHO press conference 
on 26th March, 'SARS looks like a lot of other pneumonias': 
As a doctor in the Held, or a nurse, or a primary health care worker, you can't just look 
at the patient and say 'this is SARS'. (WHO 2003, para. 82) 
Most of the pathogens known to cause pneumonia induce severe illness similar to that 
manifested in cases of SARS. But because the treatment for those former illnesses 
involve the use of a broad spectrum of drugs, knowledge of the precise identity of the 
aetiological agent(s) involved is rarely required: the patient normally recovers before 
laboratory intervention is needed.36 Thus, in the early weeks of the SARS outbreak in 
Hong Kong, and before the possibility of an aetiology involving a hitherto unknown 
virus had been considered, acute samples would simply not have been taken from a 
large proportion of patients. So, as 'often' as not, only convalescent phase sera would 
have been available in the Guangdong specimen banks. 
Or perhaps not. 
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For the second practical problem with taking paired sera has to do with the fact that 
convalescent samples are very rarely taken in each and every case either. 
Because the convalescent specimen should be obtained a minimum of 2 weeks after 
the acute specimen ... obtaining a convalescent specimen is often difficult logistically 
(Gilligan et al. 2003, 25 my emphasis) 
For 'logistical difficulties' read 'unruly bodies': bodies are discharged, bodies discharge 
themselves, bodies fail to turn up for subsequent appointments, bodies die, bodies 
refuse to submit to any further testing, and so on and so forth. 
Without total coverage, then, without 'before' and 'after' samples for each patient, the 
principle of ELISA's strategy was not fully translated into practice during the 2003 SARS 
outbreak. 
The curious thing here, however; the thing that I want to pick ELISA up on, is that 
serologic testing continued anyway. 
Consider, for example, 'Serologic and Molecular Biologic Methods for SARS-
associated coronavirus infection' (WU et aL 2004). Whilst those afore-mentioned 
practical problems are never mentioned direcdy, their effects on the subsequent data 
are clearly visible. 'According to World Health Organisation (WHO) criteria', the 
article begins: 
A person seeking treatment after November 1, 2002, with a history of high fever 
(>38°q, coughing, or breathing difficulty, and having resided in or travelled to an area 
with recent local transmission of SARS during the 10 days before onset of symptoms 
was classified as a suspected case-patient. A suspected case-patient with radiographic 
evidence of inflltrates consistent with pneumonia or respiratory distress syndrome on a 
chest x-ray was considered a probable case-patient ... Seven hundred and ninety-nine 
serum samples from 537 probable case-patients, fulftlling WHO criteria for probable 
SARS cases, were tested for antibodies to SARS-Co V by ELISA. (ibid. 304-305 my 
emphasis) 
What this meant in terms of paired sera was then stated quite explicidy: 
Of these patients, 262 had paired serum specimens, in which the acute- and 
convalescent-phase serum specimens were collected at day 1 to day 12 and at day 28 or 
more after the onset of illness, respectively. In the other 275 patients, only a single 
serum specimen was collected during their illness: 210 had the serum collected at the 
acute phase or at the early convalescent phase from day 1 to day 20, and 65 were 
164 I P age 
collected during the late convalescent phase from day 28 to day 78 after the illness 
onset. (ibid., 305) 
Here, in this latter extract, the effects of those practical problems start to become 
visible. And yet, despite this, the retrospective diagnostic tests continued regardless of 
whether paired sera were available or not. Of the 537 case-samples, '469 were subsequently 
tested by indirect ELISA method' (ibid. 306). What this means is that even if all 68 of 
the non-tested cases were from non-paired samples 194 non-paired samples would 
still have been tested. And the results from these serum tests for the 537 cases? They 
were stated, definitively, in table 2 in the 'results' section as follows: 223 were 'SARS-
Co V positive', whilst 246 were 'SARS-Co V negative' (ibid., 308). 
But why is this? Why did testing continue when based, in some cases, only on one 
sera sample? The assumption being made here by Wu et al. (2004) is one that is 
articulated at great length in a number of medical microbiological textbooks. For 
instance: 
A single measure of antibody titer indicates previous infection or exposure to a 
pathogen. For pathogens rarely found in a population. the presence of antibody may be 
sufficient to indicate ongoing. active infection. (Madigan et aL 2008,914 my emphasis) 
And again: 
In practice, it is not uncommon to test a single serum specimen for antibodies to 
attempt to diagnose current or recent infection. In many cases, the presence of IgG 
antibody is difficult or impossible to evaluate; it may represent past infection, either 
clinically apparent or subclinical (without overt symptoms). In certain other cases, 
however, such as infections that are rare (rabies) ... the presence of IgG antibody in a 
single serum may be diagnostic. (Mahon and Manuselis 1995, 147 my emphasis) 
It is this assumption which guards against the problem of when, exactly, the N protein 
had been in the sample. And yet, as Zheng's 'SARS-related Virus Predating SARS 
outbreak, Hong Kong' (Zheng et aL 2004) made clear a little earlier, SARS-Co V is 
perhaps not as rare as many people have assumed. So at the moment, at this stage in 
the court-hearing, it does not seem as if ELISA, once enrolled within my (semi-
fictitious) 'what if. .. ' scenario is able to fend off the suggestion that she was not 
actually diagnosing SARS-Co V infection in those 8% of Hong Kong SARS cases. 
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Coda: the exclusion of the pre-infected ... or the exclusion of high responders? 
So far, so straightforward. And yet at this stage in the discussion I cannot avoid some 
comment on another possible solution to the 'what if ... ' scenario; a solution that might 
have been available to microbiologists involved in the retrospective testing of SARS 
cases. Although I have been unable to find any direct mention of it in the published 
research literature it does, nevertheless, require some consideration. 
In order to understand this solution it is necessary to get a litde bit closer to the 
technical immunological details of seroconversion. For antibodies are not 
. homogenous, standardised entities. In the world of immunology, they are divided into 
two 'classes': IgM and IgG antibodies.37 IgM antibodies are the first antibodies to form 
in response to an invading antigen, whilst IgG antibodies develop only later during the 
course of an infection. With this in mind, consider the following extract taken from a 
chapter section entided 'Primary and Secondary Antibody Responses' in the Textbook 
of Diagnostic Microbiology (Mahon and Manuselis, 1995): 
After exposure to an infectious agent, the host's acquired humoral immunity may 
respond through the production of various classes of anti-body directed to one or 
more antigens associated with the agent. (ibid., 146) 
And, as the text continues: 
If the host has not been previously exposed to the antigen (s) , a primary immune 
response, characterised by the relatively rapid appearance of IgM antibodies, occurs. 
IgM antibody levels usually peak in 1 to 2 weeks, followed by a gradual decline to 
undetectable levels over the next few months. At the time when IgM levels have nearly 
peaked, IgG antibodies become detectable and continue to increase for about 1 month, 
surpassing peak IgM levels. IgG levels remain elevated for months and then decline 
slowly, often persisting at low but detectable levels for years. (ibid.) 
This, then, constitutes a primary response to infection. But 'a subsequent exposure to the 
same antigen': 
Elicits a secondary or anamnestic immune response, characterised by a rapid increase in 
IgG antibody associated with higher levels, a prolonged elevation, and a more gradual 
decline. IgM antibody synthesis plays a minor role in a secondary immune response. 
(ibid. my emphasis) 
As is clear from this extract, IgG and IgM antibodies have different profiles in a 
primary response as compared to a secondary response. In theoretical terms, what these 
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extracts are touching on is the difference between the innate and the adaptive immune 
response systems in humans. The latter response is the product of a body's 
'immunological memory', of the memory of prior exposure to a viral antigen.38 But in 
fact what the extracts are far more interested in is what can be done to turn this 
theoretical knowledge to practical ends. For what they subsequently make clear is that, 
during an infectious disease outbreak, the difference between primary and secondary 
responses allows for the separation of patients who had previously been infected with 
the same pathogen from patients who had never previously been infected with the 
pathogen. In this way, a solution to the problems introduced by the 'what if. .. ' 
scenario in the previous section is generated: 
IgM antibody synthesis plays a minor role in a secondary immune response. Serologic 
tests that are designed to separately detect IgG and IgM antibodies take advantage of 
the differences in IgM production between a primary and a secondary immune 
response. Thus, a positive test result for IgM antibody is considered indicative of a 
primary current or very recent infection. whereas the presence of IgG antibody alone 
suggests a previous infection or exposure. (ibid., my emphasis) 
In this way, it would have become possible to separate out cases displaying a 
secondary response to those displaying a primary response. In theory, then, the 'what 
if ... ' scenario becomes implausible and impossible. The defence case is blown apart. 
If anyone with pre-existing antibodies to SARS-Co V had fallen ill with a different 
kind of pneumonia during early 2003, retrospective ELISA tests would have been able 
to detect their unique adaptive immune system responses. Those who had previously 
been infected with SARS-Co V would have displayed higher levels of IgG antibodies 
and lower levels of IgM antibodies than those who had never been infected before. 
In this way, a solution to the problem of when is generated. 
Or is it? 
There is, as far as I can see, a potential problem with this strategy. It can be developed 
via a reading of a different, and rather more technical textbook. 'Immunoassays for 
the diagnosis of infectious diseases' (Carpenter 2007) is the title of a chapter that 
appeared in the Manual ofC/inical Microbiology (Murray et al 2007). It is fiercelY technical, 
presenting as perhaps the most difficult read of all the texts cited so far. The most 
interesting section therein appears under the sub-heading 'Caveats in Serologic 
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Interpretation' (Carpenter 2007, 259). 'The actual amount of antigen-specific antibody 
present in the serum of a particular individual', it is noted: 
Is not determined and is controlled by immune-response genes which are products of 
the human histocompatibility system. (ibid., my emphasis) 
And, what is more: 
The level of the IgG titer from a single serum sample to a particular infectious agent 
may not be used to determine if the infection is recent or remote. (ibid., my emphasis) 
An example is then presented in order to illustrate this theoretical point: 
Person A may be a high responder to certain antigens and a low responder to others. 
Therefore, if a high titer of IgG is obtained for an individual, it may be tempting to 
think that this may represent a less recent exposure; however. this may indicate only 
that the individual is a high responder to that particular antigen. (ibid., 259 my 
emphasis) 
Interestingly, the same is said to hold of IgMs as well: 
In general, a positive IgM titer to a particular organisms is evidence of an active (i.e., 
recently acquired) infection with that agent. However, a positive IgM titer does not 
always mean that the infection is recent. There have been reports of persistent 
elevations of IgM antibody for a year or more. (ibid.) 
From the perspective of the textbook itself, however, these are problems that can be 
overcome. The way in which 'to determine if the infection is recent' is stated as 
follows: 
To establish a primary infection is to determine acute and convalescent phase titers. 
(ibid.) 
With paired sera, high responders would still be 'high responders'. But they would 
also be high responders in which change could be traced. As the profile of IgM and IgG 
antibodies changed over the course of the two sera samples, it would be possible to 
see a standard pattern developing for: 
A. A primary infection in a high/low responder; or 
B. A secondary infection in a high/low responder. 
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That, at any rate, seems to be the textbook's solution; once it has taken us to the brink 
of suggesting that the problem of when can never be fully resolved by an indirect ELISA, 
it suddenly falls back onto the solution of the taking of two phase samples. And yet, is 
this not precisely the kind of solution that was impossible in a number of SARS cases? 
Without both samples, the problem that was articulated so forcefully in the Manual of 
Clinical Microbiology (Murray et aL 2007), the problem of when the case had been infected 
with SARS-Co V reared its head once again. Consider, for one final time, the profile of 
a secondary infection: 
A secondary or anamnestic immune response [is] characterised by a rapid increase in 
IgG antibody associated with higher levels [than in a primary response], a prolonged 
elevation, and a more gradual decline. IgM antibody synthesis plays a minor role in a 
secondary immune response. (ibid. my emphasis) 
Granted, with only one sample available to test, it would still have been possible to 
separate out those samples displaying high levels of IgG antibodies and low levels of 
IgM antibodies from other SARS patient samples. But would this have been to 
separate out those with secondary infection from those with primary infection, or 
simply to separate high responders from low responders? Without paired sera, there 
would have been no way to answer this question, definitively, one way or the other. 
H. CONCLUSIONS 
Some evidence was unavailable during this cross-examination. In fact, only the 
evidence pertaining to ELISA's first judgement was made available to the court. And 
this was far from ideal. Because the actual process of making ELISA's second 
judgement, the judgement regarding the non-existence of the multifactorial object, 
had been granted 'black box immunity', it was impossible, here in this cross-
examination, to attempt a recovery of the direct possibility of the multifactorial object. 
As a result, the case for the defence had to be built around a recognition of the 
following double bind: given that both of ELISA's judgements were inextricably 
entwined with one another, to pick some holes in the first judgement, the publicly 
available judgement that SARS was caused by SARS-Co V and SARS-Co V alone in 
each and every case diagnosed, would also, and at the same time, be to pick away at 
that second judgement, the judgement regarding the non-existence of the 
multifactorial object. To attack the seemingly unquestionable nature of the flrst 
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judgement, in other words, would be to weaken, just a litde, the seemingly 
unquestionable nature of the second. 
Did this strategy work? 
Did it manage to generate a modicum of reasonable doubt? 
Certainly I managed to fInd one particular moment at which ELISA's diagnostic 
certainty was, perhaps, on slighdy less than certain ground. That moment came when 
the diagnostic problem of when was introduced. And, having set up a 'what if ... ' scenario, 
involving a small, but nonetheless significant number of people who might not have 
been correcdy diagnosed by ELISA because of that 'problem', I went on to question 
the way in which the problem was managed and negotiated by ELISA during the 
SARS outbreak. The question of whether or not ELISA was actually diagnosing recent 
SARS-Co V infection in each and every one of those people was asked at a number of 
points along the way. And, at each of those points, ELISA did appear to have an 
answer ready and waiting to counter my examination. 
But crucially, the defence also had answers; answers that were ready and waiting to 
counter each of ELISA's counters. 
In this way, whilst performing a 'back-and-forth' dialogue between myself and ELISA, 
I sought to foreground the way in which ELISA's counters were built around the 
suppression (and perhaps even the denial) of the kind of textbook, theoretical and 
laboratory manual knowledge that managed to support my counters to her counters. 
Making those documentary sources perform the roles of 'expert witnesses' for the 
defence case, I sought to turn the diagnostic problem of when into an intractable one 
for ELISA. The end-result of the dialogue? At the very least, a slight muddying of the 
waters; a slight possibility that reasonable doubt might have been generated in relation 
to the definitive and unquestionable nature of ELISA's fIrst judgement. For now there 
are two equally possible, and equally plausible solutions to the diagnostic problem of 
when: on the one hand, ELISA's solution to the problem, which, in making a number 
of assumptions and forgettings, renders the problem solvable; and, on the other hand, 
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my own medically informed solution, which, in recognising the difficulty of making 
those assumptions and forgettings, renders the problem intractable. 
And that is it. Or rather, this is it, for the rhetorical effect sought by the defence case 
here can be captured, quite nicely, in a question that I want to leave the jury to ponder 
during the recess period: if the certainty of EUSA's first judgement can been called into 
question in this way; if she might not actuallY have been finding SARS -Co V each and every time she 
diagnosed a case of 'SARS -Co V infection ~ then on what grounds can we trust her second judgement, 
the judgement regarding the non-existence of the multifactorial oiject, to have been a'!Y more certain, 
and more unquestionable, than the first? 
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Notes 
1 The direct quote here is taken from 'Serological Assays', a sub-section of . 
Carpenter's 'Immunoassays for the diagnosis of infectious diseases' (see 2007, 259). 
The phrase 'exquisite specificity', so evocative of the Kochian doctrine of 'one disease 
has one cause', also appears in the tide to Cambrosio and Keating's Exquisite Specificiry. 
The Monoclonal Antibody Revolution (1995). 
2 I use the term 'nihilate' here in a Sartrean sense in order to signify a form of 
'going beyond' or 'transcendence'. 
3 For the notion of the 'core-set' in its full sociological glory, see Collins' work 
on scientific controversies and, more specifically, the way(s) in which new knowledge 
emerges from them (1981; 1985, 142-147). Here, however, I am using the term simply 
to convey a sense of the WHO SARS laboratory network's control over the 
'aetiological question' vis-a-vis other research laboratories around the world. 
4 This t~tal of nine can be broken down as follows: one of the 'co-factorial' 
samples came from Drosten et al. (2003); one came from Ksiazek et al. (2003); three 
came from Lee et al. (2003); and four came from Poutanen et al. (2003). 
5 For the WHO, the discovery of an aetiological object was simply the means 
to the end of developing diagnostic tests for SARS (indeed, the WHO SARS 
laboratory network was, according to its founder, set up specifically to 'expedite 
identification of the causative agent of SARS and rapidlY develop a robust and reliable 
diagnostic test (Stohr 2003, 1731)). In a 16th April press release issued to mark'the 'fmal 
confirmation' (WHO 20031, para. 1) that SARS was caused by CoV, for instance, the 
aetiological discovery itself received far less attention than the diagnostic practices and 
interventions that it would help to make possible in the future: 'The successful 
identification of the coronavirus means that scientists can now confidendy turn to 
other SARS. challenges ... today, the collaboration continues as top laboratory 
researchers have come to WHO to design the next steps, a strategy for transforming 
these basic research discoveries into diagnostic tools which will help us to successfully 
control this disease,' said [Dr. David] Heymann [Executive Director, WHO 
Communicable Disease Programme], (ibid., para. 3). 
6 To slighdy modify Latour's words in relation to what he terms the 'Modern 
Constitution' in We Have Never Been Modern (1993), ELISA, when seen through 
multifactorial eyes, is a truly modern technology: here, on the left, are [SARS-Co V 
cases]; there, on the right, are [non-SARS-CoV cases]. Everything happens in the 
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middle, everything passes between the two, everything happens by way of mediation, 
translation and networks, but this space does not exist, it has no place. It is the 
unthinkable, the unconscious of the [ELISA] (see ibid., 37). 
7 On those technologies, see WHO Guidelines for the global suroeillance of severe 
acute respiratory .ryndrome (2004a, 11-12). 
8 A non-human human? Perhaps. Although unlike Latour's friend Aramis 
(otherwise known as 'Agencement en Rames Automatisees de Modules Independants 
dans les Stations') I have forbidden ELISA the privileges of prosopopoeia during this 
court-hearing (see Latour 1996). 
9 See Costello (2001, 1048), Gilligan et al. (2002), Nairn (2007), and also see 
chapter 3, above). 
10 See Anonymous (2003b) for a virologist's comments in relation to the 
iconoclastic nature of the SARS-Co V ELISA test-kit. 
11 This 'brief textbook style introduction' has been informed by a number of 
accounts. In particular, Carpenter (2007), Fleisher (1997), Law et al. (1996), Mahon 
and Manuselis (1995), Nairn (2007), Nicholas and Nicholas (1985), Roit (1994). 
Perceptions of certainty in science, as Harry Collins once noted, typically depend on 
one's 'distance from the research front'. Put blundy, 'the closer one gets to the centre, 
the messier things appear' (1987, 692). Certainly in the case of ELISA, and in order to 
get a sense of how we got here - to a diagnostic machine that could be storied and 
presented in this way, historical accounts revealing the 'mess' and, by implication, the 
deeper theoretical and philosophical issues at stake during the development of serological 
tests, were of great use (see for example, Cambrosio and Keating (1995), Podolsky 
and Tauber (1997), and Silverstein (1989)); and, for the actual primary material where 
one is able to get a direct sense of the 'messy' origins of serological methods like 
ELISA, see Coons (1951, 1961), Coons et al. (194;), Coons et al. (1942), and, ill terms 
of cancer immunology, Old (1982). 
12 Immunoassays like ELISA have changed significandy over time with 
improvements in the types of antibodies and antigens available as well as improved 
detection systems. But, nevertheless, as a sociologist, I found it useful to pay attention 
to immunological texts that are now considered 'out-of-date'. For as noted in 
footnote 11, above, it is often with such texts, written in the 1980s and early 1990s 
when ELISA methods were far less certain and far less stable than they are now, that 
one finds the most detailed discussions of the basic theoretical and philosophical 
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principles at stake in serologic methods (see for instance Kemeny and Challacombe 
(1988), Kemeny (1991), and Nakamura eta!. (1991)). Later on, in state-of-the-art texts 
and textbooks that detail state-of-the-art ELISA methods, a great deal of knowledge is 
simply assumed. 
13 The term ELISA was introduced by Engvall and Perlmann (1971) to 
describe a subset of the widely used immunoassay technique. Unlike other 
immunoassay methods, ELISAs were designed specifically to have one of the reagents 
bound to a solid phase (usually 96-well) micro titre plate in order to allow for the 
handling of many samples at one time and the automation of the assay. For further 
discussion on the similarities and differences between the techniques comprising the 
'immunoassay family', see Kemeny and Challacombe (1988), Kemeny (1991), and 
Tijssen (1985). 
14 As a general rule, it seems that indirect ELISAs are now the preferred tool 
during the doing of practical diagnostic work. Previous studies have suggested that 
when an antibody is immobilised onto a microtiter plate, there is often a significant 
reduction in affinity (Arends 1971), coupled with a dramatic reduction in binding 
capacity (Butler et a!. 1992). More generally, on the emergence and development of 
'monoclonal antibodies' as working objects in the discipline of immunology, see 
Cambrosio and Keating (1988; 1995; 2003). 
15 These quotes are taken fromMims etaL (1998,168-169). 
16 Many different enzymes have been used as 'tracers' in ELISAs, including 
urease, alkaline phosphatase, horseradish peroxidase and ~-galactosidase (for a review, 
see for instance Gosling (1990), and Porstmann and Kiessig (1992)). But, since the 
serum samples in question during the SARS outbreak would have contained human 
antibodies, the enzyme used as a reporter there would have been an enzyme-
conjugated anti-human antibody. 
17 Writing in the wake ofWatson and Crick's 1964 article on the double helical 
structure of DNA, Canguilhem speculated that one of the revolutionary consequences 
of their work would be a redefinition of life as meaning. Why? Because contemporary 
biology had begun to shift scales, changing the level at which the phenomena of life 
could be made knowable and manipulable. It had, he suggested, 'dropped the 
vocabulary of classical mechanics, physics and chemistry ... in favour of the vocabulary 
of linguistics and communication theory. Messages, information, programs, codes, 
instructions, decoding: these are the new concepts of the life sciences ... The science 
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of life no longer resembles a portrait of life ... and it no longer resembles architecture 
or mechanics ... But it does resemble grammar, semantics and the theory of syntax. If 
we are to understand life, its message must be decoded before it can be read' 
(Canguilhem 1994, 316-317; and see the papers in Chadarevian and Kamminga 1998). 
18 More generally, on the 'molecularisation' of biomedicine over the course of 
the 20th and early 21st centuries, see Rose (2005): 'the body as a systematic 
whole ... that was the focus of clinical medicine, as it took shape over the nineteenth 
century ... [t]oday, however, biomedicine visualises life at another level- the molecular 
level. The clinical gaze has been supplemented, if not supplanted, by this molecular 
gaze ... [a]s even a cursory reading of contemporary biomedical research shows, life is 
now understood, and acted upon, at the molecular level, in terms of the functional 
properties of coding sequences of nucleotide bases and their variations, the molecular 
mechanisms that regulate expression and transcription, the link between the 
functional properties of proteins and their molecular topography, the formation of 
particular intracellular elements - ion channels, enzyme activities, transporter genes, 
membrane potentials - with their particular mechanical and biological properties' 
(ibid., 11-12). 
19 See Marra et aL (2003), and Rota et aL (2003); and see Dyer's (2003) useful 
summary of Marra et aL, and Rota et aL (2003). For a review of the early genomic-work 
on SARS-CoV, see Brown and Tetro (2003), Goldsmith et aL (2004), and Lai (2003); 
on the various strains of SARS-Co V in circulation in China during the outbreak, see 
Chinese SARS Molecular Epidemiology Consortium (2004), and for those in 
circulation more generally, see Ruan et aL (2003). 
20 On the function of Genbank for medical microbiologists, see footnote 17 in 
chapter 3 above. 
21 Though see Murray et aL (2009) for a useful account of the PCR as a 
diagnostic tool; and, more specifically in relation to SARS-Co V, see Hui et aL (2004), 
Jiang (2004), and Zhai et aL (2004). 
22 Specifically in relation to the development of primers for a SARS-Co V PCR 
test, see Zharig et aL (2003). 
23 On this see Ndifuna et aL (1998), Seah et aL (2000), and Wang et aL (2002). 
24 On the rhetorical significance of referential strategies, see Richardson (2007, 
50-52). 
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25 On the move towards recombinant based, rather than cell-extract based 
SARS-CoV ELISA's, see Woo et at. (2004): 'an approach of ELISA-based antibody-
detection tests using recombinant antigens with positive results conftrmed by westem-
blot assays that use two different antigenic proteins offers higher sensitivity, speciftcity, 
and reproducibility than indirect immunofluorescence assay and ELISA with cell-
culture extract and is easier to standardise' (ibid., 841). And, more generally, on the 
displacement of the one by the other in medical microbiology, see Cao et at. (1998a, 
1998b), Denac et at. (1997), and Yuen et at. (2002). 
26 As an aside here, it is worth noting, once more, the co-existence of the 
singular and the multiple as two very different understandings of the 'aetiological 
question' in medical microbiology. For these laboratory manuals, having begun on 
Kochian terrain, noting the 'exquisite speciftcity' of the antibody-antigen complex, 
suddenly start to wander off onto the kind of multifactorial terrain that Dubos 
mapped out over half a century ago. To recall, his multifactorial point was that 
because of the 'complex physiological status of the infected individual' (Dubos 1968, 
107), 'the manifestations of any given agent [would] differ profoundly from one 
person to another' (ibid. 106). 
27 The 'one other article' ID question here is 'Retrospective Serological 
Investigation of SARS coronavirus Antibodies in Recruits from Mainland China'. Its 
primary author was a Dr. Sumeng Yu from the Infectious Disease Control Unit, 
Logistic Department for Air Forces, Beijing Military area, and it appeared in the April 
2005 edition of the journal Clinical and Diagnostic Laboratory Immunolo!J (Yu et at. 2005). 
'In this study,' Yu suggested in a brief introductory section, the aim had been 'to 
investigate whether people from mainland China had been exposed to the SARS-Co V 
before the fIrst SARS outbreak in 2003' (ibid., 552, para. 3). And that was why '1,621 
serum samples were screened by enzyme-linked immunosorbent assay (ELISA)' 
(ibid.). The non-paired serum samples in question had been 'taken from healthy 
military recruits for routine examination in March 2002, about 1 year before the first 
SARS outbreak' (ibid., my emphasis). Perhaps only rnicrobiologists working for 
research units with close ties to the armed forces in China could have performed such 
an investigation. Serologic samples are very rarely taken, and certainly never taken on 
a systematic basis from the non-military population of China. But they are from the 
military population. In a sense, the latter population is not simply a ftghting force. It is 
called upon to act as a proxy for a laboratory animal far more often than it is called 
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upon to take up arms. Samples taken regularly, each year, from each individual in that 
population, allow for the possibility of a unique archaeology of the changing 
relationships between humans and pathogens to develop. The military recruits in 
question 'came from 17 provinces, including ,Guangdong Province, of China; they 
were all 18 year old men whose health status met the standards for army recruitment' 
(ibid.). The results from the ELISA tests on their serum samples were as followed: 
'eleven of 1,621 (0.68%) serum samples were positive for IgG antibodies against 
SARS-CoV' (ibid., para. 4). Taken at face value these are of course quite startling 
findings. SARS-Co V had previously been understood as a pathogen that had only 
managed to cross the species gap, moving from animal to human populations, during 
late 2002. Yu's results, however, seemed to be suggesting otherwise ... 
28 An interesting referential strategy: a Hong Kong laboratory research group 
describing 'Hong Kong' as a part of 'Southern China'. 
29 Although the underlying mechanisms still remain largely unexplained, this 
'seasonality' for many infectious diseases is stable and well-documented. On this see 
Chew et al. (1998), Evans (1989), and Noah (1989); and, specifically in relation to the 
2003 SARS outbreak, see de J ong and Lim (2005). 
30 As Dr. Yeoh Eng-kiong, the Hong Kong government's minister for Health, 
Welfare and Food put it during the SARS outbreak, 'the media talked about this 
atypical pneumonia, saying that there are confirmed cases in the community. This is 
absolutely right. However, what we are talking about [with] the cases reported these 
months, we have around 1,500 to 2,000 cases of pneumonia in Hong Kong, and 
about half are identified to be the bacteria and they are usually easier to treat ... the 
other half usually includes a large group of patients with atypical pneumonia. I just 
want to explain that in any country and any area, there are always cases of 
pneumonia ... In a global sense, since the mode of infection is seasonal, there exists a 
certain degree of discrepancies. But the distribution is around a 50/50 basically. 
Actually, this pattern has remained more or less the same for the past few months, 
and the number that we recorded are similar, so we're not talking about an outbreak 
of pneumonia in the community' (cited in Xiao 2008, 41 my emphasis). 
31 On the problems of identifying these 'atypical' aetiological agents in cases of 
pneumonia-like illness, see BIasi (2004), BIasi et al. (2005), British Thoracic Society 
Standards of Care Committee (2001), Cunha (2006a; 2006b), Huchon (2008), Ieven 
(2008), and Lode (2007). 
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32 Interestingly, this is precisely what happened during the flrst few weeks of 
the 2009 swine flu outbreak in the UK. By 2nd July, the rising numbers of swine flu 
cases being reported every day (458 new cases on that day alone, for instance), forced 
the government into lifting the need for laboratory testing and laboratory diagnosis of 
cases (on this, see the BBC's news web site report, 'Swine flu "cannot be contained'" 
(2nd July, available at http://news.bbc.co.uk/1/hi/health/8130097.stm). 
33 Also on this point, see Gilligan et at. (2002), and Mahon and Manuselis 
(1995). 
34 See for example Che et at. (2004), He et at. (2007), and Shi et at. (2003). 
35 The best place to start when seeking to understand how social scientists 
have sought to grapple with the rhetoric of 'principles and practices' in medicine in 
the past, is Freidson's The Profession of Medicine (1970): 'in the course of application, 
knowledge cannot remain pure but must instead become socially organised as 
practice' (ibid., 346). Also of interest here is Gaines and Hahn's 'Among Physicians' 
(1985) in which they write of the need for 'an anthropological understanding of 
biomedicine [which] will situate its practices within a cultural context and elucidate the 
cultural origins, expectations and values which drive and constrain it' (ibid, 11). More 
recenciy, Berg (1992), Fujimura (1992), and Vos (1991) have all explored the links that 
exist between medical knowledge and daily research and clinical practice. And, for a 
very different take on the 'principles and practices' rhetoric as a rhetoric that allows 
for divergent medical logics to co-exist peacefully, see Mol and Berg (1994). 
36 On the broad, and often non-speciflc treatment programmes available for 
the treatment of pneumonia-like illness in Britain, see the guidelines in British 
Thoracic Society Standards of Care Committee (2001) 
37 In relation to the speciflc properties of monoclonal antibodies, an~ their 
emergence, invention, cultivation, development and replication as microbiological 
'tools', see Cambrosio and Keating (1988, 1995), and Keating and Cambrosio (1997, 
1999). 
38 As Wilschut et at. (2006, 78 my emphasis) note, when a virus infects a body, 
'both innate and adaptive immune responses are stimulated. The innate immune 
response develops very quickly and controls virus replication during the early stages of 
infection ... [a]n important element of the transition from the innate to the adaptive 
immune response is the stimulation of Toll-like receptors (fLRs) in endosomes of 
antigen-presenting cells ... stimulation of immunological memory from prior exposure 
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to viral antigens (by natural infection with the virus or through vaccination) also 
stimulates specific pathways in the adaptive immune response'. For some other, 
fascinating accounts of 'immunological memory', see Durbin et aL (2000); Diebold et 
aL (2004); and Nairn (2007, 137). 
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6 
'For weeks he would examine sample after 
sample, always reaching the same 
Chlamydia conclusion ... '1 
Dr. Hong Tao and the suppression of multifactorality in 
popular science accounts of the 2003 SARS outbreak 
Having spent the previous three chapters studying medical technologies, it seems only 
right that in this, the final chapter of the thesis, I should study some of the rhetorical 
technologies at work within popular science accounts of the outbreak. After all, thry 
were the accounts that really mattered in mediating an understanding of the outbreak 
during the post-epidemic period. 2 The reality of SARS came to most of us not 
through research articles with titles such as 'Retrospective serological investigation of 
SARS coronavirus antibodies in recruits from mainland China', but through the filter 
of journalistic language and imagery. Indeed a complex set of factors - most notably 
SARS-CoV's rapid disappearance from the social body, and its failure to re-appear 
therein ever since WHO declared the outbreak over on 5th July 2003 -lent to popular 
science writing an almost unprecedented level of pedagogic authority. 3 With the 
'research front' firmly closed,4 the practitioners who had engaged in primary scientific-
knowledge production were safely out of the popular science spotlight: their work 
now involved the exploration of a cold hard 'fact', not an uncertain, controversial 
'thing,.5 But that spotlight was not simply switched off. Guided by writers in search of 
a good story it came to focus upon the past history of the outbreak. And unlike, say, 
the situation with HIV-AIDS during the 1980s and 1990s, where any account of the 
disease could only ever become a small-and-soon-to-be-outdated-contribution to a 
(seemingly) unending story of controversy and uncertainty,6 those who dealt with the 
2003 SARS outbreak were able to have the final and definitive say on what really 
happened. 
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How, then, did they construct their accounts of the 2003 SARS outbreak? How did 
they engage with and interpret their primary data: press conference transcripts, 
interviews, research articles? Did the imperative of their genre - the telling of an 
engaging, dramatic story - lead them to foreground certain data and certain 
interpretations of that data at the expense of other data and other interpretations?? And 
what happened after the very first such account had been published? How did 
subsequent accounts relate to that one, founding text? Did they too engage with and 
interpret the primary data? Or did they simply accept the founding text as an 
'obligatory point of passage', a flnal and definitive account of what had really 
happened,?8 
In answering these questions I will hope to gain two things. Firsdy, an understanding 
of the ways in which primary historical data come to be transformed across 
generations of popular science histories; and secondly, an understanding of the ways 
in which those transformations impact upon our ability to know "what-really-
happened-in-the-past". But whilst pursuing such understandings, I will also be hoping 
to do something with a litde more critical intent. Put simply, I will be looking for 
justice.9 The object of my care and attention will be a character who lO appears in many 
of the accounts of the 2003 outbreak of severe acute respiratory syndrome (SARS) 
published since the outbreak ended. A character by the name of Dr. Hong Tao. 
According to the accounts in question, Dr. Hong was the Chinese microbiologist who 
sought, but failed (and failed spectacularlY), to discover the aetiological agent 
responsible for causing the outbreak. But he did not just fail. For it seems that he also 
acted to 'promote' his discovery in such a way that other microbiologists in China 
were subsequendy unable to put forward what proved, ultimately, to be the correct 
aetiological claim. His failure, and his inability to accept his failure, it seems, managed 
to hold the international response to the outbreak back by a good number ofweeks. l1 
Reading of his actions during the early months of 2003, it is difficult not to 
understand Dr. Hong as one of the SARS outbreak's great scientific losers. But does 
he deserve this reputation? Does he deserve the sentence of a life-long stretch lurking 
around amongst the discarded refuse in science's backyard that has been handed 
down to him by the court of popular science?12 I want to suggest that he does not. In 
fact, I want to defend him. 
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The case for the defence will be built, initially, around a close rhetorical examination 
of just one particular account of Dr. Hong's actions: 'China's Missed Chance' 
(henceforth CMC). CMC was a 'news focus special report' that appeared in the July 
18th, 2003 edition of the prestigious journal Science. Written by the highly respected 
science journalist Martin Enserink13, it was the flrst popular science article to tell of 
the 2003 SARS outbreak during the 'post-outbreak' period, and, as such, quickly 
became an 'obligatory point of passage' for all subsequent accounts. In section I, the 
rhetorical cross-examination begins with an attempt to explain what the defence of Dr. 
Hong has to do with this thesis' more general defence of the possibility of 
multifactorality. In sections II-IV, a great deal of attention 1s given over to 
understanding the ways in which the rhetorical construction of CMC actually enabled 
Dr. Hong's original conviction. And then, in a bid to strengthen the appeal case a litde 
further, section V looks to the ways in which subsequent accounts of the SARS outbreak 
came to relate to, engage with, and appropriate CMC. In a brief concluding section, 
section VI, I look up from this localised case in order to ask whether these processes 
of transformation might not actually be more general phenomena, inf(l)ecting other 
(seemingly) factual and (seemingly) unquestionable accounts of past scientiflc episodes. 
1. CHINA'S MISSED CHANCE 
CMC tells of a race that developed between three scientiflc research groups during the 
early weeks of the outbreak. The prize sought by each was the discovery of 'the cause 
of the new disease,.t4 The scientific research groups in question were: a World Health 
Organisation (WHO) laboratory network led by Dr. Klaus Stahr, a research team 
working out of the Academy of Military Sciences (AMMS) in Beijing and led by Dr. 
Yang Ruifu, and, flnally, Dr. Hong's research team at the Chinese Centre for Disease 
Control (CCDC) , also in Beijing. There was a lot at stake here. In the world of 
medical microbiology the discovery of a hitherto unknown pathogen is big news. Very 
big news. The equivalent professional yield from such a discovery in the social 
sciences would, at the very least, be a series of articles and publications guaranteed of 
receiving a 4* world-leading classiflcation from the RAE. 
According to Enserink, the group that reallY won this race was the AMMS, led by Dr. 
Ruifu. 'By the first week of March' he suggests, 'the group had tentative evidence that 
a new virus might indeed be linked to the epidemic,.tS Having 'grown a virus of some 
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sort from the samples in so-called vero cells', 'they [had] observed what looked like 
coronavirus particles in an electron micrograph,.16 The team 'also discovered that 
serum from SARS patients could inhibit the growth of the virus - a key test to show a 
correlation between an isolated agent and a disease'. As Enserink makes clear, having 
achieved all of this they were 'weeks ahead' of the researchers in the WHO laboratory 
network. 17 And yet the AMMS were, nevertheless, to be denied the prize of a 
'prominent place in the history of the disease, and perhaps even a publication or two 
in a prestigious scientific journal' by that very same group.18 For on 16th April, some 
five weeks after the AMMS had reached the same conclusion, it was the WHO 
research team that were to receive all the plaudits, announcing at a press conference in 
front of the world's media that the causal agent was a hitherto unknown coronavirus. 
'Looking back' at this episode, Dr. Stohr is quoted as suggesting, 'had the AMMS 
researchers reported their findings immediately, the larger group [the WHO SARS 
laboratory network] might have been on the trail much sooner,.19 How had this 
situation arisen? According to Enserink, it had arisen because the AMMS 'didn't dare 
tell the world' about their discovery.2o This, however, was not a self-imposed silence, 
but one forced upon them through the actions of 'an esteemed senior microbiologist 
and member of the Chinese Academy of Engineering' - Dr. Hong Tao - and the 
institution for which he worked - the CCDc.21 In mid-February, Dr. Hong 'proposed 
that the agent was a new type of Chlamydid.22 And even though 'others suggested that 
it may have been something different altogether,,z3 there was apparendy no dissuading 
him: 
Promoted by Hong Tao, an esteemed senior microbiologist and member of the 
Chinese Academy of Engineering, the Chlamydia hypothesis had become ... well 
established.24 
The CCDC, in conjunction with other institutions in China, subsequendy forbade any 
further discussion of the aetiological question, and moved to 'prevent others from 
expressing alternate views'. In late March, for instance, and 'bolstered by WHO's daily 
reports and new, more solid data of their own, AMMS scientists reported their 
findings to the Ministry of Health'.25 The result? 'The department stuck to the 
Chlamydia theory', and set up 'a working group ... to control publicity about SARS 
pathogen studies'.26 Indeed, it was only as late as the last week of April, after the 
Chinese health minister had been sacked for mishandling the outbreak that the 
183 I P age 
coronavirus discovery came to receive official acceptance within China.27 But by then 
of course the AMMS team had been pre-empted by the WHO, and it was too late for 
them to take any credit for the discovery. This, it seems, was 'China's missed chance'. 
In a sense, this is a fairly standard popular scientific tale of the 'good' scientists (in this 
case microbiologists) versus the 'bad' scientist.28 Everything centres on just two of the 
scientific groups as the champions of the coronavirus aetiological claim: the WHO 
and the AMMS. Dr. Hong, as we have already seen, concentrated his attentions not 
on the coronavirus, but on a Chlamydia bacterium. 29 That was why he was 
subsequently able to 'promote' his 'Chlamydia hypothesis'. The interesting thing about 
CMC, however, is that in order to tell of Dr. Hong'S actions during the outbreak, in 
order to incorporate him into its overall story, it relies on just one piece of primary 
data: a research article, entitled 'Chlamydia-like particles and coronavirus-like agents 
found in dead cases of atypical pneumonia by electron microscopy' (henceforth CLA). 
Written by Dr. Hong and his research colleagues, it was published in the 25th April, 
2003 edition of the National Medical Journal of China. Given that I too have access to 
this particular article, what I want to do now is look at Enserink's gloss of CLA - the 
one piece of material evidence included within CMC - in order to strengthen his 
telling of 'China's missed chance':3o 
In a paper in the 25 April National Medical Journal of China, Hong reported having found 
'Chlamydia-like particles' in a total of seven patients. an two. he also noted the presence 
of a coronavirus which by then had been proven to be the cause of SARS.) But he was 
not able to actually isolate the microbe or characterise it further, and Chlamydia was not 
found in most SARS patients. Moreover, antibodies to known Chlamydia species did 
not react with the tissue samples. Hong therefore proposed that the agent was a new 
type of Chlamydia, but others suggested that it may have been something different 
altogether.31 
Now it seems to me that there is something about this gloss that jars with the overall 
story being told by Enserink in CMC. For therein, trapped within a parenthesis, is an 
acknowledgement that Hong had in fact discovered the coronavirus too. But before 
discussing this peculiarity at any great length, I want to present the abstract from the 
original source document CLA (the most relevant sections have been underlined)32: 
OBJECTIVE: To explore the causative agents of the atypical pneumonia (also SARS) 
that occurred recently in some regions of [China]. METHOD: Organ samples of 7 
dead cases of SARS were collected from Guangdong, Shanxi, Sichuan Provinces and 
Beijing for electron microscopic examination. 293 cell lines were inoculated with the 
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materials derived from the lungs in order to isolate the causative agent(s). The agents in 
the organs and cell cultures were revealed by immunoassay. 
RESULTS: Both Chlamydia-like and coronavirus-like particles were found by electron 
microscope. Inclusion bodies containing elementary bodies, reticulate antibodies and 
intermediate bodies of Chlamydia-like agent were visualised in multiple organs from the 
7 dead cases, including lungs (7 cases), spleens (2 cases), livers (2 cases), kidneys (3 
cases) and lymph nodes (1 case), by ultra-thin section EM [electron microscope]. In 
some few sections, coronavirus-like particles were concurrently seen. A coronavirus 
RNA-polymerase segment (440 bp) was amplified from the lung tissues of two cases. 
After inoculation with materials from the lung samples, similar Chlamydta-like particles 
were also found in the inoculated 293 cells. Since the Chlat1!Jdia-like agents visualized in 
both organs and cell cultures did not react with the genus specific antibodies against 
Chlamydta and mono clonal antibodies against C. pneumoniae and C. psittaci, the results 
might well be suggestive of a novel Chlamydia-like agent. 
CONCLUSION: Since the novel Chla~ydia-like agent was found co-existing with a 
coronavirus-like agent in the dead cases of SARS. it appears most likely that both 
agents play some role in the disease. At the present time. however. it is not possible to 
determine whether these agents interact synergistically. or whether one follows another. 
This requires further study. (Hong et al. 2003, 632)33 
So, there it is: the possibility of multifactorality. Along with Dr. Osterhaus prior to his 
macaque monkey experiments (see Chapter 4), it seems that Dr. Hong held up the 
possibility of either a double aetiology (' ... these agents interact synergistically ... ') or a 
parasitic aetiology (' ... or whether one follows another'). Reading through CLA's abstract, 
it seems34 difficult not to draw the following conclusions: firsdy, that Hong gave his 
(entirely plausible) coronavirus findings far more attention than Enserink is allowing 
for; and secondly, that Hong was far less excited about his (entirely plausible) 
Chlamydia findings than Enserink is allowing for. And the reason why it is seems 
difficult not to draw these conclusions? Because Hong made it quite clear in CLA that 
he had not yet ruled out the possibility of the outbreak under investigation having a 
multifactorial aetiology; that the cases of SARS that he had received samples from, 
might well have suffered from a complex interaction, or 'synergy', between both 
pathogens. 
But then, if these conclusions can be accepted, it is worth asking the following 
question: does CLA really support, back up or vindicate in a'!Y wC!) CMC's tale of the 
'good' microbiologists versus the 'bad' microbiologist? I would suggest not. In a sense, 
the main stumbling block, the epistemological obstacle that CMC had to negotiate in 
order to turn CLA into a textual ally, a text that could support, back up and vindicate 
CMC's tale, is precisely Hong's consideration of multifactorality.35 On the one hand, if 
the argument is to be that Hong 'promoted' his Chlamydia hypothesis, then that is not 
at all supported by the words he actually wrote within CLA: is it likely, for instance, 
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that he would have presented both discoveries so equally in CLA if he had been 
'promoting' one of them whilst ignoring the other? On the other hand, if the 
argument is to be that Hong remained silent whilst others in China were putting 
forward their coronavirus claim, then neither is that argument at all supported by the 
words that Hong wrote within CLA: again, is it likely that he would have presented 
both discoveries so equally and given them such equal significance in CLA yet 
remained so silent about the coronavirus beyond the confines of the text? Would any 
microbiologist anywhere in the world have looked on so silently whilst other 
microbiologists started to suggest that the aetiological agent behind the SARS 
outbreak was the one s/he had identified weeks ago? The obvious answer to all of 
these questions is 'no'. 
Indeed, if CLA had been considered through a multifactorial lens, it would not have 
mattered whichever way Enserink wanted to turn, to trope, the text - Hong would have 
been ready and waiting with a plausible answer in order to send him back where he 
had come from.36 
CLA, however, was not considered through such a lens in CMC. Indeed, the way in 
which CMC deals with this epistemological obstacle can be captured if a distinction 
between discovery and aetiology is introduced. What CMC could not very easily deny was 
that Hong had found two pathogens. That was a question of discovery. A question of 
that which existed. But what could be denied by CMC, indeed what had to be denied 
by CMC, is any sense that Hong took both discoveries to be of equal significance. 
And that is a question of aetiology. A question of theory. For CMC's overall story of 
the 'good' microbiologists versus the 'bad' microbiologist to function effectively, Dr. 
Hong, as with those at the AMMS and the WHO SARS laboratory, had to have been 
working with a singular understanding of aetiology and a singular understanding alone. 
Only then could Dr: Hong be held up as the fall guy for an erroneous aetiological 
claim that held the international response to SARS up by weeks; only then could Dr. 
Hong's coronavirus findings be dismissed as irrelevant precisely because he had 
focused his attentions solely upon the Chlamydia bacterium. Considered through a 
singular lens, CLA became a textual ally for CMC. Whichever way Enserink wanted to 
turn, in other words, Hong was no longer ready and waiting for him, waiting to check 
his movements. 
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Dr. Hong's credibility, in other words, was inextricably entwined with his openness to 
the multifactorial. His actions make sense when considered in that kind of an 
aetiological light. But a credible Dr. Hong was precisely that which CMC could not 
incorporate. And in order to negotiate that particular epistemological obstacle, CMC 
stripped CLA of its multifactorial framing. The result was a piece of primary data that 
could subsequendy support, back up and vindicate CMC's overall textualisation of Dr. 
Hong as an inept scientist. And that is why I want to devote this final chapter of my 
thesis to the defence of Dr. Hong: to difend Dr. Hong is to difend the possibility of 
multifactorality. In the sections that follow, I want to look at the rhetorical strategies 
through which CMC's conviction of Dr. Hong was achieved. The first examination 
will be of the ways in which Hong was made to appear as if he had failed to spot the 
significance of the coronavirus discovery and was, in any case, pre-empted by the 
other groups; and the second examination will be of the ways in which Hong was 
made to appear as if had been obsessed, almost pathologically so, with his completely 
non-credible Chlamydia findingS. 37 
n. THE DISCOVERY OF THE CORONAVIRUS 
There is one other curiosity about CMC's formulation of CLA that needs some 
mention here. Every activity detailed within CLA, including Dr. Hong's discovery of the 
coronavirus, had taken place during mid-late February, 2003. But then, if this is the case, 
then surely Hong's coronavirus findings actually pre-empted both the AMMS group 
(by a few weeks) and the WHO-SARS group (by at least a month)? If the time period 
during which Hong's laboratory research took place is taken into account then Hong 
. can quite easily be cast in the role of scientific hero! Whether he had adjudged the 
coronavirus to be the one single cause or part of a synergistic causal process would, in 
such a casting, be deemed irrelevant - for he, and he alone, would have been the first 
microbiologist to have discovered it. The curious thing about CMC's interpretation of 
CLA, however, is that it possesses a number of rhetorical devices that serve to 
background, to turn the volume down on, just such a version of events. Consider the 
following extract from CMC: 
... Hong reported having found 'Chlamydia-like particles' in a total of seven patients. (In 
two, he also noted the presence of a coronavirus).38 
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Both sentences seek to represent a process of discovery. In order to capture that 
process, however, the former sentence deploys the resources of the English language 
in a way that differs slightly from the latter. This difference, though slight, is 
consequential, structuring and regulating the ways in which· the average European 
reader of Science is able to come to an understanding of Dr. Hong's actions.39 To make 
these rhetorical consequences a little more apparent I have broken these sentential 
units down into their constituent parts: Actor, Process and Goal:40 
Hong 
[Actor] 
Hong 
reports 
[Process 1] 
notes 
finding 
[Process 2] 
Chlamydia 
[Goal] 
Coronavirus 
In both, the Actor quite obviously remains as Dr. Hong. The Goals, too, remain 
similar - although differently named entities, they are, nevertheless, entities of a 
similar, pathogenic order. The real difference, the difference that makes a difference, 
is to be found when the Processes are examined. In the first instance, Dr. Hong 
'reports' on his engagement with Chlamydia. 'To report' is to perform neither a 
material nor a mental, but rather, a verbal action process.41 Considered as an action in 
and of itself, a report would involve a conscious being sensing a phenomenon before 
then making that which had been sensed known to others. But in this particular 
instance the report is a report that a pathogen had been 'found'. And this second 
process verb, 'to fInd', immediately implies that some kind of material action process 
had also taken place - a process of doing and not simply of verbalising. In order for 
Hong's 'report' to have become possible, he would have had to have made some kind 
of material contact with the bacterium through, say, a laboratory instrument. To fInd, 
in other words, is to found; to found a relationship, the Actor having at least a degree 
of human interest in the object found. In the second sentence, however, Hong 'notes 
the presence of' a coronavirus. To 'note' is to perform a mental process action. But 
unlike in the previous example, this process action is not followed up with a material 
process action. Hong, as a conscious being, simply notes the presence of a 
phenomenon before then making that which he had sensed apparent to others. No 
material contact with the coronavirus is implied in any of this. Whereas 'finding' 
might involve something akin to a Whiteheadian event, with both entities coming to 
188 I P age 
be changed through their interrelationship, 'noting' implies nothing more than a 
passing acknowledgment of one entity by a distant other.42 
Is this rhetorically significant? I want to suggest that it is. Dr. Hong himself, for 
instance, suggested in CLA that 'both Chlamydia-like and coronavirus-like particles 
were found by electron microscope'. Indeed, not once in CLA does he use the mental 
process verb 'to note' to describe his coronavirus-work. Apart from the electron 
microscope work in which he also 'saw' the coronavirus, everything revolves around 
material process verbs: to find, to amplify, to prepare [for PCR investigations], and so on. 
Even so, might it not simply be the case that Enserink, in switching from 'finding' to 
'noting', was trying to avoid repetition ('he found x, he also reported having found 
y ... )? Perhaps. But in this scientific court of appeal, ignorance of the (rhetorical) law is 
no defence (especially not for a science journalist like Enserink). Consider, for 
instance, the following extract, taken from Paul Simpson's (2004) Srylistics. It is 
situated within a more general discussion of material and mental process verbs: 
Unlike material processes which have their provenance in the physical world, mental 
processes inhabit and reflect the world of consciousness ... the entity 'sensed' in a 
mental process is not directly affected by the process, and this makes it of a somewhat 
different order to the role of Goal in a material process. (2004, 23 my emphasis) 
So does the act of 'noting' the presence of something indicate that a scientific 
discovery has actually been made? Perhaps not. Perhaps it suggests an action that 
teeters on the edge of not being a discovery at all. To 'note' is merely to acknowledge 
the presence of an object in passing, before then moving on somewhere else. It is, on 
Simpson's reading, to leave the entity 'unaffected' by the process. A scientist who 
notes the presence of something remains at a certain remove from that 'thing'. 
Another way to make the rhetorical significance of Enserink's lexical choices clear is 
to point to the culturally entrenched ways of using language in scientific writing. 
Scientists like Dr. Hong do not build their careers around 'notings;. They build them 
around 'findings'. Robert Koch, for instance, one of the greatest bacteriologists of all 
time, did not trope his discovery of the tubercle bacilli in 1882 as a noting. It was, for 
him, and for everyone who came to read of his work, a finding.43 The very language 
with which scientific work is usually described, then, makes the rhetorical force of the 
word 'noting' clear. At the very least, it is possible to suggest that a 'noting' does not 
suggest such a clear cut a discovery as a 'finding'. Many previous studies of rhetoric 
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have argued that different process verbs have different degrees of 'opacity' with 
respect to the ways in which they make explicit agency and intention.44 But here, in 
the case of CMC, it is not so much that human agency is being foregrounded or 
backgrounded. Something slighdy different takes place. Where CLA indicated that 
both the coronavirus and the Chlamydia findings were of equal ontological standing, 
leaving their status as discovered objects clear and uncomplicated, CMC erodes this 
sense of equality. And it does so via the use of process verbs that evoke differing 
levels of Actorial contact with, and interest in, the end-GoaL 
Backgrounding these process actions now, I want to throw something else into relief 
within this three-line section of CMC: the parenthesis. Consider the section once 
more: 
Hong reported having found 'Chlamydia-like particles' in a total of seven patients. (In 
two, he also noted the presence of a coronavirus which by then had been proven to be 
the cause of SARS).45 
Why is it there? What is its purpose? On the face of it, its stylistic significance seems 
clear. Approaching the extract at a very basic level of analysis, we can see that it serves 
to surround and completely cut off from the rest of the text the only reference that is 
made in CMC to the fact that Hong and his research team found coronavirus as well 
as Chlamydia. That 'Chlamydia-like particles' - in the plural- were found in all seven of 
Hong's samples is a point that is left outside the parenthesis. That 'a coronavirus' - in 
the singular - was noted in just two samples is a point that is placed inside the 
parenthesis. This, then, is what it does. But it is not at all clear why it is made to do 
what it does here. Indeed, the separation,is an especially curious one given that Hong's 
own research article goes out of its way to avoid making any such separation. The 
very tide of the article - 'Chlamydia-like and coronavirus-like agents found in dead 
cases ... ' - seeks to draw the two discoveries together. Further, in CLA's conclusions, 
their entanglement with one another is once again made clear: 
Since the novel Chlamydia-like agent was found co-existing with a coronavirus-like 
agent in the dead cases of SARS, it appears most likely that both agents play some role 
in the disease.46 
As if the clamps used by surgeons to stop up a patient's arteries during an operation, 
however, CMC's brackets cut off all links between the two discoveries. Again, 
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rhetorically, this is highly consequential. And although litde has been written about 
parentheses in rhetorical theory, the concept of enactment, taken from the field of 
stylistics, helps to make the rhetorical significance of this clamping operation a litde 
c1earer.47 The critical and stylistic assumption made by this concept is that literary 
forms can enact or mime the meanings they seek to express. So for instance in 
Dickens's Oliver Twist, a stylistician might note how the following passage seeks to 
enact movement, noise and confusion in and as a description of the actions of 
movement, noise and confusion: 
Away they ran, pell-mell, helter-skelter, slap-dash, tearing, yelling, screaming, knocking 
down the passengers as they turn corners, rousing up the dogs, and astonishing the 
fowls: and streets, squares and courts re-echo with the sound.48 
My argument is that CMC's brackets work, in this instance, to produce a similar effect 
in relation to Hong's scientific practice. They enact the 'cognitive brackets' that Hong 
must have placed around his coronavirus 'noting' in order to come to the fmal 
Chlamydia conclusion that he would end up 'promoting': Hong dismissed the 
aetiological significance of the 'noting', and thus the brackets enact the dismissal. 
Moreover, given what is placed inside - singular coronavirus fmdings - and what is 
placed outside - multiple Chlamydia findings - they start to look less like CMC's own 
interpretation, and more like a faithful attempt at enactment. The very presence of the 
parenthesis, the cognitive- brackets, is in this way granted an explanation. And 
although not perhaps entirely convincing to a reader with some first-hand knowledge 
of CLA, it is at least plausible: Hong'S context of discovery, it seems, was a context 
built around quantitative criteria.49 Fascinated by the Chlamydia-like particles, and by 
their abundance in relation to the coronavirus particles, Hong completely overlooked 
the aetiological significance of the latter. Through the use of the parenthesis, CMC 
generates a sense that, even if we can allow that Hong's coronavirus was a discovery 
rather than a noting, it was, nevertheless, a discovery that Hong himself regarded as 
secondary and unimportant in relation to Chlamydia. 
Things, it seems, could have been very different. And nowhere was this more so than 
when it came to the question of 'who was first?' CLA could quite easily have been' 
used to index the work of a scientific group that had managed, quite impressively, to 
pre-empt both the AMMS group (by a few weeks) and the WHO laboratory network 
(by at least a month). But Enserink manages not to treat CLA in this way. In fact, he 
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manages to treat it in quite the opposite way, with the result that Dr. Hong and his 
research team start to appear as the pre-empted scientists! So how is this reversal 
achieved? Consider the following extract one final time: 
In a paper in the 25 April National Medical JournalojChina, Hong reported having found 
'Chlamydia-like particles' in a total of seven patients. (In two, he also noted the presence 
of a coronavirus which by then had been proven to be the cause of SARS).50 
In the sentence immediately before the parenthesis the reader watches through 
Enserink's eyes as a research finding from CLA is summarised. According to Enserink, 
Hong used CLA to 'report' having found Chlamydia-like particles. In narratological 
terms, the focaliser here is Enserink, the focalised object the research article.51 At no 
stage during that sentence is there any possibility of observing the actual act of 
discovery. Because CLA, and not the laboratory work, acts as the focalised object, the 
reader is placed at a remove from the actual action. The result of this 'distance' is that 
a temporal lag is made to appear; a lag between the act of finding and the act of 
communicating a finding. At some point in the past, it seems, Dr. Hong had found 
'Chlamydia-like particles'. Then, at some point later on, he reported this discovery in a 
research article. But in actual fact there is no need for me to be so vague about the 
timing of all of this. For earlier in CMC Enserink has already made clear that the 
direct act of finding took place 'on 18 February'.52 And, as is clear from the extract 
presented above, the research article based on those findings was published 'in the 25 
April National Medical Journal of Chind. As a consequence, the article itself had to have 
been submitted for publication some time between '18 February' and '25 April'. 
So much is clear. But when we turn to examine the sentence that appears in the 
parenthesis, the identity of the focalised object seems a little unclear. The reason for 
this ambiguity is the lack of any reference to 'reporting', or indeed of any reference to 
an intermediary separating Enserink, our focaliser, from Hong's laboratory work. Is 
the focalised object Dr. Hong'S research article? Or his actual laboratory work? Is 
Enserink watching a report of Dr. Hong watching the coronavirus, or is he watching 
Hong watching the coronavirus? To me, the very fact that these questions can be 
asked at all admits the possibility of more than one structural interpretation of the text. 
In the clause prior to the parenthesis, for instance, such questions would simply have 
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made no sense: one knew, quite clearly, that the act of finding and the act of 
communicating the finding were temporally separate. 
For reasons that I hope will become clear, I want to proceed by playing up to my 
feeling that Enserink is indeed suggesting that he was there, watching Hong in his 
laboratory. As a result, when he writes that 'in two [samples] he ~lso noted the 
presence of a coronavirus', we are watching through Enserink's eyes as Hong notes, in 
two patient samples, the presence of coronavirus. The consequence of this immediacy 
is that any sense of a lag-time between the finding and the act of communicating the finding 
is lost. In classical rhetorical terms, we are no longer watching as Enserink 'tells' of 
something. Instead, we are watching as Enserink 'shows' us an act that appears to l?e 
fully-present-to-him. 53 
But, if this is so, what we need to ask now is when is Enserink's immediacy in this 
formulation? When is he watching Hong doing his noting? A clue can be found in the 
second-half of the sentence: 
In two, he [Hong] also noted the presence of a coronavirus which 1y then had been proven 
to be the cause of SARS.54 
The clue is the deictic marker 'by then,.55 It anchors Enserink, the focaliser, as he 
watches Hong. But if it was 'by then', then when was this 'by then'? Let us run 
through some of the dates that were mentioned above to try and answer this question. 
Was 'by then' the 18th February, the date when Dr. Hong found his Chlamydia-like 
particles? No. It cannot have been. Why? Because 'by then' has to suggest a date after 
the 16th April; that is, the date on which the WHO officially announced that the 
coronavirus was the causal agent of SARS. By implication, the only way in which 
Enserink's 'by then' could be referring to the 18th February was if it was somehow 
trying to suggest that Dr. Hong had, in some bizarrely schizophrenic manoeuvre, 
ro:anaged to pre-empt himself ('in two he also noted the presence of a coronavirus, 
which by then he had already discovered ... '). Let us reject this possibility. 
So what about the 25th April, the date on which the article was published? Before 
answering this question directly, let us imagine for a moment that I was wrong in 
playing up to my suspicion that Enserink had 'told' us of the Chlamydia finding, yet 
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'shown' us, very directly, of the coronavirus discovery. Let us imagine, instead, that in 
both cases he had been focalising Hong's research article. If this was so, then his 'by 
then' would have been a reference to the research article: 'by then [the 25th April when 
the article was published] .. .'. And yet, he surely cannot have been making such a 
reference. Why? Because in the case of Chlamydia he had already admitted that the act 
of finding took place on '18 February'. He had, in other words, already admitted that 
the act of finding took place before the WHO made their announcement on 16th April. 
Despite the· fact that the article had been published on 25 April, then, the Chlamydia 
findings had been made on 18 February. By implication, if the coronavirus discovery 
had taken place on or around that same day, or indeed at any point before the 16th 
April, then irrespective of the date when the article was published, Enserink would, logically, 
have had to have admitted that Hong had discovered the coronavirus, and thus pre-
empted both the AMMS and the WHO laboratory network. 
What I take from all of this sleuthing around is a proof that Enserink's 'by then' 
simply has to have been a reference to the coronavirus discovery, and the coronavirus 
discovery alone. What I also take from it is a certain confidence that my suspicions 
were correct: Enserink was indeed playing around with the difference between 'telling' 
and 'showing' in his reporting of the two discoveries. The coronavirus findings, 
Enserink would have us believe, were somehow conducted separately and apart from 
the Chlamydia findings. 
So, let us ask the question again and, this time, attempt a direct answer: was 'by then' 
the 25 April? No. For the coronavirus findings to have been made and published in a 
journal on the very same day would, of course, have been impossible. But we are, 
nevertheless, closer to the correct answer now. For there was in fact a little more time 
for Enserink to play around with in his reference to 'by then'. As I noted above, and 
by Enserink's own admission, Dr. Hong's article must have been submitted for 
publication some time between '18 February' and '25 April'. If the coronavirus 
discovery was already passe by the time the article appeared, then Hong's coronavirus 
discovery could only have been made in the nine days separating the 16th April and 
the 25th April. This, I want to suggest, is the when of Enserink's 'by then'. It is, I 
submit, the only possible way in which his reference to 'by then' could have made any 
sense at all. 
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Playing around with a direct focalisation strategy, placing the coronavirus results in a 
parenthesis, and appending those results with the deictic marker 'by then', Enserink 
was attempting to bring Hong's coronavirus work forward into a time when it is 
(was?) already passe. Indeed, this rhetorical strategy is aided by the fact that CMC has 
already suggested, three paragraphs beforehand, that Hong's Chlamydia 'hypothesis' 
was already 'well established' in China. The coronavirus discovery, we could easily 
start to suspect, was a 'noting' that came afterwards. And this effect, rather 
un surprisingly, does not allow Hong to appear as a very able scientist. Instead of 
representing 'the first scientist to discover the coronavirus', he now cuts a rather 
forlorn looking, buffoon-like figure. 'What,' we might conceivably ask based on a 
reading of CMC, 'was Hong doing dithering over the identity of the causal agent when 
'by then' everyone knew that the agent was, in fact, a coronavirus?' Might there also, 
then, be a more subde connotation here: that Hong, in pursuing this course of action, 
in remaining oblivious to the findings made in other parts of the world, had failed in 
one of the most basic of scientific tasks - keeping up with the current state of 
knowledge? 
If this is indeed what Enserink is suggesting, then it is nonsense. Even a cursory 
glance at CLA would make this apparent: all the laboratory work reported therein was 
quite clearly carried out at the same time: during mid-late February. Moreover, 
whatever else it does, CLA indexes the hard scientific labour that went into its 
production. As with the AMMS' work, cell lines were inoculated with materials 
derived from SARS patients, and electron microscope examinations, serological tests 
and polymerase chain reaction (PCR) tests were conducted. Even by Enserink's 
account, this work took Ruifu's team a full 12 days - from at least the 14th February to 
at least the 26th February. Yet CMC's 'by then' seems to be suggesting that Hong 
began his coronavirus work after April 16th. If this were so, then in the 9 days between 
April 16th and April 251\ Hong would have had to have done his experimental work, 
written a 5 page scientific report, had it peer-reviewed and then published in China's 
most prestigious science journaL Put like this, the suggestion starts to appear 
somewhat implausible. 
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IlL THE DISCOVERY OF CHLAMYDIA 
Throughout CMC, Enserink makes it quite clear that the source of the erroneous 
Chlamydia claim was Dr. Hong and Dr. Hong alone. At the beginning of the third 
paragraph, for instance, he notes that: 
At the time [that is, at the time when the AMMS were trying to put forward their 
coronavirus claim] the official line in China was that atypical pneumonia, as it was then 
called, was caused by a Chlamydia bacterium. 56 
And although no direct causal link is made between this 'official line' and Dr. Hong, 
the very next sentence reads as follows: 
Promoted by Hong Tao, an esteemed senior microbiologist and member of the 
Chinese Academy of Engineering, the Chlamydia hypothesis had become ... well 
established. 57 
Now, whether or not Hong did in fact 'promote' the hypothesis outside of his 
scientific publications is not the issue here. I would suggest that neither Enserink nor 
I can know with any certainty what Hong did or did not do outside of this publically 
available research work. The issue here has to do with the one piece of material 
evidence that both Enserink and I do have access to and do make use of: CLA. If 
Hong was so certain of his Chlamydia claim, if he 'promoted' that claim, then surely 
some of that certainty should be recoverable from this, the one research paper in 
which he reported his Chlamydia findings. 
And yet, I find it extremely difficult to read any such certainty into CLA. On my 
reading, Hong appears as the Mertonian, sceptical scientist personified.58 The kind of 
certainty that Enserink seems so confidendy to draw from it is nowhere to be seen. 
As I read it, Hong and his research team, having led the reader through a discussion 
of the ways in which the various samples were tested; having presented electron 
micrographs of both Chlamydia-like and coronavirus-like particles; and having 
presented the results of their PCR and serologic tests: after all of that, they then go on 
to note in their conclusions that: 
Since the novel ChlafJ!Ydia-like agent was found co-existing with a coronavirus-like 
agent, it seems likely that both agents play some role in the disease.59 
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And they also include one final, cautionary note: 
At the present time, however, it is not possible to determine whether these agents 
interact synergistically, or whether one follows another. This requires further study.60 
This, for me, is not the kind of article that can easily be made to stand in as proof that 
Dr. Hong indulged in any promotional work with regard to his Chlamydia findings. 
Nevertheless, Enserink manages to trope CLA in such a way that it does start to take 
on just such a role. What emerges from CMC is a sense that Hong claimed, definitivelY 
and unequivocallY, that Chlamydia was the aetiological agent. The suggestion that he 
'promoted' his hypothesis is confirmed by CLA's certainty, and, conversely, CLA's 
certainty serves to explain why he was able to 'promote' his 'hypothesis'. A vicious 
circle is established - a circle from which Dr. Hong cannot escape. 
So how was this achieved? One particularly crucial rhetorical device occurs in the 
following sentence: 
Hong therefore proposed that the agent was a new type of Chlamydia, but others 
suggested that it may have been something different altogether.61 
What is Enserink focalising here? In the fIrst half of the sentence, up until the comma, 
the focalised object is CLA. Indeed, given that a passage in which Enserink writes of 
the 'paper in the 25 April National Medical Journal of Chind marks the beginning of the 
paragraph in which this information is included, it might seem safe to assume that this 
object remains the same throughout the paragraph (though this, as we shall see later, 
is not such a safe assumption to make). Reading this fIrst half of the sentence we 
watch through Enserink's eyes as he reads Hong's 'proposal' that one of the agents 
discovered was a new type of Chlamydia. As a gloss on Hong's own words, this 
passage undoubtedly displays a degree of hyperbole. In CLA it is merely noted that: 
Since the Chlamydia-like agents visualized in both organs and cell cultures did not react 
with the genus specific antibodies against Chlamydia and monoclonal antibodies against 
C. pneumoniae and C. psittaci, the results might well be suggestive of a novel 
Chlamydia-like agent,62 
Clearly, then, Hong's modalising clause - 'might well be suggestive' - is replaced by 
something more forceful - the verbal process action of 'proposing,.63 Nevertheless, 
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CMC does manage to communicate a sense that Hong had broached the idea that 
these 'Chlamydia-like particles' might be suggestive of a new strain of Chlamydia. But 
note: this suggestion has nothing to do with the aetiology of SARS. It is a passing 
observation that the discovery might have been the discovery of a hitherto unknown 
pathogen. Neither CLA, nor the first half of the sentence from CMC, suggest 
otherwise: questions of discovery and questions of aetiology are kept entirely separate. 
At this stage in the discussion, however, it is interesting to look beyond the comma, 
and analyse the second half of the sentence from CMC: 
... but others suggested that it may have been something different altogether. 
Who are these 'others'? In CLA, zero textual space is given over to the comments and 
claims of any 'other' scientists. At no stage during the text does Hong (or his research 
team) suggest that the 'Chlamydia-like particles' had been studied by others, and that, 
subsequently, those others had reached the conclusion that the 'particles' in question 
might not, in actual fact, represent 'Chlamydia-like particles'. I can only conclude, then, 
that those 'others' were not to be found within CLA. And if they were not to be 
found within CLA then this suggests that Enserink was not actually focalising CLA 
during the latter half of the sentence. In fact, what I want to suggest is that the 
'others' in question here are the scientists from the AMMS and the WHO network 
who had already been mentioned in CMC. A paragraph earlier, for instance, as 
Enserink had made clear, these were the 'others' who 'had dismissed the Chlamydia 
idea almost out of hand'. But then these 'others' were, at the time, looking for the 
aetiological agent of SARS: they 'dismissed the Chlamydia idea almost out of hand' 
precisely because they did not think it was the aetiological agent behind SARS. What 
this means is that their object of focalisation, and, by implication, the object that 
Enserink is making reference to in the second half of the sentence, is no longer 
Chlamydia as a discovered pathogen. The 'it' referred to by these 'others' is not the same 
object as the 'agent' referred to by Hong in the flrst half of the sentence. Enserink 
effectively places two separate groups together, and together in the same sentence. 
The object they refer to appears to be the same. But it is not. Hence, whilst the latter 
group appear to be chiding Hong for his mistake, the two groups are, in fact, simply 
talking past one another. This is an extremely subtle rhetorical trick, and one that only 
becomes clear when CLA is read" alongside CMC: whilst Dr. Hong asks 'is this a new 
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pathogen, something that might not have been discovered before?' the 'others' suggest 
'it is not the aetiological agent behind SARS!'. We can perhaps imagine Hong, had he 
been allowed to reply, suggesting that he had never said that it was. But of course, he 
is allowed no such right of reply. 
This shift in focalisation strategy, then, manages to confuse two separate objects. We 
move from a question of discovery - Hong's 'agent - to a question of aetiology - the 
others' 'it. In the first half of this sentence, we find the only reference that is made in 
the entire article to Hong's discovery claim. Yet the sentence ends with a reference to an 
'it' that dominates every other line of CMC: the aetiological agent behind SARS. This, to 
me at any rate, seems a bizarre and wholly unfair way to gloss Hong's article (in 
sociological terms, it is akin to treating the following sentence as a damning critique: 
'Foucault proposed that the subject is traversed by lines of disciplinary power, but 
many secondary school children suggest that it varies depending on the lesson that 
they are in'). What it effects, however, is an alteration in the way in which the clause 
'Hong therefore proposed that the agent was a new type of Chlamydia' can be 
understood. Within this one single sentence, a great deal of rhetorical work is 
achieved: Enserink's suggestion that Hong proposed a Chlamydia bacterium as the 
aetiology of SARS, is subdy confirmed, whilst, at the same time, that proposition has its 
credibility stripped away. And all the while of course, Hong is being made to 
participate in the destruction of his own reputation. 
There is one final point that I wish to make here in this section. For even in a world in 
which a coronavirus, and not a Chlamydia bacterium, had been accepted as the cause 
of SARS, it did not necessarily have to follow that the Chlamydia findings reported in 
CLA were 'wrong' or 'implausible'. Reading through CLA, I get a sense that Hong's 
Chlamydia findings were entirely plausible, built as they were around solid scientific 
work. Indeed, relying on my own knowledge of the microbiological sciences, I can 
fully understand why Hong might have seen a Chlamydia bacterium as significant: 
Chlamydia pneumoniae is, after all, one of the most common causes of severe atypical 
pneumonia worldwide. And yet CMC does not seem to see CLA in this way. In fact, it 
ends up troping CLA's account of the work that went into the discovery of Chlamydia 
in a very curious way. Consider the following extract. I have broken it down into its 
four constituent sentential units: 
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1. Hong reported having found 'Chlamydia-like particles' in a total of seven 
patients ... 
2. . .. But he was not able to actually isolate the microbe or characterise it 
further, and Chlamydia was not found in most SARS samples. 
3 .... Moreover, antibodies to known Chlamydia species did not react with the 
tissue samples ... 
4 .... Hong therefore proposed that the agent was a new type of Chlamydia.
64 
In the first sentence, a positive statement is made. Something with an existence, 
however precarious, had been discovered. In the second and third sentences, however, 
a total of four negative pieces of information are provided. A list of problems, in other 
words, sutured together via a chain of adverbs and conjuncts (seven in total, 
emboldened above). There were, it seems at this stage, serious problems with Hong's 
positive discovery. CMC, we might suppose, is building towards something negative. 
And yet, the fourth and final sentence suddenly becomes hyper-positive. We move 
from the weakly positive, through a list of negatives to this, the hyper-positive 
statement that: 'Hong therefore proposed that the agent was a new type of Chlamydid. 
The adverb 'therefore' is interesting here in that it subtly ties this hyper-positive 
conclusion to the negative information that preceded it. Hong, it seems, did not just 
do the process action of 'proposing': he 'therefore' proposed. And he 'therefore' 
proposed based on a list of negative information that he himself had accumulated. 
Between the third and the fourth sentences stands the intermediary of Hong's 
cerebral powers. Indeed, thanks to Enserink, and his presentation of Hong's 
evidential basis, the reader of CMC is granted an opportunity to assess Hong's powers 
of reasoning. 
But if that opportunity is taken, however, it becomes extreme!J difficult to understand 
those powers as anything other than disappointing. Despite all of the problems, all of 
the negative findings, Hong somehow manages to propose that he has discovered a 
new pathogen. Whereas we might therefore have proposed to go back into the 
laboratory and start again, Hong appears to have achieved a 'discovery', the hardest, 
most technical of all microbiological tasks. An entire context of discovery, it seems, 
was built around his not being able to see or isolate or characterise the something 
being discovered. What I would suggest is that this juxtaposition serves to render the 
Chlamydia claim non-credible. In its most basic sense, juxtaposition simply refers to 
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the placing of elements side by side. But the term can also refer to a rhetorical 
technique which goes beyond the straightforward placement of communicative 
elements next to each other. In this more specialised sense, juxtaposition combines 
together: 
Two or more communicative elements so as to suppress the connections between 
them and emphasise the differences, thereby provoking some surprise or puziJement at their 
close placement. (Montgomery et al. 2000, 172). 
Placing a list of negatives findings next to this hyper-positive discovery proposal does 
indeed create some 'surprise' or 'puzzlement'. And in this particular case the surprise 
and puzzlement stems from the fact that although we are able to re-enact the 
discovery for ourselves, we do not feel that we should: we see the evidence laid out before 
us on the page, and yet we struggle to reach the same conclusions as Hong. 
Fair enough, one might think. 
But is it a fair and reasonable juxtaposition to be making? 
I would argue not. The presentation is, in at least two ways, highly problematic. First 
of all, it contains some very basic factual inaccuracies and errors. The first piece of 
negative information - 'but he was not able to actually isolate the microbe' - is, quite 
simply, incorrect. Even the most cursory of glances at CLA reveals that Hong was 
indeed able to isolate the microbe, cultivating the Chlamydia particles on Vero 293 cell-
lines. Consider, too, the second piece of negative information - 'Hong was not able to 
characterise it further'. This is simply another way of wording the negative 'fact' that is 
included as the final piece of negative information - 'antibodies to known Chlamydia 
species did not react with the tissue samples'. CMC, however, clearly treats them 
separately, the adverb 'moreover' appearing to suggest that the fourth and final piece 
of negative information was different, and additional, to the first three. Yet as CLA 
makes quite clear, serological tests were the only rapid diagnostic tests available at the 
time to help in attempting to characterise the particles further. Writing that it proved 
impossible to characterise them further is thus the same thing as writing of 'antibodies 
to known Chlamydia species not reacting with tissue samples'. 
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The second inaccuracy is this: what is it, precisely, that Enserink is formulating when 
he suggests that Chlamydia was not found in most SARS patients? What is he 
presenting to us? Is it still Hong's article? I would suggest not. For if Enserink is the 
focaliser then when he writes 'and Chlamydia was not found in most SARS patients' he 
has subdy shifted his gaze. The focalized object is no longer the article, but is, in fact, 
the SARS outbreak taken at a global level. To write that 'Chlamydia was not found in 
most SARS patients' is to state something that is true only if we move our gaze away 
from Hong's paper and view the situation globally. For this is not at all what Hong 
himself found. He had 7 samples, and of those 7 samples, 7 were found to contain 
Chlamydia. As far as his article was concerned, Chlamydia was found in all of his 
samples! Yet when Enserink writes ' ... and Chlamydia was not found in most SARS 
patients' we are in the middle of a passage, and indeed a sentence, which takes as its 
focalized object, the article written by Hong. The logical thing for a reader to suppose 
would be that this object would remain constant throughout the sentence. But Enserink 
actually shifts his gaze mid-sentence, before then returning, in the next sentence, to 
the article itself (' ... Moreover, antibodies to known Chlamydia species did not react 
with the tissue samples'). The effect is akin to that of DNA splicing in recombinant 
gene technologies. One hardly notices. Again, the effect of these shifts in the focalized 
object is subde, allowing Enserink to introduce even more modalising clauses into his 
formulation of Hong's Chlamydia findingS.65 We start with a focalization of one object, 
shift to another, and yet are led to believe that no shift of gaze ever took place. And as 
a consequence, another negative piece of information is heaped upon Hong's article, 
allowing it to appear even weaker, and even more problematic. 
There is of course' a question here to do with CMC's credibility. Can we really trust 
this report if it is so lax with such basic details? But perhaps more importandy in this 
court of appeal is the effect that this negative list has on the reader's understanding of 
Hong's cerebral powers. Would it have been so easy to dismiss Hong, and to dismiss 
his Chlamydia work if the formulation of that work had been as follows? 
Hong reported having found 'Chlamydia-like particles' in a total of seven 
patients ... Having seen these particles via ultra-thin electron microscopy he and his 
research team succeeded in isolating them on Vero 293 cells. Recognising the 
cytopathic effect caused by Chlamydia on Vero 293 cells, serological tests were 
performed. That the isolated particles did not react with genus specific antibodies to 
known Chlamydia strains, led Hong to suggest that the agent might well have been 
suggestive of a new species of Chlamydia. 
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I would suggest not. 
IV. THE LOST POSSIBILITY OF MULTIFACTORALITY 
It would have been relatively easy for CMC to have used the information stored 
within CLA, its one piece of hard, material evidence, in order to paint a picture of Dr. 
Hong as a scientific hero, the microbiologist who had first laid eyes on the coronavirus. 
And yet CMC's actual formulation of CLA managed to do something quite different. 
Recoverable from CMC, for instance, are, at the very least, the following set of 
impressions: that Dr. Hong's discovery of the coronavirus had in fact teetered on the 
brink of not being a discovery at all; that Dr. Hong had thought of the coronavirus-
like particles as less significant than the Chlamydia-like particles; and that Dr. Hong 
had, in any case, been pre-empted by other groups. The creation of these impressions 
required a great deal of rhetorical effort, far more so than would have been required in 
order to trope Dr. Hong as a quasi-heroic figure. 
So why expend such effort? Because it was effort that allowed Enserink to protect 
CMC's overall story. In order for that story to work, there simply had to be a 
character like Dr. Hong present in order to make the (patendy) false Chlamydia claim. 
Granted, CMC could have represented Dr. Hong as the microbiologist who saw the 
coronavirus before anyone else, just as it could have represented him as a 
microbiologist who had taken the coronavirus' presence in patient samples just as 
seriously as that of his other discovery, Chlamydia. But then, if it had, the idea that Dr. 
Hong, having made both discoveries, would subsequendy have 'promoted' his 
Chlamydia hypothesis whilst completely ignoring his coronavirus hypothesis, would 
have started to seem a litde less believable. At the very least it would have been an 
idea requiring of some further explanation. And that, of course, was precisely the kind 
of 'further explanation' that Enserink, relying solely on the evidence presented in CLA, 
would have been unable to provide. 
This kind of an explanation is strengthened if the ways in which Enserink dealt with 
Hong's Chlamydia discovery are summarised. Again, it would have been relatively easy 
for CMC to have used the information stored within CLA, its one piece of hard, 
material evidence, in order to paint a picture of Dr. Hong as a scientist who had made 
a plausible discovery of a Chlamydia like agent in samples from patients suffering from 
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severe acute pneumonia but had then refused to draw any hasty conclusions regarding 
its aetiological significance. But again, CMC's actual formulation of CLA managed to 
do something quite different. Recoverable from CMC, for instance, are, at the very 
least, the following set of impressions: that Dr. Hong was convinced that his 
Chlamydia discovery represented the cause of SARS; that Dr. Hong's laboratory work 
was of highly dubious quality; and that Dr. Hong had ignored the fact that many, 
many others thought he was wrong. Again, the creation of these impressions required 
a great deal of rhetorical effort, far more so than would have been required in order to 
trope Dr. Hong as a plausible scientist. But if that is so, then why even attempt to 
suggest that the Chlamydia discovery was in some way non-credible? After all, even if 
Dr. Hong had been thinking in terms of singular aetiology, it surely did not have to 
follow that the Chlamydia discovery waS in some way inadequate as an aetiological 
claim? And yet, in CMC it did have to follow. The troping of the Chlamydia discovery 
as inadequate allowed for the overall narrative of CMC to survive. Granted, Hong 
could have been represented as a scientist making a plausible discovery of Chlamydia. 
But if there had have been two equally plausible discoveries emerging out of two 
equally solid scientific programmes, then CMC's tale of the obviouslY false discovery 
produced by the obviouslY ill-thought out programme, versus the obviouslY true discovery 
produced by the obviouslY well-thought out programme would have started to seem a 
litde less believable. At the very least it would have been an idea requiring of some 
further explanation. Arid that, once again, was precisely the kind of 'further 
explanation' that Enserink, relying solely on the evidence presented in CLA, would 
have been unable to provide. 
Perhaps the most important effect of CMC's refusal to treat either Hong'S 
coronavirus discovery as significant and timely, or his Chlamydia discovery as plausible, 
however, has to do with the way in which it turns the volume down on the possibility 
of multifactorality.66 The basic ingredients are still there, still fully present in CMC, for 
Dr. Hong, the microbiologist who had sought to think about the possibility of 
multifactorality: we, as readers, can see that two separate pathogenic discoveries had 
Gust about) been made. But Dr. Hong was no longer present, and no longer waiting 
to interpret their significance for us in CMC. He had in fact been refused entry into 
the text from the very outset. And, in his place, masquerading as Dr. Hong as it were, 
appeared a character intent on thinking only in terms of singularity: was it the 
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coronavirus causing SARS? Orwas it the Chlamydia? Again, we, as readers, are still able 
to see that two separate pathogenic discoveries had Gust about) been made, but only 
now, thanks to this impersonator, we lose sight of the possibility of multifactorality. 
v. REPETITION AND EMBELLISHMENT 
One final question is this: what happened to CMC after it had been published? For if 
the fate of Enserink's account was in the hands of later readers then so too was Dr. 
Hong's reputation. If CMC had been read and cited by only a few, then its portrayal 
of this Chinese microbiologist would have made little impact on our understandings 
of the 2003 SARS outbreak. But the fact is that CMC quickly became an 'obligatory 
point of passage' for subsequent accounts. As of April, 2009, for instance, I have been 
able to find some eighteen scientific research papers that cite CMC. And whilst it is 
not that unusual for scientific research papers to cite popular scientific texts, the fact 
that all eighteen of those papers did so approvingly, elevating a work of "popular 
science" to the status of "definitive historical account" is perhaps a litde unusual. 
What we find in these accounts is a form of repetition, as in the following research 
article, written by a research team from the Institute of Medical Virology, Frankfurt, 
Germany, and published in the Journal of Clinical Virology: 
Almost nobody knew at that stage that virologists in Beijing had already discovered a 
new virus in samples from some of the earliest SARS patients. However, the official 
line in China at the time was that the novel "atypical pneumonia" was caused by 
Chlamydia (Enserink, 2003).67 
As might be expected in a scientific research article, actors and their actions are 
backgrounded, whilst broad processes come to the fore. In this sense, Dr. Hong is 'let 
off the hook'. And yet, what I find so striking here is the citation strategy. If the 
metaphor of the 'official line' catches your eye; if it hints at some kind of scientific 
malpractice, then you have a reputable source to turn to in order to find out more 
about this episode: 'China's Missed Chance' written by Enserink (2003). But what 
about Dr Hong's own research article? Despite the fact that this German research 
team were writing an article of a similar order to Dr. Hong's - i.e one that discussed 
primary scientific knowledge - they eschew any reference to Hong'S primary research 
article in favour of a popular science article that glosses it. This same strategy is at 
work in each of the eighteen research articles: an approving and unquestioning 
citation of CMC, yet no citation of Dr. Hong's research article. There is something 
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else to bear in mind here too. For when the number of citations received by those 
eighteen research articles are added together, a total of four hundred and seventy-
eight citations is generated. At the very least, then, it is possible to suggest that whilst 
all four hundred and seventy-eight of those citing articles would have come into 
contact with CMC as a "definitive historical account", none would have learnt 
anything of CLA, that definitive historical account's primary source. 
But what about popular and semi-popular science accounts? How ·did they engage 
with and appropriate CMC? In a sense, they were the accounts that really mattered in 
mediating an understanding of the 2003 SARS outbreak. As mentioned earlier in the 
chapter, for most of us today the reality of something like SARS-Co V comes to us not 
through articles in the Journal of Virology, but rather, through the filter of journalistic 
language and imagery.68 As with the scientific research articles discussed above, a 
common strategy of engagement and appropriation was repetition: each article, or 
book, citing CMC approvingly, and ignoring CLA. The one difference is that here, in 
the world of popular science, the character of Dr. Hong is suddenly the centre of 
attention: 
The fact that the national CDC, the body at the apex of China's disease-fighting 
infrastructure, had announced that Chla"!}dia was the causal agent made it difficult for 
anyone else to challenge this finding publicly despite private doubts. Once Chlamydia as 
the causative agent for SARS became the official truth, no questioning of this theory or 
discussion of more plausible causes was possible. The fact that a senior microbiologist 
at the CDC. Hong Tao. had been responsible for identifying ChlamJldia made it even 
more difficult for other researchers to challenge this finding. (Abraham 2004, 123-
124).69 
But in these articles, another form of appropriation is also apparent, one that could 
perhaps be described as embellishment. Consider the following three extracts, drawn at 
random from the literature:7o 
1. In mid-Februaryl the Institute of Virology also in Beijing, under China's national 
CDC received two lung tissues ... the samples were then divided into three parts: one 
for Hong Tao, the CDC's chief virologist and CAE member to conduct an electron 
microscope examination, one for virologist U Dexin to run the polymerase chain 
reaction (PCR) testing and the third for bacterium cultivation purposes. Hong soon 
claimed, after examining it under the electron microscope. that it was Chlamydia - a 
bacterium notorious for being the pathogen of a common sexually transmitted disease 
which is not generally fatal - that was the cause of the atypical pneumonia. Cao (2004, 
262-286 my emphasis) 
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2. A senior local scientist maintained that chlamydiae [sic] bacteria had caused the 
outbreak. The theory was so prevailing that it proved inhibiting in a culture of 
deference to authority and seniority. When scientists in Beijing identified a new virus in 
late February, they chose not to say anything about it. (Balasegaram and Schnur 2006, 
211 my emphasis) 
3. The medical community's understanding of the true aetiology of SARS was delayed 
significantly by a February announcement from a senior scientist at the Chinese Centre 
for Disease Control that he suspected the infectious agent was Chlamydia - a commonly 
understood bacterial agent that would not have warranted heightened concern of 
investigation. (M:ahmoud et al. 2004,4 my emphasis) 
Gone from extract 3, for instance, are any references to Chinese institutions and 
organisations: the CCDC, the Chinese Ministry of Health, and so on. It is now Hong, 
and Hong alone who is responsible for the false claim. As the all powerful, yet totally 
inept superman, a line of moral responsibility can now be drawn, leading straight from 
this 'senior scientist' to the 'significant delay' in the 'medical community's' attempts to 
get to grips with the outbreak. And as with extract 1, even the identity of Hong's 
Chlamydia-like particles are now characterised in such a way as to make him appear 
ridiculous. In extract 1, for instance, we are able to laugh at a 'fact' that the cited 
source, CMC, never mentions: Hong's conviction that a sexually transmitted infection 
could have caused an outbreak of upper respiratory tract disease. And yet the joke, I 
would suggest, is on Cao, the author of this particular account. For there is more than 
one Chlamydia 'bacterium'. Hong, in CLA, merely refers to the viral family 
Chlamydiaceae, of the class Chlamydiae. Included within this family are two genera: 
Chlamydia and Chlamydophila. The species Chlamydia trachomatis, which causes Cao's 
sexual problems (urethritis, proctitis, trachoma, and so on), is only one of three 
Chlamydia species, and only one of the nine species included within the overall family 
Chlamydiaceae. In CLA, Hong never mentions Chlamydia trachomatis. But he does 
mention Chlamydia pneumonia and Chlamydia psittaci, species which are both known to 
. lik illn 71 cause pneumorua- e ess. 
And finally, consider extract 2. Here, Dr. Hong even has his place of work and his 
geographical location within China manipulated! Dr. Hong, the local doctor from the 
provinces appears, in this extract, to be holding up the AMMS, the big city research 
group from Beijing. To me, this account immediately called to mind the 19th century 
France of Flaubert's Madame Bovary. Conrioted is a sense that Hong, just like Emma's 
husband, Charles, was not quite good enough, medically speaking, to find a job in the 
capital city. Despite the fact that the embellishment is factually incorrect in Hong's 
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case, its rhetorical significance is clear. For does it not provide a peifect explanation for 
the errors of Hong's aetiological work? Where Charles' attempt to operate on a 
clubfooted patient was bound to end in failure, so too was Hong's attempt to discover 
the aetiological agent behind SARS bound to fail. And just as a better doctor 
eventually had to step in to perform an amputation on Charles' patient, so too did 
better scientists eventually have to step in to clear up the mess made by Hong Tao. 
It is these repetitions and embellishments that perhaps represent the real tragedy for 
Dr. Hong, and, of course, for the possibility of multifactorality that he so 
courageously held up. Where CMC at least allowed the reader to catch sight of Hong's 
double finding - coronavirus and Chlamydia-like particles - these accounts do not. 
Foregrounded in each and every case, and in some cases with an almost sadistic 
pleasure, is the Chlamydia discovery and the Chlamydia discovery alone. In CMC one 
could still hear the faint murmurings of a reasonable scientist considering the 
possibility of multifactorality. But here, in these texts, that scientist has fallen silent. 
As things solidify, they solidify in the shape of the singular. And as Hong's reputation 
slides ever further into the scientific gutter, with it goes almost all hope of reclaiming 
the possibility of multifactorality. 
VI. CONCLUSIONS 
In this chapter, I have sought to defend Dr. Hong in a hastily assembled scientific 
court of appeal. I have, in short, been looking for justice. Have I found it? Well, I 
have made clear the transformations that Dr. Hong's account of his own actions 
underwent at the hands of others. And I have also made clear the extent to which 
those subsequent accounts can, with a litde rhetorical effort, be called into question. 
That, however, is all I have been able to achieve. Put more accurately, it is all that I 
could have achieved. For the jury in this court is you, dear reader.72 Have I convinced 
you? Is Dr. Hong to receive a reprieve? A pardon, perhaps? His fate, remember, is 
now in your hands, not mine. 
His fate; but perhaps the fate of others too. For if the issue of multifactorality is 
momentarily placed to one side, there is a more general question that can be asked: 
were the rhetorical transformations, appropriations, repetitions and embellishments at 
work in this one localised instance unusual? Having rested my case, having had some 
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time to reflect on this question, I would suggest not. But then, if this is so, it raises an 
interesting (rhetorical) question, and one that I want to leave you with: who would bet 
against there being plenty more Dr. Hongs out there; that is, scientists of all kinds, 
from all eras and all corners of the world, lost in a textual purgatory and in need of 
sociological salvation? 
The French and German medical teams arrived in Egypt in August 1884. Both were fully 
expecting to find the cholera germ. They worked independently, and what amounted to a 
race to discover the cause of cholera began ... After a time, the Germans learnt that the 
French were packing up to go home. Gaffsky, in alarm, asked Koch if the French 
commission had found the cholera bacillus, and they decided to ask Roux and Thuillier if 
they could examine their specimens. On doing this they realised, late the same night, that the French 
had mistaken blood platelets, which are normallY present in the blood, for the cholera bacillus .. . In May 
1885, Koch returned to a hero's welcome in Berlin ... Lister was some years later to say 
that nothing had been more striking that "Koch's own brilliant discovery of the cholera 
microbe - picked out with unerring precision from among a multitude of bacteric 
forms"J3 
Anyone? 
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Notes 
1 The direct quote here is from an article written by the Pulitzer Prize winning 
journalist Laurie Garrett. 'A Chinese Lab's race to ID and halt SARS' appeared in the 
26th July edition of Newsweek in the United States. Ostensibly, it tells of the race to 
identify the aetiological agent behind SARS in China. But, therein, the star of the 
chapter I am about to write, Dr. Hong Tao, appears as a total and utter buffoon: 'On 
Feb 15 a minute sample arrived [in Tao's laboratory] - 50 microlitres of scrapings 
from an infected lung. Dr. Hong Tao, the group's microscope expert, examined it and 
concluded the killer microbe was a bacterium that is common in China, Chlamydia. For 
weeks. Hong would examine sample after sample. always reaching the same Chlamydia 
conclusion' (ibid., my emphasis). For now, let us take Garrett's account at face-value; 
let us accept that Dr. Hong was a buffoon. Hopefully, however, as my chapter unfolds, 
it will be possible for you, the reader, to return to this extract with a far more sceptical, 
dis-believing attitude ... 
2 To write of a 'post-epidemic period', however, is not stricdy correct. Since 
October 2004, when the WHO updated all of its SARS-CoV recommendations and 
guidelines, they have being using the term 'inter-epidemic period'. As is explained in 
the WHO SARS' Risk Assessment and Preparedness Framework (2004b), for instance, 'this 
framework and related documents use the term 'inter-epidemic period' rather than 
'post-epidemic period' because of the ongoing uncertainty about whether the world 
will experience another multi-jurisdictional epidemic of SARS' (ibid., 8). Rather 
soberingly, we are only ever 'two or more epidemiologically linked "preliminary 
positive" and/or "probable" and/or "confirmed" cases of SARS' (ibid., 9) away from 
a new epidemic outbreak of SARS. 
3 SARS' 'failure to re-appear', that is, if we ignore several instances of human 
infection that have resulted from laboratory accidents. According to the WHO's 
Guidelines for the Global Suroeillance of SARS (Updated recommendations) (2004a), 'since July 
2003, there have been four occasions when SARS has reappeared. Three of these 
incidents were attributed to breaches in laboratory biosafety and resulted in one or 
more cases of SARS (Singapore, Tapei, and Beijing). Fortunately, only one of these 
incidents resulted in secondary transmission outside of the laboratory. The most 
recent incident was a cluster of nine cases, one of whom died, in three generations of 
transmission affecting family and hospital contacts of a laboratory worker' (ibid., 6). 
And, specifically on the laboratory transmission in Beijing, see Lim et at. (2004). 
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4 The reference to a 'research front' is a nod to Harry Collins' (1987) point that 
perceptions of certainty in science (and, in this case, medical microbiological science) 
typically depend on one's 'distance from the research front' (ibid., 692): the closer one 
gets to the centre, the messier things appear. 
S The distinction between stable 'fact' and controversial 'thing' is a standard one 
within science studies (see Latour 1999; and also see Ashmore 2005). Here, though, it 
is the very brevity of SARS' time as a controversial 'thing' which lends to the event its 
uniqueness. I myself have not been able to find, in the post 1945 era, any infectious 
disease epidemics that have had such global significance, been so quickly controlled, 
and then ... vanished. 
6 For a history of the HIV -AIDS controversy, see Epstein (1996). 
7 I have in mind here Hayden White's ([1974]1978) understanding of 
'emplotment' as 'the operation' via which 'mere chronicles' are turned into historical 
'stories'. By "emplotment he meant 'simply the encodation of the facts contained in the 
chronicle as components of specific kinds of plot structures' (ibid., 83). In terms of 
popular science histories, however, perhaps better terms than 'chronicle' and 'story' to 
explain this difference are those he goes on to use in the remainder of that particular 
article: 'story-elements' and 'story'. For instance: 'no given set of casually recorded 
historical events can in itself constitute a story; the most it might offer to the historian 
are story elements. The events are made into a story by the suppression or 
subordination of certain of them and the highlighting of others, by characterisation, 
motific repetition, variation of tone and point of view, alternative descriptive 
strategies, and the like - in short, all of the techniques that we would normally expect 
to find in the emplotment of a novel or a play' (ibid., 84). 
8 For the notion of the 'obligatory point of passage' see Latour (1987, 1988). 
9 This is to paraphrase a sentence from Ashmore's (1993) study of the 'N-ray 
affair' of 1904 (an affair in which an American physicist, R.N. Wood, 'exposed' the N-
Rays that the famous French Professor Rene-Prosper Blondlot claimed to have 
discovered as nothing more than a fiction. Glossing the paper's aim of producing and 
warranting 'a far more sceptical version of the debunking of N-rays than has hitherto 
existed', Ashmore writes: 'to put it very starkly, I am looking for justice!' (ibid., 70). 
10 Having automatically and unthinkingly typed 'a character who .. .', the automatic 
spellchecker function on Microsoft Word informed me that, grammatically, I was in 
error. According to the spellchecker the correct word would have been 'that' and not 
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'who'. Yet I have stuck with the humanising 'who'. My sense of duty towards Dr. 
Hong outweighed any sense of duty that I might normally have felt towards 
grammatical correctness. To paraphrase Carl Schmitt, the textual order, like every 
other order, rests on a sovereign decision and not on a norm. I am the sovereign of 
this text, and I cannot, will not, refer to his textual representation as a non-human 
'that'. See Schmitt's Political Theology (1988, 10). 
11 Perhaps the strongest suggestion of 'blame' and 'moral responsibility' came from 
Adel Mahmoud and his colleagues. Because of Hong's aetiological claim, they suggest, 
'virologists in a Beijing laboratory refrained from announcing their discovery in early 
March of the SARS Co V, a decision that set back by weeks research on the disease 
and a more significant public health response in China' (Mahmoud et al. 2004, 10). 
12 Here I am paraphrasing David Bloor in Knowledge and Social Imagery: 'Sociologists 
would be putting themselves where their critics would, no doubt, like to see them -
lurking around the discarded refuse in science's back yard' ([1976]1991, 30). 
13 Martin Enserink specialises in infectious diseases, biodefense and science policy. 
His writing carries a significant degree of epistemic authon!J in the world of popular 
science writing (on the concept of epistemic authority in science studies, see Gieryn, 
(1999». According to his website, for instance, he is a regular contributing 
correspondent for the weekly journal Science. In addition, he writes frequent columns 
for Intermediair, a weekly general magazine in the Netherlands, for Bionieuws, a 
publication of the Dutch Institute for Biologists (NIBI), and for Foreign Poliry, the 
flagship publication of the Carnegie Endowment for International Peace in 
Washington, D.e. 
14 Enserink (2003, 295, para. 1). On each of the occaSions that I cite 'China's 
Missed Chance' over the next few paragraphs, I include, along with the page number, 
the number of the paragraph from which the extract has been taken. This is for ease 
of 'retrieval' should anyone wish to get hold of Enserink's article themselves and keep 
it to hand whilst considering what I have to say about it. In order to ease the 
experience of reading this text, however, I have decided to relegate these references to 
the footnotes. 
15 Ibid., p. 18. 
16 Ibid. 
17 Ibid., p. 295, para. 19. 
18 Ibid., p. 294, para. 5. 
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19 Ibid., p. 295-296, para. 19. 
20 Ibid., p. 294, para. 3. 
2t Ibid., p. 294, para. 4. 
22 Ibid., p. 295, para. 14. 
23 Ibid. 
24 Ibid., p. 294, para. 4. my emphasis. 
25 Ibid., p. 295, para. 15. 
26 Ibid., p. 296, para. 21. 
27 Ibid., p. 296, para. 24. 
28 That is, 'fairly standard' given the claims made by those who study popular 
science writing: 'many popular science books promote a version of science that is 
contrasted starkly with the 'other' of science - or at least the 'other' that popular 
science writers want to identify - namely, foolishness' (Erickson 2005, 148). And also 
see Schnabel (2003): 'there is a tendency in the press to report about science in a very 
positive, even ecstatic way. In fact, there are two types of exaggeration. Scientists are 
either described as heroic figures, that bring 'God's formula' down to earth. Or they 
are portrayed as some form of fallen angel, whose science has turned into something 
evil and frightening - which is the devil's contribution to the story of scientific glory' 
(ibid., 255 my emphasis). 
29 At this point, it is perhaps worth noting that when I write of Hong's article, I am 
in fact referring to Hong-and-the-twenry-other-CCDC-researchers-who-co-wrote-it's article (see 
Hong et al. (2003)). For the article was quite clearly the end product of a research 
team's laboratory work. In CMC, however, Hong doesn't appear to have a research 
team behind him. In fact, at every moment that he appears, he is isolated and alone: 
he thinks alone, he proposes alone, he discovers .... alone. Why is this? Though I have 
no time to develop this point in any great detail here, it is briefly worth considering 
what Woolgar (1988) has to say about the rhetorical importance of the 'collective' in 
scientific practice: 'the invocation of community, a concept which is important in 
downgrading the contribution of any particular individuaL .. the invocation of these 
other witnesses to the knowledge (object) enhances the objectivity of this knowledge. 
It is not the idiosyncratic production of particular individuals, but a widely recognised 
(and hence objective) state of affairs' (ibid., 76 my emphasis). 
30 Hong's research article is readily available through the U.S. National Library of 
Medicine's online database, Pubmed. Having purchased a copy of the article from the 
213 I P age 
British Library, I did, however, have to have it translated from Chinese into English. 
The strategy I am pursuing here, in which I will read a document that someone else 
has already read and sought to gloss, comes close to the method of analysis advocated 
by discourse analysts such as Jonathan Potter and Margaret Wetherell. The key 
concept for them in their analyses is 'variability'. In order to foreground the 
significance of the stylistic and rhetorical choices on display in anyone particular text, 
they look to generate a 'constant variable'. And, usually, a primary piece of data is 
made to play that role, allowing the analyst to go on to note the analytically observable 
difference, the variability, between two sets of literature that deal with that one piece 
of primary data (see for example, Wetherell and Potter 1988). 
31 Ibid., p. 295, para. 15 my emphasis. 
32 Given that this paper is effectively playing the role of a 'hearing' within a 'court 
of scientific appeal', I will make no excuse for this shameless attempt to instruct the 
reader on how to read Dr. Hong's abstract. On the importance of coding schemes 
and highlighting practices during attempts to organise and structure the perception of 
a jury during a courtroom battle, see Charles Goodwin (1994; and, also of interest are 
1995, 1996, 1997,2000,2001; and also see Goodwin and Goodwin 1996). 
33 For reasons of space, I have presented just the abstract from Hong's article. 
Nevertheless, it does summarise quite nicely what is reported within the article itself. 
And although I make some reference to the main body of CLA later on in the 
discussion, I do, for the most part, stick very closely to the information included 
within this abstract. 
34 'Seems difficult'? Well, it seems difficult to me at any rate. And I can only excuse 
this 'particularism-masquerading-as-a-universalism' by citing the following passage 
from Wittgenstein's On Certainty (1969[1989], §2): 'from it seeming to me - or to 
everyone - to be so, it doesn't follow that it is so. What we can ask is whether it can 
make sense to doubt it'. 
35 The phrase 'epistemological obstacle' is being used metaphorical& here. It derives 
from the work of the French epistemologist Gaston Bachelard (in French, it should 
be noted, the term 'pistemologie' has a narrower connotation than the cognate English 
term, its meaning being closer to 'philosophy of science' than to 'theory of 
knowledge,). For Bachelard, scientific development centred on the notion of an 
'epistemological break'. The development of science as science required a founding 
break from the assumptions and positive power of common-sense experience and 
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beliefs. Any newly developing SCience would generate new' scientific concepts, 
showing objects to possess properties not hitherto revealed. But any such 'break' 
could never guarantee its own purity: irruptions of the non-scientific, the common-
sensical, even those now outdated and supplanted scientific concepts, were a constant 
threat, blocking the path of inquiry. As such, these 'epistemological obstacles' had to 
be removed from the problematic of the new science (see Bachelard's The New 
Scientific Spirit (1984); also Bachelard's The Philosophy of No (1968); for a useful summary 
of Bachelard's historical epistemology, see the first chapter of Gutting's Michel 
Foucault's Archaeology of Scientific Reason (1989); and Dews (1995, 39-58)). 
36 The word trope derives from tropikos, tropos, which in Classical Greek meant 
'turn'. It came into modem European languages by way of tropus, which in Classical 
Latin meant 'metaphor' or 'figure of speech'. The idea that both Enserink's and my 
own purportedly factual accounts are 'tropic' in this particular sense stems from a 
reading of Hayden White's work on historical interpretation. For him, the work of 
producing a factual historical account requires the same kind of literary skill as the 
work of producing a fictional tale (see White ([1974] 1978, and see footnote 7, above). 
37 On the idea of the 'bad scientist' and/or 'pathological science', see Barber (1961), 
Langmuir (1989), Rousseau (1992), Simon (2002). 
38 Enserink (2003, 295, para. 15). 
39 What do I mean by average? The concept is, I acknowledge, almost impossible 
to defend. Nevertheless, what I intend it to suggest here are those non-Chinese 
speaking individuals who, firstly, would have read CMC in the 18th July edition of 
Science, but then secondly, would not have purchased a copy of Dr. Hong's original 
article or had it translated from Chinese into their own first languages. 
40 My approach in this section represents a basic form of transitivity analysis. 
Transitivity forms the very heart of representation. As Sara Mills has argued, 'the 
study of transitivity is concerned with how actions are represented; what kind of 
actions appear in a text, who [or what] does them and to whom [or what] they are 
done'. The crucial point about transitivity is that it has rhetorical effects: 'in producing 
texts there are a range of choices to be made, and every text which has been produced 
could have been produced differently' (Mills 1995, 143-144). This kind of analysis 
helps me to foreground the choices being made in CMC. The distinction between 
Actor, Process and Goal is drawn from Simpson (2004, 22-23); and also see Simpson 
(1993, 88). Overall, however, my analysis has perhaps been most influenced by 
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Deirdre Button's (1982, 195-214) seminal feminist-stylistic analysis of Sylvia Plath's 
The Bell Jar. 
41 The distinctions made in the following argument, between material, mental and 
verbal action process, are drawn from the field of stylistics. Although there are other, 
different types of verbs that are normally taken into account in such stylistic analyses 
(existential and relational process verbs, for example); and although material action 
processes can be further broken down into a number of sub-categories (action and 
event processes, transitive and intransitive processes, and so on) (see Simpson 2004, 
185-186): despite all of these complexities, however, the simple distinctions made here 
enable me to foreground the transitivity choices being made in my own particular 
object of study: CMC. 
42 For a recent engagement with A.N. Whitehead's philosophy of the event, see 
Bruno Latour (1999); and also Halewood (2005, 2008); and also the 'special section on 
Whitehead' in Volume 25 of Theory, Culture and Society (2008). 
43 See for example Koch ([1882]1961). 
44 In particular, see Potter's analysis of the construction of factual descriptive 
accounts (1996); also Marlin's analysis of 'intention-promoting' verbs (1984, 26-29); 
and also see Coulter (1983). 
45 Enserink (2003, 295, para. 15). 
46 Hong et al. (2003, 636). 
47 On the lack of attention to the rhetorical force of the parenthesis in modern 
literary theory, see Williams (1993). 
48 This particular example of enactment is taken from Wales' A dictionary of stylistics 
(2001, 125). 
49 The distinction between a context of discovery and a context of justification was 
central to logical positivist philosophy, and to the belief stemming from this 
philosophy that philosophy had a priori authority vis-a-vis the empirical sciences. The 
sciences, or empirical inquiry more generally, set about discovering how the world 
might be, but whatever the results of those inquiries, they had to be submitted to the 
sovereign judgement of philosophy to be warranted as valid or justified knowledge 
(on these points, see Zahar 1983,243-261; and Siegel1980, 297-321). Although this 
distinction has been discarded in nearly all post-Kuhnian studies of science, the idea 
of a 'context of discovery' is still quite a nice metaphorical way of capturing something 
of the hard epistemic work involved in scientific knowledge production. 
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50 Enserink (2003, 295, para. 15). 
51 The concept of focalisation stems from the idea that all stories are presented in 
a text through the mediation of some 'prism', 'perspective', 'angle of vision'. In any 
study of focalisation, then, the key question is: who sees? Or, as Michael Toolan puts 
it, 'who is the immediate seer here, and whose is the "zero-point" for time 
measurement here, to whom we attribute the spatiotemporal orientations we are 
given?' (roolan 1997, 63). Initially formulated by Genette (1980), the concept has 
been developed and taken in many different directions by subsequent theorists (see 
for example, Bal's ([1985]1997) discussion of the levels of focalisation; also Rimmon-
Kennan's ([1983]2002) typology of the facts of focalisation). Here, however, and in 
order to pursue my own research, I have made a basic distinction between a focalising 
subject and a focalised object (and on this basic distinction, see Toolan 1997, 61). 
52 Enserink (2003, 295, para. 12). 
53 The classical distinction here is between 'diegesis' and 'mimesis'. As Wales (2001, 
109) has noted, although the word diegesis means 'narrative' in Greek, Plato's interest 
in The Republic Bk. III is in poetic language, and in the mode of its narration: either by 
'telling' (the poet as narrator) i.e. diegesis; or by 'showing' (in the persona of another 
character, by another's speech), i.e. mimesis. 
54 Enserink (2003, 295, para. 15). 
55 For a general discussion of the rhetorical force of deixis see Wales (2001, 99). 
For more detailed discussions, see Benveniste (1971). 
56 Enserink (2003, 294, para. 3). 
57 Ibid. 
58 On Merton's norms as rhetorical resources, see Prelli (1989). 
59 Hong et al. (2003,632). 
60 Hong et al. (2003, 632 repeated on 636). 
61 Enserink (2003, 295, para. 15). 
62 Hong et al. (2003, 632). 
63 On the various techniques of 'modalisation' deployed in scientific publications, 
see Latour (1987, 22-26), and Woolgar (1988). 
64 Enserink (2003, 295, para. 15). 
65 On 'modalisation' techniques, see footnote 63, above. 
66 The trope of 'turning down the volume' is to be found in Clarke and Montini 
(1993). 
217 I P age 
67 Berger et aL (2004, 13-22). 
68 Heroe I am paraphrasing Dorothy N elkin, Selling Science: how the press covers science 
and technology (1987, 1). 
69 Abraham's Twen[y-first Century Plague: the Story of SARS (2004) is the only full 
length popular science book I have been able to fInd that deals exclusively with the 
SARS outbreak. 
70 For similar accounts, however, see Eckholm (2006), Enserink (2004), Garrett 
(2003), Hsieh (2003), Huang (2004), Kaufman (2006), the articles in Koh, Plant and 
Lee (2003), Lee et aL (2006), and Saich (2006). 
71 See, for example Everett et al. (1999) 'Emended description of the order 
Chlamydiales, proposal of Parachlamydiaceae fam. novo and Simkaniaceae fam. nov., each 
containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, 
including a new genus and fIve new species, and standards for the identifIcation of 
organisms', in the International Journal of Systematic Bacteriology. 
72 That is, if I still have any readers left at this stage ... hello? In fact, if there is 
anyone still out there, then I should point out that only those who have struggled 
through the text in its entirety can be swom in as jurors. Sorry. 
73 This particular telling of 'the race to discover the pathogen responsible for 
causing Cholera' is taken from C. and P. Barlow's biography of Robert Koch (1971, 
81-104). It appears in a number of other texts too (see for example, Thomas Brock 
(1988); and David Knight (1963)). I have to say that personally I fInd it extremelY 
diffIcult to believe that this is actually what happened. Could some of the most able 
scientists in the world at that time really have mistaken platelets - platelets! - for 
bacterial life forms? Interesting here too is the fact that Thuillier, one of the members 
of the French team who had studied those very same samples, fell ill and died shordy 
afterwards. The cause of death? Yes, you've guessed it: cholera. And what of the act 
of debunking itself? Given that these tellings had already 'laid it on' somewhat about 
the rivalry and competition between the French and the German groups, is it possible 
to believe that Robert Koch would have been allowed such easy access to the French 
samples? And why 'at night'?! Who was there with him? Who confIrmed his 
suggestion that the Vibrio Cholerae colonies were in fact 'platelets'? And why, come to 
think of it, do we not get to hear of what the French group thought of Robert Koch's 
impertinent suggestion? 
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The vanishing of multifactorality 
SARS-Co v, the last great modern infectious disease? 
To articulate the past historically does not mean to recognise it 'the way it really was'. It 
means to seize hold of a memory as it flashes up at a moment of danger. Every image 
of the past that is not recognised by the present as one of its concerns threatens to 
disappear irretrievably. (Benjamin [1940]1999,255) 
During the first few months of 2003, there was a definite possibility that a 
multifactorial understanding of the aetiology of the infectious disease SARS could 
have developed alongside a singular understanding. That possibility, however, never 
became real. The original judgement handed down by medical microbiologists to the 
possibility of multifactorality stated that the SARS outbreak had been caused by CoV 
and Co V alone. And, by implication, the judgement also ruled against the possibility 
of SARS having been, even if only in part, a multifactorial disease. In this thesis, 
having cast myself in the role of defence lawyer for the possibility of multifactorality in 
a hastily assembled court of scientific appeal, I have sought to recover the possibility 
of multifactorality from the 2003 SARS outbreak. The aim in doing so has been to try 
and generate a modicum of reasonable doubt regarding the original medical 
microbiological ruling that multifactorality was an impossibility. Re-called to the court 
in order to defend their original testimonies were the main witnesses for the medical 
microbiological prosecution: the continuous cell-culture (in chapter 3), 'Koch's 
postulates as modified by Rivers for viral diseases' (in chapter 4), the diagnostic 
technology ELISA (in chapter 5), and Martin Enserink's popular science article, 
'China's Missed Chance' (in chapter 6). During my cross-examination of those 
witnesses I was decidedly not even-handed. And deliberately so: my strategy was to 
probe away at them from a multifactorial perspective, picking holes in their testimony 
and seeking out moments during which the seemingly solid, seemingly unquestionable 
judgement that they helped to pass might, perhaps, have been slighdy weaker, and 
slighdy more questionable than any of them would have cared to admit. 
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And it is at this stage, here, in the final chapter of the thesis that I would like to make 
my closing summations to the court. 
The presidingju.dge gavels the court into session ... 
1. SARS AND THE VANISHING OF MULTIFACTORALITY 
So, have I managed to generate a modicum of reasonable doubt? 
Or, put another way, can it now be suggested that the loss of the possibility of 
multifactorality was the end-result of active forms of medical microbiological 
management and negotiation? 
Based on the close ethnomethodo10gica1 readings pursued in previous chapters, I 
want to suggest that 'yes', it can; that the denial was indeed the end-result of active 
forms of management and negotiation. But for this answer to hold any 
epistemological weight at all it immediately needs to be qualified. For what became 
clear during the performance of those readings was that the possibility of 
multifactorality was not, in fact, a possibility at all in each and every one of the 8,096 
WHO confirmed cases of SARS. In the majority of cases it seems that CoY, and CoY 
alone, was indeed the aetiological agent responsible for causing primary infection. 
What this qualification implies is that if, in the introductory chapters, I leaned too 
heavily towards the idea that the possibility of mu1tifactorality might have been 
present in all cases, then I was wrong to have done so. In Popperian terminology, my 
initial 'hypothesis' has been falsified by the readings subsequendy performed. But then 
again, maybe the Popperian terminology of falsification is not quite as appropriate 
here as the Quine-ian terminology of the undetermination of theory by data. For there 
is something in the initial hypothesis that can be saved if its totalising ambitions are 
kept in check.1 Earlier in this paragraph I wrote of how: 
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In the majority of those [8,096 WHO confinned] cases it does indeed appear likely that 
Co V, and Co V alone, was the aetiological agent responsible for primary infection. 
To write of a 'majority' is not, of course, to write of 'total coverage'. And rightly so. 
For what also become clear in the performance of those four case-study chapters was 
that a significant minority of the 8,096 confirmed SARS cases had displayed evidence 
of some kind of co-infection: each case within that minority had been infected with 
Co V and, at the same time, infected with at least one other pathogen. What is more, and 
irrespective of whether that 'other' pathogen was of bacterial (for instance, Chlamydia 
pneumonia, Chlamydia psittact~ Mycoplasma pneumoniae, Legionella, etc.) or viral (for 
instance, human metapneumovirus, adenovirus, respiratory syncytial virus, 
parainfluenza, influenza A and B, and Rotavirus A, etc.) origin, each was known to 
cause acute pneumonia-like infection. In previous chapters it was often with the 
recognition of this significant minority that it became possible to identify and to 
recover moments during which the possibility of multifactorality was actively being 
managed and negotiated. 
But then, when is a minority a significant minority? For medical micro biologists faced 
with the task of investigating an infectious disease outbreak, significance is measured 
in terms of case numbers over time.2 So could the minority I am troping as significant 
potentially have become significant for medical microbiologists? Ultimately, because 
of the singularity-creating power of ELISA, the diagnostic technology that 
retrospectively tested SARS cases, finding either 'positive SARS-Co V' cases, or 'non-
positive SARS-Co V' cases, there is no way to answer this question definitively: all 
8,096 cases are now understood, quite simply, as 'positive SARS-CoV cases'. 
Singularity reigns supreme. Nevertheless, some plausible attempts at estimating the 
size of that minority can be made. The first such attempt is based on the initial, pre-
ELISA, laboratory findings. There, and perhaps only there, it is possible to find 
reports of co-infections. In the cohorts from which patient samples were taken and 
then used in order to perform continuous cell-line culturing (chapter 3), 'Koch's 
Postulates as modified by Rivers for viral diseases' (chapter 4), and the laboratory 
findings that were at the heart of 'China's missed Chance' (chapter 6), the percentage 
figure that kept cropping up for co-infected cases was never lower than 2 - 3%, but 
actually went as high as 23% in one cohort from Hong Kong (Lee et aL 2004), 44% in 
a cohort from Canada (poutanen et aL 2003), and, of course, 100% in Dr. Hong Tao's 
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Guangdong cohort (Hong et aL 2003). If each of those cohorts is combined and an 
average percentage figure taken, then around 5 - 15% of cases in that 'meta-cohort' 
are classifiable as 'co-infected'. And if such a meta-cohort can be taken as 
representative of all cohorts from which the 8,096 confirmed cases derived, then it 
would follow that somewhere between 405 and 1214 of those confinnedcases had 
been co-infected, and hence, had held up the possibility of a multifactorial disease. 
But there is also one other plausible way to try and work out just how significant that 
significant minority was. It is useful to try it out here too in order to see how closely 
its results approximate to those presented in the previous paragraph. To recall what 
was suggested in chapter 4, at the time of the outbreak a number of reports regarding 
outbreaks in Hong Kong, Canada, Singapore, and Vietnam began to appear. Therein, 
the identification of hMPV among patients with suspected or confirmed SARS-Co V 
infection was reported. Human metapneumovirus, the reports concluded, had been 
'co-circulating' with CoY in those countries during early 2003. From a series of 
aetiological studies published by research teams in those afore-mentioned countries, 
290 retrospectivelY tested cases can be accumulated. Of that number, a total of 86 were 
found, either by cell-culture or serologic testing, to have been co-infected with Co V 
and hMPV. In percentage terms, this figure represents 29% of the 290 retrospectively 
tested cases. If that sample can be accepted as representative of the total number of 
2,307 confinned cases of SARS-CoV infection in those countries (Hong Kong: 1,755; 
Singapore, 238; Canada: 251; Viet Nam: 63), then it follows that around 669 cases 
(19%) were actually co-infected. 
So based on one plausible attempt to quantify that minority, a figure of between 405 
and 1214 cases emerges, whilst on another attempt the figure to emerge is 669. In 
both cases we are talking, potentially, about 5-15% of the 8,096 cases having been co-
infected. Even at the lower end of this scale, at around say 400-500 cases, the rapid 
rate at which they emerged would have warranted some epidemiological concern. As 
an outbreak, or distinct series of mini-outbreaks, it would, in other words, have 
represented a significant object of interest for medical microbiologists. Indeed, in 
relation to the idea of a series of 'mini-outbreaks', what the direct presentation of 
these 'co-infected' figures serves to make clear is not simply that there was this definite 
possibility of a complex, multifactorial situation having arisen, but that it was a 
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possibility with a definite and distinctive shape. Established in this way is an image of a 
number of smaller, multifactorial disease outbreaks that could, perhaps, have been 
developing at the same time as a larger, singular disease outbreak. This 'shape' can be 
represented diagrammatically as follows: 
A -------------------------------------------------------------------------------------------------------------- A 
A --------------- A 
.A --------------------- .A 
A--------A 
The top line indicates the total number of SARS-Co V cases, whilst the second, third 
and fourth lines indicate the possibility of a number of simultaneous, and co-factorial 
outbreaks caused by SARS-Co V and hMPV or SARS-Co V and Chlamydia pneumoniae 
or SARS-CoV and ... and so on and so forth. But then, if this was so, if there was a 
possibility of a multifactorial disease in a significant minority of SARS cases that never 
came to be explored, then what form did the management and the negotiation of that 
possibility actually take? That is, how did we end up with the ability to see only the 
top line in the diagrammatic representation above, and never the second, third and 
fourth lines? 
Deletion and vanishing 
What I want to try and develop whilst answering this question is a figure of speech 
capable of capturing the broad process of management and negotiation at work both 
during, and after, the SARS outbreak. 
The first metaphor that I began playing around during the research process was 
deletion, as understood within the discipline of medical genetics. It was a phrase I had 
come across whilst studying the work of microbiologists who had been seeking to 
understand the evolution of the SARS-Co V genome.3 In the textbook Medical Genetics 
(Sack, 1999), for instance, we learn that: 
Any changes in the chromosomal complement of an individual imply aberrant amounts 
and/or control of critical genetic information ... relatively simple changes within 
individual chromosomes include the loss or reorganisation of part of a chromosome. 
The loss, termed a deletion, is the physical absence of some region, notable by a change 
in the length of the chromosome. (ibid., 71 my emphasis) 
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In any such process of deletion, a portion of genetic information is, quite literally, lost. 
As an entity, a thing, it is destroyed. Annihilated. The following diagrammatic 
representations of genetic deletion make this process of destruction visibly apparent. 
The important point to note here is the way in which, between stages (A) and (C) in 
the diagram, the number '2' of the upper 'parent strand' disappears: 
FI;. t., Dl~r;l"mati' 
te-,)I'~ef'tlIrQn ofho>." ~'Ipr~ 
tor'Jl1d misp.1trir'g ('~II?pagl"j 
(A) 
(S) 
F'.1ft'nt 
~--CCt-'--8----ITJ---'- w~111~ 
~p!k..ltIOI1 
"" 
~:~:~ C;1::;:II~~~~r~~\H {C} --8--CD-EJ--[IJ-
i!'ll~ft"l'IC~rard{t!)Ct\.J'W'\" 
dt"leoor'l. IkJbt,hng Ne i<'\1 
da.<.IshlH itu.nd would Ie~ [.0 
ilf'inwrtiorl. 
Figure 1: Taken from the textbook Medical Genetics (Young 2005, 11) 
Initially, it seemed to me that the 'tenor' here, the management and negotiation of 
multifactorality, could be understood quite nicely through the 'vehicle' of deletion.
4 
Consider, for example, the close textual reading of 'A novel coronavirus associated 
with severe acute respiratory syndrome' (Ksiaszek et aL 2003) in chapter 3. Therein, it 
was made clear that despite a multitude of different laboratory technologies having 
been at play during Ksiazek's work of discovery, all were in fact dependent on just 
one single technique: the continuous cell-culture. Delving into the technical details of 
the paper what I sought to foreground were the ways in which the practice of cell-
culturing actually coerced singularity into existence: from the initial gathering of patient 
samples, to the final observation of the cultured cell-line, a number of technical 
virological practices were deployed in order to enact a singular pathogen, isolated and 
alone. Was this not, then, a form of deletion, the continuous cell-culture enacting a 
singular object, whilst at the same time deleting any hint of a multifactorial object? 
Certainly, what the techniques sought to destroy was any 'contamination'; that is, 
anything that might have been of interest from a multifactorial perspective. Again, 
224 I P age 
. consider the Koch's Postulates experiments that were placed in the research spotlight 
during chapter 4. Perhaps more so than anywhere else, it was there that the metaphor 
of deletion should have seemed most appropriate. For what emerged from a ferocious 
cross-examination of those postulates was a sense that, right from the initial 
manipulation of the content of the postulates (in order to make human/animal 
disease comparability the most crucial of Koch's Postulates) through to the final 
conduct of the hMPV and Co V tests (in which, fIrstly, the hMPV inoculums, unlike 
the CoY inoculums, did not derive from patients who had fallen ill during 2003; and 
secondly, in which human/animal comparability in hMPV infected macaques was 
treated in a different manner to human/animal comparability in Co V infected 
macaques) the possibility of multifactorality was actively avoided. 
But was any of this really best understood as deletion? I had my doubts. Looking 
again, and this time more carefully, at the close textual readings performed, it became 
apparent (to me at least) that very little was actually being deleted, if deletion is 
understood to imply some form of destruction or annihilation. After all, if all hints of 
the multifactorial had been deleted, then what would there have been left for me to try 
and recover? So no, it seemed to me that the metaphor of deletion was not quite right; 
that something more subtle had been at play during those active processes of 
management and negotiation. 'What is not present, but also not quite not present?' As 
if the Sphinx's riddle, it was a question I had to answer, and answer more effectively, 
in order to proceed along my way. 
And gradually, it was the metaphor of 'vanishing', a word often associated with the art, 
or the act, of the magician and the conjurer, that began to displace 'deletion' in my 
mind as the most appropriate answer to this riddle. Deletion implies a 'zero~sum' 
game, in which something that once existed has now been deleted and is, as a result, 
non-existent. In this sense, deletion comes into close contact with the constructivist 
theme in science studies that 'things could have been otherwise'; that alternative 
constructions of reality might have been possible once upon a time before reality 
resolved itself into singularity. Vanishing, the art or the act of vanishing, on the other 
hand, seems to depend more upon the ability to take something that exists, and then 
to create the illusion of non-existence. According to the Oxford English Dictionary, for 
example, to vanish is: 
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To disappear from sight, to become invisible, esp. in a rapid and mysterious manner: a. 
With awc!y; occas. with addition of out of or from sight, etc. 
Unlike deletion, as a form of destruction and annihilation, what this definition 
suggests is that to vanish something is not necessarily to render it non-existent, but 
rather, to 'disappear it'; to remove it 'from sight'. And in that sense, it is a metaphor 
that comes into far closer contact with the theme that I have sought to work with, and 
alongside, throughout this thesis: 'things are [not] otherwise'. What this juxtaposition 
of the present and the past tense is designed to suggest is that even after the SARS 
outbreak had resolved itself into singularity, both aetiological objects were possible. The 
ability to vanish the multifactorial in effect translates as the ability to vanish the square 
brackets around the word 'not' but without necessarijy destroying or annihilating them. 
Interestingly, it is not a science studies scholar, but rather, a historian, Marilyn Ivy, 
writing in Discourses of the Vanishing: modernity, phantasm, Japan (1995) who best captures 
the sense of vanishing that I have in mind.s Therein, she notes how 'an organising 
theme' of her study was an understanding of: 
The vanishing, which (dis)embodies in its gerund form the movement of something 
passing away, gQne but not quite. suspended between presence and absence. located at 
a point that both is and is not here ... The vanishing can only be tracked through 
attentiveness to the politics of displacement. (ibid., 20 my emphasis) 
Returning to the case-study chapters armed with this metaphor, there was more to be 
said about the active forms of management and negotiation on display there. Consider, 
for instance, the 'purification process' involved in continuous cell-line culturing. Prior 
to inoculation of a continuous cell-culture, this process involved the collection, 
storage, transportation and preparation of a sample. But despite the antibiotics, the 
sterile solutions, the centrifuges, the ether and the filters, all of which were designed 
specifically to remove anything but viral particles; and despite the standardised storage 
conditions (rapidly freezing potentially labile viruses to -70C or lower prior to 
transportation) that could, potentially, have removed as yet unknown, or labile viruses: 
despite all of this, it is (I would hope) very difficult to read that particular section of 
chapter 3 and then conclude that multifactorality had been deleted, in the sense of 
being rendered non-existent, rather than vanished, in the sense of being rendered 'out 
of sight'. Why? Because everything that would have been required in order to explore 
the possibility of its existence or its non-existence - the bacterial forms, the 'normal 
flora', other viruses, and so on - was simply removed prior to inoculation. In this 
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sense it is fair to say that the question of multifactorality's existence or non-existence 
never received a fair hearing. It was not, in fact, deleted but simply vanished: the illusion of 
non-existence was created, behind which the issue of multifactorality, its possibility, 
never actually had to be setded one wqy or the other. As I have pointed out on a number 
of occasions during the previous chapters, for instance, if I cannot definitively exclude 
the possibility of multifactorality during the outbreak, then crucially, neither can Dr. 
Stohr, Dr. Ksiazek, Dr. Osterhaus or a'!Y other of the medical microbiologists involved in the 
aetiological investigations into SARS. 
Again, and as one final example here, think of the Koch's Postulate experiments from 
chapter 4. According to Dr. Osterhaus' own formulation it appeared that the 
possibility of some kind of multifactorial disease - a 'double aetiology' - had initially 
been considered as a real possibility. Singulari!J, involving one virus and one virus 
alone, and multifactorali!J, involving 'synergy' and 'interaction' within a viral 
'assemblage', were being considered alongside the idea of a quasi-singulari!J, in which 
one virus would have acted first, before another, acting parasitically, would have come 
along and exacerbated the infection. The comparability experiments in the macaque 
monkeys were deliberately designed to ascertain which of these aetiological 
possibilities was 'the one'. They were set up in such a way that 'sets' of monkeys were 
infected either with the coronavirus (Co V) or with a human metapneumovirus 
(hMPV). A third set were infected ftrst with coronavirus and then with 
metapneumovirus. Represented diagrammatically, the experiment was set up as 
follows: 
Macaques set #1: Co V infected 
Macaques set #2: hMPV infected 
Macaques set #3: Co V and hMPV infected 
Again, represented diagrammatically, with an 'X' representing macaque disease 
comparable to human SARS disease and an '0' representing macaque disease non-
comparable to human SARS disease, the results were as follows: 
Macaques set #1: Co V infected - X 
Macaques set #2: hMPV infected - 0 
Macaques set #3: CoY and hMPV infected - X 
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The conclusion that Osterhaus and his research team reached as a result was that: 
The coronavtrus alone is capable of causing the typical symptoms. (WHO 2003m, para. 
28) 
But where had the possibility of a 'double aetiology' gone during all of this? Put 
simply, the comparability postulate had removed it as a possibility. For the fact that 
hMPV had not produced comparable disease; the fact that 'four [postulates] had been 
fulfilled for CoV and only three for hMPV' (ibid.), did not just mean that CoV was the 
agent responsible for causing SARS in patients who had been infected solely with 
Co V. Look again at the diagrammatic representation: 
Macaques set #1: Co V infected - X 
Macaques set #2: hMPV infected - 0 
Macaques set #3: Co V and hMPV infected - X 
In sets 1 and 3, the signs and symptoms were identical. In set 1 'the animals infected 
with the coronavirus alone developed full-blown disease. They developed SARS, they 
developed clinical symptoms, and they also developed the pathological lesions that are 
identical to what we have seen in people who have died from SARS' (ibid., para. 26). 
And in set 3, 'the third group of animals, first infected with the coronavirus and then 
super-infected with the metapneumovirus, did not develop more serious disease' (ibid. my 
emphasis). The only thing that could have altered the outcome in set 3 as compared to 
set 1, the only independent variable as it were, was the hMPV inoculum. But it did not 
alter the outcome. And, in this way, the additional inoculation of hMPV in set 3 was 
made to become visibly Insignificant. Because of the way in which these experiments 
had been set up, hMPV could, quite literally, be seen to be adding nothing. to the Co V 
infection. The very fact of the '0', in combination with the two identical 'X's', rendered 
the possibility of multifactorality invisible. Note that word, however: invisible, not 
deleted. For as I made clear on a number of occasions during chapter 4, if the tests 
had been carried out with a little more attention to the possibility of multifactorality, if 
they had not been weighted so heavily towards the discovery of singularity, then the 
possibility of multifactorality might have appeared once more. That is the important 
point. Under different conditions, say, if temporally comparable inocula had been 
used in each set of macaques; if similar normative standards had been applied in each 
set; if the importance of 'comparability' had been backgrounded vis-a.-vis serologic 
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results; and if the results of subsequent replication experiments had been taken into 
account: if all of those conditions' had been met, then the act of vanishing 
multifactorality might not have been possible. Represented diagrammatically, the 
following results could have been obtained: 
Macaques set #1: CoV infected - X 
Macaques set #2: hMPV infected - X 
Macaques set #3: Co V and hMPV infected - X 
And suddenly, in this scenario, with no difference in comparability (and with a lot less 
credibility given over to the issue of comparability in the first place), there would have 
been no way to separate the aetiologically important Co V from the aetiologically 
unimportant hMPV. Both would now have fulfilled all four criteria. In such a scenario 
the conjurer's illusion could, quite easily, have been un-masked, with the possibility of 
multifactorality, a possibility that still had to be considered, becoming visible once 
more. 
Some closing statements to the jury 
But let me get back to the point: this whole discussion of vanishing was originally 
intended as a response to the question of whether or not I had managed to generate a 
modicum of reasonable doubt; 
So, did any of it suggest that I have? 
Well, I have managed to foreground some of the moments at which the possibility of 
multifactorality was vanished. And I have also managed to make clear the extent to 
which those moments can, with a little rhetorical effort and a litde medical 
microbiological knowledge, be exposed precisely as vanishings and called into 
question. But that, however, is all I have been able to achieve. Pu_t more accurately, it 
is all that I could have achieved. For as I noted in chapter 2, 'Entering the Scientific 
Court of Appeal', the jury in this court of scientific appeal is you, dear'reader. Have I 
convinced you? Will the original judgement be overturned? And, if so, will the 
possibility of multifactorality receive some kind of a reprieve? A pardon, perhaps? 
Certainly, it would be pardon enough if multifactorality could have its right to a 
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possible existence, an existence that was never fully dispatched into the realms of the 
impossible, returned to it. 
Its fate is in your hands now, not mine ... 
The difence laryer returns to his seat. The presidingjudge issues some final instructions to the jury, 
re-stating the issues in the case and defining the terms and the words that may not be familiar to the 
jurors. S hi then discusses the standard of proof that jurors should appfy to the case - 'beyond a 
reasonable doubt' in this, a criminal case. Finalfy, she advises the jury that it is the sole judge of the 
facts and of the credibility (believability) of witnesses, and that the jurors are to base their conclusions 
on the evidence as presented in the trial. .. the jury retires to the jury room to begin deliberating . .. the 
judge marches off to her chambers, whilst the various other court stcif{ shuffle out of court to catch a 
breath of fresh air. A few pause on their way out to order a coffee from the cold fusion powered drinks 
machines in the foyer. Up in the public gallery, Hong Tao and Ren! Blondot fall into deep 
conversation with Franz Moewus. A 4Jspeptic looking court usher, determined to clear the gallery 
and brandishing his copy of The Philosophical Discourse of Modernity (Habermas 1987), shoos 
them towards the exit .. . as they descend the stairs, arms linked, they whisper together, 
conspiratorialfy ... the court finalfy falls silent ... onfy the difence laryer and his client, multifactorality, 
remain inside the building . 
.. . Except that it isn't in your hands. At least, not completely. Not yet, at any rate. 
The garb of the defence lawyer has only ever lain on my shoulders like a light cloak. 
And now, during this brief period of recess in which the court has emptied and we 
await the return of the jury with their final verdict, I want to cast those garbs aside, 
revealing the sociologist that has (I hope) always lurked beneath. 7 My client is, 
understandably, a little shocked at this revelation (and not a litde disappointed too). 
But what 'it' has to understand is that the generation of reasonable doubt (which 
during this recess, I can still claim to have generated) was, for me at least, only ever 
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the means to the sociological end of asking some further questions regarding 
aetiological objects past, present and, perhaps most interestingly,future. To recall the list 
of research questions posed during chapters 1 and 2, there are still a few in need of 
some attention: if the denial of the possibility of multifactorality was the end-result of 
active forms of management and negotiation, for instance, then how did we get here -
to an infectious disease that could be storied and understood in this way rather than 
any other? And is it possible, based on the recovery of that possibility, to inhabit the 
present in such a way that it becomes possible to think, in a little more detail, about 
where aetiology, as understood by medical microbiologists, might be heading in the 
future? Is it possible, in other words, to grapple with the question of whether or not 
multifactorial aetiology will always and forever more be lost to the world of medical 
microbiology? 
H. OF STYLES OF PRACTICE, SUCCESSFUL AND STALLED 
In the Critique of Pure Reason, Kant described knowledge, individual knowledge, in 
which our thoughts have objects and our judgements are capable of truth, as a 'land 
of truth' ([1781]1933, A235/B294)8 And, as with any land, it had limits, or, as he 
referred t6 them in a later work, Prolegomena to any Future Metapf?ysics ([1783] 1977), 
'bounds' (ibid., 352). These were bounds that marked the 'spot where the occupied 
space (viz. experience) touches the void' (ibid., 354). A searing phrase. The noumenal, 
things-in-themselves, the unknowable: that was what lay beyond. But could we ever 
come to know that void; that which existed outside the land of truth? If we could, then 
for Kant it would not be our faculty of understanding, but rather, our faculty of 
reason that would nurture such an expansionist impulse. Why? Because only the latter 
was capable of forming concepts of objects beyond experience: 
Our reason ... sees in its surroundings a space for the cognition of things in themselves, 
though we can never have determinate concepts of them and are limited to 
appearances only. (ibid., 352 my emphasis). 
I<ant's maxim was that we should not, therefore, 'consider the field of experience as 
one which bounds itself in the eyes of our reason' (ibid., 360). When the longing for 
the open ocean gnawed at us, as the land is gnawed by the sea, the limits of 
knowledge would, just about, be capable of fractionally exceeding the limits of 
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experience: we would generate knowledge of where experience stopped, by reaching 
out, just a litde, into the unknown.9 
I begin with this discussion of the topography of Kant's 'land of truth', because it 
seems to me that in the case of the 2003 SARS outbreak it is metaphorically very apt. 
From the continuous cell-culture in chapter 3, right through to Enserink's rhetoric in 
'China's Missed Chance' in chapter 6, it is as if the vanishing of multifactorality took 
place as a stardingly small number of people drew a line, a boundary as it were. Drawn 
quickly, and before anyone else had a chance to react, it was, in each case, a line that 
demarcated aetiological possibility from aetiological impossibility. On one side of the 
line, on their side of the line, existed the land of truth: the possibility of the singular 
aetiological object. On the other side, however, existed the void: the possibility of the 
multifactorial aetiological object. On one side, the following possibility: 
A -------------------------------------------------------------------------------------------------------------- A 
And, on the other side, the following possibilities: 
A -------------------------------------------------------------------------------------------------------------- .A 
.A ------------- .A 
.A ------------------- .A 
.6.------.6. 
But at each moment when the possibility of exploring the multifactorial might have 
become plausible, at each moment when 'reason', faced with a significant minority of 
co-factorial cases, might have sought to cross that line, to exceed the limits of present 
experience and to reach out, just a litde, into the unknown, it was a line that vanished 
away the void that lay beyond. Rhetorically, it was as if that stardingly small number 
of people had stood guard over the line, the point where singular aetiology touched 
the void, suggesting to anyone who strayed too close that they had already explored 
that which lay beyond, and that there was nothing to see there. 
Singularity as a style of practice 
But then, to write that 'a stardingly small number of people' were involved in drawing 
this line is perhaps a litde misleading. We were able to get here, to an infectious disease 
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that could be storied and understood in the ways that it was, because of more than 
just people. Based on the readings performed in the previous chapters, it seems to me 
that a great deal of the epistemological responsibility for the drawing of this line has 
to fall as much with medical technologies as medical microbiologists. In this sense, the 
doing of aetiology as a singular phenomenon can be understood as the product of a 
particular 'style of practice'. This is a term I borrow from the work of Ian Hacking 
(1992a; 1992b).1O There, it is used to put forward an 'explanation' for the fact that 
'despite our recent enthusiasm for refutation and revolution', an 'extraordinary 
amount of rather permanent knowledge' has accumulated within the laboratory sciences 
(1992a, 29). Hacking'S claim is that: 
As a laboratory science matures, it develops a body of types of theory and types of 
apparatus and types of analysis that are mutually adjusted to each other. (ibid., 30 my 
emphasis) 
Styles of practice, then, are self-vindicating entities 'in the sense that any test of theory 
is against apparatus that has evolved in conjunction with it - and in conjunction with 
modes of data analysis' (ibid., my emphasis). Hence the stability. Again, elsewhere, 
and in more detail: 
Theories are not checked by comparison with a passive world with which we hope they 
correspond. We do not formulate conjectures and then just look to see if they are true. 
We invent devices that produce data and isolate or create phenomena, and a network 
of different levels of theory is true to these phenomena. Conversely, we may in the end 
count them as phenomena only when the data can be interpreted by theory. Thus there 
evolves a curious tailor-made fit between our ideas, our apparatus, and our 
observations. (ibid., 57-58) 
It seems to me that a similarly self-vindicating style can be seen at work as we move 
from case-study chapter to case-study chapter, and as we move, simultaneously, from 
a 'pneumonia-like syndrome' to 'SARS caused by CoY and CoY alone'. The discovery 
of one single causal agent, a coronavirus, in a discipline where it was held as 
'abnormal' for one disease to be caused by more than one pathogen, was very far 
from being a serendipitous occurrence. Indeed, based on the work presented here in 
the thesis, the claim I want to make is that the theory of 'one disease one cause', first 
espoused by Robert Koch and the Berlin School of bacteriological science during the 
late 19th century, came to have such a profound impact on the subsequent 
development of the (then nascent) discipline of medical microbiology that as new 
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medical microbiological technologies were developed over the years that followed, 
they were developed with that same theoretical assumption built into them.ll 
Think fIrsdy here of the continuous cell-line culturing of samples from SARS patients. 
Everything that happened there happened in ways that aided the discovery of one 
single aetiological agent, isolated and alone. Think too of 'Koch's Postulates as 
modified by Rivers for viral diseases'. Viewed as an epistopic, as something that had to 
be done in and as practice, it is possible to see the ways in which its ability to isolate 
out just one distinct species of pathogen from amongst the multitude that existed 
within SARS patient samples relied on the inter-penetration of practice, theory and 
method, all working together. Singularity was not found, but enacted. Again, the 
enzyme-linked immunosorbent assay never simply found the 'exquisite specifIcity' of 
the reaction between one specific antigen and one antibody in the absence of anything 
more complex. It was simply that it had been designed and put together in such a way 
that it was unable to find anything else. The principle of one infective particle-one 
specific antibody was built into the very workings of that diagnostic technology, with 
the optical density of the final ELISA solution simply taken as a proxy for the 
presence, or non-presence of 'exquisite specifIcity'. But what, finally, of 'China's 
missed chance'? How can a popular science article fit with this idea of a laboratory 
style of medical microbiological practice? Certainly it seems to me that behind the 
empirical details of the fairly standard popular scientific tale that it narrates; behind 
the tale of the 'good' microbiologists versus the 'bad' microbiologist, lay a deep seated 
belief in the truth-value of singularity. In that sense singularity was, for Enserink's 
article, akin to one of Hayden White's (1973) 'modes of emplotment', operating at a 
deep, structuring level: what was never placed in question by Enserink, what could never 
be placed in question, was the fact that 'one disease has one cause'. The technology of 
rhetoric adjusted itself to the anomaly of Dr. Hong's multifactorality in ways that were 
subsequendy able to perpetuate, to entrench and to reproduce, the natural-ness of 
singularity. 
Perhaps the only point at which I differ from Ian Hacking in my use of the term 'style 
of practice' is in the emphasis I have placed upon the double-edge nature of this 
particular style. For in each case, and at each moment where one reality, one object, 
was being created, another object, another reality, was also, and at the same time, being 
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suppressed and regulated. The singular style of medical microbiological practice was a 
style involving practices that either directlY or indirectlY removed everything that might 
have been of interest from a multifactorial perspective. 
Multifactorality as a stalled style of practice 
This idea of the existence of a 'style of practice' within the discipline of medical 
microbiology also goes some of the way towards explaining why the possibility of 
multifactorality never became real; why, in Latour's (1987) words, the awkward 
(multifactorial) dissenter failed to materialise, and why we ended up with a disease that 
could be understood and storied in the singular but not the multiple. Put simply, if 
singularity was a style of practice capable of weaving together method and theory, 
multifactorality was just a theory. As became clear on a number of occasions 
throughout this thesis, multifactorality has had plenty of human advocates since the 
days of Sergei Winogradsky: Waksman, Dubos, Rivers, Hong, Plummer, Penn, 
Dworkin, Kluyver, Fredricks, and so on and so forth. But non-human advocates? They, 
on the other hand, have always been few and far between. So dominant has been the 
doctrine of 'one disease has one cause' within the discipline of medical microbiology, 
that multifactorality has never had the chance to evolve into a style of practice. 
And yet, what does it mean to write of dominance? 
Certainly here, in this particular instance, to write of dominance is not to move 
towards some form of critique. In fact, we should all be in praise of aetiological 
singularity: the practical benefits of singularity, the 'goods' it has wrought in enabling a 
degree of human control over the microbial world, are unquestionable. Without it, 
without the simple way in which it has come to allow for infections to be diagnosed 
and treated, I for one would almost certainly not be here today. Nevertheless, to write 
of dominance is to suggest that a vicious cycle has developed and persisted within the 
discipline: with only singular technologies to hand, the theory of 'one disease, many 
interacting causes' has, over the years, come to seem less and less possible; less and 
less do-able.12 
Does this kind of an explanation hold any weight at all? A good way to find out is to 
subject it to a Latourian 'trial of strength', looking briefly at the history and the 
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emergence of one of the very few multifactorial infectious disease to have been 
identified during the modern era: hepatitis D /hepatitis B.13 
In 1977, a team of researchers in Italy, led by Mario Rizzetto, published a paper 
entided 'Immunofluorescence detection of a new antigen/antibody system 
(delta/anti-delta) associated with hepatitis B virus in liver and serum of HBsAg 
carriers' (Rizzetto et al. 1977). It began with the following microbiological 'puzzle': 
While studying liver biopsies from patients who were seropositive for the hepatitis B 
surface antigen (HBsAg) in direct immunofluorescence, it was noted that an antiserum 
against the hepatitis B core antigen (HBcAg) ... also reacted with additional biopsies 
which did not contain core particles (at electron microscopy) and were negative with 
other reference antisera against HBcAg.(ibid., 997 my emphasis) 
Was this a significant finding? Was it, perhaps, a finding that pointed to the presence 
of another antigen in those patient samples? A new virus, even? Or was it merely a 
'false-positive'; the end-product of a kind of serological 'interference,?14 At that initial 
stage of discovery, it would have been difficult for Rizzetto and his colleagues to 
answer such questions one way or the other. And so, rather than dismissing the 
puzzle as an effect of 'interference', they continued to investigate. There were good 
reasons for doing so. Firsdy, as they went on to note in the same paper, it was a 
puzzle that only became detectable in patients who were already HBsAg positive (i.e. 
those who were known to have Hepatitis B infection). It might, in other words, have 
been a hitherto unknown antigen associated with HBV (ibid., 998).15 Secondly, in 
patients where both types of antigen were recovered, the course of illness was 
markedly more severe that in cases where only HBsAg was detectable (ibid.). 
So, what did they find during their further investigations? 
When the EM core positive and core negative specimens were tested with several 
HBsAg positive sera, it soon became apparent that some sera reacted with either one 
or the other liver substrate; this suggested that there were two distinct nuclear antigenic 
specificities. (ibid., my emphasis) 
What is more, subsequent blocking and absorption studies designed to detect 
interference showed that the antigen present in this preparation was not specific to 
any previously characterised hepatitis B virus (HBV) antigens or cellular antigens: 
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Immunofluorescence with antisera against the different HB virus determinants and 
blocking and absorption experiments demonstrated the specificity and independence of 
the new antigen. (ibid., 1001 my emphasis) 
The conclusion drawn from this laboratory work was that 'a new antigen-antibody 
system, distinct from Hepatitis B is present in the liver and in the blood of HBsAg 
carriers' (ibid.). Interestingly, and as they noted quite explicidy, the system in question 
'had been identified by chance,t6 (ibid., my emphasis), the result of a decision to 
investigate the kind of interference that is so often treated preciselY as interference, and 
thus dismissed as irrelevant. 
There was, for Rizzetto and colleagues then, no doubting this as yet un-identified 
antigen's relationship to HBV: 
Although this new antibody-antigen system, designated delta, was unrelated to HBV 
antigens, it was associated with HBV, since the delta antigen (HDAg) could be detected 
only in those patients who were HBsAg positive (ibid.).17 
And yet, such was the power of the doctrine that 'one disease has one cause' that, as 
Gerin et al. (2001, 3037) have noted, 'the antigen was ~tially believed to be a 
previously unrecognised hepatitis B-specific antigen; it was called delta antigen and its 
antibody, anti-delta'. Indeed, even Rizzetto and his colleagues, in their original paper, 
leant towards this kind of a (singular) conclusion: 
The nature of the new antigen is obscure; its occurrence in the same type of disorders 
in which HBcAg is detected and the reputation of the Dane particle as the HB virus 
unit capable of inducing the lesion observed in 8 positive patients ... suggest that the 
antigen is closely related to the core particle [i.e. HBcAg] or to the chain of events 
preceding its assembly or after its clearance. (Rizzetto et al. 1977, 1002 my emphasis) 
Development of a radioimmunoassay (RIA; a serologic test similar to an ELISA) and 
its subsequent use in a sero-survey of sera collected in Italy, Japan, and the United 
States confirmed the distinct association of anti-delta antibodies (anti-HD) in patients 
with HBV infection (Rizzetto et al. 1979; Rizzetto et al. 1980). 
But still the question had to be setded definitively, once and for all: did this delta virus 
work alone, in conjunction with the hepatitis B virus, or as part of the hepatitis B 
virus? In 1980, three years after the initial 'chance' discovery, Rizzetto's studies of 
transmission in chimpanzees not only 'confirmed the potential pathogenicity and 
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transmissibility of HDV', but also 'provided conclusive evidence that the 
establishment of an HDV infection depends on an obligatory helper activity provided 
by HBV' (polish et aL 1993,211,213 my emphasis). 
These studies were conducted shortly after the initial discovery by immunofluorescence 
of a new HDag-antibody system, and led to our understanding of the natural history of 
HDV infection. Sera obtained from two human carriers of HBsAg who expressed large 
amounts of intrahepatic HDAg in their livers were used as inocula in HBV-susceptible 
animals, in HBsAg chronic carriers, and in animals immune to HBV infection. 
Inoculation of the human sera into HBV-susceptible chimpanzees resulted in the 
development of HBV infection and the synthesis of HDV markers. effecting an HBV-
HDV coinfection. Inoculation of the sera into HBV carrier chimpanzees resulted in 
development of biochemical evidence of hepatitis: HDAg was concomitandy expressed 
in liver tissue and elicited an anti-HD response, a condition known as superinfection. 
HBV-HDV coinfections in experimentally infected chimpanzees can result in moderate 
to severe hepatitis characterised by a single or bimodal episode of elevated alanine 
aminotransferase (ALT) activity and the simultaneous expression of HDAg and 
HBcAg in hepatocytes. (ibid., 211 my emphasis) 
So, even after the initial 'chance' discovery, and even after the identification of the 
delta antigen in patients with HBV in many countries around the world, it still took 
three years for the possibility of multifactorality to become entrenched as a fact for 
medical microbiologists. Was this because of a theoretical impossibility? I would 
suggest not. Undoubtedly, it is true that even many years later, the 'fact' was, in some 
quarters, still being troped in ways that would have disgusted a Winogradskian: 
The virus was shown to be defective, requiring a helper function from HBV. (purcell 
1994,2403 my emphasis) 
By 1980, transmission experiments in chimpanzees had confmned that the delta 
antigen was a component of a transmissible pathogen that was defective and required 
co-infection with HBV for its replication. (Gerin et aL 2001, 3037 my emphasis) 
But even there, and as is clear from these extracts, the possibility was being accepted. 
And, in any case, more often than not it is possible to find more reasonable tropes 
being deployed during attempts to figure this multifactorial disease: 
The genome of HDV is unrelated to the genomes of hepadnavirus, of which hepatitis 
B virus (HBV) is a member. HDV ... should be considered as a satellite virus. a natural 
subviral satellite ofHBV. (WHO 2009c my emphasis) 
We are familiar with the paradigm in which each disease is caused by a single microbe. 
What if disease required the interaction of several microbes? In this setting, 
identification of a single pathogen may not reliably predict disease. The synergistic 
interaction between hepatitis D virus and hepatitis B virus is an example of this 
interaction. (Fredricks 2004,95 my emphasis) 
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So no, it was not a theoretical impossibility, but rather, instrumental and technical 
difficulties that helped to cause this temporal delay. What was lacking, in other words, 
were a set of technologies that could have allowed multifactorality to become visibly 
apparent, and rapidly so. Not only did the very birth of HDV rely on a 'chance' 
moment in which something that might otherwise have been dismissed as 
'interference' in an ELISA machine was explored in greater detail, but throughout its 
subsequent growth as a medical microbiological fact, its multifactorial nature had to 
be inferred. As will have become clear from the extracts cited above, only singular 
technologies - ELISA, animal models, radioimmunoassay - were available as means 
to visualise this virus. Consider the photographs below, for instance: 
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FIG. 2. Structural proteins of the hepatitis delta virus. West· 
ern blot 01 serum·derived HDAg with a human mono clonal 
antibody to- HDAg. Extracts of HDAg from sera of five 
humans infected with HDV (lanes 2 through 6). two chim-
panzees (Ialles 8 alld 9). and an HDV-infected woodchuCK. 
(lane 11) were analyzed. Lane 1 contains an extract of an 
HDV·negative human serum; lalle 7. an HDV-negative ch,m· 
panzee serum; and lalla 10. all' HDV-negative woodchuck 
serum. Lane M contains molecular-weight markers, and tho 
relative molecular masses in kilodaltons are indicated on the 
left margin. (From ref. 4. with permission.) 
Figure 2: Taken from 'Hepatitis Delta Virus' 
(Gerin et al. 2001, 3038). 
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FIG. 1. Electron micrograph of the hepatitis de:ta virus. Peak 
fraction from a sucrose gradient. Stained wi;h 1°~ phospho-
tungstic acid. Bar = 100 nm. (From reI. 35, with permission.) 
Figure 3: Taken from 'Hepatitis Delta Virus' 
(Gerin et al. 2001) 
Even here, even after the identification of HDV and the acknowledgement of its role 
as a 'satellite' to HBV, the multifactorial element, the co-presence, has to be inferred 
as this apparendy gregarious hepatitis D virus can only be captured, by western blot 
technique and by electron microscope, in the role of the hermit, isolated and alone. 
Ill. SARS, THE LAST GREAT MODERN INFECTIOUS DISEASE? 
How did we get here - to an infectious disease that could be storied and understood 
in this way rather than any other? Because the theory of aetiological singularity ('one 
disease has one cause,) was, is, not simply a theory. It is part of a style of practice in 
which theory and methods are mutually adjusted to one another. The theory of 
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aetiological multifactorality, on the other hand, is a theory without method; a theory 
that has to eke out an existence in those rare moments of 'chance' when the singular 
style of practice allows it to become-real. Right now, a singular style of practice makes 
it easier to vanish the possibility of multifactorality than to pause and to explore that 
possibility. 
But what of that 'right now'? Will it hold, always and forever? Might the moments I 
have tried to recover in this thesis prefigure the kinds of moments that will, one day~ 
have their rights to existence discussed not by a scientific court of appeal, but by 
medical microbiologists themselves? In short, is it possible, based on the recovery of 
those moments, to inhabit the present in such a way that it becomes possible to think, 
in a litde more detail, about where aetiology, as understood by medical microbiologists, 
might be heading in the future? At this stage, and faced with such a barrage of 
questions about a future as yet unwritten, it is interesting to return to Dr. Hong Tao's 
research article, CLA. To recall, the very final paragraph of that article suggested that: 
Since the novel Chlamydia-like agent was found co-existing with a coronavirus-like 
agent in the dead cases of SARS, it appears most likely that both agents play some role 
in the disease. At the present time, however, it is not possible to determine whether 
these agents interact synergistically, or whether one follows another. This requires 
further study. (Hong et aL 2003, 632-636) 
'This requires further study'. What can he have meant by that? How might he have 
been proposing to rule in, or to rule out, synergy? Will Dr. Hong the buffoon, the 
great scientific loser, perhaps end up having the last laugh here? Might his words 
perhaps have been pointing towards a nascent style of multifactorial practice? I want 
to suggest that they were. 
In the world of medical microbiological cell-culturing, new technologies were just 
beginning to emerge during the early 2000s; technologies that could, perhaps, have 
helped Hong to conduct his 'further studies'. But in order to make the aetiological 
significance of those technologies fully apparent, in order to allow Hong to have the 
last laugh here, it is necessary to return to the founding moments of the aetiological 
controversy that flared between Robert Koch and Sergei Winogradsky, before slowly 
tracing a path back towards the present. The aim in doing so will be to develop a brief 
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history of the present practices that either do, at present, or might, in the future, come 
to defIne medical microbiological cell-culturing. 
Robert Koch's pure cultures 
During the introduction to this thesis the dispute between Koch and Winogradsky 
was presented as a dispute stemming from crucial and wide-ranging differences in 
fundamental outlook regarding the experimental philosophy of the nascent 
microbiological discipline. And rightly so. But as Penn and Dworkin make clear in 
their article 'Robert Koch and the two visions of microbiology' (1976): 
An essential symptom of those [philosophical] differences was the technical issue of 
the use of pure versus mixed cultures. This apparently simple methodological 
difference has ... determined, to a great extent, the content of microbiology. (ibid., 276 
my emphasis) 
So what were these 'technical issues'? 
It was in a paper entitled 'Methods for the study of pathogenic organisms' 
([1881]1961), that Robert Koch staked out, for the first time, the method of isolating 
pathogens in vitro that would come to defIne the discipline of modern medical 
microbiology. 18 And, therein, one can begin to understand the technical issues 
separating Koch's pure cultures from Winogradsky's mixed cultures. 'The most 
important point in all studies on infectious diseases', noted Koch in the article's 
introduction, 'is the use of pure cultures'. This had 'been known for a long time'. 
Indeed, 'all' who have worked in 'the fIeld of infectious disease have worked hard to 
perfect methods of pure culture'. And yet, for Koch, 'the most recent results [of such 
studies] have show:n that we are not even past the fIrst groping stages in this research' 
(ibid., 101). Why? Because of the 'assumptions' that had to be made in the actual 
doing of those methods. Most importantly: 
It must be assumed that the substance used as inoculum contains no other 
microorganisms than the one desired. Even a slight contamination of the inoculum 
with another species which is faster growing than the organism desired will prevent 
anyone from ever obtaining a pure culture. (ibid., 102) 
Indeed, each of the fIve assumptions that he went on to list centred on the question 
of impunry. Each was, quite correctly in his view, built around the need 'to rid oneself 
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of the uninvited guest (ibid., my emphasis). And yet, was it possible to place any trust in 
those assumptions? Would they hold up, each and every time one sought to develop a 
pure culture? Koch thought not. 'All in all', he concluded in the first section of the 
article, 'the situation with regard to pure culture techniques is quite disappointing' 
(ibid., 103). 
But then, in one of those glorious moments that has since come to deftne what we 
now refer to as the 'bacteriological revolution,19 of the late-19 th century, he went on to 
note how: 
I have rejected completely all of the current principles of pure culture technique and 
have adopted an entirely new way. (ibid.) 
Koch's 'new way' was built around a rather humble actant: a boiled potato: 
If a boiled potato is cut in half and the cut surface is exposed to the air for several 
hours and then placed in a moist chamber ... one will Hnd in the following day or two, 
on the surface of the potato, a large number of very small droplets, all of which seem 
to be different from each other ... most often, each droplet or colony is a pure culture 
[of bacteria] and remains a pure culture until it enlarges to the point that it touches its 
neighbours. (ibid., 103-104) 
To Koch, the technical advantages which the boiled potato yielded in relation to those 
'current methods' of isolating pathogens were clear: 
If instead of the potato, a liquid medium of the same surface area were exposed to the 
air, then undoubtedly the same number and the same kinds of germs would fall as had 
fallen on the potato, but the development of these germs in the liquid would be 
different ... Some of the organisms which would have found places on the potato to 
grow undisturbed would be choked by the development of other more luxuriantly 
growing organisms ... in short, the whole liquid would reveal under the microscope 
from the beginning a tangled mixture of different shapes and sizes, which no one 
would mistake for a pure culture. What is the fundamental difference between the 
nutrient substratum which the potato and the nutrient liquid offer to the 
microorganisms? It is that the potato is solid and prevents the various species. even if 
they are motile. from becoming mixed. while in the liquid medium there is no chance 
for the different species to remain apart. (ibid., 104 my emphasis) 
Switching his attentions from the boiled potato to gelatin, a substance which had all 
the same properties as the former but could be made more 'firm and rigid' (ibid.), he 
noted some practical details. First of all, impurities present in the gelatin would have 
to be removed via a 'ffitration' and 'sterilisation' process. Secondly, and to make the 
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growth of bacterial forms visible, it was also recommended that 'the gelatin is poured 
into flat watch glasses, small glass plates or the like and allowed to set' (ibid. 106). But 
would any form of pathogen grow: on a pure gelatin culture? No: 
After I had considered that it would be hardly possible to construct a universal medium 
which would be equally suitable for all microorganisms, I limited myself to attempting 
to use the known media and such new ones as I might develop and converting them to 
a form which would be ftrm and rigid (ibid., 104 - 105). 
A seemingly innocuous, yet in actual fact crucial moment. With Koch's 'limits', the 
'bounds' he placed upon his 'land of truth', the possibility of anything but a 
standardised, universal culture system coming to define the discipline of medical 
microbiology began to fade from view: pathogens that could grow on such cultures 
would; and those that could not, would not. 
Towards the end of the article, Koch moved to present a simple, reproducible and 
understandable method for the inoculation of such cultures. There, it was noted that: 
The organism to be cultured is seeded by taking a flamed needle or platinum wire, 
picking up a very small quantity of the liquid or substance containing the organisms, 
and streaking this in three to six cross lines on the gelatine surface ... the expression 
'inoculation' for this operation seems appropriate. (ibid., 106) 
Streaking: a form of separation. A way in which to show the 'uninvited guest' the door 
(see figure 4, below). 
Fig. 7.2 The commonly adopted pattern of plating·out on 
solid medium. The area A is the weJl, and successive series 
of strokes D, C, D and E are made with the loop sterilized 
between each sequence. 
Figure 4: Taken from Collee et al. (1989): 
'The inoculum is smeared thoroughly over 
area A to give a 'well-inoculum' or 'well'. The 
loop is re-sterilized and then drawn from the 
well in two or three parallel lines on to the 
fresh surface of the medium (B, B, B); this 
process is repeated as shown, care being 
taken to sterilize the loop, and cool it on 
unseeded medium, between each sequence. 
At each step the inoculum is derived from the 
most distal part of the immediately preceding 
strokes' (ibid., 123). 
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But what if, during that inoculation process, 'contaminating colonies' started to 
appear? This was not a problem for Koch. A new 'seed' stock could be taken and 
inoculated onto a new culture. And, during their transfer to a new culture, any 
'contaminating colonies could be easily removed' (ibid., 104), as 'within a few days the 
pure cultures have developed to their maximum extent and can be inoculated further' 
(ibid., 106). But what if the taking of a 'seed' did not allow for separation? 
Now it is only necessary to take a flamed needle and remove some blood from the 
opened heart or a convenient blood vessel and streak it a few times on the nutrient 
gelatine. There will occur growth in colonies of several types of microorganisms, 
among which will be a greater or lesser number of pure, characteristically matlike and 
granular colonies which can be characterised under the microscope as those of the 
septicaemia bacteria. It will be quite easy to culture these further in pure culture. In this 
case the number of foreign organisms is at a minimum, so that it is quite easy to isolate 
the pure colonies of the appropriate organism. (ibid., 107 my emphasis) 
However, as Koch continued: 
Even if this situation were reversed and the sought-for organisms were in the minority, 
it would still be possible to have success. Although here it would not be as easy, it 
would be just as certain. It is only necessary to dilute the bacterial mixture considerably 
and then make a large number of streaks. In such circumstances it is advantageous to 
inoculate into the still liquid gelatine, in order to spread the various germs over a wide 
area, and then pour it on the slides and locate the colonies which develop under the 
microscope. (ibid.) 
Small wonder, then, that Robert Koch, looking back on his career many years later, 
could note how: 
These new methods [of pure culturing] proved so helpful and useful in dealing with 
various problems that one could regard them as the keys for the further investigation 
of microorganisms, at least insofar as they relate to medicine ... In a rapid sequence, my 
colleagues and I were successful in discovering the cause, and thereby the aetiology, of 
a number of infectious diseases. These included the wound infections, tuberculosis, 
cholera, typhoid, and diphtheria. Once the appropriate methods had been found, these 
discoveries fell into our laps like ripe fruit. (Koch 1909, 4, cited in Carter 2003, 137-138 
my emphasis) 
'The keys for the further investigation of microorganisms' that would allow 
discoveries to fall 'like ripe fruit' into the laps of microbiologists. Is it not possible to 
see those same 'keys' being turned in 'A novel coronavirus associated with SARS' 
(Ksiazek et aI., 2003)? For the sterilised and universal gelatin culture, might we not 
read the purified cell-culture, standardised and comprising clones of one single cell? 
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For the small watch glasses, the use of trypsin to produce monolayers of cells upon 
transparent glass? For the 'streak-plating' method, antibiotics, ether, the centrifuge 
and the filter? And for the 'passage' of an inoculum from one culture to another in 
order to isolate pure colonies, the development of a 'master-seed' and the range of 
different, yet standardised pure cell-cultures 0Iero E6, HeLa, and so on)? 
Figure 5: taken from Koch (1876 reproduced 
in Collard 1976, 18-19) 
Figure 6: taken from Ksiazek et al. (2003) 
If these links can be accepted; if the time of medical microbiology really is as 
'crumpled' and as 'folded' as they seem to be indicating, then perhaps it is p~ssible to 
suggest that modem 21 st century medical microbiology has never quite managed to 
break free from late 19th century Europe. Via the medium of the culture it is possible, 
at the very least, to trace a direct line of descent, drawing these apparendy distant periods 
into close proximity with one another?O 
Sergei Winogradsky's mixed cultures 
But what now of Winogradsky's mixed cultures? Winogradsky's approach to the 
cultivation of microbial life was very different to Koch's. Starting from the premise 
that interactions between organisms in nature were complex, processual and dynamic, 
Winogradsky was highly sceptical of the universal utility of the agarised meat-peptone 
or glucose-peptone media advocated by the Kochian microbiological school. 
According to one account, 'he never ceased to emphasis the limitations of this 
method' (Zavarzin 2006,502). Indeed, Winogradsky's one full-length monograph, Soil 
Microbiolo!!) (1952a), 'is filled with harsh statements concerning the incompatibility 
between his goals and the goals of medical microbiologists, personified by Koch' 
(Zavarzin 2006, 510). Where Koch held that pure culture in vitro studies were enough to 
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make the in vivo adequately knowable and orderable, Winogradsky did not. 'We 
cannot', he argued: 
Register all [pure-culture] isolated species as natural ones, identical to their wild 
prototypes, without any critical evaluation, because it is probable that they are mere 
ecological species whose properties depend on nutrient conditions. In short, they may 
be artefacts (resulting from the conditions of in vitro cultivation on pure cultures) 
(Winogradsky 1952b, 128 cited in ibid., 505 my emphasis) 
Note that: 'artefacts'. As he saw it, the problem with 'the application of pure cultures' 
was that those pure, standardised cultures: 
Eliminated the most essential ecological factor, I mean competition, since it is precisely 
this factor that determines the distribution of the processes implemented by microbes 
in nature, and automatically directs the succession of these processes. (Winogradsky 
1952a, 783 cited in ibid., 505) 
It was perhaps with the Kochian school of bacteriology in roind21 that he was to note 
how 'some bacteriologists' (i.e those who persisted in using pure-culture methods to 
study microbial life): 
Deal with hothouse varieties of bacteria, far removed from their naturally occurring 
progenitors, and would hardly recognise them when found in their natural milieu. 
(Winogradsky, 1938 cited in Waksman 1949,336 my emphasis) 
For Winogradsky, the challenge was thus to move beyond a universal but artificial in 
vitro method of cultivation, and to develop, instead, a method that could re-create the 
unruly-ness, the mess, of the in vivo as closely as possible in the in vitro environment of 
a culture: 
The method for investigation of actual processes mediated by microbes in nature 
should be based on the study of microbial communities as a whole, in nature, rather 
than on the study of species isolates from nature. (Winogradsky 1952a, 789 cited in 
Zavarzin 2006, 506) 
As Zavarzin (2006) has noted, Winogradsky did indeed introduce a method of 
cultivation based on those principles: the elective, or mixed, method, .in which 
microbial communities were to be allowed to develop together,· in interaction. 
Introduced during his studies of nitrifiers in the late 19th century, and described in an 
1895 paper devoted to the discovery of free-living nitrogen-fixing bacteria, it was 
intended, as Schlegel (1996, 67) has noted, as 'a model of natural processes'. It came 
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with instructions. Prior to cultivation the recommendation was to take the culture in 
question 'direcdy from its natural habitat' and 'to avoid exposing the subsequent 
inoculum to strong stresses during isolation, including isolation on media to which it 
was not adapted' (Winogradsky 1952a, 783 cited in Zavarzin 2006, 508). These are 
precisely the kind of suggestions that would have horrified a Kochian during the 
1890s, and perhaps even caused Ksiazek and his colleagues a litde discomfort during 
those early months of 2003. Nowhere is there to be found any talk of purity here, of 
the need to remove 'the uninvited guest', as it were. All guests were, at least initially, 
welcome. That was the first major difference separating the enriched from the pure 
culture. But what of the culture medium itself? 'The culture will be elective', stated 
Winogradsky: 
If it is favourable for the detection of the sole function ... by supporting the microbe in 
question, engaged in the life contest with other microbes, we will have a significant 
prevalence of this microbe in our cultures .. .It is obvious that this approach is 
diametrically opposite to the widespread approach based on the use of substrate (meat-
peptone gelatine) that has been considered as universal. Thus, in order to apply the 
elective culture method, it is essential: 
(1) To determine all specific properties and conditions of the culture 
(2) To study the microbe morphology so as to keep it in view until it has been isolated 
in pure culture, which is sometimes difficult to achieve 
The first requirement, a good choice of culture conditions. presents few difficulties; the 
second one requires some experience and acquaintance with bacterial forms. 
(Winogradsky 1952a, 344 cited in ibid., my emphasis) 
'Engaged in the life contest ... '. Competition was the one of the key organising themes 
here. The elective method was, in part, an experimental realisation of Darwin's (or, 
more exacdy) Spencer's principle of 'survival of the fittest' (and see figure 7, below). 
But only in part. Because here, as the extract above hints at, the experimenter had the 
power to 'determine all specific properties and conditions of the culture'. And 
although Winogradsky suggests that this task would present no special problems, it 
would, in fact, have taken great skill. The experimenter was effectively being asked to 
create various spaces of disorder, changing the nature of the culture medium in order to 
change the nature of the subsequent microbial competition. Where Koch's pure 
cultures insisted on a denuded space, a spot of propriety constituted through 
expulsion, Winogradsky's mixed cultures insisted that the microbiologist try to re-
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create certain environments and conditions in order to see how they might affect the 
development and interaction of microbial communities.22 
Figure 7: Drawing of various elective cultures taken from Winogradsky (1949) 
The aim in the latter case was to try and re-create that which Winogradsky understood 
to be a 'natural' microbial habitat. In Microbes and Man (1992), Postgate brings this 
approach to life: 
Most microbes require, in order to grow, a solution containing traces of elements such 
as iron, magnesium, phosphorus, sodium, potassium, calcium, a source of nitrogen 
such as an ammonium salt and some kind of carbohydrate food, sugar, for 
example ... Supposing, for example, one wants to examine some nitrogen-fixing bacteria, 
one can make up a sugar medium as I have described but leave out the ammonium salt. 
In these circumstances, if it were infected with a litde soil, only those microbes that 
could use atmospheric di-nitrogen could grow, and thus the culture would become rich 
in nitrogen-fixing bacteria. Once they started growing, of course, some of the nitrogen 
fixed would become available to other microbes in the soil inoculum, these would start 
to grow and the population would become pretty mixed. But it would be enriched in 
nitrogen-fixing bacteria, at least to start with. If one wanted sulphur bacteria, one could 
leave the ammonium salt in but add sulphur instead of sugar; some ferrous sulphate in 
place of the sugar would encourage iron bacteria. Instead of changing the composition 
of the medium one could change its acidity: a weakly add sugar medium favours the 
growth of yeasts and moulds rather than bacteria. Or one could exclude air, simply by 
using a botde filled to the brim and stoppered, and so enrich the medium in anaerobes. 
(ibid., 95-96) 
And yet, as this extract's constant references to soil microbiology might lead us to ask, 
who now uses enrichment cultures during the practice of medical microbiology? Who, 
for instance, was using cultures that even came close to resembling an enriched 
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culture during the aetiological investigations into the 2003 outbreak? Dr. Stahr? Dr. 
Osterhaus? Dr. Ksiazek? No. No-one was. As Postgate (1992), again, has noted: 
Medical microbiologists do not make much use of enrichment culture methods. (ibid., 
96) 
'The keys for the further investigation of microorganisms' that Winogradsky proposed, 
and, to a certain extent developed, have never, it would seem, developed in ways that 
would allow (multifactorial) discoveries to fall 'like ripe fruit' into the 'laps' of medical 
micro biologists. There is, in this sense, no line of descent that can be traced from 
Winogradsky's enrichment cultures, through to the medical microbiological 
technologies of today. 
Inhabiting23 the contemporary cell-culture 
But what of Dr. Hong's article? How does any of this previous discussion relate to his 
suggestion that the possibility of multifactorality, or, as he termed it, 'synergy', 
required 'further study'? It relates because times seem to be changing in the discipline 
of medical microbiology. And, in the same way that I was able to trace a line of 
descent, from Koch's pure cultures through to Ksiazek's continuous cell-lines, it is 
now, just about, possible to start tracing a similar line from Winogradsky's enrichment 
cultures, to some of the present practices of medical microbiologists. Dr. Hong's 
'further study' would almost certainly have taken place with what have recently been 
termed 'mixed-cell lines'. 
In Toplry & Wilson's Microbiolo!!J and Microbial Infections (VoL 2) (Mahy and ter Meulen 
(eds.) 2005), there is a chapter entitled 'The laboratory diagnosis of viral infections' 
(Specter and Bendinelli 2005). And, therein, reference is made to 'the standard cell 
culture', the 'enhanced cell culture', the 'engineered cell line', and, lastly, to the 'mixed 
cell culture'. Under the last heading we learn that: 
The most recent significant development in virus isolation methodology is the use of a 
mixture of cells in a shell vial format. (ibid., 1541) 
'Up until recently', the text continues: 
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The choice of cells has been focused on the ability to isolate and identify viruses that 
have a common pathological presentation, such as enteroviruses or respiratory viruses. 
(ibid.) 
One specific pathogen, one specific lesion. One disease, one cause. So far so obvious. 
But the 'distinctive thing' (ibid.) about mixed cell cultures is that: 
The cell mixture allows for a broader range of viruses to be isolated in a single culture. 
(ibid., my emphasis) 
And, what is more, the inoculums used in the practice of such cell-culturing do not 
depend on the removal of the 'uninvited guest'. Interestingly, the trope of the 
'cocktail', the sort of trope that would, again, have horrified Robert Koch, starts to 
appear with an ever increasing regularity: 
Techniques involving combinations of different cell types grown together as a single 
monolayer in a vial and the application of various MAbs [monoclonal antibodies], each 
labelled with a different fluorochrome, have been applied for the detection of several 
viruses in the same vial. Culturing for the simultaneous detection of adenovirus, CMV, 
and HSV in the same shell vial has been approached using a mixture of :MRC-5 and 
A549 cells in the cell monolayer and staining with a cocktail of adenovirus. CMV. and 
HSV antibodies, each raised in a different species. (Leland and Ginocchio 2007, 57) 
Is it possible to see the 'keys' to the future development of a multifactorial style of 
practice here in this extract? Certainly, for the Winogradskian instruction to 'take a 
culture direcdy from its natural habitat', and the instruction 'to avoid strong stresses 
during isolation' it might be possible to start reading of the 'several viruses in th-e same 
vial', 'simultaneous detection' and the 'cocktail of ... antibodies'. 
But there is something more to be noted here about the mixed-cell culture technique: 
the culture medium itself. For these mixed cell cultures are also being developed in 
ways that allow micro biologists to 'create various spaces of disorder in a Winogradskian 
sense, modifying the medium in order to stimulate, or reduce, the growth of a 
particular pathogen, or pathogens. Here, for instance, is Yung Huang, writing in 
'Engineered BGMK cells for sensitive and rapid detection of enteroviruses' (Huang et 
aL 2002). The problem to which he is seeking a solution therein is that of the temporal 
delay in culturing enteroviruses and coxsackieviruses (two separate species of virus 
classified within the genus 'enterovirus,). As Huang notes, 'it takes an average of 5 days 
before cytopathic effect (CPE) is detectable in tube culture' (ibid., 366). That, in his 
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Vlew, is too long to be waiting for laboratory results during an ongomg disease 
outbreak. And his proposed solution? To use a mixed cell culture in which, crucially, 
specific cell types have been 'modified', or, in his words, 'engineered': 
Decay-accelerating factor (DAF) is a 70-kDa glycosylphosphatidylinositol-anchored 
glycoprotein involved in the regulation of complement activation and in cell signaling. 
The echoviruses that hemagglutinate human erythrocytes, including serotypes 3, 6, 7, 
11, 12, 13, 19,21,24,25,29,30, and 33, bind to DAF receptor in human cells, and the 
binding can be blocked by an anti-DAF monoclonal antibody (MAb). In addition, 
coxsackievirus A21 also binds to DAF of HEp-2 and HeLa cells, and the binding of 
coxsackieviruses B1, B3, and B5 to HeLa cells can be blocked by an anti-DAF MAb. 
An anti-DAF MAb has also been shown to inhibit enterovirus 70 binding to HeLa cells 
and to protect them against enterovirus 70 infection. (ibid., my emphasis) 
'In summary', then, 'DAF is involved in the entry of quite a number of enteroviruses 
into host cells' (ibid.). And if 'BGMK cells' have been shown to be quite sensitive for 
detection of coxsackie B viruses but show relatively poor sensitivity for detection of 
echoviruses' (ibid.), then a solution is at hand: 
Since human DAF (hDAF) is a cellular receptor for a number of enteroviruses, 
especially the echoviruses, it follows that the expression of hDAF in BGMK cells may 
expand the host range and enhance their sensitivity in the detection of enteroviruses. 
(ibid., my emphasis) 
And, furthermore: 
CaCo-2, a human colon adenocarcinoma cell line, has also been demonstrated to 
support the replication of, and show visible CPE for, most enteroviruses. On the basis 
of this report and the evidence that only 13 types of echoviruses use hDAF as a 
receptor, a mixed monolayer of BGMK-hDAF and CaCo-2 cells might provide a 
broader range of enterovirus detection in a shorter time than other single- or multi-cell-
line monolayers. ~bid., my emphasis) 
Once again, might we not see here in this extract the 'keys' to the future development 
of a multifactorial style of practice? For the Winogradskian 'determination of all 
specific properties and conditions of the culture' and for the 'deliberate manipulation 
of the in vivo conditions', is it not possible to start reading of the 'engineering' of 
different cells within a culture in order to 'provide a broader range of [virus] 
detection'? 
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But one final question: the extract cited above from Topley & Wilson's Microbiology and 
Microbial Infections (VoL 2) (Mahy and ter Meulen (eds.) 2007) suggested that this had all 
begun to happen 'recendy'. So how recent is 'recendy'? The references included in 
that text, along with the references I have been able to find, are all to research articles 
dating from the early 2000S.24 The irony, it seems, is that the 2003 SARS-Co V 
outbreak, which came to be enacted as an utterly singular disease, emerged at a 
moment in time when a slight move away from the use of a Kochian, standardised, 
universal pure-cell-line culture was taking place within the discipline of medical 
microbiology. 
But what should we reallY strive to see here in these mixed-cell line cultures? A 'slight 
move away' from the past? Something of litde importance? Mere details, perhaps? 
Perhaps. But what if we look a litde harder. Is it not possible to see something a litde 
more significant lurking amongst those MRC-S and AS49 cells; something almost 
imperceptible but, nonetheless, profound? A sense that the multifactorial might just 
be coming back into vogue; that mixed-cell cultures seem to be taking on elements of 
the spontaneous culture, and allowing for the simultaneous and interactive growth of 
multiple pathogens? Let us briefly imagine that this is so; that we have managed to 
coax that something out into a space of visibility. For once this is achieved, everything 
changes. Suddenly, the questions we are able to ask without, as yet, ever being able to 
answer, are transformed. With these subde shifts in practical, everyday, seemingly 
innocuous technique, for instance, might we perhaps be teetering on the edge of an 
epistemological threshold in the medical sciences? Might the conditions of possibility 
for medical microbiology be changing, and changing in ways that will, eventually, 
transform us all into Winogradskians as much as Kochians? For surely it is the case 
that a medical microbiology re-orientated in order to incorporate multifactorial 
practices and interventions would drastically alter what it meant to speak of a 'disease', 
an 'infection' and a 'pathogen'? And, if this is so, if that 'something' is indeed lurking 
amongst those mixed cells, then what of the histories that are yet to be written? In 
years to come, when we turn our faces to the past, what might we see? The 2003 
SARS outbreak as just one amongst a long and ever expanding list of infectious 
diseases in which singularity reigned supreme? Or might we perhaps come to see it as 
the last of the great modern infectious diseases; as one last stand on a 'land of truth' 
that sought to seal out everything uncertain, irresolvable, dissolvent, before its dikes 
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and sea-walls finally collapsed under the weight of that wide and stormy ocean's dark 
fl ·di ;> U1 ty. 
Well, that is it. I have exhausted my words. And not a moment too soon. For it seems 
that a verdict is imminent. People are filing back into the courtroom. A deep 
expectant hush is suddenly upon us. Multifactorality clutches at our court documents, 
holding them close as if tiny amulets against disaster. 'Like a dog!' it suddenly starts to 
scrawl on one of them, as if it meant for the shame of it to outlive it.25 Out of the 
corner of my eye I spy the jury room door starting to open, just a litde ... 
Having reached a decision, the jury notifies the bailiff, who then notifies the judge. All of the 
participants are summoned to reconvene in the courtroom for the decision to be announced .. . onlY the 
usher fails to re-appear, as the faint trace of a smile plqys across Rene Blondlot's lips . .. the court clerk 
rises to his feet . .. 
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Notes 
1 Quine first enunciated what came to be known as the Duhem-Quine thesis 
in his 'Two Dogmas of Empiricism' essay, using his own terms and ascribing the idea 
to Duhem in one single footnote ('this doctrine was well argued by Duhem'). In the 
essay he wrote of how 'our statements about the external world face the tribunal of 
sense experience not individually but only as a corporate body' and, perhaps most 
notoriously, of how 'any statement can be held true come what may, if we make 
drastic enough adjustments elsewhere in the system' (ibid., 41). Although, of course, 
most of what I have just written here in this summary could no doubt be picked apart 
in any contemporary philosophical debate: did Duhem actually ever say what the 
Duhem-Quine thesis imputed to him? Was there perhaps some 'Quinery'involved 
(Hacking 1988, 150)? And, if so, was there even one Duhem-Quine thesis or are there, 
in actual fact, two theses, that of Duhem and that of Quine, with distincdy different 
purport (Quinn 1973; Laudan 1990)? And so on and so forth. 
2 See for instance, Checko (1996), Collier and Oxford (2000, 243-249), Evans 
(1989), Giesecke (1994), Goodman et aL (1990), Gordis (1994), and Inglis (2007, 29-
36). 
3 See for instance, Stavrinides and Guttman (2004). These authors used 
'Bayesian, neighbour-joining, and split decomposition phylogenetic techniques on the 
SARS virus replicase, surface spike, matrix, and nucleocapsid proteins to reveal the 
evolutionary origin of this recendy emerging infectious agent'. Their subsequent 
analyses supported 'a mammalian-like origin for the replicase protein, an avian-like 
origin for the matrix and nucleocapsid proteins, and a mammalian-avian mosaic origin 
for the host-determining spike protein' (ibid., 76). Also of interest here is Stanhope et 
aI's (2004) 'recombinant history of SARS-Co V': 'our results are consistent with a 
hypothesis of viral host jumping events, concomitant with the reassortment of bird 
and mammalian coronaviruses, a scenario analogous to earlier outbreaks of influenzae' 
(ibid., 15); and also see Rest and Mindell's (2003) 'history of SARS-CoV host shifting' 
which has some rather sobering conclusions: 'demonstration of recombination in the 
SARS-Co V lineage indicates its potential for rapid unpredictable change, a potentially 
important challenge for public health management and for drug and vaCClne 
development' (ibid., 219). Also see Ruan et aL (2003) and Chim et aL (2004). 
4 With this reference to the 'tenor' and the 'vehicle' of a metaphor I am 
drawing on the classical distinction made by Richards (1936). If we were to say, for 
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instance, that an eye was a camera, then the 'tenor' would be the working of the eye, 
whilst the 'vehicle' would be the camera. Knowledge of the latter would be deployed 
in order to speculate on the workings of the former. 
S Although in truth this statement is not entirely fair. Also of interest here in 
developing the idea of a 'vanishing' were the 'methodological and metaphysical 
presuppositions' that Simon (2002) presented in his study of the 'afterlife' of cold 
fusion analysis. Is cold fusion dead? Or alive? Or might such an either/ or choice be 
too restrictive? 'What if death is not the end of the story? In science studies we are 
typically sceptics and agnostics, and while we may be radical enough to attribute 
'variable ontologies' to phenomena in controversies as they come into being, live, and 
die, we have nothing to say about what. if anything. lies beyond. Perhaps open 
controversies and closed controversies are not all there is? Cold fusion is dead. We 
can prove this, and we will not contest it ... But I will suggest that cold fusion is also 
very much alive. That which is both dead and alive is. to put it bluntly. undead ... like a 
ghost, a phantom, or a spectre ... being undead is neither an intermediate nor a 
nonexistent (or imaginary) state of being. Ghosts occupy the boundaries or border 
zones between the living and the dead. (ibid., 11-12 my emphasis). 
6 The 'she' in question is, of course, Trevor Pinch's 'STS hero' (1992, 506): 
'what gender will our hero be? It would be better for these times if our hero was a she 
- so from now on let's call her a she' (ibid.). A substantial mystery still remains, 
however. As with most academics, when Trevor Pinch brought her into existence 
nearly two decades ago, she had a long list of 'things to do' - 'her flrst campaign will 
be 'Justice for the Cold-Fusion Two. Then she will go back through the history of 
science and slowly reinstate all those villains - the "Maryland One", the "N-Ray one 
hundred", and so on ... her next campaign will be to turn to technology' (ibid.). And 
yet, as far as I am aware, this, the position of judge in a scientiflc court of appeal, is 
the fIrst job that she has ever formally accepted. Is it conceivable that all traces of her 
activities could be erased from our records of this period? I would suggest not. Has 
she simply been biding her time, waiting for the right moment to strike? Perhaps. 
Maybe, just maybe, the position of appeal court judge is the position she's been 
waiting for all along: 'she will say that science is like the law. In the same way that 
justice is different between different societies, and claims to absolute justice are 
treated with a yawn or a titter, so she will say the same goes for absolute truth. She 
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will chide those who are anti-science, in the same way that she chides those who try 
and live outside the law' (ibid., 507-508). 
7 The allusion being made here is of course to the garb of Max Weber's 'saint': 
'the puritan wanted to work in a calling; we are forced to do so. In Baxter's view the 
care for external goods should only lie on the shoulders of the saint 'like a light cloak, 
which can be thrown aside at any moment' (Weber 1958, 181). I am no Saint, of 
course, but I do like the rhetorical effect, the visualtty, that Weber's words are capable 
of generating. 
8 Kant published the Critique of Pure Reason in two editions, and there are 
substantial differences between them. They are interlaced in the translation by N. 
Kemp Smith ([1781]1933) which I use here. The 'A' numbering refers to the ftrst 
edition and the 'B' numbering to the second, corresponding to the pagination of the 
German originals. Also of interest in developing an understanding of the topography 
of Kant's philosophy are Bird (1962, chapter 7), and Strawson (1966). More 
speciftcally, on the regulative role of Kantian reason in science and medicine, see in 
particular Buchdahl (1992, chapters 7-8) and Neiman (1994, chapter 2). 
9 For an inspiring reading of Kant's work, focalised as if through the eyes of 
Georges Bataille, as a set of texts caught within a restrictive economy of utility and 
limits, see Land (1992, 105-120). 
10 On 'styles of practice' in relation to the medical microbiological hunt for the 
aetiological agent(s) behind acquired immuno-deftciency syndrome (AIDS), see 
Fujimura and Chou (1994) (Agent? Or agents? That is one of the questions that they 
explore in the article). In that article, their aim is to examine the co-production of 
facts and the rules for verifying facts over time: 'we discuss these processes in terms 
of what we call "styles of scientiftc practice". In contrast to the focus of idealist 
philosophers on theory production and validation as forms of logic or ways of 
thinking, our styles of practice also include the activities of hands and eyes and the 
discourses between multiple actors in diverse situations. We discuss aspects of the 
different styles of practice deployed by opponents in a current controversy 
surrounding the aetiology of AIDS to understand how the same data are interpreted 
in different ways to support diametrically opposed views' (ibid., 1017; and, on 'styles 
of practice' in psychiatry, see Young (2000)). 
11 In the fInal few words of this sentence I am paraphrasing a statement made 
by Peter Galison in How Experiments End (1987): referring to laboratory 
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instrumentation, he noted how theoretical assumptions may be 'built into the 
apparatus itself' (Galison 1987,251). 
12 On the construction of 'do-able problems' in laboratory research, and the 
way(s) in which those problems enable research 'bandwagons' to emerge in the 
medical sciences, see Fujimura (1987; 1988). Epstein (1996), in particular, brings the 
idea of a research 'bandwagon' to life during his discussion of the reception that 
Robert Gallo's HIV-AIDS aetiological claim received during the mid-1980s: 'within 
months of the publication of Gallo's articles in Science [in 1984, and specifically in 
relation to the aetiological agent HTLV-III], other scientists began to report their 
findings ... in 1984 such researchers typically were careful to make qualified claims, 
noting that the virus was "believed" to be the cause or was the "probable" cause. But 
in practice. the qualifications meant next to nothing. because the virus - and the virus 
alone - was what all of them were busy spending their time studying~ The phrasing of 
one article in the New England Journal was typical: 'Now that HTLV-III has been 
identified as the probable cause of AIDS, it is possible to confirm the modes of 
transmission and document the spectrum of clinical disorders caused by this agent'. 
At last. the authors seemed to be suggesting. we all have something to do. A plausible 
candidate had been proposed by eminent virologists. and most researchers were 
content to endorse their judgement' (1996,91 my emphasis). 
13 For some far more comprehensive tellings of the discovery of hepatitis D, 
see Gerin et al (2001), Hadziyannis (1997a , 283-289; and 1997b, 289-298), Lai (1994, 
574-580), Polish et aL (1993), Purcell (1994), and Taylor (1996), WHO (2009c). 
14 On the problem of interference in immunoassays, see Bjemer et aL (2002), 
Boscato and Stuart (1986), Granouillet et aL (1998), Miller and Levinson (1996), Miller 
and Valdes (1991), Nernzek et al (1999), Selby (1999). 
15 On this point, also see Gerin et aL (2001,3037), and Polish et al (1993,211). 
16 The suggestion of 'chance' is commonly found elsewhere in the literature. 
As Chatzinoff and Friedman (1987, ,529) put it, for instance, 'since its chance 
discovery a mere decade ago, the delta agent has been characterised as a novel 
pathogen that poses the risk of developing into a scourge of modem times'. 
17 On this point, again, see Gerin et aL (2001, 3037), and Polish et al (1993, 
211). 
18 At least; this is the claim made in the relevant microbiological literatures. 
Thomas Brock, for instance, writing in Milestones in Microbiology (1961), wrote as 
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follows: 'if I had to choose one paper as most significant for the rise of microbiology, 
this ['Methods for the study of pathogenic organisms'] would be it. Koch presented a 
method for isolating pure cultures that is so simple, reproducible and understandable 
that it could be performed by anyone. The development of this method led to the 
isolation and characterisation, during the 20 years after 1881, of the causal organisms 
of all of the major bacterial diseases which affected mankind' (ibid., 108). 
19 At least, for those who do think a 'bacteriological revolution' took place. 
Rosenberg (1987, 141), for instance, suggests that the germ theory of disease 
'transformed every aspect of medicine'; Porter (1997, 428) refers to 'one of medicine's 
few true revolutions - bacteriology'; Brock (1988, viii) writes of Robert Koch as 'one 
of the true scientific revolutionaries' and Barnes (2003, 115) writes of how Robert 
Koch's innovations 'forever changed the nature of medical knowledge'; Tempkin's 
(1977,436-438) discussion of how Koch's bacteriological discoveries were decisive in 
altering the very meaning of disease can be read as pointing to an epistemological 
revolution; and Pelling (1993, 329) has characterised the 'bacteriological revolution' as 
'a chain reaction of findings in the 1870s and 1880s, set off by Koch's methods and 
Postulates'. For those who don't think that a 'bacteriological revolution' took place, 
their main complaint seems to be with the Unprecise use of the term 'revolution'. 
Worboys (2000; 2007), for instance, has consistently argued against the use of this 
phrase in order to describe the changes in the practice of medicine that took place 
during late-nineteenth century. 'The case for a revolution', as he puts it, remains 
'unproven': 'historians have read into the 1880s changes that occurred over a much 
longer period, and that while there were significant shifts in ideas and practices over 
the decade, the balance of continuitie~ and changes was quite uneven across medicine' 
(2007,20). 
20 On the notion of time as 'crumpled' and 'folded' rather than 'linear' and 
'flowing', see Serres' comments in Conversations on Science, Culture and Time (Latour and 
Serres 1995,57-66). 
21 I write 'perhaps' advisedly. It seems obvious that he was referring to Robert 
Koch, but as Penn and Dworkin (1976, 278) have noted, direct references to the 
Kochian school were, in his published texts, 'sparse and diffuse'. 
22 These allusions to 'a space of disorder', a 'white spot of propriety' and so on, 
are all adapted from Serres' fascinating meditation on the birth of agriculture midway 
through The Parasite ([1982]2007): 'agriculture and culture have the same origin or the 
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same foundation, a white spot that realises a rupture of equilibrium, a clean spot 
constituted through expulsion. A spot of propriety or cleanliness, a spot of belonging' 
(ibid., 179). 
23 Here I am thinking of the word 'inhabit' as it is understood in the work of 
Donna Haraway. Perhaps the best place to get a sense of just what an 'inhabitation' 
entails for Haraway, is at the very end of Primate Visions (1989) in a set of essays 
introduced as 'The Politics of Being Female: Primatology as a Genre of Feminist 
Theory'. There, attention is focused on the work of four 'North American white 
women' primate scientists: Jeanne Altmann, Linda Fedigan, Adrienne Zihlman and 
Sarah Blaffer Hrdy (ibid., 293-297). As I understand it, Haraway's aims in these essays 
are twofold. Firsdy, she wants to figure out why, and how, primatology has become a 
kind of feminist theory. But secondly, she wants to look for possibilities of hope for 
the future; to find in the work of these 'North American white women' an 'elsewhere'; 
that is, somewhere 'from which to envision a different and less hostile order of 
relationships among people, animals, technology, and land' (ibid., 15). If the first aim 
has to do with an understanding of the present, and how we got to that present, the 
second has to do with the future, and an imagining of how a 'better' science, feminism, 
and thus society might be written and lived. Of particular interest here in terms of 
'inhabiting' is the mini-essay on Sarah Blaffer Hrdy. Hrdy's work allows Haraway to 
comment on the complex and often contradictory objects that both feminism and 
primatology had become by the late 1980s. There are elements of Hrdy's 
sociobiological stories that Haraway wants to encourage: descriptions of female 
monkeys as central players, evidence that they engage in the full range of species-
defining behaviour, and arguments that their individual differences matter. And yet, 
there are also elements that she wants to resist: the model of the 'hyper-liberal' female, 
for instance, the very model of possessive individualism, which emerges to lead a 
'reproductive bio-politics [that] are finally about war' (ibid., 367). This is not part of 
the ending that she wants to write into her own stories of primatology. So if the first . 
aim has been met in this essay, if Hrdy's 'feminism' has been explored, then what of 
Haraway's second aim, that of jumping off into a future 'elsewhere'? For Haraway, the 
next move is to 'inhabit' Hrdy's stories, in the sense of troping them toward 
something she sees in primate science as more hopeful and promising. In stylistic 
terms, she 'backgrounds' much of the kind of vision Hrdy's primate science has 
foregrounded, and, as Schneider (2005, 67) has noted, 'brings forward aspects of 
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narratives that are equally available but on which the 'volume' has been 'turned down'. 
The aim of such an 'inhabitation', in other words, is to make yourself at home. In 
Haraway's case this translates into the ability to re-imagine primate science as it might 
become in ways true to the feminism she claims it to be; the ability to suggest the 
emergence in primatology of something more hopeful than the competitive and 
strategic individualism that inflect Hrdy's stories. In my case, it translates as the ability 
to find an elsewhere in medical microbiology; a space within which new forms of 
practice, and new forms of intervention less in thrall to the imperative of singularity 
might, just about, be coming into existence. 
24 Of particular interest here in relation to the identification of adenoviruses, 
influenza viruses, parainfluenza viruses and RSV are Huang et aL (2000); and St 
George et aL, (2002). 
25 'Were there some arguments in his favour that had been overlooked? Of 
course there must be. Logic is doubdess unshakable, but it cannot withstand a man 
who wants to go on living ... He raised his hands and spread out all his fingers. But the 
hands of one of the partners were already at K.'s throat, while the other thrust the 
knife into his heart and turned it there twice. With failing eyes K. could still see the 
two of them, cheek leaning against cheek, immediately before his face, watching the 
final act. 'Like a dog!' he said: it was as if he meant the shame of it to outlive him' 
(Kafka, F. [1925]1986,250-251). 
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